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Abstract 
Muscle contraction is dependent on a large Ca'+ release from its intracellular Ca2+ store, the 
sarcoplasmic reticulum (SR), through ryanodine receptor Ca2+ release channels (RyRs). In the 
resting state, striated muscle requires a tight control of Ca2+ release through Ry Rs. Another SR 
bound protein, junctin, is thought to facilitate this. Located in both skeletal and cardiac muscle, 
junctin has a short N-terminal domain (Njun) and bulky, highly charged C-terminal domain 
(Cjun), that are exposed to the cytoplasm and SR lumen respectively. Although originally 
thought to function as a linker between the SR calcium binding protein (calsequestrin) and 
RyRs, recent studies suggest the junctin may have a more complex role in regulating RyR 
activity and SR Ca2+ handling. In vitro studies have shown that addition of full-length junctin 
(FLjun) to the luminal domain ofRyR directly activates RyR in lipid bilayers. However, the 
molecular mechanism by which junctin regulates RyR activity has been unclear. 
To explore the specific regions of junctin that regulate RyR, constructs corresponding to Njun, 
Cjun and FLjun were produced. Modified co-immunoprecipitation and affinity chromatography 
were employed to evaluate the direct interactions between junctin constructs and purified RyR. 
Both Cjun and Njun bound to the full-length Ry Rs. The effect of the junctin constructs on Ry RI 
(skeletal isoform) or RyR2 (cardiac isoform) activity was tested in lipid bilayer experiments 
with I mM luminal [Ca2+] to replicate resting conditions. As found previously, addition of 
FLjun to the luminal solution increased both RyRl and RyR2 activity by -2-3-fold. Curiously, 
luminal addition ofCjun strongly inhibited both RyRl and RyR2, whereas cytoplasmic addition 
ofNjun significantly increased RyRI and RyR2 activity by - 5-6-fold. This was unexpected as 
the RyR-junctin interaction was assumed to occur only luminally. Neither luminal addition of 
Njun nor cytoplasmic addition of the scrambled Njun sequence altered channel activity, 
suggesting a specific cytoplasmic effect ofNjun. This suggestion was further substantiated as 
cytoplasmic Njun did not change the activity of native RyRs that retained endogenous junctin. 
Sequential addition ofNjun to the cytoplasmic solution and Cjun to the luminal solution 
resulted in channel activity increasing by -2-3-fold, as observed with luminal addition of FLjun. 
On the other hand, the RyR inhibition induced by luminal addition of Cjun was not altered by 
subsequent addition ofNjun to the cytoplasmic solution. 
The functional region of Cjun was localized to residues 85-l 06 that contain a KEKE motif, as 
luminal addition of a peptide corresponding to this region replicated the inhibitory effect of 
Cjun. 
In conclusion, the study demonstrates thatjunctin regulates RyRI and RyR2 via interactions in 
both the cytoplasm and SR lumen, the combined actions ofNjun and Cjun indicate that the 
V 
novel cytoplasmic Njun-RyR interaction must be established before the luminal Cjun-RyR 
interaction to replicate the FLjun modulation of RyR I and RyR2 acti vity . 
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Chapter 1 Introduction and background 
1.1 Overview of muscle tissue 
Unless otherwise stated, the material in section I. I and 1.2 is sourced from (Marieb and Hoehn, 
2007). 
The cells of muscle tissues exhibit a unique functionality in their ability to contract. Muscle 
cells, or myocytes - and consequently, muscle tissues and whole muscles - can shorten to 
produce a net movement. Muscle tissues are classified as striated muscle or smooth muscle 
according to the organization of their cytoskeletal components and the gross cellular 
organization of the tissue. If the cytoskeletal components of the cells are arranged in a manner 
which produces striations - transverse stripes - visible under light microscopy, then the muscle 
tissue is classified as striated muscle. This striated appearance comes from the tissues' 
characteristic arrangement of actin and myosin filaments. Both skeletal and cardiac muscles 
exhibit this striated phenotype. Should the cytoskeletal components have a non-striated 
appearance, the muscle then is classified as non-striated or smooth muscle. Thus, muscle tissue 
can be described as being one of three different types: 
• Skeletal muscles anchored by tendons (or by aponeuroses at a-few locations) to bones, 
and are under conscious control , or are activated by reflex. Skeletal muscle is also 
called voluntary muscle, because it is the sole muscle type subject to conscious control. 
It is responsible for overall body mobility, including walking and running, as well as 
more subtle movements such as those that compose facial expressions etc. In addition, 
contraction of skeletal muscles also fulfils other functions, such as the maintenance of 
posture and the production of heat. Skeletal muscle contracts with high force and high 
speed; however, it fatigues easily and cannot sustain contraction for long periods of 
time. Skeletal muscle cells are long, multinucleated, cylindrical and heavily striated, 
and are normally referred to as fibers. 
• Cardiac muscle is a specialized striated muscle found only in the heart and at the 
cardiac ends of the main blood vessels. It constitutes the bulk of the heart wall tissue. It 
is capable of long-lasting activity, and over a human lifespan may sustain more than 
two billion contractions without a pause. Unlike skeletal muscle fibers, the elongated 
cardiac cells, or cardiomyocytes, are short, branching cells and uninucleate ( 1-2) with 
light striations, and cannot be controlled consciously. Cardiac muscle contracts 
rhythmically and intrinsically (without external stimulation), providing the fundamental 
rhythm of the heartbeat, although neural controls may vary the heart rate for brief 
periods. 
• Smooth muscle is fo und in the wa lls of blood vessels, in the intestine, and in the urinary 
and reproducti ve tracts. The long spindle-shaped ce ll s have a single nucleus and 
assoc iate to form muscle patterns appro priate to their fu nction. For example, an annular 
arrangement in blood vesse ls, or a cri ss-cross network in the bladder. One of smooth 
musc le 's key functions is to maintain the flow of fluids and foods a long its hollow 
structures . The ti ssue type is referred to as smooth because it does not have the 
striati ons characteri sti c of other muscle types, and hence is smooth in appearance. 
Smooth muscle cannot be controlled consciously and thus acts invo luntarily. 
Contractions of smooth muscle are slow, rhythmic and susta ined . Because the main 
foc us of thi s thesis is on stri ated muscle, further detail s of smooth muscle will not be 
d iscussed. 
1.2 Striated muscle and muscle fiber anatomy 
1.2.1 Skeletal muscle 
1.2.1.1 Skeletal muscle anatomy 
An ind ividual ske leta l muscle is considered an organ of the muscular system. Each muscle 
cons ists of ske leta l muscle tissue, connective ti ssue, nerve ti ssue, and blood or vascu lar tissue. 
An indiv idual skeleta l muscle may be made up of hundreds, or even thousands, of muscle fibers 
bund led together and wrapped and held in pos ition by connective ti ssue sheaths. These 
connect ive tissue coverings prov ide support and protection for the delicate cell s and a llow them 
to withstand the forces of contraction. Each indi vidual muscle fi ber is surrounded by a fi ne 
sheath of connective tissue, the endomysi um . T he endomysium-wrapped muscle fibers are 
co ll ected into bundles, or fasc icles, themselves covered by a layer of connective ti ssue or 
per imysium. Many bundles, or fascic ul i, are wrapped in an "overcoat" of dense irregu lar 
connective tissue (epimys ium) to fo rm a whole muscle (F ig. 1-1 ). 
Each ske letal muscle fiber (Fig. 1-1 ; and Fig. l-2A), or myofi ber, is a single cy lind rical cell , 
long and narrow, and acts independen tly of its neighbori ng muscle fibers. Fiber d iameters 
typically range between IO to I 00 µm , and they may be exceedingly long, with the longest 
myofibe rs of the thigh be ing up to 30 cm. 
The cytoplasm of ske leta l musc le fibers, the sarcoplasm, conta ins large amounts of g lycosomes 
and myoglobin. Embedded in this sarcoplasm and running lengthwise through it are myofibrils 
(F ig. l-2B) , which are cylind rical bundles of contractile proteins. Each myofib ril is - 1 to 2 µ m 
in diameter. Musc le fibe rs usual ly conta in hundreds to thousands of myofi bril s that contain the 
contracti le elements of the musc le cells. A surface lipid bi layer membrane, the sarco lemma (Fig. 
l-2B: al so see Fig. 1-3), encloses the sarcop lasm, mult ip le nuclei , and many mitochondria. 
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Figure 1-1 Skeletal muscle anatomy (Marieb and Hoehn, 2007). 
As stated previously, skeletal muscle fibers appear striated (Fig. l-2A). The striations consist of 
dark A bands and light I bands, repeating along the length of each fiber. Within each A band is a 
central light area, the H zone or H band, containing a central dark liRe, the M line. The I bands 
also have a midline interruption, a darker area called the Z disc or Z line. The region between 
adjacent Z lines is referred to as a sarcomere, each of which contains an A band flanked by half 
an I band (Fig. l-2B&C). On average the 2 µm long sarcomere forms the basic contractile unit 
of a muscle fiber. 
Located within sarcomeres are regularly arranged thin and thick filaments which give a 
myofibril its banding pattern (Fig. l-2C&D). The thin filaments (7-8 nm thick) are made up 
mainly of the protein actin, complexed with troponin and tropomyosin. They extend from the I 
band into the A band, ending at the start of the H zone and are essentially inert and serve as 
"rachets" upon which force can be exerted to drag together the Z discs. In vertebrate muscle, the 
thin filaments are arranged in hexagonal array on two Z discs: each sarcomere has a number of 
these arrays. Inside each hexagonal "cage" formed by the six thin filaments is a thick filament 
(Fig. l-2E). The thick filaments (about 16 nm in diameter) contain primarily myosin and extend 
the entire length of the A band. They are connected to adjacent Z lines by very thin, elastic 
strands oftitin. The thick filaments have long, fibrous tails and globular heads, the latter binding 
to actin in order to do the actual work of contraction. Their myosin heads also bind to ATP, 
which is the source of energy for muscle movement. 
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Fig ure 1-2 M icroscopic a natomy ofa skeleta l muscle fib er. (A) Photomicrograph of porti ons of two isolated 
muscle fibers (700 x). (BJ Diagram of part ofa muscle fiber showi ng the myofibril s. One myo fibri l extends from the 
cut end of the fiber . (C) A small portion of one myo fibril enlarged to show the myofilaments responsib le fo r the 
banding pattern. Each sarcomere extends from one Z di sc to the next. (D) Enlargement of one sarcomere (sectioned 
lengthwise). Notice th e rnyosi n heads on the thick filaments. (E) Cross-sectional view ofa sarcomere cut through in 
different areas. (Mari eb and Hoehn . 2007) 
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Muscle contracts when the thick and thin filaments slide past each other - this is the sliding 
filament mechanism of contraction. In skeletal muscle, contraction is initiated by a nerve 
impulse leading to Ca2+ ions release into the myofibril. Binding of Ca2+ to troponin-C (TnC), the 
regulatory subunit oftroponin, removes troponin 's inhibitory effect on actin and myosin and 
thus allows contraction . In a fully contracted sarcomere the thick and thin filaments maximally 
overlap with the thick fi laments reaching the Z line and the thin filaments reaching the M line, 
so that the sarcomere shortens. By contrast, in a relaxed muscle, the thick and thin filaments 
overlap only at the ends of the A band (Guyton and Hall , 2006). 
1.2.1.2 Sarcoplasmic Reticulum (SR) and T (Transverse) -tubules in skeletal muscle 
fiber 
Two important sets of intracellular tubules in skeletal muscle fibers participate in the regulation 
of muscle contraction, the SR and the T-tubules (Fig. 1-3). 
The SR is a specialized endoplasmic reticulum, an entirely intracellular membrane bounded 
compartment which is not continuous with the sarcolemma. Most of these tubules run 
longitudinally along the myofibril and are thus termed longitudinal SR (ISR); these are 
important for Ca2+ sequestration, though not EC coupling. Other tubules form larger, 
perpendicular compartments at the A:I band junctions, called terminal cisternae or junctional SR 
(jSR). The main function of the SR in muscle is to regulate intracell~lar levels of ionic calcium 
by storing Ca2+ and releasing it to the myoplasm on demand. The terminal cisternae are the site 
of Ca2+ release from the SR and accommodate many crucial proteins and regulators of 
excitation-contraction (EC) coupling, including the ryanodine receptor (RyR) Ca2+ release 
channels. The SR in skeletal muscle is very highly organized. Except for the junctions between 
the SR and sarcolemma, the SR membrane appears fairly homogeneous (Bers, 2002). 
At the junctions of the A and I bands, tube-like extensions of the sarcolemma called transverse-
tubules or T-tubules enter the sarcoplasm and are aligned with the terminal cisternae of the SR. 
The lumen of the T-tubules is continuous with the extracellular space. They are termed 
"transverse" because they run perpendicular to the long ax is of the fiber. The T-tubules branch 
extensively inside the sarcoplasm, which al lows each sarcomere to be encircled by two T-
tubu les. The arrangement of the T-tubule network ensures that no part of the cytoplasm is more 
than - I µm away from the nearest T-tubule, thus permitting the depolarization signal to 
propagate, virtually simultaneously, throughout the cell such that every myofibril in the muscle 
fiber contracts at the same time (Dulhunty, 2006). The T-tubules lie close to the ends of the 
terminal cisternae. This part oftenninal cisternae membrane is termed the junctional face 
membrane (JFM). In skeletal muscle, most of the T-tubule membrane is involved injunctional, 
triadic complexes with the SR. The "triad" refers to the coupling of two SR terminal cisternae to 
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either side ofa T-tubule (Fig. 1-3, ri ght pane l). Conta ined in the T-tubule are the voltage-
sensitive dihydropyridine receptors (DHPRs), one of the key proteins involved in EC coupling, 
as we ll as many other proteins involved in the transmission of regulatory second messenger 
pathways (Brette and Orchard, 2003). 
It is of physiologica l importance fo r EC coupling (see section 1.4) that the T-tubules are 
positioned close to the terminal cistemae of the SR, as thi s arrangement allows fo r physica l and 
functional contact between DHPRs and RyRs . Thus, an action potentia l propagating a long the 
sa rcolemma activates DHPRs wh ich cause RyRs calcium channels in the terminal cisternae to 
open, which in tum enables Ca2+ release from the SR into the cytoplasm and causes the 
intracellu lar [Ca2+] to increase . 
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Fig ure 1-3 Schematic diagram of sarcoplasmic reticulum and T-tubular network of skeletal muscle (Marieb 
and Hoehn. 2007). 
1.2.2 Cardiac muscle 
Cardiac muscle. like skeletal musc le, appears stri ated and it too contracts via the s liding 
filament mechanism. However. in contrast to the long, cylindrical , and multinucleate skeleta l 
muscle fibers. the cardiomyocytes (cardiac myocytes) are short, fat, branched, and 
interconnected . Each fiber contains one or at most two large, pale, centrally located nuclei (F ig. 
J-4A). Card iac myocytes are typically< 20 µmin diameter, whereas the diameter of skeleta l 
muscle fibers (section 1.2.1.1 ). can be up to I 00 µm. 
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Unlike skeletal muscle fibers, which are independent of one another both structurally and 
functionally, the plasma membranes of adjacent cardiac cells interlock at dark-staining junctions 
or intercalated discs (Fig. 1-4), thereby enabling adjacent myocytes to contract co-ordinately. 
These discs contain intermediate junctions, desmosomes, and gap junctions (Fig. l-4B top right 
panel). The intermediate junctions and desmosomes are of central importance in the mechanical 
connection of one cell to the next, preventing adjacent cells from separating during contraction. 
Gap junctions are located predominantly on parts of the intercalated disk parallel to the long 
axis of the cell. They are low resistance electrical pathways that specifically allow action 
potentials to spread in the myocardium by permitting the passage of ions between cells, thereby 
transmitting depolarization across the entire heart. Because cardiac cells are electrically coupled 
by the gap junctions, the myocardium behaves as a single coordinated unit, or functional 
syncytium. This allows the chambers of the heart to contract and pump blood in a highly 
synchronous and coordinated manner (Guyton and Hall , 2006). 
Approximately 25-35% of the volume of cardiac cells is occupied by large mitochondria, a 
much higher fraction than is found in skeletal muscle (- 2%). This gives cardiac cells a high 
resistance to fatigue. Sarcomeres account for most of the remaining cell volume. The 
sarcomeres in cardiomyocytes have Z discs, A bands, and I bands similar to those found in 
skeletal muscle, reflecting the arrangement of the thick (myosin) and thin (actin) filaments (Fig. 
1-4B bottom right panel). However, in contrast to skeletal muscle, the cardiac myofibrils vary 
considerably in diameter and branch extensively, accommodating abundant mitochondria 
between them. This produces a banding pattern less distinctive than that seen in skeletal muscle. 
Notably, the system for delivering Ca2+ is less elaborate in cardiac muscle cells. In contrast to 
the extensive and well organized SR networks with large terminal cisternae (TC) abutting 
narrow T-tubules found in skeletal muscle, the SR systems in cardiac muscle are typically 
simpler, more sparse, and less rigid organized, with smaller TC at the cell surface and at 
junctions (Fig. 1-48). Cardiac T-tubules are much wider (200 nm in heart vs. 30-40 nm in 
skeletal muscle) and fewer in number than in skeletal muscle. In contrast to skeletal muscle, T-
tubules enter the cells once per sarcomere at the Z discs. The larger volume:surface ratio in 
cardiac muscle T-tubules allows a given ion flux across the membrane to produce smaller 
depletions and accumulations of ions. The T-tubule membrane is normally apposed to a single 
TC (forming a dyad; Fig. l-4B bottom right panel), where the TC may wrap around the T-
tubule. Peripheral couplings are also formed, in which a junction of the jSR is apposed to the 
surface sarcolemma. Occasionally a triad is present, but with a different appearance from the 
skeletal muscle triad due to the wide lumen of the T-tubule and narrower TC. Despite different 
architecture, in both skeletal and cardiac muscle, triads, dyads and peripheral couplings are 
broadly structurally and functionally equivalent. Collectively, these intracellular junctions are 
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termed EC coup ling units, couplons or calcium release un its (CRUs) (Franzini-Armstrong et a l. , 
1998, 1999) , and are the loci where the exc itation-contraction (EC) coupling mechanism takes 
place (Schneider and Chandler, 1973). Additionally, special CRUs occur in the cardiac muscle, 
constituted by jSR domains bearing RyRs that are not assoc iated with either exterior membranes 
(co rbular or extended junctional SR, EjSR) (Franzin i-Armstrong et al. , 1999). 
Figure 1-4 Microscopic anatomy of cardiac muscle. (A) Photomicrograph of cardiac muscle (700x). The dark-
staining areas are intercalated discs. or junctions. between adjacent cells. (B) Cardiac cell relationships at the 
intercalated discs (bottom left) and relationships ofT-tubules. SR and myofi laments (bottom right). (Marieb and 
Hoehn. 2007) 
1.3 Major components and anatomy of the calcium release units (CRUs) 
As mentioned in the previous sect ion ( 1.2 .2) , ca lcium release units (CRUs) are constituted by 
specia li zed junctional domains of the SR and exteri or membranes (with the exception of 
corbular SR described in section 1.2.2). The two assoc iated domains are in turn separated from 
each other by the nonj unctional domains of the two compartments, which conta in a different 
complement of prote ins. 
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In both skeletal and cardiac muscle, CRUs are located mostly along the T tubule networks. The 
networks are located either in a single transverse fairly narrow band at the level of the Z line, or 
in two bands close by the Z line, positioned symmetrically distant from it (Franzini-Armstrong 
et al., 1999). 
The two central elements of the CRUs essential to EC coupling are ryanodine receptors (RyRs, 
also see section 1.6) and dihydropyridine receptors (DHPRs). In muscle cells, both DHPRs and 
RyRs are strategically located within CRUs such that RyRs can receive a signal from the 
DHPRs. The grouping ofDHPRs and RyRs (and other junctional SR proteins) forms a large 
functional signal transduction complex at the junction, a couplon, which may act in concert with 
other coup Ions during EC coupling (Sommer, 1998). 
The Ca2+ release channels of the SR, the RyRs, were first observed as two rows of electron 
density occurring on the junctional face of cisternal , though not the longitudinal, SR membrane 
(Franzini-Armstrong, 1970). These densities project out from the SR towards the exterior 
membranes, forming large "feet" visible via electron microscopy (lnui et al. , 1987a). These foot 
structures proved to have a 4-subunit structure, and have been subsequently identified as the 
cytoplasmic components of the homotetrameric RyR protein. The cytoplasmic domains ofRyRs 
bridge the junctional gap (10-12 nm) separating the SR from the exterior membranes (Franzini-
Armstrong and Nunzi , 1983; Franzini-Armstrong et al. , 1999; Wagenknecht and Radermacher, 
1997). The RyRs are packed in highly ordered arrays, with very similar inter-unit spacings 
(Block et al., 1988). In skeletal muscle, the RyR feet are arranged in a tetragonal disposition 
with an approximate center-to-center distance of29 nm. In cardiac muscle, the RyR are 
arranged in regular intervals approximately equal to those of the skeletal muscle units (Sommer, 
1998), but the precise parameters of their disposition are not known. 
DHPRs are voltage-dependent, L-type Ca2+ channels located in the plasma membrane and T-
tubules which sense depolarization. Each DHPR consists of four homologous ' repeats'. In both 
skeletal and cardiac muscle cells, the action of DHPRs appears to trigger the release of 
intracellularly stored Ca2+ by promoting opening of nearby Ry Rs, via either direct allosteric or 
indirect chemical mechanisms (see section 1.4). In skeletal muscle, DHPRs have been identified 
with large intramembrane particles injunctional domains of the plasma membrane and T-
tubules in isolated triads (Block et al. , 1988; Takekura et al. , 1994); a similar identification has 
been proposed for cardiac muscle (Sun et al., 1995). The disposition of DHPRs, however, is 
significantly different in cardiac and skeletal muscles. 
In skeletal muscle, DHPRs are grouped into a diamond-shaped arrangement (a 'tetrad ' ), or 
clusters of four DHPRs, located at the corners of hypothetical squares (Fig. l-5C). The tetrads 
in tum are disposed in larger ordered arrays, which occur with a constant stoichiometry in 
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relation to the RyR tetramer such that one tetrad is associated with every other RyR (Fig. 1-
5A&C). Such a regular pattern is only observed in skeletal muscles, and it constitutes the 
structural basis for the direct allosteric interactions between a lternate RyRs and the DHPR 
tetrads (see section 1.4). In contrast to skeleta l muscle, cardiac DHPRs within these junctional 
domains are much fewer in number and not organized in regular arrays oftetrads. A typica l 
cardiac coup Ion may have about I 00 Ry Rs and I 0-25 DHPRs (Bers, 2001 ). In addition, 
a lthough also being clustered in c lose proximity to RyRs, they are not disposed in a detectable 
ordered arrangements and thus do not appear to be specifically associated with the RyRs (S un et 
al. , 1995) (Fig. 1-58&0). In mammalian cardiomyocytes, there appear to be 4-10 RyR per 
DHPR at each dyad, depending on species (Bers, 200 I). This apparent difference in anatomy 
from skeletal muscle reflects the different activation mechani sm applied in cardiac muscle. The 
DHPR-RyR interaction in these muscles is thought to be indirectly mediated by Ca2+ (see 
section 1.4 ). 
A. Skeletal B. Cardiac 
~ 
Figure 1-5 Co mparison of DI-IPR a nd RyR arrangements in skeletal and cardiac muscles. (A)-(B) Diagram 
comparin g the organizati onal di fferences berween skeletal and cardiac T-tubule junctions. In the upper diagrams. 
trapezoids denote RyRs and fil led ovals DHPRs. Note that DHPRs are sparse and less a ligned in the heart (B). 
Image from (Bers. 2002). (C)-(D) Freeze-fracture electron micrographs of the surface membrane of developing 
mouse skeletal and cardiac musc le. DHPRs are clustered in both skeletal and cardi ac muscle but in a different 
manner. In skeletal muscle, DHPRs form arrays oftetrads (C. arrows point to individual tetrads), whi le in cardiac 
muscle DHPRs are randoml y disposed (D). Image from (Franzin i-Armstrong et a l. , 1998) 
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ln addition to the two calcium channels (DHPRs and RyRs), CRUs contain numerous key 
regulatory proteins such as calmodulin, FK-506 binding proteins (FKPBs), and PKA; they also 
contain proteins located at the luminal SR surface (e.g. calsequestrin, triadin and junctin) that 
are associated with RyRs. 
1.4 Excitation contraction coupling 
1.4.1 Overview 
In cardiac and skeletal muscle contraction occurs through a phenomenon known as excitation-
contraction (EC) coupling. Broadly, EC coupling is defined as the process beginning with 
electrical excitation and ending in contraction of the muscle fiber. More narrowly, EC coupling 
is considered to be the process linking surface/T-tubule membrane depolari zation to Ca2+ 
release from the SR - and subsequent activation of contractile proteins - which in turn triggers 
muscle contraction (reviewed in (Dulhunty, 2006)). The essential elements of thi s process are 
the ryanodine receptor (RyR., see section 1.3 and 1.6) and the surface voltage-activated L-type 
Ca2+ channel, the dihydropyridine receptor (DHPR, see section 1.3), both of which are located 
at the triad junctions. Failure in the expression of either prote in leads to death at antenatal or 
neonatal stages. 
Despite substantial differences between skeletal and cardiac muscle (discussed in section 1.4.2), 
the general scheme of E-C coupling is similar in both tissue types (Fig. 1-6). Electrical 
excitation of the surface membrane leads to an action potential which rapidly propagates as a 
wave of depolarization along the sarcolemma and down the T-tubules. At the triad junctions, the 
DHPR detects the depolarization and undergoes a conformational change (Rios and Brum, 1987; 
Schneider and Chandler, 1973), leading to a mechanical or chemical signal which activates the 
RyR on the closely opposed SR membrane. Ca2+ is then released from the SR into the cytosol, 
raising the cytoplasmic [Ca2+] from nM to µM levels, thereby facilitating binding of Ca2+ to 
troponin-C in sufficient quantities to activate contraction (Szent-Gyorgyi, 1975). 
1.4.2 Mechanism of EC coupling 
As mentioned previously, significant differences exist between the skeletal and cardiac EC 
coupling mechanisms. EC coupling in cardiac muscle depends not only on Ca2+ release from the 
SR, but also Ca2+ entry across the sarcolemma. Skeletal EC coupling, on the other hand, is 
dependent almost exclusively on Ca2+ released from the SR, with Ca2+ entry across the 
sarcolemrna being quantitatively insignificant during a normal twitch (Bers, 2001). 
In cardiac muscle, extracellular Ca2+ entry across the sarcolemma is an absolute requirement for 
EC coupling. The primary role of DHPRs in this muscle type is to function as a voltage-
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Figure 1-6 Scheme of ske letal and cardiac excitation-co ntracti on (EC) cou pling events. Electrical 
excitation at the sarco lemmal membrane activates the vo ltage-gated Ca2"" channel DH.PR. leading to a 
mechanical (in skeletal muscle. AJ or chemi cal signal (i n cardiac muscle. BJ which activates the RyR: the 
resultant Ca2• release from the SR in tum acti vates contracti le elements. The dark arrow indicates physical 
interaction between DHPR and RyR in skeletal muscle (A) while purple arrows ind icate depolarization. Green, 
red and blue arrows indicate movement of Ca'· du ri ng EC coupling (A. BJ. RyR I. ske letal RyR isofonm: 
RyR2. cardiac RyR isofonm (for detail. see section 1.6). 
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sensitive Ca2+ channel; correspondingly, the interaction between the DHPR and the RyR is 
chemical in nature. The action potentials, generated in the local pacemaker tissues, pass along 
the surface membrane and activate the DHPR in the T-tubule membrane. The DHPR opens 
rapidly, allowing the influx of extracellular Ca1+. The Ca1+ entering the cell binds to and opens 
the RyR in the nearby SR membrane, which triggers a massive release of Ca1+ from the SR. 
This Ca1+ release from the SR activates adjacent RyRs, thus reinforcing Ca1+ release. This 
process is known as Ca2+-induced Ca1+ release (CICR) (Fig. l-6B). Notably, although CICR is 
the main mechanism in cardiac EC coupling, under some circumstances direct or indirect 
physical coupling between DHPRs and RyRs may also occur (Dulhunty and Pouliquin, 2003). 
In vertebrate skeletal muscle, EC coupling is mediated by homologous proteins but employs a 
very different mechanism, involving a direct mechanical interaction between the DHPR and the 
RyR (Block et al., 1988). The action potential generated at the neuromuscular junction 
propagates over the surface membrane and into the T-tubule, which is far more extensive than in 
cardiac muscle (see section 1.2.1.2 and 1.2.2). The depolarization is detected by the voltage 
sensor, the DHPR, which is a different L-type channel isoform than in cardiac muscle. The 
DHPR undergoes a conformational change that is transmitted through direct physical 
interactions with the RyR I in the SR membrane, leading to the RyR channel opening and 
subsequently a rapid release of ca2+. This process is termed voltage-induced Ca2+ release 
(VICR), or depolarization- induced Ca1+ release (Fig. l-6A). Howev~r, it should be noted that 
CICR may be very important in recruiting the approximately 50% ofRyRs which are not 
physically coupled to T-tubule tetrads (see section 1.3), the Ca1+ is from release through coupled 
RyRs not through DHPRs. Importantly, DHPRs only mediate a small, very slow influx of 
extracellular Ca2+ in skeletal muscle (Field et al. , 1988; Lamb and Walsh, 1987; Tanabe et al. , 
1988). Notably, in invertebrate skeletal muscle and neonatal vertebrate skeletal muscle, EC 
coupling is more similar to that in cardiac muscle, requiring an influx of extracellular Ca2+ for 
full contraction. 
1.5 Sarcolemmal and SR caz+ fluxes during muscle twitch 
As previously described, the majority of the Ca1+ involved in the normal activation of skeletal 
muscle contraction is derived from the SR. The skeletal muscle DHPRs carry little Ca1+ current 
(Tanabe et al., 1988). During the cardiac action potential, Ca2+ enters the cell mainly through 
sarcolemmal L-type Ca2+ channels (DHPRs), which is critical in the activation of SR Ca2+ 
release (CICR), and a lso contributes to the activation of myofilaments and to the replenishment 
of the SR Ca1+ stores. However SR Ca1+ release in the heart is the major source of activator Ca2+. 
In rabbit ventricular tissue, Ca2+ influx and SR Ca2+ release supply 25-30% and -70% of the 
activating Ca2+ respectively (Bers, 2001). 
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Rel axation occurs with removal of Ca2+ from the cytoplasm, lowering intrace llular [Ca2+] 
([Ca2. ]i) to the po int that Ca2+ will dissociate from TnC. Four different Ca2+ transport 
mechanisms are invo lved in transport ofCa2+ out of the cytop lasm. Ca2+ can be: I) pumped back 
into the SR via the SR Ca1• A TPase (SERCA), which dominates during re laxation; 2) 
transported out of the ce ll by the sarco lemmal Ca2•-ATPase pump (SLCP); 3) transported to the 
extrace llular space by the sarco lemmal Na +/Ca2• exchanger (NCX); or 4) trans located into 
mitochondria via the Na •1ca2+ uni porter (Fig. 1-6; indicated by blue arrows). With respect to 
Ca2+ efflux fro m the ce ll , in ske letal muscle SLCP is the most effecti ve pathway, with optimal 
activation at cytosolic [Ca2+] above I 00 µM ; in cardiac muscle, the SLCP ap pears relative ly 
unimportant. The NCX is the main mechani sm of efflu x in the heart during relaxation (d iasto le), 
but plays a less prominent role in skeletal musc le. Additionally, Na+/Ca2+ exchange can a lso 
mediate Ca2+ influx to a degree suffic ient to activate cardiac cel l contraction, but this like ly does 
not occur under normal physiological conditions. The mitochondrial pathway contributes only 
fractionally (e.g. less than 1% in rabbit ventricle) to the removal ofCa2+in both skeletal and 
cardiac muscles (Bers, 200 I; Fieni et a l. , 2012). 
Importantly, in order for a steady state to be achieved, the amount ofCa2+-influx must be 
ba lanced with the amount ofCa2+-efflux during the same contraction-relaxation cyc le such that 
the cell does not experience a net gain or loss of Ca2+. 
1.6 Ryanodine receptor Ca2+ release channel (RyR) 
The RyR is located in the membranes of interna l Ca1+ storage organelles (Franzini-Armstrong 
and Protasi , 1997). It was first observed (a lthough not spec ifically identified as an RyR) in 
skeletal muscle in the early 1970s, where it was visualized as amorphous material projecting 
from the SR membrane and joining the distal segment of the SR to the plasma (T-system) 
membrane - it was therefore referred to as the junct ional foot protein (Franzini-Armstrong, 
1970). The RyR received its name due to its specific affinity for a plant alkaloid, iyanodine 
(Flei scher et a l. , 1985; lnui et al. , 1987b), which faci litated the purification and characterization 
of the protein. As the largest ion channe l known to date, the RyR forms homotetrameric 
assemblies with a tota l molecula r mass of - 2.2 MDa, with each monomer consisting of 
approx imate ly 5000 resid ues (lnui et a l. , 1987b; Lai et al. , 1988). The RyR is structurally 
re lated to the inosito l 1.4 .5-triphosphate receptor (IP3R), and these together form the 
superfamily of intracel lular Ca1• release channels. The !P3R res ides mostly in the endop lasmic 
reticu lum (ER) membrane of all ce ll types (Foskett et a l. , 2007), and is predominantly expressed 
in non-musc le ce ll s (Berridge et al. , 2000). The RyR and IP3R proteins share considerable 
structural si111 il arity and so111e sequence homologies, especial ly in the ca rboxyl-ter111ina l 
sequences which fo rm their channel pores and di splay approximate ly 40% homology. Together 
with IP .1 R, RyR provides a regu lated path way fo r the release of stored Ca2+ during Ca2+-
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mediated signalling processes such as muscle contraction, fertilization, and cell proliferation 
(Berridge et al., 2000). 
1.6.1 RyR genes, isoforms and distribution 
There are three isoforms ofRyR expressed in mammals: RyRI , RyR2, and RyR3 , which are 
encoded by three different genes res iding on separate chromosomes (Mattei et al., 1994). RyRI 
was first identified and iso lated from skeletal muscle (Takeshima et al. , 1989; Zorzato et al., 
1990), RyR2 was first detected in cardiac muscles (Nakai et al. , 1990; Otsu et al. , 1990), and 
RyR3 was originally identified in the brain, and hence often referred to as the brain isoform 
(Hakamata et al., 1992). RyRI and RyR2 are also known as the skeletal and cardiac types 
respectively, based on the abundance and timing of their purification from various tissues. The 
RyRI isoform is also expressed at low levels in cardiac muscle, smooth muscle, and in some 
parts of brain and many other tissues (Giannini et al. , 1995 ; Lee et al., 2002; Nakai et al. , 1990; 
Neylon et al., 1995; Vukcevic et al. , 2010). RyR2 is also expressed at high levels in the brain 
and at low levels in other tissues (Furuichi et al. , 1994; Giannini et al., 1995 ; Kuwajima et al., 
1992; Lai et al., 1992; Nakanishi et al., 1992). ln turn , RyR3 - the least understood of the RyR 
isoforms - seems to play its most prominent role during striated muscle development, and is 
ubiquitously distributed in smooth muscle and non-muscle cells (Furuichi et al., 1994; Giannini 
et al., 1995; Hakamata et al., 1992; Lai et al. , 1992; Neylon et al. , 1995; Ogawa et al., 2000), 
with small amounts also found in adu lt skeletal and cardiac muscles. In non-mammalian 
vertebrates, three isoforms, RyRa, RyRp and the cardiac type, are expressed, wh ile only one 
isoform has been found in lower organisms, including nematodes, fruit flies, and lobsters 
(reviewed in (Lanner et al. , 20 IO; Zissimopoulos and Lai, 2007)). Ry Ra and RyRp are highly 
homologous to mammalian RyRI and RyR3 respectively (Ottini et al., 1996; Oyamada et al., 
1994). 
There is approximately 65% sequence homology across the three mammalian isoforms 
(Hakamata et al. , 1992), with the highest rates of homology present at the carboxyl-terminal end. 
The largest degree of difference is found in three major regions of diversity, known as DI 
(residues 4254-4631 in RyRI and 4210-4562 in RyR2), D2 (residues 1342-1403 in RyRI and 
1852-1890 in RyR2), and D3 (residues 1872-1923 in RyRJ and 1852-1890 in RyR2). DI is the 
most variable region, whereas D2 is absent altogether in RyR3. DI is predicted to be 
fanctionally critical in the pore forming region (Zorzato et al. , 1990), and mutations in DI alter 
the Ca2+ and caffeine sensitivity of RyRI (Du et al., 2000). D2 may be critical for the 
mechanical interactions between RyRJ and Cavl. I (Perez et al. , 2003), and D3 may contain 
Ca2+ dependent inactivation sites (Hayek et al. , 1999). These three hyper-variable regions are 
thought to partially underlie the functional differences between the three isoforms. 
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1.6.2 RyR structure 
High reso lution structural information is essential to understand how ryanodine receptors 
function. However, it has so far not been poss ible to obtain RyR crystal structures due to the 
protein ' s massive size and the difficulty inherent in crystallizing integral membrane proteins. 
This is further compounded by the multiple modulators and the dynamic nature of the RyRs. 
However, progress in cryo-electron microscopy (cryo-EM) and single-particle three-
dimensional reconstruction (30 cryo-EM) has made it poss ible to obtain low reso lution 
structural architecture of these large proteins and to reveal some mechanisms of calcium release 
channel gating over the last two decades. Early cryo-EM studies of the structure of skeletal RyR 
were reported in the middle of the 1990s (Radermacher et al. , 1994; Serysheva et al. , 1995 ; 
Wagenknecht et al. , 1989; Wagenknecht and Radermacher, 1995), albeit at modest resolution 
(20-40A). Since 2005 , more highly detailed structures ofRyRl at sub-nanometer reso lution 
have emerged (Ludtke et al. , 2005; Samso et al., 2009; Samso et al. , 2005 ; Serysheva et al. , 
2008). Most cryo-EM studies have focused on RyR I (Benacquista et al., 2000; Ludtke et al. , 
2005; Orlova et al. , 1996; Radermacher et al. , 1994; Radennacher et al., 1992; Samso et al., 
2009; Samso et al., 2005; Serysheva et al., 2005; Serysheva et al., 2008; Serysheva et al., 1995 ; 
Serysheva et al., 1999), although some studies have been performed on RyR2 (Liu et al. , 2002; 
Sharma et al. , 1998) and RyR3 (Liu et al., 200 l ; Shanna et al. , 2000); however, at much lower 
resolution than RyRl structures. Further, the structure ofRyR2 has been studied with 
comparative modeling and bioinfonnatics mapping techniques (Bauerova-Hlinkova et al. , 2011 ; 
Bauerova-Hlinkova et a l. , 201 O; Welch et al. , 2004). Fourteen probable domains were revealed 
in the human RyR2 monomer via bioinfonnatics analysis in the study by Bauerova-Hlinkova et 
al. (2011 ), of which eight domains are located in the N-terminal region, three domains in the 
centra l region and three domains in the C-tenninal part. A model of the N-termianl region of 
human RyR2 (res idues 12-543) was constructed (Bauerova-Hlinkova et al. , 2011) based on the 
structure of the homologous N-terminal region of rabbit RyR 1 detennined by Tung et al. (2010), 
and the first three N-terminal domains wi thin thi s region have been verified to be able to behave 
as separate, independent protein units (Bauerova-Hlinkova et al. , 20 11 ; Bauerova-Hlinkova et 
a l. , 20 I 0) . Some small RyR segments have recently been obta ined via x-ray crystallography 
(Amador et a l. , 2009; Lobo and Van Petegem, 2009; Tung et al., 20 10). ln genera l, the EM 
structures of all three isoforms are very sim ilar, consistent with their high degree of sequence 
identity (- 65%). Nevertheless, the sma ll differences revea l the molecular basis of the 
specialized functional ro les of each isofonn . 
Overall , the basic architecture of the Ry Rs has been described as resembling a mushroom, with 
a large ' cap' (corresponding to the cytoplas mic assembly, or CA) and a smaller transmembrane 
(TM) ' sta lk ' extend ing fro m the base of the cytoplasmic region into the SR lumen 
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(Radennacher et al., 1994; Serysheva et al. , 1995). The structure of Ry Rs exhibits four-fold 
cyclic symmetry, reflecting its homotetrameric architecture. The cytoplasmic assembly, shaped 
like a square prism, has overall dimension of - 275x275xl 00 A (Wagenknecht and Samso, 
2002), and is composed of a series of interconnected tubular structures, which account for 
approximately 80% of the total protein mass. The transmembrane assembly has a square 
tapering prism shape with maximal dimensions of 115xl 15x60 A, and is localized to the 
carboxyl terminal of the protein. The transmembrane region is rotated by - 38° with respect to 
the cytoplasmic region (Radermacher et al., 1994; Serysheva et al. , 1995; Wagenknecht et al. , 
1989). In addition, there is a space of 14 A spanned by intra-assembly columns between the two 
structures (Orlova et al., 1996; Samso et al. , 2009; Samso et al., 2005; Serysheva et al., 2005), 
which defines the transmembrane assembly boundaries. 
1.6.2.1 Cytoplasmic assembly 
The cytoplasmic assembly consists of several morphologically distinct segments: the ' clamp' -
shaped domains (C) at its periphery, the interconnecting ' handle ' domains, and a ' central rim ' 
that surrounds the central cavity of the cytoplasmic region (reviewed in (Capes et al., 2011 ; 
Lanneretal., 2010; Van Petegem, 2012), also see Fig. l-7A). These segments have been further 
subdivided into 15 subregions per subunit (Serysheva et al., 2008), each likely corresponding to 
one or several protein folding domains, with an open arrangement allowing a substantial 
fraction of the cytoplasmic assembly volume to be available for interaction with the modulators 
that bind within the N-terminal regions ofRyR. These subregions are indicated by identifying 
numbers (Samso et al., 2005; Serysheva et al., 2008) on the model depicted in Fig. 1-7, with the 
column region having been designated as subdomain 12. At sub-nanometer resolution, 36 a-
helices and 7 P-sheets at various orientations have been resolved on the cytoplasmic region of 
each monomer (Serysheva et al., 2008); these appear interconnected and merge toward the 
center of the channel (Samso et al., 2005). 
The 'clamp' domains, comprising subdomains 5-10, define the comers of the cytoplasmic 
assembly. They have been shown by higher resolution (- 10 A) cryo-EM to be formed by two 
separate structures: a flat tubular structure that loops around the outer comers of the square 
prism (domains 8a, 8 and 7) and a smaller elongated, tapering structure that extends toward its 
comer from the side of the square (domains 9-10). Two divergent areas were mapped in the 
clamps (Liu et al. , 2004; Zhang et al. , 2003). Seven a-helices and three P-sheets have been 
localized to this domain (Serysheva et al., 2008). This region exhibits major conformational 
changes during the opening and closing of the channel (Orlova et al., 1996; Samso et al., 2009; 
Shanna et al., 2000). In skeletal muscle, the 'clamp' region is most likely to interact with 
dihydropyridine receptors (Paolini et al., 2004), where it senses depolari zation of the plasma 
membrane and controls RyRI channel activity during excitation-contraction coupling. 
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Figure 1-7 C ryo-EM reconstruction of RyR I at 9.6 A resolution (Electron Microscopy Data Bank entry 1275) 
(Serysheva et al. , 2008). Two orientations are shown : (A) " top" view along the fourfold symmetry axis, looking 
from the cytoplasm toward the SR/ER; (B) "side" view showing the cytoplasm ic and the transmembrane (TM) 
assembly/region. One of the "clamp" and "handle" structures and the "centra l rim" are indicated in (A). The 
numerals indicate the distinctive subregions. Figure modified and adapted fro m (Lanner et al. , 20 I 0). 
The T-tubule faci ng surface of the RyR, structurally resembling a rhombus, is also fo rmed of 
tubular structures, and is comprised of domains 2, 4, 5 and 6. It has been proposed that inter-
domain interactions may occur among at least three separate bulks of mass in close proximity 
(pairs of domains: 2-4a ' , 5-6, I0-8a) (Samso et al. , 2005). 
The fl at, s lab-shaped ' handle ' domains, formed by subdomains 3 and 4 (Lanner et al., 20 I 0), 
where the FK506-b inding prote ins and calmodulin (CaM) binding sites are located, define the 
side of the cytoplasm ic assembly. This region has been fo und to contain an expanded region of 
divergence (Samso and Wagenknecht, 1998), and a P3 sheet has been mapped to subdomain 4, 
bridging the centra l rim with the clamp (Serysheva et a l. , 2008). A crev ice (see Fig. l-7B), 
bounded by domains 3, 4, 8a and 8, extends to the T-tubule side from the SR side. Two more P-
sheets have a lso been resolved in the central rim (subregions I and 2a) (Serysheva et al. , 2008). 
1.6.2.2 Trans membrane assembly 
The square-shaped strncture spanning the SR mem brane, and the fou r high density co lumn 
domains attached to it, together form the transmembrane assembly, or the ' stem ' region of the 
' mushroom ' (Serysheva et a l. , 2005). The fo ur co lumns which connect the cytoplas mic and the 
transrn embrane domain s were first observed in (Orlova et a l. , 1996), and were al so reported in 
(Serysheva et a l. , 2005), but we re not described in detail. At higher reso lutions - - 10 A (Samso 
et al. , 2005) and 9.6 A (Samso et al. , 2009) - the columns' structure and their movement upon 
gat ing have been studied more thoroughl y. Formed from the SR-prox imal part of the 
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cytoplasmic assembly, the - 14 A columns span the gap and provide direct continuity between 
the cytoplasmic and transmembrane regions (Samso et al., 2005). A ~-sheet has further been 
located in the column region (Serysheva et al. , 2008). The four columns are together composed 
of four peripheral branches, which merge to define the external TA boundaries, and four inner 
branches of higher density located in the central region (Fig.1-8). These columns have been 
proposed to constitute an important component in orthograde RyRI signaling between the 
protein ' s two major domains (Samso et al. , 2005). The two columnar bundles converge into a 
ring of high density, possibly the ion gate. The structure of the columns has been further refined 
by the same group (Samso et al. , 2009): the cytoplasmic " inner branches" stretch from the ion 
gate to the peripheral cytoplasmic domain, and the TM " inner helices" extend from the lumen to 
the ion gate. Three main constrictions along the four-fold axis are defined by the inner branches 
and inner helices: the cytosolic constriction defined by the distal enlargement of the inner 
branches; the ion gate defined by the meeting of the two bundles; and the opening to the SR 
lumen for the lowest constriction, formed by the pore helices in a region equivalent to the 
selectivity filter of the K + channels. Upon channel gating, a precise relocation of the two 
bundles results in an approximately 4 A increase in the diameter of the ion gate, due to a 
converging of the conformational change in the cytoplasmic domains, underlying a long-range 
allosteric mechanism. A central cavity, or vestibule, four peripheral cavities, and the mouth of 
the presumed ion channel have also been defined (Fig. I-SB) (Samso et al. , 2005). 
Peripheral 
branch 
Inner 
branch 
B 
Inner branch 
Mouth 
10nm 
Figure 1-8 Internal structure of the columns and transmembrane region. (A) Section ofRyRI cut along the 
plane indicated by the dashed line in B seen from the SR lumen, the internal and peripheral regions of the columns are 
shown . (B) Slice across the side view showing the two branches of each column and basic architecture of 
transmembrane region. Figure modifi ed and adapted fro m (Samso et al. , 2005). 
Compelling evidence suggests that the conduction pathways in the RyR channels are contained 
in the C-terminal part of the protein. The C-terminal 1000 residues of the RyR form a functional 
channel which binds to ryanodine with high affinity, preserves wild-type (WT) channel 
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conductance, and is activated by Ca2+ (Bhat et al. , I 997 ; Treves et al. , 2002; Wang et a l. , 1996); 
rev iewed in (Dulhunty and Pou liquin , 2003). 
1.6.3 Transmembrane segments and pore forming region 
1.6.3.1 Transmembrane topology of RyR 
The transmembrane topology of the RyR carboxyl-terminus is not yet fully understood , and 
several models have been proposed. 
The number oftransmembrane helices has been the subject of much debate, and the pred icted 
number varies from between 4 to 12 (Brandt et a l. , 1992; Takeshima et al. , 1989; Tunwell et a l. , 
I 996; Zorzato et a l. , 1990), with data for these predictions derived mostly from hydropathy 
profiles. Two popular topological models for the transmembrane assembly of 4-TM (Takeshi ma 
et a l. , 1989) and I 0-TM have been proposed (Zorzato et al., 1990) - the four segments of the 4-
TM model correspond to MS, M6, M8 and M IO respectively of the I 0-TM model. A th ird 
model suggests the existence of six transmembrane heli ces (6-TM), located in the carboxyl-
terminal region of RyR I (Brandt et a l. , 1992) and RyR2 (Tun we ll et a l. , 1996). 
Experiments using immunologica l techniques with site-directed antibodies (Grunwald and 
Meissner, I 995 ; Marty et a l. , I 994) in comb ination with proteolysis (Marty et al. , I 994) 
demonstrate that both the N- and C-terminal domains of the RyRI are on the cytoplasmic side 
of the SR, indicating an even number of membrane span ning segments. At least four membrane-
spanning segments were suggested (Grunwald and Meissner, I 995), which is consistent with a ll 
models currently proposed (Brandt et a l. , I 992; Takeshima et a l. , 1989; Tun we ll et a l. , 1996; 
Zorzato et al. , I 990). 
Exper imenta ll y determined TM segments using C-terminal-truncated channels fused w ith a C-
terminal GFP tag, suggest either six or eight TM he lices per subunit (Du et a l. , 2004; Du et al. , 
2002). Studies us ing 30 cryo-EM at a refined reso lution of - IO A show a more detailed picture 
o f the channe l pore structure. At least s ix TM a-hel ices per monomer were suggested in (Samso 
et al. , 2005); however, on ly five helix- like densiti es were identified by Ludtke et a l. (2005) at 
s imilar reso lution (9.6 A). In a more recent study (Samso et al. , 2009) , the open and c losed 
confonnat ions of the channel have been compared, and three independent 30 reconstructions 
have been obtained, all of which suggest at least s ix trans membrane heli ces, supporting the 
previous study (Sam so et a l. , 2005). The current pred icted RyR membrane topology (RyR I and 
RyR2) is depicted in Fig. 1-9. 
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Figure 1-9 Membrane topology for ryanodine receptor 1 (RyRl) and 2 (RyR2). Coordinates given are for 
rabbit RyRl (black) and rabbit RyR2 (red in brackets). The green oval denotes acid ic residues contributing to a ring 
of negative charge at the mouth of the pore; the purple region denotes the GGGlGD selectivity filter. Figure 
modified from reviews by Zissimopoulos and Lai (2007) and Dulhunty et al. (20 12). 
1.6.3.2 Pore forming region 
Both molecular modelling (Ramachandran et al., 2013; Ramachandran et al. , 2009; Welch et al. , 
2004) and cryo-EM (Ludtke et al. , 2005; Samso et al. , 2009; Samso et al. , 2005) have identified 
the probable pore-forming region (PFR) of RyR with structural elements equivalent to that of 
K+ channels, with similar overall topography. By using the known X-ray crystal atomic 
structure of the bacterial K+ channel KcsA from Streptomyces lividans as a template (Balshaw et 
al., 1999; Doyle et al. , 1998; Welch et al., 2004), as well as the predicted structure of 1P3R 
(Balshaw et al., 1999; Zhao et al. , 1999), a model of the putative PFR of RyR has been 
predicted, with the primary sequence of this region being highly conserved (>90% identity) 
across RyR isoforrns (sequence alignment of the putative PFR ofRyRl and RyR2 is depicted in 
Fig. 1-10) (Welch et al. , 2004). This model incorporates two transmembrane helices, the outer 
and inner helices, and the pore loop (P- loop) which links the two helices. The P-loop contains a 
pore helix and an amino acid motif (GGGIGD) simi lar to the selectivity filter motif (TVGYGD) 
of the KcsA channel, with a high density of negative charges exposed at both the luminal and 
cytosolic mouths of the pore. Fitting this structure to 4-TM and 12-TM model suggests that the 
M3 and M4 in the 4-TM model (Takeshima et al. , 1989) or the MS and MIO helices in the 12-
TM model (Zorzato et al. , 1990) form the outer and inner helices respectively, and that the pore 
helix is formed by the M3-M4 luminal loop in 4-TM, or M9 in the 12-TM model. More recently, 
a slightly altered version of the model of PFR has been proposed by (Ramachandran et al., 2013) 
(Fig. 1-11). This model is based on homology modeling and cryo-EM data. Notably, the new 
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model adjusts the sequences of the six transmembrane segments (compare with the RyR 
membrane topology in Fig. 1-9) and includes the S4-S5 linker. 
This hypothetical structure of the RyR pore is supported by mutations in a highly conserved 
GXRXGGGXGD motif within the P-loop - and a lso to adjoining residues - which produce 
dramatic alterations to unitary conductance, or abolish it (Du et al. , 200 I ; Lynch et al. , 1999; 
Zhao et al. , 1999). On the other hand, the high densities of acidic residues identified at both 
ends of the pore, which give ri se to significant negative e lectrostatic potentials, have been 
proposed to not only provide a mechanism for maximizing the cation conductance of RyR 
channels, but al so to contribute to se lecting cations over anions and to providing the necessary 
discrimination between di va lent and monovalent cations (Welch et a l. , 2004). In support of thi s 
proposa l, the neutralization of acidic residues identified at the luminal entrance to the se lectivity 
filter in the RyR2 PFR model (ED4832AA, mutated residues highlighted in yellow in Fig. 1-10) 
results in substantia l alterations to RyR2 ion handling and gating characteristics (Mead-Savery 
et al. , 2009). Although the mutant channel discriminates between cations and anions, it no 
longer discriminates between divalent and monovalent cations and cation conductance is 
significantly a ltered, e.g. , unitary K+ conductance is reduced at low levels of K+ activity but 
increases dramatica lly as activity is increased and shows little sign of saturation . ln addition, the 
ED4832AA channel di splays a higher open probability than that of the WT channel (Mead-
Savery et al. , 2009). Interestingly, the regulatory proteins triad in (section 1.8) and junctin 
(section 1.9) interact with thi s region, poss ibly through negatively charged res idues located in 
the luminal end of the pore helix and the loop connecting the pore helix to the inner helix 
(A ltschafl et a l. , 20 11 ; Goonasekera et al. , 2007; Lee et a l. , 2004). lndeed, three acidic res idues 
(04878, D4907 and E4908) in this reg ion are critical for triad in binding to the RyR I 
(Goonasekera et a l. , 2007; Lee et al. , 2004). 
As with RyR I (see section 1.6.2.2), the putative PFR of RyR2 also fo rms a gated ion channel 
when incorporated into lipid bilayers, albeit with different gating and ion handling properties to 
those of the full-l ength RyR2 channel (Euden et al. , 2013). This is not surpri sing, since the other 
domains of the full-length molecule would contri bute to the structure of the PFR and the 
mechanisms govern ing fu nction in the intact tetramer (Euden et a l. , 2013). 
The diameter of the RyR (RyR I and RyR2) pore has been estimated to be approximately 3.5-7 
A and the length approximate ly IO A (Orlova et al. , 1996; Tinker and Williams, I 993 , 1995 ; Tu 
et al. , 1994a); reviewed in (Dulhunty and Pouliquin, 2003). The re lative short, wide RyR 
channel pore would allow a high rate fo r Ca2+ fl ow down its concentration gradient, and hence 
to support its ro le as an effective Ca2•-release channel (Williams et a l. , 200 I ). 
1.6.4 Ion selectivity and conductance 
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hRyR2 
rRyR2 
hRyRl 
rRyRl 
hRyR2 
rRyR2 
hRyRl 
rRyRl 
hRyR2 
rRyR2 
hRyRl 
rRyRl 
hRyR2 
rRyR2 
hRyRl 
rRyRl 
Outer helix Luminal Pore helix 
MGFKTLRTILSSVTHNGKQLVLTVGLLAVVVYLYTVVAFNFFRK FYNKSEDGDTPDMKCD 4805 
MGFKTLRTILSSVTHNGKQLVLTVGLLAVVVYLYTVVAFNFFRK FYNKSEDGDTPDMKCD 4809 
MGVKTLRTILSSVTHN GKQLVMTVGLLAVVVYLYTVVAFNFFRK FYNKSEDEDE PDMKCD 4878 
MGVKTLRTILSSVTHNGKQLVMTVGLLAVVVYLYTVVAFNFFRK FYNKSEDEDE PDMKCD 4877 
**.****************** : ***************************** * ****** 
GGGIGD 
Selectivity filter Inner helix 
DMLTCYMFHMYVGVRAGGGIGDEI EDPAGDEYEIYRIIFDITFFFFVIVILLAIIQGLII 4865 
DMLTCYMFHMYVGVRAGGGIGDEIEqPAGOE YEIYRIIFDITFFFFVIVILLAIIQGLII 4869 
DMMTCYLFHMYVGVRAGGGIGDEIEDPAGOEYELYRVVFDITFFFFVIVILLAIIQGLII 4938 
DMMTCYLFHMYVGVRAGGGIGDEI EDPAG OEYELYRVVFDITFFFFVIVILLAIIQGLII 4937 
**:***:**************************:**: : *********** ** *** ****** 
Cytoplasmic remainder of the carboxy tail 
DAFGELRDQQEQVKEOMETKCFICGIGNOYFDTVPHGFETHTLQEHNLANYLFFLMYLIN 4925 
DAFGELRDQQEQVKEDMETKCFICGIGNDYFDTVPHG FETHTLQEHN LANYLFFLMYLIN 4929 
DAFGELRDQQEQVKEDMETKCFICGIGS DYFDTTPHGFETHTLEEHNLANYMFFLMYLIN 4998 
DAFGELRDQQEQVKEDMETKCFICGIGS DYFDTTPHGFETHTLEEHNLANYMFFLMYLIN 499 7 
***************************.*****.*********:*******:******** 
remainder of the carboxy tail 
KDETEHTGQESYVWKMYQERCWE FFPAGDCFRKQYEDQLN 4965 
KDETEHTGQESYVWKMYQERCWE FFPAGDCFRKQYEDQLN 4969 
KDETEHTGQESYVWKMYQE RCWDFFPAGDCFRKQYEDQLS 5038 
KDETEHTGQESYVWKMYQERCWDFFPAGDCFRKQYEDQLS 5037 
********************** · **************** 
Figure 1-10 Sequence nlignment of the pu tative pore-forming region from human ryanqdine receptors (hRyR) and rabbit ryanodine receptors (rRyR), with crucial 
residues or sequences highlighted (see legend). The corresponding residues RyR are highlighted according 10 (Welch et a l., 2004). The letters coloured in blue denote predicted 
outer and inner helices in putative PFR; the letters co loured in orange denote putative pore helix; the underlined letters in black denote putative selectivity fi lter ; the letters 
co loured in red or light green denote positively or negatively charged amino acids respectively in the cytoso lic and \uminal mouths of the pore; the letters highlighted in yellow 
denote mutated residues in study by Mead-Savery ct al. (2009). The aligned residues are either identical(*), similar(:), weakly similar(.) or dissimilar. Alignment and similarity 
was determined using a CLUSTALW multiple sequence alignment (Combe! et al. , 2000). 
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Figure 1-11 A revised model of the pore-form ing region for RyRI , in cl ud ing four more transmembrane 
segmen t (S!-S4) and the S4-S5 linker. Figure modified and adapted from (Ramachandran et al. , 2013). The 
boundaries of the TM helices are indi cated. 
The permeation properties of the RyR channel are similar across the RyR isoforms. The RyR 
ion channel is permeable to a wide range of divalent and monovalent cations, but shows very 
little discrimination between different monovalent cations and nearly no se lectivity between 
various di va lent cations. The RyR channel is moderate ly se lecti ve, between mono- and diva lent 
cations (se lectivity Ca2+/K+ -6 .5, Ca2+/Na+ -5, Ca2+/Tri s+ -14, Ba2+/K+ -4.3). However, it is 
highly se lective for cations over anions, the latter having very limited permeability. Converse ly, 
the channel displays very high levels of conductance for both diva lent and monovalent cations 
(reviewed in (Dulhunty et al. , 1996; Fill and Cape llo, 2002; Meissner, 1994; Williams, 1992). 
In symmetri cal so lutions containing a monovalent cation charge-carrying species, the slope 
conductance of the RyR channel is usually >500 pS, e.g. 700-800 pS fo r K+ (250mM symmetric 
K+), 550-600 pS for Na+ (500mM symmetric Na+), and - 525 pS for Cs+ (250mM symmetri c 
Cs+). The conductance of RyR2 from sheep heart fo r for monovalent cations ( in the asence of 
any divalent cations) ranges from 723±9 - 2 15±3 pS, with a sequence ofK+ > Rb+= NH/ > Na+ 
= Cs+> Lt and - 17.4 pS fo r Tris+ (Lindsay and Williams, 1991 ). O rganic tetra-
a lkylammonium (TAA) cati ons including tetramethylammonium (TMA +), tetraethylammonium 
(TEA•) and tetrapropy lammonium (TPrA +), which are a ll of similar dimen stions to Tris+, do 
not permeate under s imilar cond itions (L indsay and William s, 199 1; T inker et al., 1992a). ln 
asymmetrica l so lutions containi ng a di va lent cation as the main pennea ting species, the RyR 
channe l di sp lays a s lope conductance of - I 00 pS, e.g. 120±30 pS for Ca2+ (50 mM luminal Ca2+ 
wi th 250 mM cytop lasmic K. or Na+). The equivalent conductance sequence for diva lent cations 
is Br2+ > Sr2+ > Ca2+ > Mg2+, within the range 202±3 - 89±4 pS (Tinker and Williams, 1992). 
T he relati ve ly high unit conductance of the RyR channel is fundamental to its physiolog ica l ro le 
of providing rapid release ofCa2• into the cytoso l upon exc itation. The channel' s apparent 
deficiency in cati on di scrimination may not phys iologica lly relevant, s ince the maj or driving 
force fo r translocation is the Ca2+ gradient across the SR membrane (Williams, 1992). 
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Both pH and temperature modify RyR channel conductance. A reduction of luminal pH from 
7.4 to 6.8 produces a 27% decrease in single-channel Ca1+ conductance in both rabbit skeletal 
and canine cardiac RyR channels (Rousseau and Pinkos, 1990). With Ca2+ as the charge carrier, 
single-channel conductance drops with lowering the bathing solution temperature from 32 to 
5 °C (Sitsapesan et al. , 1991). 
Multiple subconductance states of both native and purified RyR channels have also been 
resolved in single channel studies. In addition to a fully open state, three distinct conductance 
levels are seen at 25%, 50%, and 75% of rnaximun. It has been suggested that this may be 
related to either uncoordinated opening of conducting pores in each RyR subunit, or a single 
central pore presenting in several discrete conductance states within the tetramer (Liu et al. , 
1989; Smith et al. , 1988); reviewed in (Dulhunty et al. , 1996; Meissner, 1994). A 12-kDa or 
12.6-kDa FK506-binding protein (FKBP 12 or FKBP 12.6, respectively) is associated with the 
RyR protein with a stoichiometric relationship of four FKBPs per homotetramer (Jayaraman et 
al., 1992; Lam et al., 1995; Qi et al., 1998; Timerrnan et al., 1993 ; Timerman et al., 1996); 
reviewed in (MacMillan, 2013). Removal ofFKBP12 increases the occurrence of 
subconductance opening in RyRl (Ahern et al., 1994, 1997; Brillantes et al. , 1994; Shou et al., 
1998). FKBP 12.6-deficient RyR2 channels display a similarly increased subconductance 
opening (Kaftan et al. , 1996; Shou et al., 1998; Wehrens et al., 2003; Xiao et al. , 1997). 
Therefore, FKBPs are proposed to be responsible for stabilizing inter_-subunit coordination 
within the RyR and for the synchronization of the openings of these separate permeation states 
(Ahern et al. , 1994; Brillantes et al. , 1994; Ondrias et al. , 1996). However, it should be noted 
that subconductance opening is not always observed upon FKBP' s removal (Barg et al., 1997; 
Mayrleitner et al. , 1994; Timerrnan et al. , 1996), leading to controversy about FKBP ' s role in 
modifying RyR channel conductance. 
1.6.5 RyR regulation 
1.6.5.1 RyR modulation by main regulatory ligands 
RyR is regulated by numerous physiological agents (e.g. , Ca1', Mg2+, and ATP), large organic 
proteins and enzymes, various cellular processes (e.g. , phosphorylation, oxidation, etc.), and 
exogeno.us compounds (e.g., ryanodine, neomycin, caffeine, and ruthenium red). Among the 
endogenous effectors, Ca2', Mg1', and ATP are key regulators ofRyRs (Laver, 2010). 
Currently, four types ofCa1+ sensing sites have been identified on RyR. Two Ca2+-activation 
sites are located in the luminal and cytoplasmic domains ofRyR, along with two inhibitory sites 
on the cytoplasmic domains (Laver, 20 I 0). Magnesium is a potent RyR channel inhibitor, 
whereas ATP stimulates RyR activation by luminal and cytoplasmic ca2+. The function of these 
three major ligands ofRyR is briefly reviewed below. 
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1.6.5.1.1 Cytoplasmic Ca2• 
Ca2+ is the most im portant cationic modulator of RyR activity. In the absence of other 
regulatory ligands such as Mg2+ and ATP, the activ ity of RyR has a be ll-shaped dependence on 
cytoplasmic Ca2+ (Bull and Marengo, 1993 ; Chen et a l., 1997; Chu et a l. , 1993 ; Ca pello et al., 
1997; Fabiato, 1985 ; F ill et a l. , 1990; Jeyakumar et al. , 1998; Laver et al. , 1995 ; Ma et a l. , 198 8; 
O'Brien et al. , 1995; Perciva l et a l. , 1994; Si tsapesan and Williams, 1995; Smith et al. , 1988; 
Tri pathy and Meissner, 1996). RyR channels are activated by a micromolar Ca2• concentration 
range ( 1- 10 µM) , with a threshold fo r channel acti vation at approximately I 00 nM . Exposure to 
high Ca2+ concentrat ion (500 µM - 10 mM) inhibits the channels. The biphasic behav ior is 
proposed to be produced by two classes of Ca2+ binding sites on the cytoplasmic side of RyR, a 
high-affini ty acti vation s ite (A site, - I µM affini ty with both RyRI and Ry R2) and a low-
affinity inhibition site (!/ -site, - 200 µM affi nity with RyRl and 10 mM with RyR2) (Laver, 
2007; Meissner et a l. , 1986; Meissner et al. , 1997) . More recently a high-affini ty inacti vation 
site on RyR2 (12-site, - 1.2 µM affini ty) has a lso been identifi ed (Laver, 2007). However, the 
precise locations of these sites have not yet been detennined (Laver, 201 0). In resting muscle, 
cytosolic [Ca2+) ra nges from I 00-1 50 nM (Bers, 2001 ; Lopez et a l. , 2000; Perez et a l. , 2005), 
and ri ses to micromolar levels during contraction (- 20 µM in skeleta l muscle (Hollingworth et 
a l., 1996) and 1 µMin cardiac myocytes (Bers, 2001 )). Although cytoso li c Ca2• regulates RyR l 
and Ry R2 in a similar way, i.e., a biphasic response, the two isoforms have different 
sensiti vities to ca2•. One of the most important di fferences is that RyRI is almost enti re ly 
inhi bited by I mM ca2•, whereas RyR2 is less sensitive to iahibition by high Ca 2• . RyR3 
responds to cytosolic Ca2+ in a fashion more similar to that of RyR2 than RyR 1. The reported 
RyR2 and RyR3 half-maximal inhibi ting Ca2+ concentrations range from 2 to> IO mM. Such 
high cyto plasmic Ca2• concentrations are unlikely to occur in ce ll s, even in microdomains, and 
thus the physio logica l role of th is Ca2+ inhibi ti on is unclear. RyR I cannot be fu lly activated by 
Ca2• a lone; whereas for RyR2 and RyR3 are, a lmost maximally acti vated by Ca2+ alone at - I 00 
µM (rev iewed in (Ziss imopou los and Lai, 2007)). Another di fference is that RyR I is 
functionally heterogeneous to acti vati ng cytoplasmic Ca2+ levels, whereas RyR2 and RyR3 
chan nels are more homogeneous in their responses to cytoso li c Ca2+ (Chen et a l. , 1997; Chu et 
a l. , 1993; Capello et al., 1997; f ill and Capello, 2002; Jeyakumar et al. , 1998 ; Laver et al. , 1995; 
Ma, 1995 ; Perciva l et a l. , 1994); this may be due to the d ifferent redox states of the isoforrns 
(Marengo et al., 1998; Z iss imopoulos and Lai, 2007). 
1.6.5.1.2 Lumin al Ca>+ 
Consistent results have been obta ined in Ca2• re lease studies showing that Ca2+ release is 
enhanced w ith increasing luminal [Ca2+] but decreased when the Ca2+ store is depleted in both 
intact rnusc le cel ls and skinned muscle fi bers (Donoso et a l. , 1995 ; Lamb et a l. , 200 I ; 
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Lukyanenko et al., 1999). This store-dependent Ca2+ release suggests a distinctive regulation 
mode of the RyRchannel by luminal ca2• . In support ofthis hypothesi s, single channel bilayer 
studies of Ry Rs demonstrate the responsiveness of RyR to alterations in luminal [Ca2+] although 
with some di screpancies between di fferent studies (see below) (Lamb et a l. , 2001; Laver et al., 
2004; Sitsapesan and Williams, 1994b, 1995; Xu and Meissner, 1998). The total concentration 
ofCa2+ in the SR is estimated to be - 20 mM (Fryer and Stephenson, 1996); however, most of 
Ca2+ in the SR is bound to luminal Ca2+ buffering protein CSQ and other Ca2+ binding proteins 
in the SR, resulting in a resting free [Ca2+]sR of around 1 mM (Bers, 2004; Fryer and Stephenson, 
1996; Shannon et a l., 2003 ; Szegedi et al. , 1999). It is the free rather than total luminal Ca2+ that 
determines many aspects of the Ca2+ store ' s operation and creates the large Ca2+ gradient 
between the SR lumen ( I mM) and the cytoplasm (0.1 to 10 µM) which ensures efficient Ca2+ 
release. 
Activation of single RyR channels by luminal Ca2+ was first demonstrated by Sitsapesan and 
Williams ( 1994b) with lipid bilayer studies. Despite many similar studies having followed, the 
mechanism supporting luminal Ca2+ regulation of the RyR and the locations of the RyR-Ca2+ 
binding sites and/or sensors remains to be clarified. Although recent works by Qin et a l. (2009) 
have presented evidence that luminal Ca2+ does not regulate the RyRl channels, there is general 
agreement that channel activity is augmented when luminal [Ca2+] is increased. This may be 
attributed to an increased sensitivity of the RyR channel to cytosolic <tgonists such as cytosol ic 
ca2•, ATP, and caffeine, and an alleviation ofMg2+ inhibition (Gyorke and Gyorke, 1998; 
Sitsapesan and Williams, 1997). However arguments remain abo ut the mechanism of effects of 
luminal [Ca21 . Furthermore, different profi les of changes in RyR activity as a function of 
luminal [Ca21 (from nM to mM), i.e. activation, inhib ition and biphas ic, have been observed 
(Beard et al., 2005; Ching et al. , 2000; Gyorke and Gyorke, 1998; Gyorke et al. , 2004a; Gyorke 
et al., 2002; Herrmann-Frank and Lehmann-Hom, 1996; Laver et al. , 2004; Q in et al. , 2008; 
Sitsapesan and Wi lliams, 1995; Szegedi et al. , 1999; Tripathy and Meissner, 1996; Wei et al., 
2009a; Wei et al. , 2006). Nevertheless, it should be noted that in these studies, the luminal 
protein/protein interactions and the RyR macromolecular complex have not been genera ll y 
taken into consideration. 
The regulation of Ry Rs by lurninal Ca2+ has a complex dependence on membrane potentia l and 
lumina l (Ca21 (Laver, 2007; Xu and Meissner, 1998) indicating both c a2•-dependent activation 
and inhibition mechanism (Tripathy and Meissner, 1996). Two mechanisms for RyR 
modulation by luminal Ca2+ have been proposed. The "true luminal" hypothesis proposes that 
luminal regulation invo lves Ca2+ binding site(s) on the lumina l side of the RyR (S itsapesan and 
Williams, 1995), which is supported by the evidence that tryptic digestion of the lum inal 
domains of the RyR2 abolished luminal ca2•-acti vation, presumably destroying the Ca2+ sensing 
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site (C hin g et a l. , 2000). On th e other hand, the " feed-through" mechanism in vo lves luminal 
Ca2+ permeatin g the pore and bi nding to cytosol ic Ca2• s ite, namely A s ite (Herrmann-Frank and 
Lehmann-Ho m , 1996; Laver et a l. , 2004; T ri pa thy and Meissner, 1996; Xu et a l. , 1996b ). It 
appears th at e ither mechanism can o perate under diffe rent conditi ons (Laver, 2007; Laver et al. , 
2004). Three modes o f action associated w ith Ca2+ sensors are proposed: a luminal activation 
s ite (L-site, 40- 60 µM affinity with RyR2) (Laver, 2007; Laver and Honen, 2008), a 
cytoplasmic activati on site (A site) and cytoplasmic inactivati on 12-s ite (see secti on 1.6.5. 1.1). It 
is proposed that luminal Ca2• -activati o n is a multi step process. The initial Ca2• binding to the L 
site tri ggers brief channel o penings (- 1 ms durati on at rates of 1- 10 s" 1) , w hich a llows lumina l 
Ca2• to access the A-site, producing up to J O-fold prolongation of o penings; furthermore, the 
cytop lasmic Ca2•-inactivation site (12-s ite) causes a reducti o n in channel open durati ons at high 
leve ls of Ca2• feed-throu gh. In addition luminal Ca2+ has been shown to regulate Ca2+ rel ease 
from RyRs by (a) modi fy ing th e A-s ite affinity for cytoplasmic Mg2+ through a noncompetitive 
and a llosteric mechanism (Laver et al. , 2004) and (b) potentiating the RyR2 gating in the 
presence of ATP, predominantly by binding to a luminal s ite with an affinity in the mM range 
(Tencerova et a l. , 2012) . 
It is a lso poss ible that luminal Ca2• regulation is modulated by RyR accessory proteins. Multiple 
Juminal Ca2+ sensors have been suggested: CSQ (section 1.7) is o ne of the candidates (Beard et 
a l., 2005; Gyorke et al. , 2004a; Wei , 2008 ; Wei et al. , 2009a ; W ei et a l. , 2006). Indeed, by 
suppressing Ca2+ "feed-through", two luminal Ca2+ regulatory mechani sms have been identified 
in RyR2 (Qin et al. , 2008) . One is a Ry R2-res ident, CSQ2-independent luminal Ca2+ mechani sm 
that mod ul ates th e maximal effi cacy of cytosolic Ca2+ acti vatio n. H owever, it does not 
dist ing ui sh between lumina l Ca2+ and Mg2', making the physiological relevance of thi s CSQ2-
independent regu latio n uncertain . The other is a C SQ2-dependent luminal RyR2 Ca2+ regu lation 
mechan ism w hich does di scrim inate between luminal Ca2+ and M g2• . It has been suggested that 
this CSQ2-dependent mechan ism alte rs the cytosoli c Ca2+ sensit iv ity o f th e channe l and the 
c a2· -dependent CSQ2-triadin interact ion is likely th e key luminal Ca2•-sensing step (Qi n et a l. , 
2008) . Furthermore, thi s second CSQ2-dependent mechani sm is dependent o n th e presence or 
the absence of cytoso li c M g2+ and ATP (Chen et a l. , 2013) (see sectio n I. 7.3 .3). In addition , it 
has been shown by Q in et a l. (2009) th at CSQ-depend ent Juminal Ca2• regul ation of RyR2 Jacks 
CSQ isofo rm specificity, as both CSQ I and CSQ2 regulated RyR2 in a s imila r way (Qin et a l. , 
2009) . C urious ly, in co ntrast to RyR2 , no CSQ ]-depend ent lumina l Ca 2• regulati o n of RyR I 
channe ls was detected in the same study (Q in et a l. , 2009) . Anoth er accessory protein, junctin 
(secti o n 1.9), is a lso implicated in thi s luminal Ca2•-sensing process (Chen et a l. , 20 13 ; Gyorke 
et al. , 2004a; Wei et a l. , 2009a) . A recent study by A ltschafl et al. (2011 ) a lso suggests that 
junctin may affect th e RyR2 's sens iti vity to Jumi na l Ca2• . In general , more investigati ons a re 
required to e luc idate the prec ise mec hani sm of Jumina l Ca2+ regulation and Jum ina l Ca2+ sensors. 
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In cardiac muscle, luminal Ca2+ also contributes to the initiation and termination of inter-RyR2 
Ca2+-induced Ca2+ release (Chen et al. , 2013; Laver et al., 20 13; Terentyev et al., 2002). [n 
skeletal muscle, luminal Ca2+ modulates coupled gating of RyRl s (Laver et al. , 2004; Porta et 
al., 2012). 
1.6.5.1.3 Magnesium 
As a potent inhibitor ofRyRs, Mg2+ plays an important role in shaping both the cytosolic and 
luminal Ca2+-dependence ofRyR activity in the cell (Laver and Honen, 2008; Meissner and 
Henderson, 1987). In the cytoplasm, magnesium (9 mM) is buffered by ATP (- 8 mM) so that 
the free [Mg2+]cy1o is - 1 mM (Godt and Maughan, 1988). The free [Mg2+] in the SR has not been 
directly determined but is predicted to be sim ilar to that in cytoplasm and approximate ly half 
that of free [Ca2+]sR (between 0.7 and 1.0 rnM) (Laver and Honen, 2008). RyRl is inhibited 
by >500 µM cytoplasmic Mg2+ and completely inactivated by millimolar concentrations 
(reviewed in (Ziss imopou los and Lai, 2007)). Thus, cytoplasmic Mg2+ inhibition is believed to 
be crucial for maintaining RyRl in a closed resting state. In contrast, RyR2 and RyR3 are much 
less sensitive to Mg2+ inhibition than RyR I (reviewed in (Zissimopou los and Lai, 2007)). The 
mechanism by which Mg2+ inhibits the RyR channel activity is complicated. As yet, three forms 
ofMg2+-inhibition have been identified which involve the binding ofMg2+ to the A-, L- and I1-
Ca2+ sensing sites on the RyR. Mg2+ can inhibit RyRs by: (a) Mg2+ competing with Ca2+ for the 
activation site (A site) and acting as a RyR antagonist in the absence ofCa2+ (Laver et al. , 2004); 
(b) Mg2+ binding to the low affinity inhibition site (Il -site) as a surrogate for Ca2+, both (a) and 
(b) cause charmel closure; and (c) a recently discovered Juminal Mg2•-inhibition mechanism, 
which involves Mg2+ displacing Ca2+ from the L-site and then Mg2+ flowing through the channel 
and binding to the A-site, thus terminating channel opening (Laver and Honen, 2008). The 
affinity of Mg2+ for A site is approximately 40-1 000 fold lower than that of Ca2+ (Laver et al., 
1997b; Meissner et al., 1986), while the affinities ofil - and L-sites for Mg2+ are identical to that 
for Ca2+ (JI -site: -200 µM with RyR I and -10 mM with RyR2 ; L-site, - 40 µM with RyR2) 
(Laver et al. , 1997a; Laver and Honen, 2008; Laver et al. , 2004; Laver et al. , 1995); the very 
low affinity for the II-site in RyR2 a lso explains the low sensitivity of RyR2 to Mg2+ inhibition 
and accordingly, Mg2+ should play on ly a minor inhibitory role at physiological concentrations 
(- 1 rnM) in cardiac muscle. In contrast, intracellular Mg2+ (- 1 mM) can exert a powerful 
inhibitory effect on RyRl at rest. Consequently, in skeletal EC coupling, RyRl cannot be 
activated simply by Ca2+ binding to the A site. Both luminal and cytoplasm ic Mg2+ inhibition 
can be alleviated by increasing [Ca21L or [Ca21c (Laver and Honen, 2008). In addition in 
skeletal muscle, Mg2+ inhibition can be relieved by depo larization oftbe surface membrane 
(Lamb, 1993; Lamb and Stephenson, 1991). More recently, a study by Porta et al. (2012) has 
indicated that Mg2+, together with ATP and high luminal [Ca21, is required for the coupled 
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gating of RyR Is, and that ATP alone was not as effective as A TP/Mg2+ in a llowing coupled 
gating. 
1.6.5.1.4 Adenine nucleotides 
Aden ine nucleotides, including ATP, are maj or modulators of Ca2+ release channel function. 
Cytop lasmic ATP acts as both an energy source for muscle fu nction and an effecti ve RyR 
activator, both at rest and during EC coupling (Meissner et a l., 1986; Rubtsov and Batrukova, 
1997). At concentrat ions above I mM, ATP exerts its near-maximal action on the RyR. Other 
adenine nucleotides also enhance RyR channel activity but to a lesser extent, with a potency of 
AMP-PCP > cyc lic-AMP (c-AMP) > ADP> AMP (Kermode et al. , 1998; Laver et al. , 2001 ; 
Meissner et al. , 1986). In the cytoplasm, the resting concentration of ATP is arou nd 6-8 mM, 
with most of the ATP existing in a Mg2•-bound form (Sonnleitner et al. , 1997). The three RyR 
isoforms exhibit di stinct patterns of modulation by ATP (Laver, 20 IO; Zucchi and Ronca-
Testoni , 1997). Single channel experiments show that A TP ' s effect on RyR2 is less remarkable 
than its effect on RyRI s (Meissner and Henderson, 1987; Xu et al. , 1996a); ryanodine binding 
assays confirm that ATP sens itivity is lower in cardiac muscle than in skeletal muscle 
(Michalak et a l. , 1988; Zimanyi and Pessah, 199 l ). In cardiac Ry Rs, ATP promotes channel 
activation by Ca2+ but cannot open the channel in the absence of Ca2+ (reviewed in (Laver, 
2010)) . Cardiac RyR activation by ATP is controlled by luminal Ca2+ levels: low [Ca2+]1,m (1 
mM) enhance the affinity ofRyR2 for ATP, but ATP does not activate the channel ; at higher 
[Ca2+]1,m (8-53 mM, which is outside the physiological range encountered during normal Ca2• 
cycling), the activation effect of ATP on RyR2 is markedl y amplified without altering the 
affinity ofRyR2 for ATP (Tencerova et al. , 2012). ln contrast, ATP augments skeletal RyR' s 
act ivity in a Ca2•-independent manner and a combination of millimolar ATP and micromolar 
cytoplasm ic Ca2• e li c its persistent chan nel activation (Meissner et al. , 1986). ATP al so enhances 
RyR3 channel activi ty and overcomes inhibition by millimolar Ca2+ (Chen et al. , 1997; Manunta 
et a l. , 2000). The isoform -specific modulation by ATP partly underlies the vari ed characteristics 
of the Ca2+ release mechanisms found in different muscle types (reviewed in (F ill and Capello, 
2002)). Several studies indicate that the acti vating effect of ATP occurs through direct binding 
to one or more sites on RyR I that fu nction cooperatively in the tetrameric channel (Hohenegger 
et al. , 1995; Lai et al. , 1988; Meissner, 1984). Covalent photo-reactive labeling demonstrates 
that three regions in RyR I are in vo lved in ATP-binding (Popova et a l. , 20 12). These regions are 
widely separated in the primary structu re of RyR I. The putative ATP-binding to conserved 
moti fs within residues 427- 1302 (fragment 8) provide a structural basis fo r the ATP binding 
pocket; and two other fragments 15 and 11 (res idues 2402-2795 and 4476-5037 respective ly) 
could e ither participate in the confo rmational arrangement of the same ATP binding pocket or 
constitute non-canonica l ATP bind ing s ites in RyRI (Popova et al., 2012). 
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1.6.5.2 RyR interaction with luminal proteins 
In all muscle types, RyR forms the center of a large multi-protein complex, including 
extracellular, cytoplasmic and SR luminal components linked by transmembrane entities, which 
together enable the RyR complex to sense the envirorunent in each compartment (whether 
extracellular, cytoplasmic, or SR lumen) and to properly regulate intracellular Ca2+ release. 
Luminal proteins associated with RyR include calsequestrin (CSQ), the major luminal Ca2+ 
binding protein , and junctin and tri ad in, the anchoring proteins which link CSQ to RyR, and 
themselves modulate RyR activity, thereby playing a ro le in controlling Ca2• rel ease from the 
SR. The molecular interactions between CSQ, junctin, triadin , and RyR in the SR lumen may 
faci litate changes in Ca2+ release in response to alterations in SR Ca2+ load, and are believed to 
be of fundamental importance to Ca2+ homeostasis, as manipulation of the expression levels of 
any of the proteins can lead to mass ive adaptive changes. Additionally, several other Ca2+ 
binding proteins and small molecules are also present in the SR lumen and play a role in RyR 
regu lation and Ca2+ homeostasis, e.g. , hi stidine-rich Ca2• binding (HRC) protein, sarcalumenin 
(SLM), junctate, JP-45 , and CSQ-like proteins. Subsequent sections will focus on the maj or 
luminal regulators of both skeleta l and cardiac RyR: CSQ, junctin and triad in. 
1.7 CSQ 
Calsequestrin, or CSQ, was first iso lated from the SR of rabbit skeletal muscle in the early 
1970s (Ikemoto et al., 1972; MacLennan and Wong, 1971; Meissner et al. , 1973), and was 
identified as a major Ca2+ storage and buffering prote in of approximately 400 residues with a 
molecular weight of-44 kDa. This skeletal isoform of CSQ has since been referred to as CSQJ. 
A few years later, another CSQ isoform was identified in cardiac tissue (Campbell et al. , J 983) 
and termed CSQ2. Structural studies have shown that CSQ is concentrated in the proximity of 
the SRjunctional face on which RyR arrays can be fo und (Campbell et al., 1983; Saito et al., 
1984), where it appears as an electron dense matrix in the SR lumen. Deep-etch electron 
microscopy reveals the presence of thin strands, or anchoring filaments - likely to be triad in and 
junction - that seem to connect CSQ to the SR (Franzini-Armstrong et al. , 1987). CSQ is by far 
the most abundant Ca2•-binding protein in the SR of both skeletal and cardiac muscle. CSQ 
binds Ca2• with a high capacity (40-50 mo! Ca2• mol"1 CSQ) and either a low or moderate 
affinity (Kd~ I mM) depending on the isoform under consideration (reviewed in (Beard et al., 
2004)). The high storage capacity of CSQ allows SR-stored Ca2+ to reach levels of up to 20 mM 
while the free Ca2• concentration remains sufficiently lower at - 1 mM. The stored Ca2• enables 
frequent muscle contraction with minimal run-down in Ca2+ ava ilable for release and in tens ion 
- both being essential for the maintenance of movement. 
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CSQ is highly hydrophilic and acidic, with ro ughl y 30% of its residues acidic, and a 
commensurate isoelectri c point (pl ) of - 3. 75 (S lupsky et al. , 1987). The carboxyl-terminal 
domain conta ins the highest surface negati ve charge density. An aspartate-rich region (residues 
354-367 in rabbit CSQ J) at the C-terminus is the major Ca2+ binding motif of CSQ - and also 
interacts with "KEKE" moti fs present in tri ad in and poss ib ly junctin (see section I .8 and I .9), 
perhaps by fo rming a po lar zipper-like structure (Kobayashi et al. , 2000; Shin et al. , 2000). It is 
therefore currently accepted that the C-terminus of CSQ constitutes the reg ion which binds Ca1+, 
triadin and/or junctin. 
1.7.1 CSQ gene, isoforms 
The two mammalian isoforms of CSQ I and CSQ2 are encoded by two different genes (Fliegel 
et al. , 1990 ; Scott et a l. , I 988) . CSQ I is the sole isoform found in fast-twitch ske letal muscle 
and the maj or isoform found in slow-twitch skeletal muscle, while CSQ2 is the only isoform 
expressed in the heart and a minor component in slow-twitch muscles (Fliegel et al. , I 990; 
Labat et al. , 200 I ; Paolini et a l. , 2007; Scott et al., 1988). ln addition, CSQ is expressed in 
smooth muscle, the cerebe llum, and plant cells (Krause et a l. , I 989 ; Volpe et al. , 1990; Volpe et 
a l. , I 994 ). 
There is a high degree of sequence homology (from 74% to 98%) between the skeleta l and 
cardiac CSQ in a number of different species (reviewed in (Bea rd et al. , 2004), suggesting a 
structu ra l similarity. One maj or difference between the two isoforms can be found in the ir C-
terminal domains. Compared with skeletal isoform, the cardiac isoform has an extended C-
terminus (res idues 367-39 1 ), composed of 7 I% acidic residues. Curiously however, Ca1+ 
binding to CSQ2 is 50% lower than to CSQ I and, as [Ca'+] increases from the n.M to the mM 
range, CSQ2 undergoes fewer confo rmational changes than does CSQ I (Cozens and Reithmeier, 
I 984; Ike moto et a l. , I 972; Ikemoto et al., I 974; Ostwald et al. , I 974; Park et a l. , 2004; Slupsky 
et al. , I 987 ; Wei et a l. , 2009b). The di fference in sequence between the two isoforms is very 
like ly to underli e the ir diffe ring behaviours, and thi s may in turn explai n the isofonn-spec ificity 
ofCSQ's regulat ion of RyRs ((Wei et a l. , 2009b) and section I .7.3.3). 
1. 7 .2 CSQ structure and Ca2+-binding properties 
The crysta l structure of CSQ I deri ved from rabbit skeleta l muscle was determined in the late 
90s, at a reso lution of2.4 A (Wang et al. , I 998). The CSQ monomer is composed of three 
a lmost identica l di sk- like do mains, each with a compact thioredoxin-like fold with fou r a-
he li ces surrounding a ~-sheet core which is sta ble in the presence o f Ca1+. Each domain is 
hydrophob ic due to high aromatic ami no acid content. However, a great number of acidic 
residues on the exterior domain surfaces ensure an overa ll e lectronegati ve potential. The three 
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domains are connected by short inter-domain loops, which also contain many acidic res idues. 
The arrangement of these three domains of the CSQ monomer provide it with a characteristic 
acidic and hydrophilic center, which is important in a llowing cation binding to CSQ which then 
neutrali zes charge repulsion and stabilizes CSQ' s confo rmation. The crystal structu re of both 
canine and human cardiac CSQ has subsequently been found to be very similar to that of rabbit 
skeleta l CSQ (Kim et al. , 2007; Park et al., 2004). 
In general, CSQ ex_ists either as a monomer or as CSQ polymers with a wide range of molecular 
masses, depending on the local ionic strength and Ca1+ concentration (Kim et al. , 2007; Park et 
al., 2004; Park et al. , 2003). Increasing [Ca1+] promotes CSQ polymerization, which in turn 
further increases CSQ' s Ca1+-binding capacity (Wang et al. , 1998); converse ly, K+ inhibits this 
process by inducing CSQ fo lding. Changes in pH may also be an important regulator of CSQ 
polymerization. A substantial amount of evidence shows radical changes in the structure of 
CSQ upon Ca2+ binding (reviewed in (Beard et al. , 2004; Novak and Soukup, 20 I I)). Briefly, 
when Ca2+ is absent, CSQ is highly extended, with about 11 % a-helical content in CSQ I and 
- 3.5% a-helical content in CSQ2 (Cozens and Reithmeier, 1984; Ikemoto et al., 1972; Ikemoto 
et al., 1974; Ostwald et al., 1974). Ca2+ binding induces CSQ compaction, causing a loss of 
overall hydrophob icity with decreases in conformational asymmetry and increases in the protein 
a-helical content (20-35% in CSQI and I 0.9% in CSQ2 at l mM Ca2+) (Cozens and Reithmeier, 
1984; Ikemoto et al., 1972; Ostwald et al. , 1974). The polymer fo rms as more Ca2+ ions bind to 
CSQ. It is believed that the structural changes CSQ undergoes upon binding Ca2+ lead to a 
compact fo rm which is required for high capacity Ca1+ binding (He et al., 1993). Moreover, Ca2+ 
binding to CSQ prevents other proteins from interacting with CSQ - for example, triadin and 
junctin - and further helps protect CSQ from proteolytic digestion (Mitchell et al. , 1988; 
Ohnishi and Reithmeier, 1987). 
Wang et al. (1998) predicted that two types of interactions are required for CSQ polymerization 
- front-to-front dimerization and then back-to-back packaging, which generate linear polymers. 
Deletion mutation studies confirm the invo lvement of both the N - and C-termin i of the 
monomer in front-to-front and back-to-back interactions respectively (Ba] et al. , 20 IO; Gatti et 
al., 200 I ; Park et a l. , 2003). Furthem10re, the front-to-front interaction occurs prior to back-to-
back interaction as the N-terminal arm has fewer charged amino acid residues than the C-
terminal tail and thus requires less cations to shie ld the acid ic residues (Park et al. , 2003). It was 
proposed that an increase in [Ca21 to - 10 µM causes CSQ monomer compaction and fu rther 
increases to between 10 µM and 1 mM lead to dimerization and thence polymerization (Beard et 
al., 2004). Studies by Wei et al. (Wei, 2008; Wei et al. , 2009b) demonstrated that CSQ! and 
CSQ2 are monomeri c at 0.1-100 µM [Ca2l , and with a physio logical [Ca2l of 1 mM, CSQI is 
mostly polymerized while CSQ2 is still mostly monomeric/dimeric. Park et a l. (2003) proposed 
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that regulation of [Ca2+] by CSQ involves an interplay between protein folding, Ca2+ binding, 
and CSQ polymeri zation. Additionally, the differences between the skeletal and cardiac CSQ's 
dispos ition in the jSR (Franzini-Armstrong, 2009) and functional domains has been suggested to 
be likely consequent to the ratio ofCSQ to triadin andjunctin. These authors also concluded 
that the c lustering of CSQ in the junctional domain of SR required a specific interaction of CSQ 
with triadin andjunctin, and further, that this interaction also defined the specific architecture of 
CSQ (Franzini-Armstrong, 2009). Recent results obtained both in vivo (living cell image 
analys is) and in vitro strongly suggest that the presence of junctin is required for 
depolymerization of CSQ upon Ca2+ depletion, and therefore that direct interactions between 
junctin and CSQ are necessary for CSQ-mediated control of[Ca2+] in SR (Lee et al. , 201 2). 
1.7.3 CSQ function 
A considerable body of evidence supports the concept that CSQ plays at least two different roles 
in skeletal and cardiac myocytes (reviewed in (Beard et al. , 2004; Beard et al. , 2009 ; Gyorke et 
a l. , 2009; Gyorke and Terentyev, 2008; Knollmann, 2009; Novak and Soukup, 2011 )). This is 
mostly deri ved from experiments using knockouts and mutations which express different levels 
ofCSQ isoforms, in addition to reconstitution into lipid bilayers. As a Ca2+ buffer in the SR 
lumen, CSQ supp lies the bulk ofCa2+ and participates actively in muscle contraction by 
loca li zing Ca2+ near its points of release and regulating the amount ofCa2+ released through the 
RyR channel. At the same time, it helps keep the free Ca2+ concentration relatively low, thus 
a llowing more efficient inward transport by the sarco/endoplasmic reticulum calcium ATPase 
(SERCA) pumps. On the other hand, CSQ serves as a modulator of SR Ca2+ release channel 
activity, e ither directly or via triadin/junctin , in a luminal Ca2+-dependent manner, potentially by 
acting as luminal Ca2+ sensor for RyR. Whether this modulation is an essential component of 
EC coupling re mains to be determined (Beard et al. , 2005 ; Dulhunty et al. , 2006; Gilchri st et al., 
1992; Gyorke et al. , 2004b; Terentyev et a l., 2006; Terentyev et a l. , 2003; Toyoshima and lnesi, 
2004). The impact of CSQ on RyR charmel act ivity is st ill under debate as both activation and 
inhibition by CSQ have been reported, regardless of which CSQ isoform is under cons ideration 
(for more deta il , see section 1.7.3.3). 
1. 7.3.1 Changes in CSQ expression in genetic mice models and myocytes 
1.7.3 .1.1 Overexpression 
Transgenic mouse hearts express ing IO to 20-fo ld higher levels of either canine or murine 
ca rdiac CSQ develop cardiac hypertrophy and heart failure , due to enlargement of ventricular 
myocytes, impaim1ent ofCa2• release from SR, and a decrease in Ca2+ spark frequency (Jones et 
a l. , 1998; Knollmann et al. , 2000; Sato et al. , 1998; Wang et al. , 2000). A marked increase in the 
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SR Ca2+ content was observed in cardiac myocytes in tbese studies, consistent with the theory 
that SR Ca2+ storage capacity increases with CSQ2 overexpress ion. The reason for depressed 
Ca2+ transient and contracti li ty may be explained by the excess CSQ2 binding more ca2•, 
leading to a reduction in free Ca2+ ava ilab le in the SR for rel ease. Furthermore the 
overexpress ion of CSQ results in a considerable widening of the jSR cisternae and an a ltered 
appearance of its contents, which become more finely granular and diffuse (Jones et al. , 1998; 
Tijskens et al. , 2003). This is ascribed to excess CSQ2 not binding to the membrane via triadin 
or junctin and therefore acquiring a more diffuse di sposition (Franzini-Armstrong et al. , 2005). 
In addition , chronic CSQ2 overexpression induces adaptation by altering the express ion of other 
proteins. RyR, triad in, and junctin expression leve ls can be downregulated (Jones et al. , 1998), 
while Ca2+-ATPase and phospoholam ban can be increased (Sato et al. , 1998). The changes 
make it diffi cult to attribute the changes in myocyte structure and function so lely to CSQ2. 
Two acute overexpression studies have been performed to minimize the impact of adaptive 
developmenta l responses in the whole animal (M iller et al., 2005 ; Terentyev et al., 2003). 
Overexpression of CSQ2 generated by adenovirus-mediated transfection of cardiomyocytes by a 
factor of - 4 x over 48-56 h resulted in proportiona l increases in the SR Ca2+ load, SR Ca1+ 
re lease, and a prolongation of the rel ease phase. This suggested that tbe inactivation of RyR2 
was delayed by the buffer action of CSQ2, although no specific inhibitory action of CSQ2 on 
RyR2 was observed (Terentyev et a l. , 2003). A limited increase in CSQ2 (- 1.6-fold) express ion 
Jed aga in to an increase in SR Ca2+ levels, but reduced EC coupl ing (Miller et a l. , 2005). This 
latter resu lt was observed in one transgenic mouse model (Jones et al. , 1998; Sato et al. , 1998), 
altbough not in others (Terentyev et al. , 2003 ). Whi le discrepancy exists among these various 
studies, in general, most of the results suggest an inhibitory effect of CSQ2 on RyR2 activity, 
and as a Ca1+ storage prote in. 
In contrast to CSQ2, overexpression of skeletal CSQl in cultured mouse C2Cl2 myotubes led 
to an enhancement in caffeine- and vo ltage-induced Ca1+ release, associated with an increase in 
the SR Ca2+ load (Shin et al. , 2003). The differences between the skeletal and card iac models 
may be due to specific Ca2+ signaling modulation by the ske letal and cardiac CSQ and RyR 
isoforms (Wei et al., 2009b). A profo und depress ion of store-operated Ca1+ entry (SOCE) was 
also observed in the CSQ I overexpression model , indicating the participation of CSQ I in the 
regulatio~ of SOCE in skeletal muscle; th is CSQ-mediated inhibition of SOCE was attributed to 
the C-terminal aspartate-rich tail, since overexpression of CSQ I witbout thi s region did not alter 
SOCE (Shin et al. , 2003). Importantly, this aspartate-rich region is necessary for Ca2• 
binding/CSQ polymeri zation, as wel l as for interacting with triadin and/or junctin (Shin et al., 
2000). In agreement with the Shin study (Shin et al., 2003), CSQl -knockdown skeleta l muscle 
fibers exhibits significant elevation in SOCE (Zhao et al. , 20 I 0). 
35 
1.7.3.1.2 Down-regulation 
Despite the important function s ascribed to CSQ, the genetic ablation of CSQ I, CSQ2, or both 
is not birth-lethal in mouse models. Initial evidence from null CSQ mutations in C. elegans wa ll 
musc les (which express a s ingle CSQ isoform) (Cho et al. , 2000) also suggests that CSQ is not 
essential for muscle function. Knollmann et al. (2006) characteri zed the first CSQ2 knockout 
mouse as a model for CPVT associated with CSQ mutations. CSQ2-null mice are viable and 
maintain relatively normal Ca2+ rel ease, myocyte contractile function , and SR Ca2+ load under 
basa l cond itions, although they exhibit an increase in SR vo lume and a near absence oftriadin-1 
and junctin. So far, there is no consensus on the mechanism which compensates for CSQ-
ablation , a lthough SR Ca2+ storage capacity is preserved (Knollmann, 2009). One poss ibility is 
that changes in expression of other SR proteins such as triad in and junctin increase the SR Ca2+ 
content by affecting Ca2+ release through RyR2s. In support of thi s, homozygous CSQ2 
nonsense mutations in humans do not alter contractile function (Postma et al. , 2002). However, 
myocytes show significantly increased SR Ca2+ leak when exposed to isoproterenol , a drug used 
to induce CPVT (Knollmann, 2009; Knollmann et al. , 2006) . Loss ofCSQ2 is thus suggested to 
contribute to an increased ri sk of triggered arrhythmia, but may paradoxically protect against 
reentrant-type arrhythmia (Komyeyev et a l. , 2012). Thus, it appears that CSQ2 is not essential 
for cardiac Ca2+ storage, but protects the heart against premature Ca2+ release and triggered 
arrhythmias. Together with triadin, CSQ2 seems important for the structural organization of the 
SR. 
Considerable evidence has shown that [Ca2+] in the SR lumen regulates RyR (see section 
1.6.5.1.2) and that the rate of SR Ca2+ leak is propotional to SR luminal [Ca2J in a nonlinear 
fas hion (Gyorke and Gyorke, 1998; Gyorke et al. , 2002; Lukyanenko et al. , 1996; Lukyanenko 
et a l. , 200 I; Shannon et al. , 2002; Terentyev et al. , 2002). Ablation of CSQ2 results in a steeper 
re lationship between SR Ca2+ leak and Ca2+ content in the SR, increasing the overall probabili ty 
o f spontaneous Ca2+ rel ease at lower load leve ls (Du lhunty et a l., 2012; Knollmann et al., 2006). 
Heterozygous CSQ2-KO mice with only a modest (- 25%) reduction in CSQ2 al so have a 
steeper SR Ca2• content-SR Ca2• leak re lationship (Chopra et al. , 2007; Chopra and Knollmann, 
2009). Hearts lack ing CSQ2 demonstrate a larger SR Ca2+ release triggered at the same free 
intra-SR ca2· concentration (Kornyeyev et a l. , 2012). These results support a role for CSQ2 in 
luminal Ry R2 regul ation, which is in add iti on to its ro le in globa l SR Ca2• buffering. However, 
it remains uncertain whether the loss of RyR2 regulation is due to the reduction in levels of 
CSQ2 itse lf or to changes in expression of prote ins mediating CSQ2 's binding to RyR2 
channels, i.e., triad in and junctin (Gyorke et a l. , 2004a; Wei et al. , 2009b). The greater Ca2+ 
re lease with lower luminal Ca2• load fo llowing CSQ2 deletion or reduction may underlie the 
triggered beats in CSQ2-null myocytes, and the ventri culuar tachycardia observed in vivo 
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(Faggioni and Knollmann, 2012; Knollmann, 2009). Restoring CSQ2 in CSQ2-null mice by 
vira l gene transfer restored normal levels of both triadin and junctin, rescued 
electrophysiological and ultrastructural abnormalities, and prevented life-threatening 
arrhythmias (Denegri et al. , 2012) 
Extensive work has also been done with CSQl-null mice. The first knockout mouse lacking 
CSQ 1 was generated and characterized in 2007 (Paolini et al., 2007). Under standard housing 
conditions, CSQl-null mice are viable and fertile , capable of muscle contraction, and develop 
normally, in spite of muscle atrophy. However, there are changes in both the EC coupling 
apparatus and the intracellular Ca2+ flux in CSQ I-null mice; more evident in fast-twitch muscles 
(EDL) than slow-twitch muscles (soleus), likely because soleus expresses CSQ2. Lack ofCSQI 
alters the ultrastructure by a) proliferation of SRjunctional domains; b) reducing the size of SR 
terminal cisternae; c) increasing the density ofCa2+-release channels (RyR); and d) increasing 
numbers of mitochondria. This demonstrates the importance of CSQ I in the correct assembly of 
calcium release units (CRUs) and for the geometry of the SR in mature fast twitch fibers. In the 
knockout animals, twitch force is preserved; although characterized by a prolonged time course, 
reflecting slower Ca2+ re-uptake by the SR. CSQ I knockout also leads to an increased SR Ca2+ 
depletion rate and the inability of muscles to sustain tension during a prolonged tetani. Thus, 
CSQ I is indispensable for normal SR and CRU development and for the storage and release of 
appropriate amounts of SR Ca2+. Contractile function in CSQ I-null mice under normal 
conditions may be due to adaptive changes in muscle structure and protein composition. It 
should be noted that in this study (Paolini et al. , 2007), there was a relatively small reduction in 
electrically evoked Ca2+ transients and the total amount of releasable Ca2+ in the SR; sim ilar 
unexpected findings were also reported in other skeletal studies (Royer et al. , 2010; Wang et al., 
2006) and in the cardiac field (Knollmann, 2009; Knollmann et al. , 2006), suggesting that a 
means of Ca2+ storage unrelated to CSQ must play a key role in muscle - at least in the CSQ 1-
null animals. The experiments confirm the role of CSQ as a Ca2+ storage device, though this 
role may not be as critical as was previously thought. 
Although CSQl ablation does not appear to impair motor activity under normal conditions, 
surprisingly, male CSQ]-null mice displayed a significantly increased incidence of spontaneous 
mortality and are susceptible to halothane- and heat-induced sudden death (Dainese et al. , 2009), 
the phenotype of malignant hyperthermia (MH) and environmental heat stroke (EHS) in humans 
and animal models. Both this study and the work done by Royer et al. (20 I 0) support the 
proposed role of CSQ I as a luminal Ca2+ sensor that inhibits RyR-mediated SR Ca2+ release 
(Beard et al. , 2002; Wei et al. , 2006). The authors of these three articles argue that loss-of-
function mutations in CSQ! strongly enhanced MH and EHS susceptibility in mice, providing 
evidence that disruption in the regulation of RyR by CSQI represents a novel pathogen ic 
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mechanism that underlies skeleta l muscle (MH and EHS) di seases (Dainese et al. , 2009; Protasi 
et al. , 2011 ; Protasi et al. , 2009), analogous to CSQ2 and CPVT. 
These stud ies (Da inese et al. , 2009; Paolini et a l. , 2007) indicate a perturbation in calcium 
handling in the cell. To address the nature of the calcium dysregulation, CSQ l-KO and 
CSQ I /CSQ2-null ( i.e., CSQ-double KO, DKO) mice were generated and free [Ca2+] ins ide the 
SR of flexor digitorum brevis (FOB) was measured directly us ing a targetable ratiometric 
FRET-based calc ium indicator (Canato et a l. , 2010). While no obvious difference in free SR 
[Ca2+] at rest was observed between WT, CSQ I-KO and CSQ-DKO fibers, ablation of CSQ 
( either CSQ I alone or both CSQ I and CSQ2) led to dramatic decrease in intraluminal free SR 
Ca2+ during electrical stimulation and a concomitant depletion of the SR Ca2+ store. In contrast, 
changes in the WT were small during sustained contraction, reflecting the potent buffering 
capabilities ofCSQ. 
Changes in CSQ 1-null mice could be caused either by CSQ I depletion or by adaptive changes 
that mask CSQ I function. Reconstitution of CSQ I in FOB fibers from CSQ I-null mice restored 
Ca2+ storage capacity and prevented SR depletion, showing that the SR Ca2+ storage ab ility and 
proper coordination ofCa2+ release and reuptake both require CSQl. In addition, the terminal 
c isternae (TC) lumen was filled with electron dense matrix referable to CSQ, and its width was 
increased to that of WT fibers. The results support the cruc ial role of CSQI in both Ca2+ 
homeostasis and TC structu re (Tomasi et al. , 2012). 
1.7.3.2 CSQ polymorphism 
Catecho lam inergic polymorphic ventricular tachycardia (CPVT) is an i11herited arrhythmogenic 
condition. The di sorder manifests at a young age and is characterised by syncope events, 
se izures , and sudden cardi ac death fo llowing exercise or emotional stress, without any gross 
st ructural changes of the myocardium . The disease has been related to mutations in the cardiac 
RyR2, cardi ac CSQ2 or tri ad in (Trisk 32) (Roux-Bui sson et a l., 2012), with RyR2 mutation 
be ing most commonl y linked to thi s di sease. CSQ2-linked CPVT accounts fo r 3-5% of al l 
CPVT cases (Fagg ioni and Knollmann , 2012), and the mutations in CSQ are autosomal 
recess ive. To date, 15 mutati ons in the CSQ2 gene have been assoc iated w ith CPVT, including 
missense, nonsense, deletion, or frameshift mutations which may deplete CSQ2 in the SR 
(Faggioni and Knollmann , 20 12). Various CSQ2 mutations like ly act through at least two 
different mechani sms to induce arrhythmia: a) altering the Ca2+ storage and buffering function 
o f CSQ2 and b) changing the way in which RyR2 is modulated by CSQ2, e.g., by affecting the 
interacti ons of CSQ2 with the RyR2 complex (Gyorke and Terentyev, 2008). Specifically, the 
CSQ2 0 307H mutant prevented Ca2+-dependent confonnational changes, di srupted Ca2+ 
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binding to CSQ, and led to a failure of CSQ to bind normally to triadin and jun ct in (Houle et al. , 
2004). 
CSQl gene polymorphisms have been associated with type 2 diabetes. The gene is encoded on 
chromosome I q21, a region that has been linked to type 2 diabetes in diverse populations (Fu et 
al., 2004). More than ten single nucleotide polymorphisms (SNP) have been identified, each 
encoding a single missense, deletion, or insertion (Das et al. , 2004). Increased CSQ expression 
and calcium binding was reported in diabetic rat skeletal muscle, although not in their cardiac 
muscle (Howarth et al., 2002). Therefore, CSQ I may play a potential role in diabetic 
susceptibi li ty. 
1. 7.3.3 Effects of CSQ on RyR channel activity revealed by lipid bilayers study 
The direct effect of CSQ on the kinetics of RyR channel opening and closing has been evaluated 
in single channel lipid bilayer. However, the molecular interactions between CSQ2 and RyR2 
are currently less well-characterized than those ofCSQl and RyRl. 
CSQl inhibits native RyRl in complex with triadin andjunctin: the inhibition depends on 
lurninal [Ca2+] and is mediated through junctin, though not triad in. In contrast, purified RyRl 
channels (lacking triadin andjunctin) are activated by CSQl (Beard et al., 2005; Beard et al. , 
2002; Wei et al., 2009a; Wei et al. , 2006). At a physiological luminal [Ca2+] of 1 mM, CSQ I in 
its polymer conformation inhibits RyR l opening. This inhibi tion is lost after a 2-3 min exposure 
to .'.S 100 µM Ca2+, as CSQ l depolymerizes, leaving on ly non-functional monomers remaining 
associated with the anchoring protein, e.g. , triadin and/or junctin . The immediate effect of 
lowering luminal Ca2+ is reduction in activity which is maintained until CSQ depolymerizes. In 
contrast, while RyRI is CSQl regulated, lowering luminal [Ca2+] either does not alter or rapidly 
reduces activity. Thus the CSQ polymer prevents excess Ca2+ release by reducing RyR activity 
when luminal [Ca2J is transiently depleted (Wei et al. , 2006). Higher [Ca2+] (2: 3 mM) exposure 
for 3-5 min a lso results in the loss of inhibition, as CSQl becomes super-compacted and 
dissociates from triad in and junctin (reviewed in (Beard et al. , 2009)). In conclusion the luminal 
Ca1+ dependence of the regulatory effects ofCSQ l supports the notion that CSQ may serve as a 
luminal Ca1+ sensor for RyRI in a manner facilitated by junctin. Curiously, no action of either 
CSQl or .CSQ2 on RyR I channels has also been reported (Qin et al. , 2009). This finding led the 
authors to believe that the CSQ I primarily serves as an intra-SR Ca2+ buffer in skeletal muscle 
and not as a RyRl regulator (Qin et al., 2009). Clearly, CSQ I-dependent RyRl regulation 
warrants further investigation. 
The regulation ofRyR2 by CSQ2 is more controversial. Gyorke et al. (2004a) found a simi lar 
inhibitory effect of CSQ2 on RyR2 associated with luminal triad in and junctin, although no 
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inhibition was ev ident with CSQ2 added to purified RyR2. The observed inhibition was Ca2+-
dependent, i.e., it occurred at low (20 µM) but not at high (5 mM) luminal Ca1+ levels (Gyorke 
et al. , 2004a). The inhibition was proposed to be transmitted through triadin (Qin et al. , 2008; 
Terentyev et al. , 2007) and possibly junctin. The purification of RyR2 led to a loss of its ab ility 
to respond to luminal ca2+, while re-association with both CSQ2 and the anchoring prote ins 
resto red RyR2 ' s responsiveness to luminal Ca2+. The results suggested that CSQ2 may have a 
ro le as a luminal Ca1+ sensor for RyR2, as proposed for CSQI /RyR I described above. However, 
studies by two other independent groups fo und that CSQ2 activates CSQ2-stripped native RyR2 
channels wi th both I mM and lower luminal [Ca2+] genera lly in the physio logica l range (Qin et 
a l. , 2009; Q in et a l. , 2008; Wei et a l. , 2008; Wei et al. , 2009b). The apparent di screpancy could 
be due to the experimenta l conditions, e.g., purified or nati ve RyR2, the luminal [Ca2+], the 
presence or absence of cytosolic Mg2+ and ATP, etc. The issue has been further add ressed in a 
recent study (Chen et al., 2013). WT-CSQ2 action on RyR2 function was determined by 
cytosol ic MgA TP. When endogenous CSQ had been removed fro m RyR2, adding exogenous 
WT CSQ2 in the presence of cytoso lic MgA TP decreased channel acti vity and reduced 
activation by cytoso lic Ca2+. The reconstituted WT CSQ2-RyR2 complex was insensitive to 
luminal Ca2+ between 0.1 and I mM. Converse ly, when cytosolic Mg2+ and ATP were absent, 
the add ition ofCSQ2 increased RyR2 opening, and the same change in luminal [Ca2+] 
s ignificantly increased RyR2 acti v ity (Qin et al. , 2008). Thus, CSQ association/d issoc iation was 
suggested to be a prominent RyR2 regulatory event in vivo. The absence of a luminal Ca2+ 
response in the presence of both Mg2+ and ATP, questions the ro le ofCSQ2 as luminal Ca2+ 
sensor as Mg2+ and ATP refl ect ce llular cytoplasmic environment. Neverthe less, the CSQ2-KO 
RyR2 (with a concomitant ly profound reduction in triadin and junctin leve ls) resu lted in 
enhanced cytosolic Ca2+ sensitivity, and the observation that adding back CSQ(WT) to KO 
RyR2 did not ful ly restore WT-like function is cons istent with normal CSQ2-RyR2 functiona l 
interactions requiring a normal complement oftriad in/j unctin to be present. 
It shou ld be noted that recent experi ments in thi s laboratory (Hanna, Beard and Du lhunty, 
submitted for publication) show that sheep RyR2 channels maintain usual luminal Ca 2+ 
sensitivity in the presence ofMgATP, provided the lumina l and cytoplasmic so lutions are redox 
buffered with GSG:GSSG. 
1.8 Triadin 
Triadin, an integra l SR membrane prote in , is believed to serve as a CSQ anchoring protein that 
reta ins CSQ close to the JFM and in close proximity to the RyR, and has also been suggested to 
play a role in modulating RyR act ivity, in mediating fu nctional EC coup ling, and in maintaining 
Cal+ homeostas is (Goonasekera et a l. , 2007; Gyorke et a l. , 2004a; Ohkura et al., 1998; Wei et 
al. , 2009a). Triad in is loca li zed to the junctiona l SR in skeletal and cardiac muscle (Brandt et a l. , 
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1993; Caswell et al. , 1991 ; Guo and Campbell, 1995; Knudson et al. , 1993). It directly binds to 
RyR, CSQ, andjunctin , most likely through its C-terminus (Guo and Campbell, 1995 ; Guo et a l. , 
1996a; Zhang et al. , 1997) . 
1.8.1 Gene and isoform 
Triadin was first identified as a highly enriched 95-kDa protein of the junctional SR in rabbit 
skeletal muscle (Brandt et al. , 1990; Caswell et al., 1991 ; Kim et al. , 1990b ), named Trisk 95 
(Marty et al., 2000). It was subsequently discovered that severa l shorter triadin isoforms with 
masses of 32, 49 and 51 kDa (Trisk 32, Trisk 49 and Trisk 51, respectively) are a lso present in 
skeletal muscle (Marty et al., 2000; Vassilopoulos et al., 2005). Trisk 95 and Trisk 51 are the 
maj or triadin isoforms in skeletal muscle, and are equally expressed in rabbit, rat and mouse 
skeletal muscle (Marty et al., 2009; Marty et al. , 2000). Curiously, in human skeletal muscle, 
where Trisk 95 and Trisk 51 are present, Trisk 51 is the predominant isoform while Trisk 95 is 
either not detectable (Thevenon et al. , 2003) or makes up on ly 40% of the total triadin content 
(Marty et al. , 2009). Both Trisk 95 and Tri sk 51 are localized within the triad junction and 
co localize w ith the RyR, while Trisk 49 and Trisk 32 are fo und in different parts of the 
longitudinal SR, and are not associated with the RyR. 
As in skeletal muscle, multiple triadin isoforms are expressed in cardiac muscle (Peng et al., 
1994). Three cardiac triadin isoforms are fo und in rabbit heart: triadin ·1, triad in 2 and triad in 3 
(at 35 kDa, 40 kDa and 92 kDa respectively on SDS-PAG E) (Carl et al., 1995 ; Guo et al. , 
1996b). The three cardiac isoforms are a lso referred to as CTI (triadin I), CT2 (tri adin2) and 
CTI (triadin 3) (G uo et al. , 1996b). CTI is the predominant isoform, whi le CT2, CT3 are 
expressed at substantia lly lower levels in rabb it heart (Guo et al., 1996b). Only two of the 
cardiac triadin isoform s (CTI and CT3) are found in canine cardiac muscle, with CTI again the 
predominant isoform. CT2 was found to be a glycosylated fom1 ofCTl (Kobayashi and Jones, 
1999). Subsequent stud ies revealed that simi lar triadin expression patterns are also present in 
rabbit, pig, human, rat and mouse cardiac muscle, with CTI cons istently the predominant 
isoform, and CT2 being a glycosylated form ofCTl (Kobayashi and Jones, 1999). 
All of the skeletal and cardiac isoforms oftriadin are alternative spliced products of the same 
gene (Oddoux et al., 2009; Shen et al., 2007; Thevenon et al., 2003). Shorter triadin isoforms 
are truncated versions of the longest isoform, Trisk 95 (composed of706 residues), but each bas 
its own unique C-terminal tail. Interestingly, skeletal Trisk 32 is identica l to the cardiac CT! of 
mice and rats (Marty et al., 2009; Vass ilopoulos et al., 2005); further, it migrates as a triplet on 
SDS-P ADE, suggesting that like CTI , it is susceptible to glycosylation. Trisk 32/CTl is the 
only isoform expressed in both skeletal and cardiac muscle. However, it should be noted that 
unl ike Trisk 32, which localizes in the longitudinal SR in ske letal muscle as previous ly 
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mentioned, CT! localizes in the junctional SR and associate with RyR2 in the heart (Guo et al. , 
1996b; Vass ilopou los et a l. , 2005). 
1.8.2 Primary and secondary structure, KEKE motif 
The secondary structure of triad in has been assessed via hydrophobicity analysis and 
biochemical assays with antibodies against specific regions. There is a consensus that the 
prote in contains a short cytoplasmic N-term inal domain (residues 1-47), a s ingle membrane-
spanning helix (res idues 48-68), and a long C-terminal tail in the SR lumen (G uo et al. , 1996b; 
Knudson et al. , 1993; Taske et a l. , 1995). In fact, all triadin isoforms, both skeletal and cardiac, 
share identica l sequences over the first 250-260 residues (Guo et al. , 1996b; Hong et al. , 2001 ; 
Knudson et a l. , 1993; Kobayashi and Jones, 1999; Taske et al. , 1995 ; Vassilopoulos et al., 2005). 
This common region encompasses the short cytoplasmic N-terminal domain, the transmembrane 
segment, and the first part of the luminal domain. Therefore, it is expected that all triadin 
isoforms share the same single transmembrane domain structure, but contain C-termina l tails of 
varying lengths. 
Triad in is bas ic and has a high density of charged amino ac ids in its luminal domain. In 
particular, Trisk 95 is abundant in charged amino ac ids (44.2%), with 46 more basic residues 
than acidic residues, giving triad in a pl of I 0.18 (Knudson et al. , 1993). Even CTI , a much 
shorter isoform, contains - 42.5% charged amino acids (Guo et al. , 1996b). There are multiple 
c lusters of charged amino ac ids in the luminal domain , with alternating positive and negative 
charge, enriched in Lys and Glu/Asp residues (Jones et a l. , 1995). These mixed charge clusters 
are named "KEKE motifs" (Realini et al. , 1994) and may be responsible for its interactions with 
CSQ, junctin, RyR and the histidine-rich Ca2+ binding protein (HRC) (Jones et al. , 1995; 
Kobayashi et al. , 2000; Zhang et al. , 1997). Indeed, one of KEKE motif (residues 200-232 in 
Trisk 95 or 2 10-224 in CTI) is found to be important for Trisk 95 binding to RyR, CSQ and 
poss ib ly HRC (Kobayas hi et al. , 2000; Lee et al. , 200 I ; Lee et al. , 2004) (for more detail see 
section 1.8 .5). However, it remains to be determined whether the three prote ins (RyR, CSQ and 
HRC) compete fo r identica l res idues or whether they can be accommodated simultaneously. 
1.8.3 Post-translational modification 
1.8.3.J Disulfide bond formation 
Trisk 95 contains two cysteine residues in its luminal domain , Cys270 and Cys671 (Knudson et al., 
1993), which al low it to forn1 a di sulphide-linked o ligomer. All other isoform s lack the C67 1 
res idue (Guo et al. , 1996b; Hong et al. , 200 I ; Kobayashi and Jones, 1999; Marty et al. , 2000; 
Vass il opoulos et a l., 2005). The cysteines are likely to form di sulfide bonds with cysteines on 
neighbouring Trisk 95 monomers i.e. Cys270 binds Cys270 and Cys671 binds Cys67 1 (Fan et al. , 
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1995). Mutating either cysteine to alanine reduces the total number ofTrisk 95 polymers, 
indicating that disulfide bridging between both cysteines is required to fully enable Trisk 95 
polymerization . Polymerization oftriadin is predicted to help maintain the structura l integrity of 
junctional couplings (Froemming et al. , 1999). Moreover, different isoforms may also bind and 
polymerize with each other, demonstrated by co-immunoprecipitation ofTrisk 95 and Trisk 51 
(Vassi lopoulos et al. , 2010). 
On the other hand, CT I/Trisk 32 has its unique divergent region at the C270 location in Trisk 95 
(Guo et al. , 1996b; Hong et al., 2001 ; Kobayashi and Jones, 1999). Therefore it does not contain 
cyste ine residues and does not polymeri ze. Indeed, none of the cardiac isoforms fo rm multirners 
via disu lphide bonding (Guo et al., 1996), despite the fact that CT3 contains the Cys270 residue. 
1.8.3.2 Glycosylation 
Lnitial sequencing identified four potential N-linked glycosy lation sites on Tri sk 95 , two 
cytoplasmic (Asp9 and Asp21 ) and two luminal (Asp75 and Asp625) (Knudson et al. , 1993). It has 
been suggested that res idue Asp625 is more likely to be mod ified by post-translational processing, 
i. e. glycosylation (Knudson et al., 1993); this is confirmed by Fan et al. (1995). The migration 
of expressed rat Tri sk 51 , which does not contain the equivalent Asp625 of rabbit Tri sk 95 , as a 
double band on SDS-PAGE unless deglycosylated suggests the existence of other glycosylation 
sites common to both Trisk 95 and Tri sk 51 (Marty et al. , 2000). 
Cardiac triadin isofonns are also natura lly glycosylated. For example, canine CTI is -50% 
glycosylated; CT2 is the glycosylated fo rm of CTI (section 1.8. 1); and CT3 , upon 
endoglycosidase-H treatment, shows a 4 kDa decrease in molecular weight, suggesting it is also 
glycosylated (Kobayashi and Jones, 1999). The glycosylation site ofCTl is Asp 75 (Kobayashi 
and Jones, 1999) . Both glycosylated and unglycosylated triadin are present in substantial 
amounts in the heart, however unglycosylated triadin degrades rapid ly via proteasome-
dependent pathways (Milstein et al. , 2008). Although the significance oftbis rapid degradation 
remains to be investigated, it bas been proposed that the glycosylation state oftriadin may be 
important for main ten ing triadin levels (M il stein et al. , 2008) . 
1.8.3.3 Phosphorylation 
There are multiple potential phosphorylation sites on Trisk 95 (Knudson et al. , 1993), only two 
of which (residues 15 and 35) are cytoplasmic. Tri sk 95 is a substrate for the endogenous 
ca lmodul in-dependent protein kinase LI (CaMKII) which is associated with the junctional SR 
(Damiani et al. , 1995). A consensus CaMKII target sequence RXXS/T is located between 
residues 34 and 37 (in the cytoplasmic N-terminal domain) oftriadin, and Thr37 is thought to be 
the phosphorylation site (Col po et al. , 200 I). It has been proposed that triad in modu lates RyR I 
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in a phosphorylation-dependent manner (Col po et al. , 200 I), since Thr37 inhibits RyR channel 
activity (Damiani et a l. , 1995) and RyR inhibition by CaMK.l l is due to triadin phosphorylation 
(Ha in et al., 1995). However, the phys iological signifi cance of triad in phosphorylation still 
awaits further investigation. 
1.8.4 Over-expression and down-regulation 
1.8.4.1 Over-expression 
In cardiac muscle, targeted CT I overexpress ion in both iso lated ce ll s and animal models has 
yielded confounding results. Overexpression of CTI in rat ventri cu lar myocytes results in 
reduced Ic,- induced Ca2+ transients amplitude but with widened and fl attened vo ltage 
dependency (i. e., small l ea at low and high depolarizations triggers maximal Ca2+ transients, and 
increased susceptib ility to arrhythmia, all accompanied by a lower SR Ca2+ content (Terentyev 
et al. , 2005). Correspondingly, the channel activity of RyR2 iso lated from CT I overexpress ing 
myocytes is a - 5-fo ld increase in P 0 • Therefore, it appears that tr iadin enhances cardiac EC 
coupling by directly stimulat ing RyR2 (Terentyev et al. , 2005). On the other hand, a negative 
role of triad in in cardiac EC coupling has also been suggested in mice overexpress ing CTJ, 
which display reduced contractility (Kirchhefer et al. , 2004b; Kirchhefer et al., 200 J ). Triadin-
null hearts exhibit a blunted contractile and Ca2+ handling response upon ~-adrenergic 
stimulation and develop ventricular tachycardia (Kirchhefer et a l. , 2004b; Kirchhefer et al. , 
2007 ; Kirchhof et a l. , 2007). Further, the SR Ca2+ load is either reduced (Terentyev et a l. , 2005) 
or increased (Kirchhefer et al. , 2004b; Kirchhefer et al. , 2007). Some data suggest that triadin 
plays an inhibitory ro le in card iac EC coupling. However, an increased Ca2+ spark amplitude 
(Kirchhefer et al. , 2004b) and an increased [31-!Jryanodine binding to RyR2 (Kirchhefer et al. , 
200 I) from CT I overexpress ing cardiomyocytes suggest that RyR2 is more sensiti zed to 
activat ion when in the presence of excess triad in, in agreement with data from (Terentyev et al. , 
2005). Although the physio logica l role oftriadin in the heart is not clearly revealed by these 
confounding results, it can be concluded that normal triad in levels are obligatory for the 
optimi sation of normal SR Ca2+ hand ling, cardiac EC coup ling, and contracti le function . 
In skeletal musc le, adenovirus mediated overexpress ion ofTri ske 95 or Trisk 51 in rat ske letal 
muscle primary culture shows that Trisk 95, not Trisk 5 J overexpress ing myotubes, 
s ignifi cantly inhibits KCI depo larization-induced Ca2+ release (Rezgu i et al. , 2005). No 
alterations in the express ion or co- loca li zation of other key Ca2+ handling proteins were detected 
in the same study (Rezgu i et al. , 2005). These results suggest that triadin , and in particular Tri sk 
95 , acts as a negat ive regu lator of skeletal EC coupling (Rezgui et al., 2005). This is in contrast 
to enhanced cardiac EC coupl ing in CTJ overexpress ion (Terentyev et a l. , 2005). The reduced 
depo larizat ion-induced Ca2+ re lease with Trisk 95 overexpression is a lso related to a reduction 
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in SOCE efficiency (Vassilopoulos et al., 2007). Recently overexpression ofTrisk 95 in C2Cl2 
and rat skeletal muscle cells decreased the amplitude and frequency of Ca1+ sparks and a 
depressed level of depolarization-induced Ca1+ transients (Fodor et al., 2008), supporting the 
idea that in skeletal muscle triadin plays a regulatory role in EC coupling. However, a myotube 
study by Goonasekera et al. (2007) has shown that disrupting the RyR I -triad in interaction 
impairs both Ca1+ release and skeletal EC coupling. Therefore, it seems that a moderate 
concentration oftriadin is required to mediate EC coupling in normal skeletal muscle. However, 
results from these overexpression studies should be interpreted cautiously due to triadin's 
propensity for polymerization. In particular, triadin in high concentrations is more likely to self-
aggregate, which may result in a reduction in overall free triadin able to associate with RyR. 
1.8.4.2 Down-regulation 
Triadin-null mice, void of all the triadin isoforms, have been developed (Oddoux et al., 2009; 
Shen et al. , 2007). Homozygous triadin-null (Trdn·1-) mice do not exhibit embryonic or birth 
lethality, and do not present any obvious functional phenotype (Oddoux et al., 2009; Shen et al. , 
2007). However, triadin-null skeletal muscles display a significant reduction in strength 
(Oddoux et al., 2009). No changes in the amplitude of KCI depolarization-induced Ca1+ 
transients were detected in triadin-null mice (Oddoux et a l. , 2009) or in shRNA mediated 
triadin-knockdown rat skeletal myotubes (Fodor et al., 2008). Thes~ findings challenge the idea 
that triadin plays a critica l role in skeletal EC coupling as suggested in the overexpression 
models ( 1.8.4.1 ). However, significant reductions in the amplitude of electrical and KCI 
depolarization-induced Ca1+ transients have been shown in both adult skeletal muscle fibers and 
cultured myotubes in other triadin-null mouse models (Boncompagni et al., 2012; Eltit et al. , 
2011; Shen et al., 2007). Similarly, siRNA-mediated knockdown oftriadin in C2CI2 skeletal 
myotubes causes a decrease in KCI depolarization-induced Ca1+ transients (Wang et al., 2009), 
suggesting that triad in is likely to faci litate depolarization-induced Ca1+ release. The reason for 
the discrepancies between these studies remains unclear. A clear assessment of the functional 
alterations directly attributable to the loss oftriadin is confounded by: I) a ltered expression of 
other Ca1+ handling proteins (DHPR, RyRl /2, junctin, CSQ 1/2, SERCA 1, FKBP l 2, 
junctophilin-1 and junctophilin-2) during development in the transgenic mice (Boncompagni et 
al. , 2012 ; Chopra and Knollmann, 2009; Oddoux et al., 2009; Shen et al. , 2007); 2) remodelling 
of the junctional SR associated with loss of triad in (Boacompagni et al., 2012; Oddoux et al., 
2009; Shen et al. , 2007); and 3) different cell types being used, i.e. cultured myoblasts from 
neonatal animals versus adult muscle fibers, which may display different Ca1+ handling 
properties (Capote et a l. , 2005 ; Janowski et al., 2006; Marty et al. , 2000 ; Vassilopoulos et al., 
2005). 
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The functional consequences observed in triadin-null ske letal muscles, the alterations in CSQ 
expression, and the remodelling o f the junctional SR were tied together in a recent study 
(Boncompagni et al. , 2012). The reducedjunctional SR vo lume and SR Ca2+ load were 
correlated with the decreased leve l of polymerized CSQ I visua li zed as anchored to the 
junctiona l SR, wh ich in tum is like ly to influence EC coupling efficacy (Boncompagni et al. , 
2012). Thi s suggested that triad in mainly serves as an anchoring or structural protein . In fact, 
the absence of periodic "anchors" that connect CSQ to the junctional SR membrane in triadin-
null muscles (where junctin and CSQ are still present), could indicate that triad in is the anchor 
that retains CSQ, and thus indirectly maintains the structure of the junctional SR, which in turn 
supports EC coupling (Boncompagni et al. , 2012). Supporting this line of reasoning, Oddoux et 
a l. (2009) show a flattened and reduced vo lume of the junctional SR terminal cisternae and a 
loss of CSQ density assoc iated with a lack of triad in. A reduction in the contacts between 
junctional and T-tubule membranes in cardiac muscle has also been observed (Chopra et al. , 
2009). Together these resu lts a ll suggest a structural role for triad in . On the other hand, transient 
knockout of triadin in skeletal myotubes does not lead to changes in CSQ ! expression or SR 
Ca2+ load, but does result in a reduced level of KC! depolari zation-induced Ca2• release (Wang 
et al. , 2009). Therefore, the effects oftriadin deficiency cannot be full y attributed to loss of 
CSQ I or to changes in the junctional SR volume. 
Interestingly, although whole-cell patch clamp studies revea l almost nonnal bidirectional 
signalling in triadin-null myotubes, with no changes in DHPR Ca2+ current densities and vo ltage 
dependency, triadin-null cells di splay a moderate reduction in peak amplitude of vo ltage-evoked 
Ca2+ release, and therefore, reduced orthograde s ignalling between DHPR and RyRI (E ltit et al., 
20 1 I). On the other hand , triadin-null myotubes exhibit significant alterations to overa ll Ca2+ 
homeostas is, likely driven in part by the di srupti on of the RyRl /FKBP 12 interaction (E ltit et al., 
20 I 0). RyR Is from triad in-null mice exh ibit lowered sensitivity for the binding of exogenous 
FKBP 12 and a marked increase in subconductance activity (Eltit et al. , 20 I 0). Thus, loss of 
triad in may destabili ze the RyRI-FKBPI 2 interaction. Addition of FKBP 12 or FKBPI 2.6 to 
triad in -devoid RyR Is reduces the subconductance acti vity . Overexpression of FKBP 12.6 a lmost 
complete ly reverses the effects of lack oftriadin express ion on Ca2+ homeostasis and full y 
restores depo larization-induced Ca2+ release to WT leve ls (E ltit et al. , 2011 ). These findings 
suggest that the effects of triad in loss on the orthograde s igna l may be mediated by effects on 
the RyR 1-FKB P 12 interacti on, supporting the idea that ske letal triad in is not directly invo lved 
in ske leta l EC coupling. This al so he lps exp lain the functional consequences oftriadin knock 
out which are not accounted fo r by CSQ loss and changes in junctional SR vo lu me (Wang et al. , 
2009). 
1.8.5 Protein-protein interactions 
46 
1.8.5.1 Triadin-DHPR 
Early studies in skeletal muscle suggested that triadin binds to both DHPR and RyR and 
mediates functional couplings between the two during EC coupling (Brandt et al. , 1990; 
Caswell et al., 1991 ; Kim et al. , 1990b ) . However, a later study has failed to show any 
interaction between triadin and DHPR (Guo and Campbell, 1995), and no further evidence has 
been provided to either support or disprove direct structural or functional interactions between 
the two proteins. Moreover, with the elucidation of the topological structure oftriadin, which 
presents only one short 46-residue N-terminal domain in the cytoplasm, it has become highly 
unlikely that the triadin-DHPR interaction occurs in vivo . The predicted cytoplasmic domain is 
too short to span the distance ( 120 A) between the SR and T-tubule membranes and thereby 
facilitate a triadin-DHPR interaction (Knudson et al., 1993 ; Marty et al. , 1995). Although it 
could be argued that the DHPR or its beta subunit might extend partially into the junction space, 
the veracity of an interaction with the DHPR is doubtful. 
1.8.5.2 Triadin-RyR 
lmmunohistochemistry studies have localized most triad in isofonns at the junctional SR in the 
vicinity ofRyRs, indicating the close association of the two proteins in both skeletal and cardiac 
muscles - with the notable exceptions ofTrisk 32 and Trisk 49, which appear to be segregated 
to the longitudinal SR (Carl et al. , 1995; Kim et al. , 1990a; Knudson et al. , 1993). The triadin-
RyR interaction has been mostly investigated in the skeletal system. Indeed, direct triadin-RyR I 
interactions have been confirmed in many studies (Caswell et al. , 1991 ; Caswell et al., 1999; 
Groh et al. , 1999; Guo and Campbell , 1995; Kim et al. , 1990a); both cytoplasmic and luminal 
interactions between triadin and RyR have been reported. 
1.8.5.2.1 Cytoplasmic interactions 
A functional cytoplasmic triadin-RyR interaction has been suggested by severa l studies. Trisk 
95 reduces [3H]ryanodine binding (which indirectly reflects P0 ) to Trisk 95-null SR vesicles, 
and inhibits the activity of isolated RyR Is in lipid bilayers when added into the cytoplasmic 
so lution (Ohkura et al. , 1998). Correspondingly, a peptide comprising residues 18-46 oftriadin 
inhibits channel activity (Groh et al., 1999). Despite the consistent functional studies, the nature 
of physical interactions between the cytoplasmic domains of the two proteins has proven elusive. 
An early study fai led to find a cytoplasmic interaction between Trisk 95 and Ry RI (Guo and 
Campbell, 1995) or between the cytoplasmic regions of CT I and RyR2 (Guo et al., 1996b) at I 
mM [Ca2+]. On the other hand, Groh et al. ( 1999) found that a peptide corresponding to residues 
18-46 ofTrisk 95 interacts with RyR I in a [Ca2"!"]-dependent fashion , being strongest at low 
[Ca2+] (I mM EGTA) and inhibited by increasing [Ca2+], was lost at 2 mM [Ca2+]. Conversely, 
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Caswell et a l. ( 1999) failed to detect binding between a Trisk 95 residues 2-49 peptide and 
RyR I, with a [Ca2+J of l 00 µM Ca1+ or in the presence l mM EGT A. These find ings raise the 
question of whether the cytoplasmic interaction actual ly exists. Neverthe less, it is still plausible 
that the cytoplasmic RyR-triadin interaction may occur in vivo and potentia lly play a role in 
RyR regulation in response to changes in cytop lasm ic ca2+. 
1.8.5.2.2 Luminal interactions 
Compelling evidence suggest that the luminal domain oftriadin interacts with the RyR 
(Goonasekera et al., 2007; Guo and Campbell , 1995; Lee et al., 2006; Lee et al. , 2004; Wium et 
al., 20 12). Two modes of binding were proposed between the luminal domains ofTrisk 95 and 
RyRl : I) a low affinity ionic interaction between large, positively charged portions ofTrisk 95 
and negative ly charged regions of RyR l ; and 2) a specific high-affinity binding of a short 
relatively hydrophobic segment of triad in (residues 110-280 of Trisk 95) to RyR 1 (Caswe ll et 
al., 1999). More recently, mutagenic analys is has revealed that the triad in-binding s ite of RyR I 
may res ide between the negatively charge residues Asp4878, Asp4907 and G lu4908 in the C-tenninal 
intra-luminal loop of the RyRl (Lee et a l. , 2004). Mutations of these res idues e ither abolish 
(04907 A/E4908A; D4878N D4907 NE4908A) or reduce (D4878ND4907 A) the triadin-RyR I 
association (Goonasekera et a l. , 2007). Likewise, the corresponding RyR-binding site oftriadin 
has been mapped to a charged c luster ofKEKE residues (residues 200-232) within the luminal 
domain , which pattern of res idues is known as a KEKE motif (Lee et al. , 2004). This same 
KEKE motif is conserved across all of the ske letal and cardiac isofonns oftriadin (Kobayashi et 
a l. , 2000; Lee et a l. , 2004; Wium et al. , 2012). 
Functional luminal triadin-RyR interactions have been extensively investi gated. Lumi nal 
add it ion of purified skeleta l or cardiac triadin to purified RyRI or RyR2 fu sed into lipid bilayers 
increases channel acti vity (Gyorke et al. , 2004a; Wei et a l. , 2009a) in a Ca2+ -independent 
manner (Gyorke et al. , 2004a). The idea that triad in acts as a lumi nal activator of RyR in vitro is 
supported by the observation that [3H]ryanodine binding to purified WT RyR 1 s is significantl y 
enhanced by the add ition of purified skeletal triad in , indicating an increase in channel activ ity 
(Goonasekera et al. , 2007). lt has a lso been shown that di sruption of the phys ica l tri adin -RyR I 
assoc iat ion dramatically impairs e lectricall y evoked Ca1+ transients, near ly ablating skeletal-
type EC coupling without any noticeable effects on other RyRl functions (Goonasekera et a l., 
200 7; Lee et al. , 2006). ln summary, the current accumulated data from in vitro studies suggest 
that lumi nal triadin act ivates RyRs and plays an important ro le in ensuring fast and robust Ca1+ 
release du ri ng EC couplin g in skeletal muscle. 
1.8.5.3 Triadin-CSQ 
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Triadin directly interacts with CSQ (Guo and Campbell , 1995; Guo et al., 1996b; Zhang et al. , 
1997) and functions as a CSQ anchoring protein (Boncompagni et al., 2012). Binding 
interactions between triadin and CSQ occur in a Ca1•-regulated fashion such that the interaction 
is enhanced when the Ca1+ concentration is decreased and is inhibited by an increase to 
millimolar [Ca1+] (Guo and Campbell, 1995; Kobayashi et al., 2000; Mitchell et al., 1988; 
Zhang et al., 1997). In addition, the triadin-CSQ interaction is independent of CSQ' s 
phosphorylation status (Beard et al., 2008). The Asp-rich C terminus of CSQ (residues 354-367 
in rabbit CSQ I) has been identified as responsible for binding to triad in in the skeletal system 
(Shin et al. , 2000). Likewise, the CSQ binding domain of CT I has been localized to a single 
KEKE motif at residues 200-224 (Kobayashi et al. , 2000). The critical amino acids oftriadin 
binding to CSQ are the even-numbered residues Lys210, Lys1 12, Glu214, Lys216, Gl/ 18, Gln220, 
Lys122 and Lys224. These residues are conserved within the KEKE motif across all triadin 
isoforms and species. Notably, the KEKE motif in triadin responsible for its binding to CSQ is 
the same motif that is critical for its binding to RyR (1.8.5.2.2). This may explain the inability 
oftriadin to mediate signalling between CSQI and RyRl (Wei et al. , 2009a), as an inability of 
triadin to bind to both CSQ and RyR at the same time. On the other hand, triad in seems to be 
able to relay the inhibitory effect of CSQ2 to RyR2 either by itself or together with junctin 
(Gyorke et al. , 2004a). Thus, it remains to be determined whether the same KEKE motif can 
accommodate RyR and CSQ simultaneously. 
1.8.5.4 Other protein-protein illleractions ljunctin, HRC) 
In addition to binding CSQ, triad in also directly interacts with other SR luminal proteins, such 
asjunctin and the histidine-rich Ca2•-binding protein (HRC) (Arvanitis et al., 2007; Glover et al. , 
2001 ; Lee et al., 2001 ; Zhang et al., 1997). Junctin is another CSQ anchoring protein, which has 
a simi lar structure to triadin and also contains multiple "KEKE" motifs (section 1.9, also see 
(Zhang et al. , 1997)). ln contrast to triadin 's interaction with CSQ, the triadin-junctin interaction 
is ca2· -independent. The specific triadin-junctin interaction is predicted to occur at "KEKE" 
motifs, but the binding regions have not yet been located in either triadin or junctin (Zhang et al. , 
J 997). Regardless, it is yet to be determined whether the triadin-junctin interaction occurs in 
vivo and whether this interaction plays any functional role. HRC is a c a2•-binding protein found 
in small amounts in the SR lumen. In both skeletal and cardiac muscles, it has been shown that 
HRC binds to triadin in a ca2•-sensitive manner through the same KEKE motif that is involved 
in triad in' s binding to CSQ (Lee et al. , 200 I; Sacchetto et al. , 200 I ; Sacchetto et a l. , 1999). This 
suggests that a binding competition to triadin may occur between HRC and CSQ. However, the 
existence of such a competitive binding in vivo remains to be investigated. 
1.9 Junctin 
49 
1.9.1 Junctin gene, structure, isoform 
Junctin , a 210-am ino ac id 26 kDa protein, was identified in the late 1980s as a majo r CSQ-
binding protein, present in the junctional SR membranes of canine cardiac and skeleta l muscle 
(Mitche ll et a l. , 1988). Protein sequence and topological analysis shows that j unctin is an 
integral SR transmembrane protein and shares a similar membrane topology and overa ll 
structure with triadin, containing a short cytoplasmic N- terminal tail (AAs 1-22), a single 
hydrophobic he li x that spans the SR membrane (AAs 23-44), and a bulky, highly charged C-
terminal ta il (AAs 45-210) located in the SR lumen (Jones et al. , 1995) (F ig. 1-1 2). It is 
loca lized to the jSR and is absent from other SR compartments, and comprises -4.4% of the 
totaljSR protein mass (Jones et a l., 1995). Since its discovery, junctin has been thought to play 
a major ro le as a CSQ anchoring protein, keeping CSQ close to the junctional face membrane 
(JFM) and in c lose proximity to the RyR. This long-held view, however, is now being re-
examined, and a more complex ro le for junctin has emerged. It has become apparent that the 
protein a lso plays a major ro le in regulating the Ca1+ release channel activity (reviewed in 
(Beard et a l. , 2009; Dulhunty et al. , 2009; Fan et a l. , 2008; Pritchard and Kranias, 2009) and 
a lso (A ltschafl et al. , 2011 )). 
So far, junctin from fo ur spec ies (canine, human, rabbit, and mouse) has been cloned and 
characterized (Dinchuk et a l. , 2000; Jones et a l. , 1995; Lim et a l. , 2000; Wetzel et al. , 2000). 
The protein is generally expressed as one gene product - i.e., one isofonn - in skeleta l and 
cardiac muscle, as we ll as in many other tissues. The express ion density from highest to lowest 
is: fast skeletal muscle fiber, slow skeletal muscle fiber, and fi nally, cardiac muscle fiber 
(Dinchuk et a l., 2000; Jones et a l. , 1995). Curiously, in human cardiac muscle, there are two 
alternat ive ly spliced junctin isoforms. The second isoform is characterized by the inclusion of 
15 amino ac ids at residue 55 (Lim et al. , 2000). This add itional isofonn has not been confirmed 
in other species and its physiological and/or pathophys io logica l ro les are as yet unknown. 
Junctin is one of the alternative splicing variants of the locus aspartyl-p-hydroxylase (APH)-J-J , 
whi ch is located on human chromosome Sq 12. 1 and, through a complex pattern of a lternative 
splicing can g ive ri se to four disti nct c lasses of prote ins, including: (i) the non-catalytic product 
junctin , described in this section; (ii) aspartyl-P-hydroxy lase, or Asph, a member of the alpha-
ketoglutarate-dependent dioxygenase fam ily; (iii) junctate, a moderate affini ty, high capacity 
Ca1+ binding protei n (Treves et a l. , 2000); and (iv) humbug, a truncated version of Asph, 
lack ing its cata lytic domai n, and sharing with junctate a high capac ity / moderate affinity Cal+ 
binding domain (Dinchuk et al. , 2000; Treves et a l. , 2009). Transcripts ofj unctin start from 
exon la under the control of the P2 promoter, the induction of which is contro lled by the muscle 
specific transcription factor MEF-2 (Feri otto et al. , 2005). Exon 2 encodes the transmembrane 
domain , and together with exon 3, is shared by all fam ily members derived from the APH-J-J 
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Figure 1-12 Topology of Junctin in the SR membrane. The N-terminal tail is located in the cytoplasm and the 
C-terminus end in the SR lumen. A single helix spanning the membrane connects the two domains. Positively and 
negatively charged amino acids are denoted by pluses and minuses, respectively. Taken from (Jones et al. , 1995). 
locus. The carboxyl-tenninal portion of junctin results from the transcription of exons 4a and Sa, 
while all other products are generated via transcription of exons 4-24 and result in a variety of 
products of different sizes (Dinchuk et al. , 2000; Feriotto et al. , 2005; Treves et al., 2000). 
1.9.2 Junctin homology, KEKE motif 
Comparisons between human, rabbit, and canine junctin have revealed a significant sequence 
identity (>80%), and a -90% homology across species (Lim et al. , 2000 ; Wetzel et al., 2000). 
Specifically, there is striking homology (>97%) in the putative membrane spanning region and 
in the first 61 luminal residues ; these same domains also exhibit a high degree of sequence 
homology with triadin (62% identity, (Jones et al. , 1995)). An identity of - 86% was found in 
the N-tenninal domains of human and canine junctin. The highly conserved amino-terminal 
region of the protein suggests that the transmembrane domain, the initial luminal portion, and 
possibly the N-tenninal region may all play an important functional role and may contain the 
interaction sites for triadin, CSQ and RyR (Yazaki et al. , 1990; Zhang et al., 2001). The C-
tenninal region, however, exhibits only 72 to 75% sequence homology (Wetzel et al. , 2000). 
The intraluminal domain from human junctin contains minimal junctional SR targeting 
sequences (Rossi et al., 2013 ). 
Like triadin, a remarkable feature ofjunctin is that it has a high density of charged residues 
( 4 7.1 % ), with 17 more basic residues than acidic, and consequently, an estimated pl of 9 .3 7. 
The cytoplasmic N-tenninus contains 36.4% charged residues (8 of 22) with a calculated pl of 
9.7. By comparison, the luminal segment is enriched in charged amino acids (54.8%) with a pl 
of9.3 l. Junctin also contains multiple "KEKE!' motifs throughout its luminal domain that are 
presumed to be involved in junctin' s interactions with CSQ, triad in and RyR (Jones et al. , I 995; 
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Kobayas hi et al. , 2000; Zhang et al. , 1997). There is evidence that multiple KEKE motifs are 
required fo r junctin's binding to RyR and CSQ (Altschafl et a l. , 2011 ; Kobayashi et a l. , 2000). 
Regardless, the precise regions in both junctin and its binding partners which interact have yet 
to be defined. 
To date, no post-translational modifications fo r junctin have been reported. The protein contains 
no cysteine res idues and does not fo rm oligomers. In addition, junctin is not glycosy lated , and 
contains no consensus g lycosylation sites. However, the observation of junctin migrating as a 
c losed spaced-doublet on SOS-PAGE in early studies (Costello et al. , 1986; Jones et al. , 1995) 
raised the possibility that partial proteolysis or post-translation modification may occur; further 
investigations are required to test this poss ibili ty. 
1.9.3 Junctin changes in the developing heart 
SR is less important in intracellular Ca1+ cycling in the neonatal mammal ian heart than in adult 
heart. ln the neonata l myocardium, Ca2+ influx and efflux via the sarcolemma is more important 
than the SR fluxes in regulating contraction-re laxation cycling. This is attributed to the poorly 
developed EC coupling machinery and the immaturity of SR function in neonates (Mahony, 
1996; Page and Buecker, 1981). The maturation of SR Ca1+ cycling is c losely co rrelated with an 
increase in SR Ca1+ cycling protein leve ls and their activity (Mahony, 1996; Moorman et al. , 
1995; Vetter et a l. , 1995). Junctin mRNA express ion levels in foeta l rabbit cardi ac muscle are 
only - 16% of adult levels, but increase dramatica lly, to 40% at day one post-birth, and to 87% 
by day five . Adu lt leve ls of mRNA are then reached - 15 days post-birth (Wetze l et al., 2000), 
parallel to maturation of SR function 5-15 days post-birth (Mi ller et al. , 1997). An age-
dependent increase in j unctin protei n is observed in human and rat hearts (Jung et a l. , 2005). Ln 
agreement, a specific increase in the junctin content of the jSR is detected, along with structural 
maturation ofthejSR, during the deve lopment of mice heart (Tij skens et al. , 2003). Taken 
together, the progress ive increase in junct in leve ls suggests thatjunctin may be invo lved in the 
maturation of the SR Ca1+ release mechanism, and also in establishing the functional EC 
coupl ing machinery in mamma lian heart. 
1.9.4 Overexpression and down-regulation ofjunctin 
1.9.4.1 Cardiac junctin modulation 
1.9.4.1.1 Junctin overexpression 
The functi onal significance ofjunctin has been explored in the heart by the up-regulation or 
ab lation o f the protein . Mouse mode ls with heart-spec ific overexpression ofjunctin consistent ly 
show depressed contractility and impaired muscle relaxation in association with a decreased SR 
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Ca2+ load (Hong et al., 2002; Kirchhefer et al. , 2004a; Kirchhefer et al. , 2006; Kirchhefer et al. , 
2003; Zhang et al., 2001). The diminished SR Ca2+ content is attributed to the potential role of 
junctin as a "placeholder" for ca2+, competing alongside with luminal Ca2+ for the free binding 
sites on CSQ (Kirchhefer et al., 2006). Up-regulation of junctin in mice displayed a gene-dosage 
dependent effect on function. Transgenic mice with 29-fold higher levels ofjunctin in the 
myocardium exhibit severe cardiac hypertrophy, atrial fibrillation, fibrosis , increased L-type 
Ca2+ current density, and prolonged action potential duration , accompanied by heart failure and 
bradycardia (Hong et al. , 2002). Mouse hearts with a I 0-fold overexpression of junctin develop 
a modest impairment of relaxation, a lower Ca2+ transient amplitude, with unaltered contraction 
rate. These hearts are only mildly hypertrophic and showing no signs of fibrosis (Kirchhefer et 
al. , 2003). Overexpressing myocytes demonstrate narrower jSR cisternae, a higher density of 
CSQ2 in the jSR, and the extension of jSR domains to 11011-junctional regions (Hong et al., 2002; 
Tijskens et al., 2003 ; Zhang et al. , 2001). This suggests thatjunctin may be involved in SR 
morphogenesis and in the assembly of the molecular components of the Ca2+ release machinery 
injSR. However, chronic overexpression ofjunctin in these mice models leads to compensatory 
changes in other Ca2+ handling proteins: triadin and RyR levels are decreased (Hong et al., 2002; 
Kirchhefer et al. , 2004a; Kirchhefer et al. , 2003; Zhang et al., 2001), Na+/Ca2+ exchanger (NCX) 
expression is reduced , and the phosphorylation of RyR at residue 2809 increased by 64% 
(Kirchhefer et al. , 2006). It is plausible that changes in these transgenic mouse models reflect 
secondary effects consequent to hypertrophy, alterations in the SR ultrastructure, and alterations 
of gene expression, all of which may prevent an assessment of alterations directly attributable to 
junctin. Acute adenoviral-mediated overexpression ofjunctin in adult rat cardiomyocytes shows 
that overexpression of junctin by either 2-fold (Gergs et al., 2007) or 1.6-fold (Fan et al. , 2007) 
results in the depression of contractility, Ca2+ transient amplitude, and rates of contraction and 
relaxation, as well as a parallel decrease in SR Ca2+ load. There is no alteration of other Ca2+ 
handling protein levels, although a decrease in RyR2 was observed in the first study (Gergs et 
al. , 2007). Conversely, neonatal rat cardiac myocytes overexpressingjunctin do not show any 
alterations in either basal Ca2+ transients or SR Ca2+ content, this is likely due to the relatively 
moderate level of overexpression (Gergs et al., 20 I I). 
1.9.4.1.2 Cardiac junctin ablation 
Conversely, ablation of junctin in the heart produces an opposite effect. Acute downregulation 
of junctin by 40% in cardiomyocytes via adenoviral transference of antisense mRNA resulted in 
a significant increase in both fractional shortening and the rate of contraction and relaxation, as 
well as an increased Ca2+ transient peak and a faster Ca2+ decay, with no changes in other Ca2+-
handling protein levels (Fan et al. , 2007). Likewise, cardiomyocytes isolated from junctin-
de~cient mice demonstrated augmented Ca2+ transient and kinetics, along with enhanced 
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contracti li ty and a parallel increase in SR Ca1+ load and elevated Ca1+ spark frequency 
indicative of increased SR leakage. In vivo, cardiac function in junctin -null mice is also 
enhanced (Yuan et al. , 2007). Unlikej unctin overexpress ion mouse mode ls, junct in-KO mice do 
not exper ience any a lterat ions in cardiac morphology or to any of the major Ca1+ cycling prote in 
express ion leve ls. An exception is a 70% increase in the NCX express ion, accompan ied by a 
concom ita nt elevation in current density, perhaps to compensate for the high lumina l [Ca1+] 
(Yuan et a l. , 2007). Importantly, in the junctin-null mice, the changes in cardiac performance 
include de layed after-depoloarization (DAD)-induced arrhythmias and an increased 
susceptibility to premature death during conditions of phys iological stress. The increased 
incidence of DADs assoc iated with aftercontractions injunctin-null cardiomyocytes has been 
attributed to aberrant RyR Ca1+ re lease in the absence ofjunctin (Yuan et al. , 2007). Together 
with data from overexpression models, these resu lts demonstrate an inverse relationship 
between junctin, cardiomyocyte SR Ca1+ content and contractile functi on, suggesting a negative 
regulatory ro le of junctin on RyR activity and further, the phys io logica l importance of junctin in 
the maintenance of nonn a l SR Ca1+ handling and cardiac performance. 
A comprehensive study utili zing the junctin-KO mouse model of (Yuan et al. , 2007) has 
revealed both novel mechanisms by which junctin controls the luminal Ca1+ sens iti vity of RyR2 
and the ro le junctin pl ays in cardiac dysfunction (Altschafl et al., 2011 ). Instead of a s imple 
negative ro le for j unctin as suggested in prev ious studies, thi s study demonstrates complex, 
lum ina l [Ca1+]-dependent effects ofjunctin dep leti on on intracellular Ca1+ homeostasis and 
RyR2 activ ity, and supports the notion that junct in defi c iency contribute to arrhythmias under P-
adrenerg ic sti mulation or stress. Activator or inhibitor ro le of junctin are proposed under periods 
of preva lent parasympathetic or sympathetic activity, respectively. The maintenance of norma l 
junctin express ion leve ls is obligatory for optima l SR Ca1+ handling, and protects against 
cardiac arrhythmias (Altschafl et a l. , 2011 ). Indeed, in heterozygous junctin-deficient mice, the 
presence of only - 50% nonnal junctin levels is sufficient to prevent SR Ca1+ leakage, DAD-
triggered arrhythmias, and prematu re death. At the same time there is enhanced card iac 
contractili ty and SR Ca1+ content, as well as e levated NCX activity (Yuan et al., 2009). The 
absence of either junctin or junctin/ triadin exacerbates the detrimental effects of 
ischemi a/reperfusion inju ry by impairing contractil e recovery and increas ing cell death in the 
myocardium, suggesting important ro les for these proteins in maintai ni ng cardiac contractili ty 
and ce ll surviva l in response to such injuries (Ca i et al. , 2012). 
1.9.4.Z Skeletaljunctin ablation 
The phys io log ical rol e ofjunctin in Ca2+ release from skeleta l muscle SR is less we ll 
characteri zed . To date, two ske letal junctin-null models have been examined . An early study 
reported that knocking down junctin ( I 00% reduction) in ske leta l muscle myotubes (C2C 12) 
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resulted in significant impairment ofK+-induced Ca2+ release consequent to a reduced SR Ca2+ 
store, accompanied by down-regulation of RyRl and CSQI protein expression, although not 
their mRNA levels. There was no significant change in the resting cytosolic Ca2+ levels. These 
data indicate that lack of junctin may increase the rate of degradation ofRyRl and CSQl, thus 
disrupting the macromolecular Ca2+ signalling complex (Wang et al., 2009). However, a more 
recent study with transgenic mice shows that ablation ofjunctin has only a very limited effect. 
There was no change in expression of other proteins in the Ca2+ release machinery, including 
RyRl and CSQl, in this model. There was also no change injSR ultrastructure, although a 
slight change in the totaljSR volume was detected. Furthermore, there was no significant 
alteration in E-C coupling, caffeine-induced Ca2+ release, or SR Ca2+ in the absence of junctin 
(Boncompagni et al., 2012). In contrast to (Wang et al., 2009), junctin depletion resulted in an 
elevated myoplasmic resting free [Ca2+] (Boncompagni et al., 2012). The reason for the 
disparity between these studies is unclear. Overall, the reductions in junctin levels, which 
resulted in severe deterioration of the heart's performance, showed only mild consequences in 
skeletal muscle. Curiously a severe pathology in junctin/triadin double-null muscles does 
support a role for junctin in regulation of Ca2+ homeostasis in skeletal muscle (Boncompagni et 
al. , 2012). 
It should be kept in mind that different targeting strategies in knocking out junctin may also 
cause variable alterations in the expression levels of other splice variants of the locus aspartyl-
P-hydroxylase (APH)-J-J - Asph, humbug and junctate (J .9. 1) - possibly leading to some non-
specific effects which may partly explain the discrepancies across different studies 
(Boncompagni et al., 2012). 
1.9.5 Junctin and diseases 
A role for junctin is suggested in cardiac and skeletal muscles pathologies. 
In failing human hearts, junctin levels are decreased to almost undetectable levels (Gergs et al., 
2007). At present, it remains unclear whether junctin down-regulation contributes to impaired 
SR Ca2+ handling, causing cardiac hypertrophy and heart failure , or whether it is compensatory 
to alleviate the deterioration of cardiac function. Based on transgenic studies, it was speculated 
that in failing hearts the reduced levels of junctin may compensate for lower SR-Ca2+ content 
arising from increased SR Ca2+ leak, or be an adaptation to chronic P-adrenergic stimulation. 
Reduction in junctin levels may therefore improve contractile function in heart failure states 
(Altschafl et al., 2011; Fan et al. , 2007; Gergs et al., 2007; Yuan et al., 2009). In support of this 
idea, expression ofjunctin is significantly decreased in a transgenic mouse model of heart 
failure with cardiac-specific overexpression of the Pl-adrenoceptor. Junctin levels declined with 
age and closely paralleled the development of cardiac hypertrophy and heart failure (Engelhardt 
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et al. , 200 I). This supports the notion that junctin expression attempts to compensate fo r 
dysregulation of SR ca2+-cycling in heart failure and plays an important ro le in normal cardiac 
functio n. 
Another pathological condition re lated to junctin is diabetes- induced card iac dysfunction, with 
consequent massive oxidative stress being particularly evident in heart tissues (Yildirim et al. , 
20 J 3). There is marked ly more junctin in diabetic cells: a Juciferase reporter assay revealed that 
this up-regulation ofj unctin is effected by a down-regulation ofmiR-1 in the diabetic heart. 
Furthermore, the expression of junctin is c losely associated with oxidative stress in the heart, 
since N -acety lcysteine (NAC)-treatment of diabetic rats prevents ajunctin increase. This study 
suggests that junctin is active ly involved in the development of diabetic cardiomyopathy. 
So far, no mutations injunctin have been implicated in any human cases ofCPVT. However, 
under high stress, junctin-KO mice exhibit a CPVT phenotype with enhanced [Ca2J; transients, 
DADs, aftercontractions, and triggered arrhythmias related to an increased probability of 
spontaneous SR Ca2+ release (Altschafl et al., 20 11 ). The way in which junctin' s absence leads 
to these clinical phenotypes is suggested to be similar to CPVT linked to RyR2 and CSQ2 
mutations, where excessive RyR Ca2+ release during diastole is the primary cause of pathology 
(Priori and Chen, 201 1). Thus, junctin ablation may alter RyR ' s Ca2+ sensitivity by impairing 
the physical interaction between the constituents of the prote in complex - between CSQ and 
RyR - and thereby induce aberrant RyR openings (Dulhunty et al., 2012; Fan et al. , 2008). 
Junctin ab lation or mutations may mimic the etiology ofCPVT by causing increased diasto li c 
Ca2+ leak under ~-adrenergic stimulation or stress conditions (A ltschafl et a l., 2011 ). However, a 
functional link between junctin and CPVT has yet to be clearly elucidated. 
An association betv,een junctin and skeleta l myopathy has been indicated in a patient with mild 
myopathy characterized by the presence of hexagonally cross-linked tubular arrays in ske letal 
muscle fibers (Di Blasi et al., 20 I 0). lmmunohistochemi stry has shown that the rod-like 
inclusions are positi ve fo r junctin (as well as CSQ and caveo lin 3), suggesting an abnormal 
accumulation of the prote in leading to rod format ion, since protein crysta ls only rare ly 
accumulate in ti ssues, usually as a consequence of an a lteration in their synthes is, processing, or 
degradati on. However. no mutations in the juncti n encoding gene Asph were found in thi s case 
(Di Blasi et al.. 20 I 0). 
1.9.6 Junctin protein/ protein interaction 
1.9.6.1 Junctin and RyR (binding, regulation) 
As a key component of the RyR Ca2• release complex, junctin has been found to interact with 
RyR directly in a Ca2• -independent fashion (Zhang et al. , 1997). 
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Notwithstanding the early discovery of the binding betweenjunctin and RyR, the ro le ofjunctin 
in the regulation of the RyR is not well understood, and the respective binding sites on each 
protein are unknown. Most of our knowledge about functional effect of junctin on Ry Rs is 
derived from transgenic studies focusing on the cardiac system (section 1.9.4 .1 ). The 
observations that junction levels are inversely correlated with contractile function , and that 
junctin knockout or knockdown results in aberrant Ca2+ release, have suggested thatjunctin may 
act as a "brake" that inhibits RyR2 activity (Yuan et al. , 2007). However, it is unclea r whether 
thi s action is a direct effect ofjunctin per se on RyR2 activity, or an indirect effect whereby 
junctin serves as a transducer of CSQ signa ls. 
ln an in vitro li pid bilayer study Gyorke et a l. (2004a) show that the inclusion of junctin to the 
lwninal so lution a long with purified RyR2 enhances RyR channel activity in the presence of 
either 20 µMor 5 mM luminal [Ca2+), suggesting a positive role ofjunctin on RyR2 channel 
gating. However, the luminal [Ca2+) used was outside the range encountered during normal Ca2+ 
cycling (- 0.1 to I mM) (Chen et al., 1996; Ginsburg et a l., 1998) and reviewed in (Bers, 2002; 
Dulhunty et al., 2012). Neverthe less, the data suggest that junctin can modulate RyR activity. 
The discrepancy between this study and the transgenic stud ies may be due to different in vitro 
and in vivo conditions. It has been shown that junctin together with triad in can indirectly alter 
RyR2 activity via junctin- and/or triadin-CSQ interactions (Gyorke et al., 2004a). Similar resu lts 
have been reported with junctin in ske letal muscle, w ith junctin having been shown to stimulate 
the acti vity of purified RyRl in lipid bilayers, but also to inhibit channel activity when CSQ I is 
added to the same luminal solution; the latter able to occur in the absence oftriad in (Wei et al. , 
2009a). 
A recent study revealed a novel mechanism by which junctin regulates RyR2 (Altschafl et al. , 
20 I I) . RyR2 channel activity from junctin-KO and WT cardiac SR implies thatjunctin has a 
luminal Ca2+-dependent effect on RyR2. At low luminal Ca2+ (<l mM), junctin activates RyR2 
channel (loss of junctin reduces RyR2 opening); converse ly, at high luminal Ca2+ (> I mM), 
junctin inhibits the chatmels (RyR2 channels are more active in the absence of junctin). The 
crossover point occurs at - I mM luminal [Ca2+]. Thusjunctin may both attenuate and increase 
RyR2 activity depending on SR Ca2+ loads . However, the possibility that this dual effect may be 
related_ to regulation of RyR2 by CSQ2 cannot be exc luded. Indeed, a steeper increase in RyR2 
activity as a function of luminal [Ca2+) is also observed in the absence ofCSQ2 (Dulhunty et al. , 
2012), that is simi lar to the effect observed in junctin-devoid RyR2 (above). Therefore, the 
prec ise way in which junctin regulates RyR2 channels remains to be clearly determined, as does 
junctin ' s regulation ofRyRI. The interactions betweenjunctin and RyRJ or RyR2 are 
extensively investigated in the study reported in this thesis. 
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The oppos ing lumina l Ca2+-dependent effects of junctin on RyR2 (Altschafl et al. , 201 1) 
strong ly suggests that multiple junctin-RyR2 interaction sites may exist. This is supported by 
experi ments showing two domains ofjunctin bind to two di ffe rent domains of the RyR2 
(Altschafl et a l. , 2011 ). Luminal residues 4 7-77 of j unctin bind spec ifically to RyR2 lumina l 
M5-M6 linker (res idues 4520-4553) (F ig. 1-9), while luminal res idues 78-2 10 bind to the RyR2 
pore loop (res idues 4789-4846). The pore loop contains the pore helix and selecti vity filter fo r 
the Ca2+ channel (F ig . 1-9, and al so section 1.6.3 .2), therefore thi s junctin binding site is a 
strateg ic location which influences the gating and conductance of the channe l. Signifi cantly, 
prelimi nary ev idence from the Muscle Research Group indicates that the luminal domain of 
junctin binds to the pore loop of RyR I which is equiva lent to the pore loop region in RyR2. It is 
noteworthy that the same Ry RI pore loop region which binds junctin is also the single binding 
site for triadin , invo lv ing res idues: D4907, E4908, and D4878 (Lee et a l., 2004). Disrupting 
triad in ' s binding to RyR I by mutating the three res idues does not affect the abil ity of junctin to 
bind to RyR I, ind icating that the binding s ite for junctin on thi s luminal loop may differ from 
that oftriadin (Goonasekera et a l. , 2007) or that there are other j unctin binding sites on the 
luminal domains of the protein. 
There have been no studies of possible cytoplasmic interactions between junctin ' s N-terminal 
tail (Njun) and RyRI or RyR2 . The observations that cytoplasmic ta il of skeleta l triad in can 
bind to the cytoplasmic domain of RyRI and inhib it the channel (Groh et a l. , 1999; Ohkura et 
a l. , 1998) raise the poss ibility that a cytoplasmic RyR/j unctin interaction may exist. Some 
evidence suggests that the luminal part ofjunctin (which contains the bul k of the prote in) 
interacts with the RyR (Zhang et a l. , 1997). The luminal domain of junctin is suffi cient fo r 
binding with RyR2, and affin ity binding assays have fa iled to detect a phys ica l interaction 
between Nj un and RyR2 (Zhang et al. , 1997). However, thi s does not rul e out the possibility of 
cytoplasmic interactions if the bind ing s ite on RyR ofNj un is buried within the prote in , or if 
bi nding between the cytoplasmic domains of the two proteins is weak (Dulhunty et a l. , 201 2). 
The cytoplasmic regulation of RyR by Nj un in both ske leta l and cardiac muscle has been 
partiall y rev iewed in (Dulhunty et a l. , 2012) and will be addressed in the Result chapters (see 
Chapter 5). 
1.9.6.2 Junctin, CSQ, and triadin 
1 .9 .6.2 .1 Junctin and CSQ 
The function origina lly proposed fo r j unctin is as a linker connecting CSQ to the RyR, since 
junctin binds to 125CSQ (J ones et al. , 1995 ; Mitchell et a l. , 1988) . Similar to the triad in-CSQ 
interaction, j unctin-CSQ assoc iation was demonstrated to be Ca2+-dependent, so that increasing 
[Ca2+] resulted in the gradual di ssoc iation ofj unctin and CSQ. Junctin ' s CSQ-binding region 
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has been localized to its luminal domain (Zhang et al. , 1997), with multiple binding sites on 
junctin indicated for junctin-CSQ association, since deletion of any one of several widely 
separated segments of the junctin luminal domain abolished CSQ2 binding (Kobayashi et al., 
2000). In vitro binding assays have demonstrated a ca2+-dependent interaction between the 
carboxyl terminal portion of CSQl (aa 193-367) and junctin, with the Asp-rich region (354-367) 
at the CSQl C-terminus being believed to form at least part of this interaction site (Shin et al., 
2000). Curiously, skeletal CSQ binding to junctin is affected by CSQl phosphorylation 
(threonine 353) (Beard et al. , 2008). Only phosphorylated CSQ can bind to junctin at low Ca2+ 
(lOOnM, where CSQl exists as monomer). In contrast, the binding oftriadin to CSQ is not 
influenced by CSQ's phosphorylation (Beard et al., 2008). Based on these observations, Beard 
and colleagues proposed thatjunctin ' s binding site on the CSQ C-terminus may differ from that 
oftriadin, and further, that it may be formed at the monomer interface in CSQ multimers (Beard 
et al., 2008). Consistent with this proposal, a recent study revealed that a stoichiometric quantity 
ofjunctin is required for CSQ2 depolymerization upon Ca2+ depletion (Lee et al., 2012). FRET 
analysis revealed constant interactions between CSQ2 andjunctin irrespective of the SR Ca2+ 
concentration, suggesting thatjunctin may be an essential component of the CSQ scaffold (Lee 
et al., 2012). 
Althoughjunctin's function as a CSQ anchoring protein is well recognized, the importance of 
this function has been recently challenged. Comparisons of mouse models lacking either triad in 
(Tdn-null), junctin (Jct-null) or both (Tdn/Jct-null) illustrate that the structural roles oftriadin 
andjunctin are not equivalent in skeletal muscle (Boncompagni et al., 2012). "Periodically 
disposed electron opaque densities (anchors)" that connect CSQ to the RyR-bearingjSR 
membrane were present in both WT and Jct-null muscles but absent in Tdn-null (with junctin 
and CSQ still present) muscles. This observation indicated that triadin is the major component 
of the CSQ-retention anchoring system, although a less dense anchor profile in Jct-null muscle 
does suggest some contribution ofjunctin to the structure. Nevertheless, the role ofjunctin 
mediating the link between CSQ and jSR membrane does seem of lesser importance than has 
been previously suggested - at least in skeletal muscle in these mouse models. 
Lipid bilayer studies with reconstituted purified RyRl reveal that the function ofthejunctin-
CSQl interaction conveys CSQl 's inhibitory signal to RyRl , and that this function cannot be 
duplicated by triadin (Wei et al. , 2009a). Results obtained with the cardiac isoforms indicate 
thatjunctin and triadin together mediate interactions ofCSQ2 with RyR2 (Gyorke et al. , 2004a; 
Wei et al., 2009b). However, the separate roles of the junctin-CSQ2 and triadin-CSQ2 
interactions with RyR2 have yet to be established in the cardiac system. 
1.9.6.2.2 Junctin and triadin 
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Interestingly, junctin al so binds directly to tri ad in (Zhang et al. , 1997). The interaction between 
junctin and triadin is Ca2+-independent and has been suggested to stabilize a quaternary complex 
that anchors CSQ to the RyR, possibly through thei r KEKE motifs (Guo and Campbell , 1995; 
Zhang et a l. , 1997). However, it remains to be determined whether junctin and triadin bind to 
each other in vivo. 
1.9.6.2.3 Interdependent expression among junctin, triadin and CSQ 
Evidence from mouse transgenic models with e ither CSQ2 or triad in ablation suggests an 
interdependence of expression of the three jSR Ca'+-handling proteins: junctin, triad in , and CSQ 
(Chopra and Knollmann, 2013 ; Knollmann, 2009). Both CSQ2-null and CSQ2 R33Q knock-in 
(with a 55% reduction in CSQ2-R33Q) mice exhibit a severe reduction in both triadin and 
junctin (Knollmann et al. , 2006; Ri zzi et al. , 2008). Similarly, knockout of triadin causes the 
near-complete loss of CSQ2 and junctin (Chopra et al. , 2009). These observations suggest the 
existence of a protein complex fo rmed by the three proteins in vivo, consistent with in vitro 
studies. Notab ly, junctin levels are significantly more reduced as compared to triadin-1 and 
CSQ2 leve ls in all three models, indicating thatjunctin requires CSQ2 and triadin in order to 
maintain a stable conformation. Conversely, mice with gene-targeted ablation of junctin do not 
show any changes in CSQ2 and triad in expression (Altschafl et al. , 2011 ; Yuan et al. , 2007), 
implying thatj unctin itse lf may not be necessary for stability of thejSR protein expression. 
1.9.6.3 Other interactions (possible interactions) 
Junctin a lso binds to a 31 kDa protein and two CSQ-like proteins (-90 kDa) as shown in 1251-
junctin overlay assays (Zhang et a l. , 1997) . The 31 kDajunctin-like protein (as described in 
(Jones et al. , 1995)) was purified and identified to be an (ADP)A TP translocase (AA T) protein, 
a protein mainly expressed in mitochondria, which binds to junctin as we ll as to CSQ (Kagari et 
a l. , 1996; Yamaguchi et al. , 1999; Yamaguchi and Kasai, 1998). It was suggested that CSQ, 
junctin , and AAT may fo rm a protein complex in the terminal cisternae of the SR and play a 
role in regulating RyR and EC coupling (Kagar i et al., 1996). In addition, the CSQ-junctin -AA T 
interaction might be re lated to the CRU-mitochondrion Ca2+ cross-ta lk (Shkryl and Shirokova, 
2006). It has been shown that mitochondria are connected to the SR and in proximi ty of release 
sites (CRUs) via small strands or tethers (Boncompagni et al. , 2009; Ogata and Yamasaki , 1987; 
Ross i et a l. , 20 11 ). However, the phys iological relevance and significance of thi s interaction 
still await fu rther in vestigations, as does the nature of the potential interactions betweenjunctin 
and the two CSQ-li ke proteins. 
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1.10 Project aims 
For many years, junctin was considered to play a major role only in connecting CSQ to the RyR 
in skeletal and cardiac muscle, but it has been recognized as having a more complex role in 
recent yearts (detailed in section 1.9.4 and 1.9.6). Both in vitro and in vivo sh1dies show a strong 
correlation between junctin and SR Ca2+ load, and junctin has been proposed to be very 
important for regulating RyR activity and SR Ca2+ handling. It is notable thatjunctin protein 
expression is significantly reduced in some models of heart fai lure, suggesting its involvement 
in the dysregulation of SR Ca2+-cycling in failing heart (see section 1.9.5). To date, most of our 
knowledge about the effect ofjunctin on RyRs, particularly RyR2, is derived from transgenic 
studies (see section 1.9.6), which suggestjunctin plays a role as either a RyR2 suppressor (Yuan 
et al., 2007) or as both an activator and inhibitor depending on SR Ca2+ levels (Altschafl et al., 
20 11 ). However, due to the confounding factors associated with changes in junctin expression 
in these studies, the specific physiological roles of junctin remain unclear. It is therefore, 
interesting to determine the direct regulatory effect of junctin on the RyR. 
Despite the overall importance ofjunctin, there are only limited studies testing the direct effect 
ofjunctin on the RyR (see section 1.9.6.1). In contrast to the results of transgenic studies, in 
vitro lipid bilayer studies showed thatjunctin activates RyR2 when added to the luminal side of 
purified channels (Gyorke et al., 2004a), suggesting a positive role ofjunctin in regulating 
RyR2. However, the luminal Ca2+ concentrations used in these experiments - either 20 µMor 5 
mM - differ from the physiological concentrations that might be expected during normal Ca2+ 
cycling (0 .1-1.5 mM) (Chen et al. , 1996; Ginsburg et al. , 1998) and reviewed in (Bers, 2002 ; 
Dulhunty et al. , 2012)). Thus, the role of junctin in regulating RyR2 has not been conclusively 
defined. Findings by others in the Muscle Research Group demonstrate that luminal addition of 
junctin under physiological Ca2+ concentrations directly enhances purified RyRI channel 
activity (Wei et al., 2009a), although the specific mechanism behind this activation remains to 
be explored. Consequently, the work of this thesis had the following aims: 
I) To investigate the specific ro le of junctin in regu lating RyR2 activity at I mM luminal 
Ca2+. To faci li tate an accurate comparison, the effect ofjunctin on RyRI has been re-
addressed in this study. A second component of this aim was to investigate the precise 
mechan ism by which junctin affects RyR I and RyR2 activity. Experimental findings 
regarding this aim are presented in Chapter 3. 
2) To identify the specific roles ofjunctin's cytoplasmic N-terminus (Njun) and luminal C-
terminal domain (Cjun) on RyR regulation. The reported activation of purified RyR I 
and RyR2 by junctin added to a luminal so lution suggests that junctin activates RyR 
primarily via a luminal interaction. A cytoplasmic RyR-junctin interaction and its 
contribution to RyR regulation in conjunction with the luminal interaction have not 
6 1 
been previously exp lored. Therefore, thi s aims focused on exploring the respective roles 
ofNj un and Cj un in modulat ing RyR activity. Complementary to thi s aim is an 
examination of how Cjun and Njun regulate RyR in concert. The full hypothes is and 
investigations of the second aim are detailed in Chapter 4 and 5. 
3) To identi fy potential binding domains on junctin for RyR that are responsible for 
interaction between the two proteins. Multiple junctin-RyR interaction sites have been 
suggested (A ltschafl et al. , 2011; DuLhunty et al. , 20 12; Goonasekera et al. , 2007). 
KEKE moti fs have been proposed to faci litate protein-protein assoc iations (Perutz, 
1994; Realini and Rechsteiner, 1995; West et al. , 2000), and junctin contains multiple 
KEKE motifs in it C-terminal domain (one "true" KEKE motif and two other KEKE-
like moti fs , defined in Chapter 6.1 ), which are presumed to participate in its interaction 
with RyR (Jones et al. , 1995; Zhang et al., 1997). However, the role ofKEKE motifs in 
the interaction between junctin and RyR remains unclear. Of particular interest to thi s 
study were the potential interactions between the "true" KEKE motif (residues 84-105) 
in j unctin and RyR. Experimental findings with respect to thi s aim are presented in 
Chapter 6. 
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Chapter 2 Materials and Methods 
2.1 Materials 
2.1.1 Reagents and Chemicals 
All materials used were of analytical grade. Acrylam ide/B is (37.5: I) solution, ammonium 
persul fate (APS), TEMED, Precision Plus Protein Dual Color standards, silver stain plus kit 
prep, cell dialys is membrane and Ni2+-nitrilotriacetic acid agarose were purchased from Bio-
Rad Laboratories, fnc. (N .S.W., Australia). Novex Dry ease large cellophane, Minimal Essential 
Medium (MEM) and Dulbecco' s Modified Eagle Medium (DMEM) were obtained from 
Invitrogen Pty. Ltd (Mount Waverley, Australia). Tris, glyc ine and glycerol were from Bacto 
Laboratories Pty. Ltd. (N.S.W, Australia). The BCA protein assay kit, SuperSignal West Pico 
Chemiluminescent Substrate and PVDF membrane, NeutrAvidin-agarose and prote in NG plus 
agarose were from Thermo Fisher Scientific Lnc. (Rockford , IL, USA). Fuji medical X-ray film 
was from Fujifilm Corporation (Tokyo, Japan). All stock solutions ofphospholipids 
(phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylcholine (PC)) were 
purchased from Avanti Polar lipids (A labaster, USA). The monoclonal mouse anti-RyR 34C 
was obtained from Developmental Studies Hypridoma Bank, DSHB. A polyclonal ant i-junctin 
antibody was raised against ajunctin peptide (K.LH-C-SKHTHS~GNNQKRKN-OH, 
manufactured by GL Biochem, Shanghai, China) by !MYS Veterinary Services, Austra lia and 
purified. Precision StrepTactin-HPR conjugate for detecting biotinylated peptide was obta ined 
from Bio-Rad Laboratories, Inc. (N.S. W. , Austra lia). Anti-mouse, anti-rabbit lgG HRP 
secondary antibodies were from Santa Cruz (Santa Cruz, CA, USA). Nunc ce ll cu lture fl asks 
were purchased from Thermo Fisher Scientific Lnc. (Rockford, IL, USA) and petri d ishes were 
from Bacto Laboratories Pty. Ltd. (N .S.W, Austra li a) . Complete protease inhibitor cocktail 
tablets were obtained from F. Hoffmann-La Roche Ltd. (Roche Diagnostics, Germany). 
lsopropyl P-D-1-thiogalactopyranoside (IPTG) was from Astral Scientific (Caringbah, 
Australia). Lysozyme and MOPS were from Amresco (Solon, USA). A ll restriction-digestion 
enzymes were purchased from New England Biolabs (NEB). T4 DNA ligase was from Promega 
Corporation (Wisconsin, USA). All other chemicals were obtained from Sigma-Aldrich (Castl e 
Hill, Australia). All PCR primers were synthesized by Gene Works, Australia. Unless otherwise 
specified, all solutions and chemicals were di ssolved or diluted in MilliQ-water, obta ined fro m 
Milli-Q Advantage AlO ultrapure water purification system (Millipore Corporation, Bi llerica, 
USA). New Zealand white rabbits used to obtain skeletal muscle junctin were housed at the 
John Curtin Schoo l of Medical Research An imal House. 
2.1.2 Peptides synthesized 
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Peptides were synthes ized by the JCSMR Biomolecular Resource Facility using the 9-
fluoren y lmethyloxycarbonyl method on a CEM Microwave-assisted Peptide Synthesizer (CEM 
Corporat ion; Matthews, NC, USA). Synthesis was performed using Fmoc chemistry and so lid 
phase peptide synthesis (SPPS) techniques. T he N-terminus was protected by acety lation. 
Njun: 1MAEETKHGGHKNGRKGGLSQSS22 
Nj unscramb1,d : STGENKGHGLSGKHKSEGRAMG 
Canine cardiac Jun KEKE 84 KRKTKAKVKELT KEELKKEKEK 105 
For affi ni ty chromatography a biotin tag was conjugated to the N -terminal end ofNjun, 
Nj un,crnmbl ed , can ine cardiac JunKEKE peptides. 
T he rabbit ske letal JunKEKE peptide, 86KRKTKAKVKEL1.KEELKKGKEK '07, was manufactured 
by GL Biochem (Shanghai ) Ltd (Shanghai , C hina). 
A ll peptides were purified using high performance liquid chromatography (HPLC) 
(SHIMADZU, Japan) and purity was determined using mass spectroscopy (MALO! 
TOF/OFT™ Model 4800, Applied B iosystems, USA). 
I mg/ml stock peptides were prepared either in distilled water or relevant buffer depending on 
the down-stream application, snap frozen and stored in IO µI aliquots at -20 or -70 °C. The 
precise concentrat ion of the peptide so lutions were confinned by BCA assay method (see 
section 2. 7. I ). 
2.3 SR vesicle isolation and RyR purification 
The experimenta l procedures of SR ves icle iso lation and RyR I /RyR2 purification were 
undertaken by Mrs. Suzy Pace and Mrs. Joan Sti va la (M uscle Research Group, John Curti n 
Schoo l of Medica l Research , Austra li an National Uni versity, Canberra, Australia). A ll steps 
were performed at 4 °C. 
2.3.1 Isolation of skeletal and cardiac SR vesicles 
2.3.1.1 Preparation of skeletal muscle RyR-enriched SR vesicle 
For nat ive skeletal SR ves ic les, back and leg musc les (predominantly fast twitch skeletal muscle) 
were removed from New Zea land white rabb its, and SR vesicles were prepared using the 
methods of (Sa ito et al. , 1984) w ith minor changes (Ahern et a l. , 1994). The skeletal musc le 
was removed and rinsed immediate ly in phosphate buffered sa line (PBS), which contains 137 
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mM NaCl, 7 mM Na2HP04, 2.56 mM NaH2P04, and 2 mM EGT A(ethylene glycol-bis[b-
aminoethyl ether}N,N,N',N '-tetraacetic acid), pH 7.4. Excess fat was removed, the muscle 
tissue was then diced and snap-frozen in 50 g aliquots in liquid nitrogen and stored at -70 °C 
until required. 
The diced muscle tissue was snap frozen. During preparation of SR vesicles, 100 g tissue was 
homogenized in a Waring blender (Waring Products Div. , Connecticut, USA) for 4 x 15 son 
high speed in a homogenizing buffer consisting of 5 mM imidazole, 300 mM sucrose, pH 7.4 
and a cocktail of protease inhibitors (l mM benzamadine, 0.5 mM PMSF, 3 µManti-cal pain I, 3 
µM anti-calpain II, 2.3 µM leupeptin and 1.46 µM pepstatin A) . In all cases, pH was adjusted 
using a TPS digital pH meter (Bacto Laboratories; Lane Cove, Australia). The homogenate was 
centrifuged at 11,000 x g for 20 min in a Beckman J2-21 centrifuge, JA-14 rotor (Beckman 
Instruments, Gladesville, Australia). The pellet was resuspended in the homogenizing buffer, 
followed by another homogenization and centrifugation as described above. The resultant 
supernatant was then filtered through four layers of cotton gauze and centrifuged at 110,000 x g 
in a Beckman Coulter Optima XE- I 00 ultracentrifuge, Ti-45 rotor for 1-2 h. 
The pellet, containing crude SR, was collected and resuspended in 42 ml homogenising buffer 
in a Dounce Teflon homogeniser (Edwards Instrument Company; Narellan, Australia). Eight ml 
of homogenized vesicles was loaded onto a discontinuous sucrose density gradient comprising 
of 4 ml of 45%, 7 ml of38%, 7 ml of34%, 7 ml of32% and 4 ml of27% (w:v) sucrose layers. 
Sucrose solutions were prepared in a SR diluting buffer containing 20 mM imidazole, pH 7.4 
and a cocktail of protease inhibitors as described above. 
The sucrose gradient was centrifuged at 72,000 x g overnight in a SW28 rotor (Beckman L8-70 
Ultracentrifuge, Beckman Instruments, Australia) at 4 ·c to allow the sub-fractionation of crude 
SR vesicles . The bands at the 34-38% (band 3) and 38-45% (band 4) were collected and diluted 
with at_ least two volumes of diluting buffer. Finally, the diluted fractions were centrifuged at 
125,000 x gin a Beckman Ti-45 rotor at 4 °C for 1 h (Beckman LS-70 Ultracentrifuge, 
Beckman Instruments, Australia). The final pellet was resuspended in 1 ml homogenizing buffer 
and protease inhibitor cocktail, divided into 15 µI aliquots, snap frozen and stored at -70 °C. 
2.3.1.2 Cardiac crude SR preparation 
Cardiac crude SR was prepared as described by Chamberlain and Fleischer (1988) with 
adjustment. Sheep hearts were collected in ice cold phosphate buffered saline (PBS, contents 
see 2.3.1.1) with 2 mM EGTA and then rinsed several times to remove blood. Fat was trimmed 
from the ventricles and the auricles removed. The ventricles were cut to small pieces in Petri 
dishes in homogenizing buffer containing 0.29 M sucrose, 10 mM imidazole, 0.5 mM OTT and 
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3 mM NaN3, pH 6.9, and homogenized in a Waring blender 3 x IO son high. The homogenates 
were centrifuged at 9,700 x g in a Sorvall SS-34 rotor for 20 min. The resultant supernatant was 
filtered through four layers of cotton gauze, followed by a further high speed centrifugation in a 
Beckman Ti-45 rotor for 2 hat l 04,537 x g. The pellet was then resuspended in 60 ml of 
Solution A (homogenizing buffer with 0.65 M KCI , plus standard protease inhibitor cocktail: 
mM benzamadine, 0.7 mM PMSF, 2.3 µM leupeptin (1 µg/ml) and 1.46 µM pepstatin A (1 
µg/ml), in a Potter homogenizer (Edwards Instrument Company; Narellan , Australia). The 
homogenate was set on ice for 30 min and centrifuged at 4,350 x g for 10 min in Beckman JA-
20 rotor, to remove insolubles. The supernatant was then centrifuged at 257,090 x gin a 
Beckman Ti-70 rotor for l 00 min. The crude SR pellet was finally suspended in 15 ml of 
Solution A, snap frozen in 15 µI or l ml aliquots and stored at -70 °Corin liquid nitrogen. 
2.3.2 Purification ofRyR1 and RyR2 
RyRl and RyR2 were purified from rabbit skeletal SR and sheep cardiac SR respectively using 
the same procedure according to (Lee et al. , 1994) and (Laver et al., 1995) with minor 
modifications. RyR was purified from so lubilized SR vesicles using a discontinuous sucrose 
gradient. Gradient and solubilization solutions contained 25 mM Na-PIPES (piperazine-N,N' -
bis (2-ethanesu lfonic acid)), l M NaCl, l mM DTT (dithiothreitol), 0.5% (w/v) CHAPS, 0.25% 
(w/v) L-cx-phosphatidylcholine (Avanti), 100 µM EGTA, 92 µM CaC'2, 500 µM AMP, pH 7.4 
and protease inhibitors recommended by the provider (Roche ' Complete ' tablet). Sucrose 
gradients were made of four 7.5 ml layers (5%, l 0%, 15% and 20% (w/v) sucrose), and kept for 
at least 4 h before use. A mixture of l O mg of SR vesic les were solubilized on ice for 0.5-1 h in 
so lubilization so lution at a final protein concentration of2.5 mg/ml , where the vesic les were 
homogenized for I min every 10 min using a glass Potter homogenizer (Kontes Glass Company; 
Vineland, New Jersey, USA) during incubation. The insoluble membrane fragments were 
removed by centrifugation at J 63 ,200 x g for 20 min (Beckman rotor TLA I 00 .3). Supernatant 
containing the so lubili zed SR (4 ml) was loaded on to the continuous 5-20% sucrose gradient 
and centrifuged overnight (14-16 h) at 71 ,935 x gin a Beckman SW28 rotor. Fractions (2 ml) 
were then co llected, and RyR-enriched fractions were identified on silver-stained SDS/PAGE 
and irnmunoblot. Selected fractions containing purified RyR 1 /RyR2 were sequentiall y 
concentrated - 10-fo ld using a Yi vaspin 2 concentrator (Sartorius Stedim Biotech ; Bohemia, 
USA), snap frozen in 15 µI aliquots and stored at -70 °C. Protein concentration was determined 
by DC prote in assay (Lowry assay) (Bio-Rad). The purified RyRs were routinely checked with 
irnmunobl ot using anti-CSQ, anti-triadin and anti-junctin antibody to ensure there was no 
contaminati on by those regulatory proteins (F ig. 2- 1 ). 
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Figure 2-1 Purification of skeletal RyRl and cardiac RyR2. (A) lmmunoblot of purified RyRI (--0.35 µ g) from 
rabbit skeletal SR vesicles using anti -RyR 34C, ant i-triad in (IIG 12 for skeletal isoform), anti-CSQ I (Vil lD2 I) and 
anti -junctin antibodies. (B) lmmunoblot of purified RyR2 (- 0.5 µg) from sheep cardiac SR vesicles using anti-RyR 
34C, ant i-CSQ2, anti-triadin (EIS fo r cardiac isoform) and anti-junctin antibodies. (A) and (B) confirmed the 
presence and the purity ofRyRI and RyR2 respectively (no CSQ, triadin andjunctin contam inat ion). The posit ion of 
the molecular weight markers are shown to the left of the lanes. 
2.4 Recombinant RyRl and RyRZ preparation 
2.4.1 RyR1 preparation 
2.4.1.1 RyRl plasmid construction 
The construction ofRyRl plasmids (GFL) was undertaken by Dr. Shamaruh Mirza (Canberra, 
Australia). 
A Hindi!! restriction enzyme site was introduced by PCR upstream of the initiation codon of 
rabbit RyR I cDNA; forward and reverse primers were 5 · - AAG CTT ACA CCA TGG GTG 
ACG GAG G and 5 ' - GGC CGT CGA CAG GTG CAG GTA respectively. Amplification 
conditions were denaturation 92 °C 30 s, annealing 55 °C 30 s, extension 72 °C 45 s, with a total 
of35 cycles. The PCR amplified Hindillpotyi;nke,/SaU546 fragment was ligated into Hindlll/Sall 
sites of the polylinker of the pEGFP-C l to form the GHS construct. Subsequently the 
Sall546/Sallpotyhnk" from the pTZ full length RyR cDNA (kindly supplied by Dr. Francesco 
Zorzato, Department of Biomedicine and Anesthesiology, Basel University Hospital , 
Hebelstrasse, Basel, Switzerland; (Zorzato F, 1990)) was removed and cloned in-frame into 
GHS to form GFL (RyR tagged at the 5 ' -end with EGFP). 
2.4.1.2 Expression and purification of recombinant RyRl constructs 
HEK293 cells were grown in MEM (Minimal Essential Medium) (lnvitrogen, Mount Waverley, 
Australia) with I 0% FCS, 0.1 % PSN (Penicillin G+ Streptomycin Sulphate+ Neomycin 
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Su lphate), at 37 °C, 5% CO2 in Tl 75 culture fl asks. The day before transfection, cells were 
plated out at 50% confluence and the medium was changed 3 h before transfection. Cell s were 
transfected with RyRl plasmids (80 µg DNA per flask) using calcium phosphate precipitation. 
Cell s were incubated at 37 °C for 24 h before the medium was changed and for another 24 h 
before harvesting. The cells were washed in PBS briefly and then harvested in cold PBS 
followed by centrifugation at 1500 x g for 20 min. The resultant pellets were suspended in 
sucrose- imidazole buffer (3 00 mM sucrose, 5 mM imidazole, pH 7.4, plus protease inhibitor 
cockta il tab let (Roche Diagnosti cs, Germany)), homogenized, and centrifuged in an Eppendorf 
centrifuge (-11600 x g) fo r 20 min at 4 °C. The pellets were resuspended in sucrose buffer and 
re-homogenised. After ultra-centrifugation at 91943 x g fo r 2 h at 4 °C in a Beckman TLA 120.2 
rotor, the pellets were homogenised using potter homogenizer with I 00 strokes and resuspended 
in sucrose-imidazo le buffer. The homogenates were snap-frozen and stored at -70 °C. 
2.4.2 RyR2 preparation 
2.4.2.1 RyR2 construct 
Recombinant RyR2 in stab le, inducible HEK293 cell lines was obtained from collaborator Dr. 
Magdolna Varsanyi (lnstitut fur Phys iologische Chemie, Ruhr-Uni vers itat, Bochum, Germany). 
For generation of the stab le, inducible HEK293 cell lines, please refer to (Koop et al. , 2008). 
2.4.2.2 Expression and purification of recombinant RyR2 mutant 
The stab le, inducib le HEK293 ce ll lines were grown in DMEM (Dulbecco's Modified Eagle 
Medium) high glucose with sodium pyruvate (lnvitrogen, USA), with I 0% FBS, I% PS(! OOU 
Penici llin G, and I 00 µ g/ml Streptomycin Sulphate), 2 mM L-glutamine, 0.1 mM non-essential 
amino acids, and 50 µg/m l Hygro myc in B, at 37 °C, 5% CO2 in Nunc cell culture flasks. Before 
inducing expression, ce ll s were sp lit into med ia without Hygromyc in Band incubated at 37 °C 
for 24-48 h. Express ion was induced by incubating ce ll s in media with I µg/ml tetracyc line and 
without Hygromyci n B fo r another 24-48 h as described previously (Kong et al. , 2007; Koop et 
al. , 2008). After harvesting ce lls, the ce ll pe ll ets were homogenized the same way as fo r RyR I 
constructs described in sect ion 2.4.1.2. Briefly, when cell s reached fu ll confluency, they were 
co llected in PB S and centrifuged at 1500 x g for 20 min, the resultant pellets were then 
suspended in sucrose-imidazole buffer (for buffer content see above, section 2.4.1.2), 
homogenized and centrifuged ( l 1600 x g). The pellets were resuspended in sucrose-imidazo le 
buffer and re-homogeni sed . After ul tra-centrifugation (9 1943 x g), the pellets were 
homogenised and resuspended in sucrose-imidazo le bu ffe r. The homogenates were snap-frozen 
at 15 µ I a liquots and stored at - 70 °C until required. 
2.5 Junctin purification 
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2.5.1 Endogenous junctin purification from rabbit skeletal muscle (SOS preparative 
gel electrophoresis) 
Isolation ofjunctin from rabbit skeletal muscle tissue was carried out by SDS preparative gel 
electrophoresis in a Bio-Rad 491 prep cell (Bio-Rad; N.S.W., Australia) using the procedure 
described in Wei et al. (Wei, 2008; Wei et al., 2009a) with modifications. The Bio-Rad 491 
prep cell is an apparatus for purifying proteins or nucleic acids from complex mixtures by 
continuous-elution electrophoresis. Different percentages of resolving and stacking gels were 
used. The resolving gel was prepared on a casting stand in a 28 mm diameter gel assembly tube 
at a 6.5 cm height, containing 12% acrylamide/bis (37.5: 1), 0.375 M Tris-HCI (pH 8.8), 0.025% 
ammonium persulphate (APS), and 0.025% N,N,N,N-Tetramethylethylenedianime (TEMED). A 
stacking gel of double the sample volume was prepared and contained 4% acrylamide/bis 
(37.5: 1), 0.125 M Tris-HCI (pH 6.8), 0.05% (APS), and 0.1 % TEMED. 
To isolate junctin, skeletal crude SR vesicles (see section 2.3.1.1) were solubilized in 1 %/0.5% 
CHAPS/PC, lmM DTT, lMNaCI, 20mM MOPS, and 200µM EGTA pH 7.4 plus protease 
inhibitors, with homogenization on ice for 1 h. Solubilized SR vesicles were then centrifuged at 
135,000 x g for 15 min in a Beckman TLA 100.3 rotor to remove insoluble membrane 
fragments . The supernatant was diluted 2: 1 with a sample buffer containing 188 mM Tris-RC], 
pH 6.8, 30% glycerol, 6% SDS, 0.06% bromophenol blue, and 15o/o.~-mercaptoethanol and 
boiled for 5min before being loaded onto the preparative gel. 
The electrophoresis was run at a constant current of 40 mA in a denaturing buffer containing 25 
mM Tris, 191 mM glycine, 0.1 % SDS, pH 8.3. Fractions were collected when the tracking dye 
started to migrate out of the gel, approximately 4 h after the electrophoresis started. Two ml 
fractions were collected at a flow rate of lml/min using a Model EP-1 Econo peristaltic Pump 
(Bio-Rad; N.S.W., Australia) and a BioLogic BioFracction collector (Bio-Rad; N.S.W., 
Australia). Eighty fractions were collected and analyzed by mini SOS-PAGE followed by 
coomassie blue stain or silver stain and immunoblot (using anti-junctin antibody) to locate 
junctin. 
To re-nature the junctin protein purified from the denaturing system (SDS), detergent exchange 
was used by replacing the denaturing buffer with a non-denaturing buffer to induce protein 
refolding. Junctin was firstly co-precipitated from fractions by adding potassium chloride (KCI) 
(Carrara et al., 1991; Wei, 2008) to a final concentration of 400 mM, incubating at room 
temperature for 20 min with gentle agitation. The fractions were then centrifuged in an 
eppendorfcentrifuge (-15,800 x g) for 15 min. The precipitated protein was eluted and re-
folded by detergent exchange in a buffer contain'ing 0.2% Triton X-100, 20 mM MOPS, 150 
mM KCI, and 200 µM EGT A, pH 7.4 plus protease inhibitors, and incubating at room 
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temperature fo r I h. The mixtu re was then centrifuged as above fo r IO min to remove SDS-KCI 
precipitates. Di ssolved protein remained in the supernatant, which was diluted at least 20-fold to 
remove res idual Triton X-100 (the concentration of Triton X-100 was reduced to di srupt 
prote in-detergent mice ll es) by washing samples 4 times in MOPS buffer (20 mM MOPS, 150 
mM NaCl, pH 7.4 with protease inhibitors), using Millipore 's Amicon Ultra-4 centrifugal filter 
devices fo llowing the manufacture 's instruction (Mi llipore corporation) . During the final wash, 
the purifiedj unctin was concentrated to 0.2-0.4 mg/m l and stored at -70 °C until requi red. 
2.5.2 Recombinant canine cardiac full-length junctin (FLjun) 
2.5.2.1 Plasmid construction 
The construction of6 xHis-FLj un plasmid was undertaken by Dr Shama Mirza (Canberra, 
Austra lia). 
Recombinant fu ll-length canine junctin in the pBlueScript II SK vector (Jones et al. , 1995) was 
sub-cloned into a pETl 5b.ep (modified) vector using fo rward and reverse PCR primers 5' -
GGG GGG CAT A TG GCT GAA GAG ACA AAG and 5 ' - CGG GAT CCTCAG TIC TIC 
TTC TTC respectively. Amplification conditions were denaturation 95 °C 30 s, annealing 56 °C 
30 s, extension 72 °C 36 s, total 30 cycles. The PCR am plified NdeVBam Hl poiyJ;nk" was digested 
by Nde l and BamHl and subsequently subcloned into the NdeVBamHl sites of the polylinker of 
the pET I 5b.ep (modified) vector, downstream and in-frame with a poly-histindine-tag. FLjun-
pETI 5b.ep (modified) was fo rrned by digesting the pET I 5b.ep (mod) plasmid and PCR 
amplified FLjun fragment with Nde l/BamHl fo llowing with ge l-pu ri fy ing the DNA fragments 
and ligating for 45 min at room temperature. Constructs were verified by sequencing (JCSMR 
Biomo lecu lar Resource Facili ty). 
2.5.2.2 Expression and purification of recombinant FLjun by /MAC (Immobilized metal 
affinity chromatography) 
The majority of th is work was conducted by Miss Umaya l Narayanan (Muscle Research Group, 
John Curtin School of Medical Research , Australian National University, Canberra, Austral ia) 
under my superv ision. All steps were carri ed out at 4 ' C un less otherwise noted. 
The FLjun-pETI 5b.ep (mod) plasmid was transforrned into E. coli BL2 I (DE3) and FLj un was 
expressed as a Hi s fusio n protein in E.coli. A single co lony was inoculated into 5 ml ofLuri a-
Bertani (LB) broth supp lemented wi th 125 µg/ml ampici llin at 37 °C overnight. The culture was 
transferred to a larger vol ume of fresh LB broth (I: I 00 dilution) supp lemented with 125 µg/ml 
ampicil lin, incubated at 37 °C with agitation until A600 was between 0.6 and 0.8. Prote in 
expression was induced by adding isopropyl-P-D-th ioga lactoside (IPTG) to a final 
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concentration of0.6 mM, and incubation was continued for another 3-4 hat 37 °C. The bacterial 
cells were centrifuged (5,000 x g, 20 min at 4 °C). Cell pellets were either used immediately for 
FLjun purification or frozen at -20 °C until required . 
The cell pellets were resuspended in cold PBS (137 mM NaCl, 7 mM NaifIP04, 2.56 mM 
NaH2P04, pH 7.4) plus 1 % Triton X-100, 5% glycerol and protease inhibitor cocktail tablet 
(Roche Diagnostics, Germany). Then the cells were lysed in 0.5 mg/ml lysozyme for 20 min on 
ice followed with sonication using Branson Sonifier S-250A Analog Ultrasonic Cell 
Disruptor/Homogenizer (Branson Ultrasonics Corporation, Danbury, Connecticut, USA) for a 
complete disruption of the cell membrane. The lysate was centrifuged at 15,000 x g for 25 min 
at 4 °C twice in a SS-34 rotor (Sorvall) to remove any unbroken cells and debris. The cleared 
supernatant was again centrifuged at 150,000 x g for 45 min at 4 °C either in a TLAl00.3 or 
Ti70 rotor (Beckman ultra). The resultant supernatant which contains solubilized FLjun was 
then incubated with Ni2+-nitrilotriacetic acid (NTA) agarose (Bio Rad) (with 25 mM imidazole) 
at 4 °C for 2 h, allowing the poly His-fusion protein to attach to the matrix. Following 
incubation, the FLjun-poly His-Ni2+-NTA agarose complex was washed in cold Buffer A (50 
mMNaH2P04, 300 mMNaCl, pH 8.0 with 1% Triton X-100, 5% glycerol and 25-35 mM 
imidazole) and the fusion protein was finally eluted with Ni elution buffer (50 mM NaH2P04, 
300 mM NaCl, 250 mM imidazole, pH 8.0 with I% Triton X-100 and 5% glycerol) . The protein 
was concentrated and dialyzed against MOPS buffer (20 mM MOPS, pH 7.4, 150 mM NaCl 
plus 0.2% Triton X-100 and 5% glycerol). Triton X-100 was removed using Bio-Beads SM-2 
adsorbents (Bio-Rad; N.S.W. , Australia) that were degassed before usage according to 
manufacturer's instructions. Purified FLjun from above steps was then incubated with the 
prepared adsorbents at room temperature for 1 hand 45 min followed by centrifugation in an 
eppendorfcentrifuge (-1000 x g for 3 min). The supernatant that contains purified FLjun but 
not Triton X-100 was concentrated using Millipore ' s Amicon Ultra-4 centrifugal filter devices 
following the manufacture' s instruction (Millipore corporation) (- 0.2 mg/ml). Final sample was 
snap-frozen and stored at -70 °C until required. 
NB. The methods for recombinant canine cardiac FLjun purification are novel and were 
developed and optimized by me as a part of this project. 
2.5.3 Recombinant canine cardiac junctin C-terminus (Cjun) with His-tag 
2.5.3.1 Plasmid construction 
Construction of the 6xHis-Cjun plasmid was conducted by Dr Dan Liu (Molecular Genetics 
Group, John Curtin School of Medical Research, Australian National University, Canberra, 
Australia.) 
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Luminaljunctin (Cjun) co rrespondi ng tojunctin aa46-210 was made using fo rward and reverse 
PCR primers 5 ' -CGG AA T TCC TTG TTG A TT A TG AAG AAG TT and 5 ' -CGG GA T CCT 
CAG TTC TIC CTC TTC TGG T respectively, from fu ll lengthjunctin in the pBlueScript II 
SK vector (Jones et al., 1995). Amplificat ion cond itions were denaturation 95 °C 30 s, an nea ling 
52 °C 30 s, extension 72 °C 40 s, tota l 30 cyc les. The PCR amplified Eco RJ 136/BamHlpolyJ;nkec 
fragment was ligated into EcoRJ/BamHl sites of the poly linker of the pGADT7 to form the 
Cjun-pGADT7 construct. Subsequently this construct was digested by Ndel and BamHI and 
subc loned into the Ndel and BamHI sites of the polylinker of the pET I 5b.ep (modified) vector, 
downstream and in-frame with a poly-histidine-tag, to form Cj un-pET I 5b.ep (mod) by digesting 
the plasmids pETl 5b.ep and pGADT7-Cjun with Ndel/BamHJ followin g with ge l-purify ing the 
DNA fragments and ligating overnight at 4 ·c. Constructs were verifi ed by sequenc ing (JCSMR 
Biomolecu lar Resource Facility). 
2,53.2 Expression and purification of recombinant 6xHis-Cjun by /MAC 
The Cjun-pETI 5b.ep (mod) plas mid was transformed into E. coli BL2 l (DE3) and Cjun was 
expressed as a His fusion protein in E. coli. A single colony was inoculated into 5 ml of LB 
broth supplemented with 125 µg/ml ampicillin at 37 °C overnight. The cu lture was transferred to 
a larger vo lume of fresh LB broth ( 1: I 00 dilution) supplemented with 125 µ g/ml ampici llin, 
incubated at 3 7 °C with agitation until A600 was between 0.6 and 0.8. Protein expression was 
induced by adding isopropyl-~-D-thiogalactoside (IPTG) to a final concentration of 0.6 mM, 
and incubation was continued fo r another 3-4 h at 37 °C. The bacterial ce ll s were centrifuged 
(5 ,000 x g, 20 min at 4 °C). Ce ll pellets were e ither used immed iately for Cjun purification or 
frozen at -20 °C until required. 
The ce ll pell ets were resuspended in co ld PBS plus protease inhibitor cocktail tablet (Roche 
Diagnostics, Germany) and lysed in lysozyme (0.5 mg/ml ) for 20 min on ice fo llowed with a 
FRENCH Pressure ce ll ( I 000 ps i) for cell membrane di sruption. The lysate was centrifuged at 
I 00,000 x g for 40 min at 4 °C either in a TLA I 00.3 or Ti70 rotor (Beckman ul tra). The 
supernatant which contains Cjun was then incubated with Ni2+-NTA agarose (Bio Rad ) (I ml of 
50% slurry was used fo r 500 ml bacteria culture) at 4 °C for 2.5 h fo llowed with wash in co ld 
Buffer A (50 mM NaH2P04, 300 mM NaCl, pH 8.0 with I 0-20 mM imidazo le) to remove non-
specific bindi ngs, the fusion protein was eluted with Ni e lu tion buffer (50 mM NaH2P04, 300 
mM NaC l, 500 mM imidazole, pl-I 8.0). The protein was concentrated and the buffer was 
exchanged wi th MOPS buffer (20 mM MOPS, pH 7.4, 150 mM NaCl) using Mil li pore ' s 
Am icon Ultra-4 centrifugal filter devices (Mi lli po re corporati on). Purified 6 xHi s-Cjun (- 0.5 
mg/m l) was snap-frozen and stored at - 70 °C. 
2.5.4 Recombinant canine cardiac junctin C-terminus (Cjun) without His-tag 
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2.5.4.1 Plasmid construction 
To ensure there is no non-specific interaction between poly His-tag and RyRs, pHUE system 
was employed (Baker et al. , 2005 ; Catanzariti et al. , 2004b), as this system enables the His-tag 
to be cleaved from Cjun by using a catalytic fragment of the deubiquitylating enzyme 
(ubiquitin-specific protease) mouse Usp2cc, which was also fused to a poly-histidine tag (see 
section 2.5.4.2). Cjun was made using forward and reversed PCR primers 5 ' -
GACCCGCGGTGGACTTGTTGATTATGAAG and 5'- CGAAGCTT 
TCAGTTCTTCCTCTTC respectively, from Cjun-pETl 5b.ep (mod) vector, see section 2.5.3.1. 
Amplification conditions were denaturation 95 °C I min, annealing 50 °C I min, extension 72 
°C I min for a total of28 cycles. The PCR amplified SacII/HindIIIpolyhnkec fragment was digested 
by KspI (KspI and SacII recognize the same restriction site) and HindIII and subsequently 
subcloned into the Saeli and HindIII sites of the polylinker of the pHUE vector, downstream 
and in-frame with a poly-histidine-tagged ubiquitin. Cjun-pHUE was formed by digesting the 
plasmid pHUE and PCR amplified Cjun fragment with Kspl/HindIII following with gel-
purifying the DNA fragments and ligating overnight at 4 °C. 
After ligation, the products were then transformed to DH5a competent cells. Several colonies 
were picked to plate out, and inoculated in 5 ml LB+Amp. Plasmid has been extracted with 
miniprep kit (Qiagen) followed by digesting with Kspl/HindlII The- digested plasmids were then 
run on a 1% agarose gel. Those with right size band (- 500 bp) were regarded as positive 
colonies, which were further verified by sequencing (JCSMR Biomolecular Resource Facility). 
2.5.4.2 Expression, purification and His-tag cleavage of recombinant Cjun 
The Cjun-pHUE plasmid was transformed in E.coli strain BL2l(DE3) and Cjun was expressed 
as a poly His-ubiquitin fusion protein in E.coli colonies in the same way as for Cjun-pETI 5b.ep 
described in section 2.5.3.2. Briefly, a single colony was grown in LB broth supplemented with 
125 µg/ml ampicillin at 3 7 °C overnight and then transferred to a larger volume of LB broth 
(1:100 dilution) with ampicillin, incubated at 37 °C to an optical density of0.6-0.8 at 600 nm . 
Protein expression was induced by 0.6 mM IPTG for 3-4 hat 37 °C before bacteria were 
collected by centrifugation (5 ,000 x g, 20 min at 4 °C). Cell pellets were either used 
immediately for Cjun purification or frozen at -20 °C until required. 
Recombinant protein was purified in a similar way as for 6xHis-Cjun (section 2.5.3.2). The cell 
pellets were resuspended in cold PBS plus protease inhibitors and lysed by using lysozyme 
followed with a FRENCH Pressure cell (1000 psi). After centrifugation at 100,000 x g for 40 
min at 4 °C, the recombinant Cjun was purified from the clear lysate by affinity chromatography 
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usingN i2+- NTA agarose and finally eluted in N i e lution buffer (for buffer content see section 
2.5.3.2) . 
After purification, the 6xHis-ubiquitin tag used fo r the affi nity chromatography was 
subsequently c leaved by digestion with Usp2cc, in the presence of I mM DTT at 25 °C fo r 3 h. 
As the Usp2cc was a lso fused to a po ly-histidine tag, thi s protein was obtained and purified 
using a s imi lar method of E. coli express ion and IMAC as described in Catanzariti et a l. (2004a) . 
The excised 6xHis-ubiqu itin tag and Usp2cc were then removed by incubating the digested 
recombinant protein with N i-NT A agarose at 4 °C fo r 2 h. The resin was then spun down at 453 
x g fo r IO min, the supernatant, conta ining purified Cjun, was washed , concentrated in MOPS 
buffer (20 mM MOPS, 150 mM NaC l, pH 7.4) (- 0.6 mg/ml) using Amicon concentrators and 
stored at - 70 °C until required. This strategy provides recombinant Cjun without any add itiona l 
residues. 
2.6 Electrophoresis and immunoblot 
2.6.1 SDS-Polyacrylamide Gel Electrophoresis (PAGE) 
Denaturing SDS-PAGE was performed to analyze and visua li ze the proteins using a Bio-Rad 
Mini-PROTEAN® Tetra Cell system acco rding to the method ofLaemmli ( 1970). 0.75 mm 
thick mini Tris-Glyc ine ge ls of various polyacry lamide percentages, inc luding 7%, 10%, 12%, 
as well as 4- 15%, 5-17% gradient ge ls, were used according to the molecular weight of the 
analyzed proteins. Running gels were composed of an appropriate percentage of acry lamide-bis 
(37.5: I v/v), 0.1 % SDS, 0.3 75 M Tris-HCI (pH 8.8), 0.05% APS and 0.2% TEMED in Mill iQ-
water. A stacking ge l, the top 1.5 cm of the 7.0 cm gel, was normally composed of] or 4% 
acry lamide-b is (37.5 : I v/v), 0.1 % SOS, 0.1 25 M Tris-HCI (pH 6.8), 0.1 % APS and 0.2% 
TEMED in MilliQ-water. Protein samples were mixed with a 4 x sample buffer conta ining 250 
mM Tris-HCI (pH 6.8), 40% glycero l, I 0% SOS, 20% mercaptoethano l and 0.1 % bro mophenol 
blue. Gels were run at 200 V constant vo ltage on a B io-Rad power pac 200/3 00 (B io-Rad; 
N.S. W., Austra li a) for approximate ly 60 min in electrophores is buffer, composed of 25 mM, 
J 91 mM Glyc ine and 0. 1 % SDS, pH 8.3. 
Bio-Rad Prec ision Plus Prote in Dual Color standards (Bio-Rad ; N.S.W. , Australia) were used as 
protein standards unless otherwise noted. 
2.6.2 Protein stains 
2.6.2.1 Coomassie Brilliant Blue 
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Protein bands were visualized by staining gels with Coomassie blue stain, containing 0.1 % 
coomassie brilliant blue, 40% ethanol and I 0% glacial acetic acid, for at least I h with gentle 
agitation. Excess staining of gel background was then removed by destaining gels using a 
destaining solution composed of20% ethanol and 5% acetic acid. The spent destain solution 
was periodically exchanged with fresh destain until the background are completely destained. 
The gels were either stored in MilliQ-water and photographed or dried as described in section 
2.6.3. 
2.6.2.2 Silver Stain 
Silver staining is a highly sensitive method for detecting proteins in polyacrylamide slab gels, 
and is 10-50 folds more sensitive than Coomassie brilliant blue R-250 for proteins (detection is 
-0.1 ng/mm\ A Silver Stain Plus kit was used according to manufacturer' s instructions (Bio-
Rad; N.S. W., Australia). After gel electrophoresis, the gel was placed in a Fixative Enhancer 
solution containing 50% methanol , 10% acetic acid and 10% fixative enhancer concentrate for 
20 min with gentle agitation. The fixing step renders the protein molecules in the gel insoluble 
and prevents them from diffusion. Substances such as ions, denaturant, or detergents that 
interfere with silver staining are removed during this step. After fixing, the gel was then rinsed 2 
x 10 min in MilliQ-water followed by developing in staining solution, containing 5% silver 
complex solution (contains N&N03 and AgN03), 5% reduction muderator solution (contains 
tungstosilicic acid), 5% image development reagent (contains formaldehyde), and 2.5% (w/v) 
development accelerator reagent (contains Na2C03). Under mildly acidic conditions, silver 
ions are prevented from being reduced and thus can react with proteins. Upon addition of 
formaldehyde, the silver ions are reduced to metallic silver at high pH (Na2C03 renders the 
development solution alkaline) . The gel was developed for about 15 min until desired 
staining is achieved, which was stopped by placing the gel in 5% acetic acid for a minimum 
of 15 min. after stopping the reaction, the gel was washed in MilliQ-water for 5 min and 
dried or photographed . 
2.6.3 Gel drying 
A gel drying apparatus (lnvitrogen, USA) was used for preserving gels. After extensive washes 
in MilliQ-water, gels were equilibrated in a dehydrating buffer (2% glycerol, 20% ethanol) for 
at least 20 min. Two sheets of cellophane were soaked in dehydrating buffer for I min. The 
equilibrated gels were then sandwiched between the two cellophane sheets, which again were 
sandwiched between drying frames for 12-36 h. The dried gels were documented by digital 
imaging on a flat bed scanner. 
2.6."4 Immunoblot 
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2.6.4.1 PVDF membrane transfer 
lmmunoblot analysis was performed as described previously (Towbin et a l., 1979). SOS-PAGE 
was performed as described in 2.6.1. Following e lectrophoresis, the ge l was transferred to a 
transblot cassette (B io-Rad) overlaid with a 0.45 µm PVDF membrane and sandwiched between 
layers of fiber pads plus filter paper. The PVDF membrane was prepared soaking in methanol 
for 1 min , in MilliQ-water for 5 min and finally equilibrating in transfer buffer, containing 37 
mM Tris , 140 mM glyc ine and 20% methanol for at least IO min. The final cassette was 
clamped and placed in a transblot tank and protei ns were e lectrophoretica lly transferred at 35 V 
for 1 h, then at 100 V for 2 h in transfer buffer using a Bio-Rad Power Pac HC (Bio-Rad; 
N.S.W ., Australia). 
2.6.4.2 lmmuno-detection 
After protein transferred, the blot was immersed in 5% (w/v) skim milk di sso lved in PBS (to 
block non-specific binding) for I h at room temperature. With respect to multiple protein bands 
detection, as the bands required different probes, the membrane was cut according to molecular 
weight as indicated by prestained protein standards. After a brief wash with TPBS (0.05% 
Tween-20 in PBS), the membrane was then incubated in primary antibody (containing antibody 
in TPBS with appropriate dilution) with rotation overn ight at 4°C. The membrane was washed 
extensively in TPBS (6 x 5 min) and then exposed to a horseradish peroxidase (HRP) labe lled 
secondary anti body ( I :6000 of anti-mouse, anti-rabbit in TPBS) for 1-2 h at room temperature 
with rotation. Fo llowing washing with 5 x 5 min TPBS and I x 5 min PBS, the blot was finally 
visuali zed (for visuali zation of multiple protein bands, the cut membranes were reassembled in 
the same cassette for exposure). For detection of biotin bound peptide, the membrane was 
blocked in 5% milk overnight at 4 °Cat first, fo llowed with 5 x 5 min of wash with TPBS and 
then exposed to StrepTactin ( I :5 000 in TPBS) for 1-2 h at room temperature (and washed as 
li sted above) and visua li zed. 
2.6.4.3 Visualization (SuperSignal Chemiluminescence) 
After ant ibody exposure, the membrane was exposed to SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Fisher Scientific) according to company 's instructions. 
Briefly, the work ing so lution was prepared by mixing equal parts of the Stable Peroxide 
So lution and the Luminol/Enhancer Solution. The blot was then incubated with working 
solution for 5 min . After be ing removed from working so lution, the blot was placed in a plasti c 
membrane protector (p lastic wrap) and then a fi lm cassette with the prote in side facing up . ln a 
darkroom, the membrane was exposed to Fuji Super RX medica l X-ray fi lm (Fujifilm 
Corporation, Japan) for seconds to minutes, exposure time varied to achieve optimal results. 
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The film was then developed by submerging in Kodak Readymatic dental Developer 
(Carestream Helath; Rochester, USA) (lmin) and Kodak Readymatic dental Fixer (lmin) with 
shaking sequentially, and finally washed in water and air dried. 
2.6.5 Protein densitometry 
Protein bands density (either stained gels or x-ray films from lmmunoblot) was quantified by 
Quantity One 1-D Analysis software (Gel Doc XR) (Bio-Rad; N.S.W., Australia). The 
background was removed by subtracting the density of a section directly underneath the protein 
band from the density of the protein band. 
2. 7 Protein determination 
2.7.1 BCA protein assay 
Protein concentration was determined by using a Pierce BCA protein assay kit according to 
manufacturer's instruction. The assay was conducted in a 96 well flat bottom IWAKI-
ELISA/assay plate (Asahi Techno Glass Corporation). Working Reagent (WR) was firstly 
prepared by mixing 50 parts BCA Reagent A with I part Reagent B (Reagent A:B, 50:1). 
Protein standards were prepared by weighing out BSA and dissolving it in solution the same as 
protein sample solution. Ten µl of sample solution and protein standards of 0.125, 0.25, 0.375. 
0.5, 0.75, 1, 1.5 and 2 mg/ml (BSA) were added in triplicate to the wells, followed by I Oul of 
protein samples in duplicates or triplicates. 200 µl WR was added to each well, and the plate 
was covered with parafilm (Pechiney Plastic Packaging, Inc. Chicago, USA) and mixed 
thoroughly for 30 son a titertek plate shaker (Flow laboratories; North Ryde, Australia). After 
incubating at 3 7 °C for 30 min, the plate was cooled to room temperature; the absorbance was 
measured at 562 nm (reference wavelength: 750 nm) using a EL8000 Universal Microplate 
reader (BioTek Instruments, Inc. Winooski, Vermont, USA). Sample protein concentrations 
were determined by using the standard curve generated by the KCjunior software (BioTek 
Instruments, Inc. Winooski, Vermont, USA). 
2. 7 .2 Protein A280 
When a rapid estimation of protein concentration was required, spectrophotometric 
determination of absorbance at 280 nm (A280) was used. Absorbance was measured on a 
Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific). This method is applicable to 
purified proteins that contain tryptophan (Trp, W), tyrosine (Tyr, Y) residues or cysteine (Cys, 
C)-cysteine disulphide bonds and exhibit absorbance at 280 nm. 
The·protein concentration was calculated according to Beer's Law: 
77 
c=A l£ b 
Where c is the molar concentration of the ana lyzed protein so lution (moles/ liter or molarity (M)); 
A, the abso rbance va lue; E, the molar absorption coefficient (M-1cm-1) and b, the path length 
(cm). At 280 nm, the va lue of the molar absorption coefficient, i.e. E, was approximated by the 
fol lowing eq uation: 
E = (nW x 5500) + (nY x 1490) + (nC x 125) 
Where n is the number of each res idue. 
2.8 Protein binding assay 
2.8.1 Modified Co-Immunoprecipitation (Co-IP) 
To investigate prote in-protein interactions between FLjun or recombinant Cjun and purified 
RyRI /RyR2 iso lated from skeletal/cardiac muscle, a modified co-immunoprecipitation (co-IP) 
(Beard et a l. , 2008) was performed using the Pierce Co-lmmunoprecipitation (Co-IP) kit 
(Thermo Fisher Scientific) according to manu facturer's instructions with modificat ions. For 
each experiment, 20 µl of protein NG plus agarose was prepared by washing with 200 µI of 1 x 
coupling buffer (containing 0.01 M sodium phosphate, 0.15 M NaCl, pH 7.2) followed with 
centrifugation to remove the supernatant. The wash step was repeated tw ice. The control 
agarose (Thermo F isher Scientific) was prepared the same way as for protei n A/G plus agarose. 
All centrifuge steps were 1000 x g fo r 1 min at room temperature in thi s experiment. 
To eliminate non-spec ifi c binding of RyR or junctin to protein NG agarose, 10 µg of purified 
RyR or junctin was diluted in IP/Lysis buffer, composed of 0.025 M Tris, 0.15 M NaC l, 0.00 I 
M EDTA, 1% NP-40, 5% glycero l, pH 7.4, to 0. 1 mg/ml and then pre-cleared by incubating 
with I 00 µI of prepared contro l agarose with rotation for 2 h at 4 ' C. The mixtures were 
centrifuged and the supernatant was removed and used in the subseq uent co-IP assay. 
2.8.1.1 Co -IP precipitation ofjunctin by RyR 
For junctin precipi tation by RyR co-IP, anti-RyR 34C anti body, which recogni zes both RyR I 
and RyR2, was used . Ten µg of 34C anti-RyR anti body was adjusted to I 00 µI with I x 
coup ling buffer, and then associated with protein A/G plus agarose by rotati ng fo r I h at roo m 
temperature . Any unbound antibody was removed with three repeats of a wash step with 1 x 
coupling buffer followed by centrifugation and then removi ng the supernatant. 
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The resultant protein A/G resin-antibody was incubated with 3% BSA (prepared in 1 x coupling 
buffer) with rotation for I h at room temperature to block the agarose resin, followed by 
centrifugation to remove supernatant. Pre-cleared purified RyR (methods see above) was then 
added to the antibody bound agarose and incubated with rotation at 4 °C overnight. Following 
incubation, the samples were spun down and the supernatant was removed. Any RyR protein 
not bound to the antibody was removed by washing three times in cold IP/lysis buffer (2 x 200 
µl plus 1 x I 00 µl). The protein A/G-antibody-RyR complex was finally incubated with pre-
cleared Cjun with rotation for 2 hat room temperature followed by three washes with cold 
IP/lysis buffer as above to remove unbound protein. The pre-cleared Cjun was also incubated 
with protein A/G agarose alone as control. Immunoprecipitated samples were eluted from the 
beads by incubating at 65 °C for 10 min in the standard Laemmli sample buffer (Laemmli, 
1970), separated on SDS-PAGE (see section 2.6.1), transferred to immobilon membranes 
(section 2.6.4) and immunoprobed (using anti-RyR 34C or anti-junctin antibody) to identify 
proteins bound to the protein A/G plus agarose. 
Z.8.1.2 RyR precipitation by junctin co-IP 
The reverse assay was also performed, with anti-junctin first bound to protein A/G sepharose, 
then coupled with pre-cleared FLjun or Cjun, then incubated with pre-cleared purified RyRI or 
RyR2 and processed as described above (section 2.8.1.1). 
2.8.2 NeutrAvidin agarose affinity chromatography 
Binding of peptides (i.e., Njun, Njunscrnmbl,d or JunKEKEcanin,)to protein constructs (e.g. 
recombinant RyRl or RyR2) could not be determined by using co-IP, as the peptides seemed to 
intrinsically bind to the protein A/G sepharose (section 2.8.1), with pre-clearing unable to 
resolve the problem (data not shown). Therefore, NeutrAvidin agarose affinity chromatography 
was employed. All centrifuge steps were 1000 x g for 3 min at room temperature in this 
experiment. 
To prepare neutravidin-agarose (Thermo Fisher Scientific), 500 µl of PBS was added to 100 µl 
of neutravidin-agarose 50% slurry, which were subsequently centrifuged and the supernatant 
was removed. The wash step was repeated twice and the resultant pellets were resuspended in 
50 µl binding/wash buffer (PBS + 0.1 % SDS) to obtain a 50% slurry. One hundred µg of 
biotinylated peptide (diluted to 1 µg/µl with binding/wash buffer) were added to 100 µl of 50% 
prepared agarose slurry and then incubated with rotation at room temperature for 2.5 h. The 
supernatant was removed after centrifugation. The unbound peptide was removed with five 
repeats of a wash step protocol which involved r.esuspending the pellets in 500 µl of 
bincjing/wash buffer followed by centrifugation and then supernatant removed. 
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N inety ,tg (for each experiment) of recombinant RyRl or RyR2 were diluted in binding buffer 
(PBS + 0.1 % SD S + prote in inhibitors: AEBSF (S igma-Aldrich, USA) or Protease Inhibitor 
Cocktai l (Roche Diagnostics, Germany)) and pre-cleared by incubating with I 00 µI of contro l 
agarose res in for 2 h at room temperature to e liminate any RyR that may bind to neutrav idin-
agarose. Pre-cleared supernatant were then incubated with NeutrAvidin-agarose-bound 
biotinylated normal peptide or scrambled peptide or with NeutrAvidin-agarose alone overnight 
at 4 °C. Fo llowing incubation, the NeutrAvidin agarose-complex was centrifuged and the 
supernatant was removed. Any prote in that had not bound to the peptide was removed with fi ve 
times of a wash step protocol (above) . Bound proteins were e luted from the beads by incubating 
at 65 °C fo r 10 min in 15 µI of Laemmli sample buffer. The e luted protein in the supernatant 
were then run on SOS-PAGE (see section 2.6.1), transferred to immobilon for immunoblot (see 
section 2.6.4), using anti-RyR 34C antibody to detect recombinant RyRI or RyR2 and 
StrepTactin-HRP conjugate to detect biotinylated peptide. 
2.9 Artificial Planar lipid bilayers 
2.9.1 Overview oflipid bilayer system set up 
Single channel recording was performed according to (Hamilton 1989) with some modifications 
(Laver, 2001 ). The planar lipid bilayer was set up with a Derlin cup (Caillac Plasti cs; Seaford, 
Australia) being fitted into a Tefl on chamber, so that the chamber was di vided into two 
compartments. The Derlin cup conta ins a 150-200 µm aperture across which a lipid bilayer was 
painted. T he aperture was viewed using a light microscope (Olympus; Tokyo, Japan) at 40 x 
magnification and illuminated w ith a fiber optic light (Nari shige scientific instrument lab; 
Tokyo, Japan). Stock so lutions were added directly into both compartments before the lipid film 
was pa inted across the aperture. Electri ca l connection between the so lutions and an Axopatch 
2008 Integrat ing Patch c lamp (Axon Instruments, Foster City, CA, USA) or a Warner BC-525 
Bilayer clam p am plifier (Warner Instruments, Hamden, USA) was established via s il ver 
chlor ide (AgCI) coated sil ver e lectrodes through a CV 2038V head stage (Axon instruments, 
USA). Both electrodes were inserted into sa lt agar bridges (2% (w/v) aga r powder in 250 mM 
CsC I) to reduce j unction potentials on AgC I electrodes. 
The compartment to which the SR vesicles were added is known as the cis chamber and was 
vo ltage clamped at +40 or -40m V under a ll conditions. The oppos ing compartment, referred to 
as the trans chamber, was grounded. The potentials are expressed acco rding to standard 
phys io logical convention as Ye,., - Y ,,ans· The current/signal was fi ltered at I kHz with a low pass 
8-pole Bessel filte r integrated in the Axopatch 2008 and di splayed using the in-house 
Cont inuous analog/d igita l conversion program 1.0 (SLM I), and recorded at a bandwidt h of 5 
kHz. The parameters give a sampli ng interva l of200 µs, i.e. one point every 200 µs. The entire 
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setup, both chambers and head stage, was housed in a grounded Faraday cage with a sliding 
front to reduce electrical and vibrational noise. 
2.9.2 Lipid bilayer formation and vesicle incorporation 
The artificial lipid was a mixture composed of phosphatidylethanolamine (PE), 
phosphatidylserine (PS) and phosphatidylcholine (PC) at a ratio of 5:3:2 (v/v). Once mixed, the 
chloroform in which the lipids were stored was evaporated under nitrogen gas. The dried lipids 
were then redissolved in a hydrophobic solvent 11-decane at a final concentration of 45-50 
mg/ml. The bilayer was formed by applying the lipid to the aperture in the Derlin cup using a 
flame polished glass rod. A thick lipid film was initially produced after painting the lipids with 
two monolayers across the aperture and the solvent 11-decane trapped in between. During bilayer 
formation, the compressive force of solutions on both sides of the lipid and lipid tail aggregation 
facilitate the drainage of solvent away from the two monolayers such that the bilayer can be 
formed (Laver, 200 I). The initial lipid film can reflect light strongly whereas the field where a 
bilayer forms becomes dark thus allowing observing the bilayer formation under a microscope. 
This process can occur either spontaneously or by applying a gentle pressure using a glass rod 
to the edge of the film thus helping 11-decane removal. SR vesicle was normally added after a 
bilayer with an optimal thickness being achieved for better incorporation. The thickness of the 
membrane was monitored by observing the capacitance changes of the bilayer through applying 
I V/s triangular ramp via a ramp generator (JCSMR workshop, ANU; Canberra, Australia). An 
increase in bilayer capacitance denotes the thinning of the lipid bilayer, which is indicated by 
the respondence of the amplitude of the current to the applied voltage ramp (C=l/(dV/dt)). 
SR vesicles containing ion channels were added to the cis solution (to a fuial concentration of 1-
50 µg/ml depending on vesicles being used with vigorous stirring. Vesicle incorporation was 
promoted by i) an osmotic potential gradient created by 250 mM cis cesium ions (Cs+) versus 50 
mM trans Cs+ (see section 2.9.3); ii) a high cis [Ca2+] (minimum I mM) (Laver, 2001 ; Miller and 
Racker, 1976). Once channel gets incorporated into the bilayer, which can sometimes be 
detected as an increase in conductance of the bilayer membrane or appearance of channel 
openings, cis [Ca2+] was adjusted to I µMor 100 nM in RyRI and to I µMin RyR2 to prevent 
further vesicle incorporation. Two mM ATP (buffered to a pH 7.4 by IO mM TES) was added 
to activate RyRs in some cases. In general , channels incorporated in such a way that their 
cytoplasmic surface faces the cis chamber, while the luminal side faces the trans solution 
(Miller & Racker, 1976; Sitsapesan & Williams, 1994). In this study, the orientation of RyR 
channel incorporation was confirmed by the characteristic response ofRyR to its agonists (ATP 
and Ca2+) or antagonist (ruthenium red). 
2.9.3 Lipid bilayer experimental solutions 
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Al l so lut ions were adjusted to a pH of 7.4 w ith CsOH or HCI using a digital pH meter (TPS pty. 
Ltd, Brisbane, Austra li a) and made using MilliQ-water. The solutions used in lipid bilayer 
experiments were e ither stored at 4 °C (cis and trans so lutions and ruthenium red) or at -20 °C 
(BAPT A, ATP). The incorporation so lutions were cis (cytop lasmic) containing: 23 0 mM 
CsCH30 3S (CsMS), 20 mM CsCI, I mM CaCl2 and JO mM TES, pH 7.4 and a trans (luminal) 
so lution contai ning: 30 mM CsCH30 3S, 20 mM CsCI, I mM CaC12 and IO mM TES (pH 7.4). 
The fast Ca2+ chelator 1,2-bi s (2-aminophenoxy)ethane-N,N,N,N-tetraacetic acide (BAPTA) 
was used to adjust the free [Ca2+] in the solution. The amount ofBAPTA required was 
calcul ated using the in-house program Bound and Determined (BAD) (Brooks and Storey, 
J 992). The purity of BAPTA and free [Ca2+] in the so lution was determined by a Radiometer 
Analytical ISE25Ca Ca2+ electrode (V illeurbanne Cedex, France Rad iometer Analytica l SAS, 
Vi ll eurbanne, France). 
In bi layer experiments, Cs+ was chosen as the current carrier instead of Ca2+ for multiple 
reasons: a) fo r RyR, the conductance of Cs+ is significantly higher than that ofCa2+, leading to a 
5-fold increase in signal to noi se ratio (Sitsapesan and Willi ams, 1994a); b) compared w ith Ca2+, 
Ct has a much weaker regulatory effect on RyR (Laver et al. , 1995); c) ct can block SR K+ 
channels effective ly, which ensures that the current s igna ls recorded was RyR activity but not 
K+ channel activ ity (Cukierrnan et al. , 1985). CH30 3s· was used as the maj or anion ; thi s is to 
prevent cu rrent through anion channels, e.g. SR C J" channe ls due to their low permeability to 
CH30 3s· (Laver et a l., 1995). 
2.9.4 Channel recording 
Chan ne l activity was recorded usi ng the BLM I program w ith Axo patch 200 Amplifier (Axon 
Instruments, Foste r C ity, CA, USA). After channel incorporation, the recording commenced and 
the fo ll owing changes were made to standard so lutions: 200 mM CsMS was added to the trans 
chamber to ac hieve symmetri ca l so lutions (with respect to [Cs J, [Cr] and (CH30 3S"]), so that 
there was no ionic gradient across the bilayer; the cis [Ca2+] was adj usted to I µM (by the 
addition of 1.32 mM BAPTA) or 100 nM (by the addi tion of 4.25 mM BA PTA), 2 mM ATP 
was added to cis so lu tion in some control conditions. The effect of junctin constructs add ition in 
this study was not affected by the presence of absence of ATP; therefore, channel data with 
ATP and wi thout ATP were poo led and included in calcu lation of average channe l activ ity. 
There was no change in pH w ith the addition of BAPTA, ATP or CaC l2 to the so lutions. The 
so lution was stirred for 20-30 s after the addition of substances to ensure equ ilib ration. Bilayer 
potential is expressed as Yw - V,,0 ,,5 • Therefore when a vo ltage of +40 mV was applied , V,ppl;,d = 
Yw - V,,0 ,,., = 40 - 0, current would fl ow from cis to trans chamber, while w ith -40 mV current 
would fl ow fro m !rans to cis chamber. The bilayer potential was changed between +40 mV and 
-40 m V every 30 s. C urrents were recorded continuous ly throughout the experiments with a 
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minimum of 5 min for control activity. Junctin constructs were added into either cis or trans 
chamber as designated to desired concentrations and channel activity was recorded for about I 0 
min in most cases. Additional recordings were carried out after the add ition of20 µM ruthenium 
red, an RyR-specific antagonist, to the cis chamber at the end to further confmn channel was a 
RyR (Ma, 1993). 
Details of each individual experimental procedure are given in results chapters. A ll channel 
experiments were conducted at 23±2 °C 
2.9.5 Single Channel analysis 
Single channel parameters were obtained from an in-house program, Channel 2 (developed by 
P.W. Gage and M. Sm ith, John Curtin School of Medical Research; Canberra, Australia). 
Channel parameters were measured from 90 s of channel activity at each potential , before and 
after the add ition of junctin protein/peptide. The following parameters were determined: open 
probability (P0 ) , fractional mean current (I' F), mean open time (T0 ), and mean closed times CTc). 
Tbe above parameters are defined by the fo llowing equations: 
Open probability (P0 ) = Tope,/Tr1me [Equation 2. 1 J 
Fractional Mean Current (I'F) = ['/ f mox [Equation 2.2] 
Mean open time (T0 ) = Tope,/ 11 [Equation 2.3] 
Mean closed time (Tc)= Tc10sein [Equation 2.4] 
Where Topen is the total charrnel open time; Tc1osed is the total channel closed time; T,,,,, ,, the total 
duration of analyzed record; n, the number of channel opening events; I' , mean current, an 
average of all data points during a recording period and I man maximal current of the analyzed 
record. 
In this study, RyR activity was quantified by assess ing open probability (P0 ) in two ways, either 
the probability that the charrnel wou ld be open at any one time, as T0p,,,IT,,,,,, (equation 2.1) , 
where threshold level for charrnel opening was set at - 20% of the maximum single channel 
conductance, and the closed threshold was placed above baseline noise or halfway in between 
open threshold and baseline in order to exclude baseline noise. P0 was also approximated by the 
average current as a function of the maximum current, i.e. I'F (equation 2.2). I'F is 
approx imately equal to the Po measured by thresho ld discrimination when most of channel 
openings are to the maximum conductance. It has been shown that P 0 and I'F values obtai ned 
from a s ingle channel record from a predominantly active channel are very simi lar (Beard et a l., 
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2008). P0 is the most accurate measure of RyR channe l activ ity when only one channe l is active 
in a bi layer, whereas l'p most accurately quantifies RyR activity when multiple channe ls are 
active . Since l'p is approximate ly equa l to P 0 (Beard et a l. , 2008), all chan ne l activ ity (measu res 
either as J'p or P0 ) is ex pressed as P0 . Slow fluctuation s in the baseline current were co rrected 
using an in-house correction program Baseline (written by Dr D.R. Laver, Uni vers ity of 
Newcastle, Austra li a). In thi s study, data from +40 mV and -40 mV were poo led and included in 
calculation of average channe l activity as there was no signifi cant difference between each 
potential. 
In addit ion, a more detailed ana lysis of the effect of the FLj un, Cjun and Nj un on purified RyRI 
or RyR2 channe l act ivity was derived from the statistics of amplitudes and durations ( i. e. open 
and closed dwell-times, the time constant di stributions) according to (S igworth and Sine, 1987; 
Tae et al. , 2011 ). To obtain the frequency di stribution of dwell times, the data of open and 
closed times were grouped into bins that are equally spaced on a log sca le, and the square root 
of the re lative frequency of events (P 112) was plotted against the logar ithm of the open ( open 
circles) or closed times (fill ed circles) in milli seconds. T he open and c losed times were fitted 
with three exponentia l components in both RyR isoforms, and the appropriate fit was 
determined using least square ana lys is . In thi s study, 1-10 ms were ass igned to , 01 one 1, I 0-50 
ms to , 02 or Tc2, and 50-500 ms to , 03 or , c3. An example was shown in F ig. 2-2. 
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Figure 2-2 A probab ility (the sq uare root) distribution of open (open circles) and closed (filled circles) dwell-
times. Exponential open and closed time constants were determined . Examp le is shown from a simulated. single 
channel recording. fi gure adap1ed and modified from (Laver, 200 I). The arrows indicate individual open time 
constants {t01 , t 02, and t 03) and indi vidual closed time constants (tci, tc2, and tc3). The so lid lines are theoretical 
probability function s. 
2.10 caz+ release from skeletal and cardiac SR vesicles 
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Part of this work (Ca2+ release assay with Cjun) was undertaken by Mrs. Suzy Pace (Muscle 
Research Group, John Curtin School of Medical Research, Australian National University, 
Canberra, Australia.) 
A Cary lE UV-Visible spectrophotometer (Varian, Sydney, Australia) was used to monitor Ca2+ 
release from populations of intact SR vesicles at 710 nm, using the Ca2+ indicator antipyrylazo 
III (Dulhunty et al. , 1999; Hanna et al., 2011; Jalilian et al., 2008). It should be noted that the 
native RyR-containing SR vesicles used in this assay were prepared from either skeletal or heart 
muscle following well established procedures analogous to previously published methods 
(Chamberlain and Fleischer, 1988; Saito et al. , 1984); for details, see section 2.3.1).These 
vesicles have been shown to retain morphologically well -preserved junctional feet (RyR) 
structures projecting out of the vesicles, with similar orientation to feet observed in micrographs 
of intact fibers (Saito et al., 1984 ). Therefore, the SR vesicles were expected to be of the same 
"polarity" (i.e., the cytoplasmic domains of the RyRs facing outside the vesicles). In addition, as 
the natural consequence of the structure of the RyR-containing microsomal vesicle, the RyR 
channels was always inserted in the bilayer with its cytoplasmic domain exposed to the cis 
chamber when the vesicles were added to the cis solution (Tu et al. , 1994b ). Therefore, the 
response ofRyR in SR vesicles to the constructs tested (Cjun/Njun) here was assumed to reflect 
the interaction between Cjun/Njun and the cytoplasmic domain ofRyR. Changes in absorbance 
as a function of time were observed using the Kinetics program (Varian, Sydney, Australia). 
The temperature was maintained at 25 °C for all experiments unless otherwise stated and the 
cuvette solution was magnetically stirred throughout the experiment. Calibration curves were 
obtained by measuring optical density changes with addition of four consecutive 12.5 µM (50 
µM in total) CaCl2 to the cuvette solution at the start of each day (Eager and Dulhunty, 1999). 
The calibration curve was not affected by Njun, Cjun, caffeine, or ruthenium red. Changes in 
absorbance as a function of time were observed using the Kinetics program (Varian, Sydney, 
Australia). The extravesicular [Ca2+) could be calculated by measuring the change in absorbance 
that occurs with addition of known amount of Ca2+ using the following equation, which was 
used to determine the rate of Ca2+ release in each experiment (Chu et al. , 1988). 
Ca2+ Calibration= 50nmo!Ca
2
+ 
~ absorbance 
[Equation 2.5) 
2.10.1 Njun/Cjun induced Ca2+ release from SR vesicles 
SR vesicles (for skeletal vesicles- SO µg/ml ; for cardiac vesicles-100 µg/ml) were added to a 
cuvette to a total volume of2 ml containinglOO mM KH2P04• 0.5 mM antipyrylazo III, 1 mM 
Na2ATP, and 4 mM MgCl2• The addition ofNa2{\.TP and MgCb (MgATP) activated the 
SE~CA pump leading to an uptake of extravesicular Ca2+. After equilibration of the solution (1 
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min for ske leta l vesic les and 3 min for cardiac vesic les), the SR was loaded with four add itions 
of7.5 µM CaC l2. One min (skeletal)/ 3 min (card iac) equilibration time was allowed between 
each Ca2• add ition. Thapsigargin (300 nM for skeletal SR vesicles and 2.25 µM for cardiac SR 
ves icles) was then added to block the SERCA to prevent Ca2+ uptake during the experiment 
(Sagara and lnes i, 1991 ), so that Ca2+ release could be specifically measured. Njun/Cjun (5 µM) 
was added 30 s after thapsigargin to examine the ability of high concentrations ofNj un/Cj un to 
immediately stimu late Ca'+ release by measuring the optical density. Ruthenium red (5 µM) was 
then added to confirm that Ca2+ release was through the RyR, which caused a flatline of the 
optical dens ity. The flatline indicated that Ca2+ was not being released or taken up by the SR 
vesicles and that both the RyR and the SERCA pump were blocked. F ina lly Ca2+ ionophore 
(A23 I 87) ( 1.5 µg/ml) was added to release any Ca2+ remaining in the SR into the extravesicular 
space. The rate of Ca2+ release induced by Nj un/Cj un was ca lcu lated (see section 2.10.3) and the 
results were compared to control experiments where either MilliQ-water (where Njun peptide 
was disso lved) or MOPS buffer (20 mM MOPS, 150 rnM NaC l, pH 7.4) (where Cjun was 
disso lved) was used in place ofNjun/Cjun to obtain a base line leak ofCa2+ from the SR, in the 
presence of SERCA pump being blocked by thapsigargin. 
2.10.2 Ca 2• release from SR vesicles pre-incubated with Njun/Cjun 
SR vesic les (50 µg/ml for ske leta l vesicles and I 00 µg/ml fo r cardiac vesic les) were incubated 
w ith Njun/Cj un (5 µM) (or with MilliQ-water/MOPS bu ffer a lone for control experiments) fo r 
30 min on ice prior to the ir addition to the cuvette so lution (see section 2.10. 1 for the 
compos ition of the so lution). The concentration ofNj un or vehicle buffer in the cuvette was 
adj usted to the incubation concentration , and the ves ic les were loaded with Ca2+ in the usual 
way (see section 2. 10.1 ). Following inhibition of SERCA with thapsigargin (300 nM for 
skeleta l SR ves icles and 2.25 µM for cardiac SR ves ic les) , Ca2+ release was stimulated with 
either 0.5 rnM (ske leta l) or 5mM (ca rdiac) caffe ine and the rate of caffei ne-induced Ca2+ re lease 
measured fo llowing incubation in either: buffer plus Nj un/Cjun, or buffer plus MilliQ-
water/MOPS buffer. T he experiment was completed w ith the addition of ruthenium red and 
Ca' + ionophore A23187 as in section 2. 10 .1. The results w ith Njun/Cj un were compared to 
control experiments where ves ic les were pre-incubated with MilliQ-water/MOPS buffer in place 
of Njun/Cjun. The amo unt of Ca2+ loaded into the SR was not a ltered by incubation of SR 
ves ic les with Njun, Cjun or contro l buffer. 
2.10.3 Data analysis-calculation of rate ofCa2• release from SR vesicles 
Ca2• release rate was determined by measuring the rate of change in optica l density immediate ly 
fo llowing stimulation ofCa2+ release. The init ial re lease rate was the most rapid Ca2+ re lease per 
unit t ime (Olson et al. , 2000). The rate ofCa2+ release was determ ined by drawing a ta ngent line 
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to the initial release data, the slope of which was measured by the Kinetics program. The slope 
of the curve measured was used in the following equation (equation 2.6) to calculate the slope 
of Ca2+ release (Chu et al. , 1988): 
Slope of Ca2• release= Li absorbance 
time (min) [Equation 2.6] 
This value, together with the value obtained for the Ca2+ calibration (equation 2.5), the rate of 
Ca2+ release in nmol ca2•/mg protein/min was calculated with the following equation: 
Rate of Ca2• release 
2.11 Statistics 
slope of Ca 2• release I uptake x Ca2• calibration 
protein (mg) [Equation 2.7] 
Average data are given as mean ±SEM. Statistical significance between control and test values 
was evaluated using paired or unpaired Student 's I-test or ANOVA (analysis of variance) as 
appropriate. To reduce effects of variability in control parameters, data withjunctin constructs 
(J) are expressed relative to control (C), (e.g., log10Xrlog10Xc, X=P0 , T0 , T" rate ofCa2+ release, 
etc). Numbers of observations (n) are given in tables and figure legends. AP value <0.05 was 
considered to be significant. 
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Chapter 3 Full length junctin interacts with purified RyRl and 
RyR2 channels 
3.1 Introduction 
As deta il ed in Chapter 1 (section 1.7-1 .9), proteins associated with the RyR in the SR lumen 
inc luding CSQ, triad in and junctin, play a ro le in modulating Ca2+ release through the RyR. In 
recent years, the ir importance in both the regulation ofCa1+ store and Ca1+ re lease from the RyR 
has been increas ingly recognized. The main focus of thi s chapter is on direct regulation of 
iso lated RyR I and RyR2 ion channel acti vity by junctin. 
As di scussed in Chapter 1.9, most of our knowledge about the functional effect of junctin on 
RyR2s is deri ved from transgenic studies, which suggest thatjunctin suppresses RyR2 acti vity 
(Yuan et al., 2007) or acts as both an acti vator and inhibitor depending on SR Ca2+ load 
(A ltschafl et a l. , 2011 ). However, it remains unclear whether thi s action is a direct effect o f 
junctin on RyR2 activity or an indirect effect through CSQ, s ince changes injunctin expression 
may influence interactions between CSQ2 and RyR2, thus fun ctional changes may be due to 
a lterations in CSQ regulation of Ry Rs rather than junctin e ffects per se (Yuan et al. , 2007). 
Even in a study carefu lly carried out by Altschafl et al. (2011 ), where CSQ2 was mostl y 
exc luded fromjunctin-KO and WT cardiac SR in lipid bilayer studies, the poss ibili ty that the 
effects may be related to altered RyR2 regulation by CSQ2 and altered tri adin interactions 
cannot be entire ly excluded . Therefo re, the direct regulatory effect of junctin on the RyR2 
remained to be c learly elucidated. 
In contrast to the results in the transgenic studies, in vitro lipid bilayer studies showed that 
addi tion of j unctin to the luminal s ide of purifi ed RyR2 (Gyorke et al. , 2004a) in lipid bil ayers 
evoked s ign ifi cant channel acti vation, indicating a pos itive effect of junctin on RyR2 acti vity. 
Nevertheless, it is wo rth not ing that the lum inal [Ca2+] used in the Gyorke study (20 µM or 5 
rnM) do not inc lude the physiologica l concentrations between 0.1 and 1.5 mM . Hence, the ro le 
o f juncti n in modulating RyR2 acti vity still remains elus ive. Due to the physiologica l 
importance ofjunct in in the ma intenance of normal SR Ca2+ handling and cardiac funct ion 
suggested from transgenic stud ies, it is important to determine the molecular interactions 
betweenjunctin and the RyR2 at a more phys io logica l Ca1+ concentration, i.e. I mM luminal 
[Ca1+]. 
So far, the first and the only study to look at the direct effects ofjun ctin on the ske letal RyR 
channel elegantly carr ied out by others in the Muscle Research Group revea led that the j unctin 
added to luminal side of pur ified RyR I evoked significant channel activat ion with physio logical 
cyto plasmic and lu mi nal Ca1- concentrations (Wei et al. , 2009a), ind icat ing thatjunctin may 
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thus activate the channels in skeletal muscle . Nevertheless, the precise way by which junctin 
modulates RyRI remained unclear. This problem will be discussed in the following chapters 
(Chapter 4 and 5). 
As mentioned in Chapter 1.9.1 , junctin contains a single membrane spanning domain, a short 
cytoplasmic N-terminal tail and a longer C-termina l tail in the SR lumen. 1n this chapter, junctin 
will be investigated as a whole, i.e . full length junctin (FLjun). The body of work described in 
this chapter has defined the overall interaction between FLjun and the RyRs. 
Aim: 
The primary aim of the experiments described in this chapter was to characterize the functional 
effects ofj unctin on purified RyR2 at resting luminal [Ca2+] (1 mM). The direct effect ofjunctin 
on purified RyRI activity was also tested for comparison. A second component of thi s a im was 
to investigate the precise mechanism by which junctin regulates RyRI and RyR2 activity . An 
additional aim was to develop a method to generate the full length recombinantjunctin to 
overcome the low yield problem sometimes encountered during muscle junctin purification. 
3.2 Methods 
3.2.1 Methods overview 
Junctin was first purified from rabbit skeletal muscle for the investigation of its interaction with 
the RyR I and RyR2. The one isoform ofjunctin is expressed in both the skeletal and cardiac 
systems. In add ition, recombinant FLjun was expressed and purified from E.coli. Modified co-
immunoprecipitation (co-IP) was carried out to evaluate the physical interaction between FLjun 
and purified RyRI or RyR2. Single channel recording in lipid bilayers was employed to explore 
the direct funct ional effect of luminal junctin on Ry RI or RyR2 channel activity at resting Ca2+ 
(I mM). A control experiment was also carri ed out to detennine whether junctin in the 
cytoplasm affected the RyR activity. 
3.2.2 SR vesicle isolation and RyR purification 
As detailed in section 2.3. I , skeletal SR vesicles were prepared from rabbit ske leta l muscle and 
sheep heart respectively. Skeletal RyRl and cardiac RyR2 were solubilized and purified fro m 
skeletal and cardiac SR vesicles respectively as descr ibed in section 2.3.2. 
3.2.3 Junctin purification 
3.Z.3.1 Endogenous junctin purification from rabbit skeletal muscle 
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Skeletal junctin was purified using SOS preparative gel e lectrophoresis from rabbit ske leta l 
muscle tissue as detailed in section 2.5.1. ln brief, the crude SR ves ic les were so lubilized by I% 
CHAPS to remove inso luble membrane fragments. Solubilized SR was separated by a 12% 
preparative gel e lectrophoresis fo r junctin purification . Fractions containing the band with a 
molecular mass of - 25 kDa (normally in fractions 45-60), ana lyzed by analytical mini SDS-
PAGE, were precipitated by 400 mM KCI , redi sso lved in Triton X- 100 and washed and 
concentrated. 
3.2.3.2 Recombinant canine cardiac Fljun 
Due to difficulty in reproducing results with preparative gel e lectrophores is from rabbit skeletal 
muscle, recombinant FLjun was expressed and purified from E. coli (detailed in section 2.5.2). 
Recombinant FLjun was obtained by subcloning canine cardiac muscle junctin cDNA and 
expression in E. coli as a poly-histidine (6xHis) fu sion protein. Maximum yield of recombinant 
protein was achieved by express ing the protein for 4 hat 37 °C following induction with 0.6 
mM IPTG. The fusion protein was purified using Ni2+-nitrilotriacetic acid agarose matrix by 
IMAC under native conditions with I% Triton X-100. 6xHis-FLjun was coupled to the affi ni ty 
matrix after incubating protein supernatant with the agarose . Any unbound proteins were 
removed by extensive ly washing the beads. The fusion protein was eluted aga inst 500 mM 
imidazole e lution buffer. Triton X-100 contained in the e luted sample was subsequently 
removed using Bio-Beads SM-2 adsorbents. 
3.2.4 Modified co-IP between FLjun and RyRl and RyR2 
Direct binding between skeleta l FL jun and the RyR I and RyR2 was assessed using a modified 
co-IP. T he assay was performed in two ways: I) co-IP precipitation of RyR I (n=3) or RyR2 
(n=3) by FLjun, 2) FLjun precipitated by RyR I (n=3) or RyR2 (n=3) co-IP as described in 
section 2.8. 1. To e li minate non-specific binding between the protein and the matrix, a) both 
purified FLjun and RyR I or RyR2 were pre-cleared in I 00 µ I contro l agarose res in and b) the 
protein A/G agarose-antibody complex was blocked with 3% BSA to occupy any possible 
binding sites on the resin . The final RyR/j unctin-antibody-protein A/G agarose complex was 
subjected to extensive washing to remove any unbound proteins, and then e luted by incubating 
at 65 °C for IO min in Laemm li sample buffer and tested with SOS-PAGE and immunoblot. 
Anti-RyR 34C and anti-ju nctin antibody were used to probe RyR l/RyR2 and FLjun 
respectively. 
3.2 .5 Single channel recording and analysis 
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Single RyR channel recordings were carried out and analyzed as described in section 2.9. Stable 
control activity was recorded for a minimum of 5 min before adding FLjun, alternating between 
+40 and -40 mV every 30 s. 
RyR is well known for the large variation between the activity of individual channels, possibly 
due to differences between the degree of phosphorylation, nitrosylation, or oxidation of the 
channels (Capello et al., 1997; Marengo et al., 1998). To reduce effects of variability in control 
parameters (P0 c), data with FLjun are expressed relative to control, i.e. the difference between 
the log 10 Xc and log10X1 (X= P0 , T0 , Tc) for each channel (e.g., log10P01 - log10P0c). The fractional 
mean current (J'F) was measured in the recordings where multiple channels incorporated (see 
section 2.9.5 and below section 3.3.1.1 ). When J'F under test conditions is normalized to control 
J'F, it is approximately equal to relative P0 (Beard et al. , 2008). All channel activity (measured 
either as J'F or P0 ) is expressed as P0 both in this chapter and the following chapters. 
3.3 Results 
3.3.1 General properties of RyRt and RyR2 
3.3.1.1 General observations 
Following lipid bilayer formation, purified Ry RI s or RyR2 was added to the cis chamber. The 
incorporation of the RyRs generally occurred from 3 min up to more than 15 min after their 
addition. Channel incorporation was usually indicated by a step increase in bilayer conductance, 
or the appearance of channel openings . If incorporation did not occur after 20 min following 
vesicle addition, more vesicles (-10-25 µg/ml) were added to the cis chamber. If there was still 
no incorporation after another 20 min, the chambers were washed, the solutions were replaced 
and the procedure was repeated. 
After an initial fusion event, 200 mM CsCH30 3S was added to the trans chamber to bring trans 
[Cs+] to 250 mM, therefore equilibrating the [Cs+] in the chambers to prevent further fusion; 
[Ca2+] in the cis chamber was adjusted to I µMin most cases with trans [Ca2 ' ] being a constant 
1 mM; 2 mM ATP was added to the cis chamber in some cases (see Methods, section 2.9.4). 
Multiple channels often incorporated into the bilayer, regardless of the RyR isoform being used. 
The number of channels incorporating into an artificial lipid bilayer varies and the activity also 
varies between one channel opening and more than one channel being active. Fig. 3-1 shows 
recordings with up to 4 channels (for both RyRl and RyR2) opening simultaneously. The 
presence of multiple active channels in the bilayer does not alter the overall response ofRyRl 
or RyR2 to RyR modulators, e.g. ca2+, ATP, rutlienium red. The activity of multiple channel 
bilayers was measured as mean current (see section 2.9.5 for detail), with data presented as 
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fractional mean current J'F (average current/maximal channel amplitude) which is 
approximately equa l to P0 • 
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Fig ure 3-1 Multiple cha nnel incorporation into lipid bilayers. Five second recordings of multiple RyRJ (A) and 
RyR2 (8) activity at +40 mV are shown. Multiple channel openings are upward from zero current {c, so lid line) to 
maximum open conductance (o 1, one channel open, o2, o3 and o4 simultaneous opening of two, three or four 
channels). 
3.3.1.2 General RyR characteristics 
3.3.1.2.1 Purified RyRl and RyR2 channel conductance 
Channel identity in lipid bilayers was confirmed by eva luating the voltage-dependence of 
channel act ivity and its conductance as wel l as its response to ligands (section 3.3.1.3). The 
maximum current amplitudes of a single RyR (both Ry RI and RyR2) were very similar at +40 
and -40 mV under control conditions (I µM cis [Ca2+] and I mM trans [Ca2+]; Fig. 3-2A&B). A 
current-voltage curve was constructed us ing the maximum current obtained from Fig. 3-2A&B, 
showing the linear current-vo ltage re lationsh ip tnrough zero (Fig. 3-2C&D) as previously 
reported for RyR I and RyR2 channels (La i et al. , 1988; Laver et al. , 1995; Liu et al. , 1989). 
The maximum ion channel conductance (G) depends on I) the maximum current thro ugh the 
channel (I); 2) the vo ltage across the b ilayer (V); 3) the ion charges on either side of the lipid 
bilayer. Due to the symmetric [Cs+] (250/250 mM) set for control conditions, the reversal 
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potential for Cs+ (Ee,) fel l at O mV. Therefore, the conductance of a channel can be calculated 
using the following equation: 
Gma.x =lmax/V [Equation 3.1] 
Where Gma.x is the maximal conductance at a particular vo ltage (S), !max is the maximal 
current at a particular vo ltage (A), and Vis the voltage across the lipid bilayer (V). 
The average maximal single channel conductance at +40 mV was 281.8± 14.5 pS or 288.1±10. 7 
pS at -40 mV for purified RyRl channels (n=l6). Purified RyR2 displayed a maximal single 
channel conductance of269.6±15 .77 pS at +40 mV and 263.7±14.3 pS at -40 mV (n=J2). These 
results demonstrate an approximately equal channel conductance at both +40 m V and -40 m V 
under control conditions. The average of these conductance va lues is 284.8±9.1 pS for RyR I 
and 266.6±10.5 for RyR2 under conditions with J µM cis [Ca21 and 1 mM trans [Ca2+]. These 
observations are similar to va lues previously reported for RyRl and RyR2 conductance under 
identical experimental conditions with 250 - 300 pS (Dulhunty et al., 200 I a), and are in 
agreement with literature on RyRl(Lai et al. , 1988; Liu et a l. , 1989; Meissner, 1994) and RyR2 
(Laver et al. , 1995; Tinker et al. , 1992b) conductance which varies between 200- 525 pS. As 
mentioned in Chapter 1.6.4, channel conductance was expected to be - 525 pS under equal 250 
mM [Cs 1 in the cis and trans chambers (Laver et al., 1995 ; Tinker et al. , 1992b ), so much 
higher than the values reported in this study. However, it should be noted that those high va lues 
were obtained either in the absence of diva lent cations (e .g., Ca2+) (Tinker et al., 1992b) or with 
very low free cytoplasmic and luminal [Ca2+] at I 00 µM (Laver et al. , 1995). As detailed in 
Chapter 1.6.4, RyR favours the passage of divalent as opposed to monovalent cations, e.g., the 
relative permeability of Ca2+ with respect to Cs ' (P c/P c.J bas been reported within the range 13 
- 30 (Laver et al., 1995); and Ca2+ has a much lower conductance through the RyRs with - 100 
pS conductance at - 50 mM trans [Ca2+] (Smith et al. , 1986; Tinker and Williams, 1992). As 
such it is expected that millimolar trans Ca2+ in our system would compete wi th Cs+ for pass ing 
through the pore of RyR channels, therefore lowering the conductance recorded (Chu et al. , 
1993). This is exemplified in Fig. 3-3A&B, where reducing cis Ca2+ from I mM to I µM 
resulted in a sl ight increase in both RyR 1 and RyR2 channel conductance. There have been no 
reports that any experimental compounds used in this study influence RyR conductance. No 
changes· in RyRI or RyR2 conductance with the addition ofj unctin constructs used were 
observed during this project. 
Ln addition to channel conductance, the identification of RyR channels in lipid bilayers was also 
determined by their responses to cytoplasmic regulators, including cytoplasmic Ca2+, ATP and 
ruthenium red as described in the fo llowing section (section 3.3.1.3). This also determined 
whether the channel incorporated with the correct orientation. 
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Figure 3-2 C urrent - voltage relationship for purified RyRI and RyR2 chan nels at+40 and -40 mV. (A)-(B) 
Maximum single current amplitude was measured at +40mV and -40mV for RyRI (A) and RyR2 (B) under 
contro l conditions where ionic strength was symmetrical (250/250 mM Cs ), cis [Ca2+] was I µM and trans [Ca2J 
was I mM. n = 16 channel records for RyR I and n= J 3 for RyR2. (C)-(D) The linear fit (solid line) is based on the 
mean values (fill ed black circles) for the scatter of si ng le current amplitude (open circles) at each voltage 
analyzed. 
3.3.1.3 Regulation of purified RyR1 and RyR2 by characterized ligands 
3.3.1.3.1 Cytoplasmic Ca2 + 
As mentioned previous ly (Chapter 1.6.5.1. 1 ), cytoplasmic Ca2+ is an important modulator of 
RyR activity. It either inhibits or enhances channe l activ ity in skeletal and cardi ac musc le 
dependi ng on Ca2+ concentration. M icromolar cytoplasmic Ca2+ ( 1- 10 µM) acti vates the 
channel s, with a thresho ld for chan nel activation at approxi mately I 00 nM; wh ile higher Ca2+ 
concentrations (500 µM -10 mM) inhibit the channels. A lthough cytoplasm ic Ca2+ has a biphasic 
effect on both RyR I and RyR2 activ ity, RyR2 is at least 10-fold less sensitive to cytoplasmic 
[Ca2+] inhibition than the RyRI (Laver et al., 1995). RyR I is a lmost entire ly inhibited by I mM 
Ca2+ (Fi ll et al. , 1990), whereas RyR2 is maxi mally activated (Chu et al. , 1993; Laver et al. , 
1997a; Laver et al. , 1995) (see Fig. 3-3A&B top traces). Fo llowing RyR incorporation, the cis 
[ca2· J was reduced from I mM to I µM with the addi tio n of the Ca2+ chelator BAPTA to the cis 
solution (sect ion 2.9.4) . The reduction in cis [Ca2+] increased RyR I channe l open probability 
(P0 ) by 3.29± 1. 19-fold . In contrast, RyR2 activity was reduced to submaximal leve ls shorty 
after lowering cis [Ca2+J (Fig. 3-3C). These changes in activity occurred at both +40 mV and -
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40 mV and stabili zed witbin 1-2 min, thus confirming the cytoplasmic orientation of the channel 
and its identity as RyRJ or RyR2. These observations agree with previous reports on the 
response ofRyR I and RyR2 to cis [Ca2+] (Chu et al., 1993 ; Laver et al., 1997a; Laver et al., 
1995; Meissner et al., 1986). 
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Figure 3-3 RyR regula tion by cis Ca'• and ATP. (A), (B), (D) & (E) Records of 3 s of single channel activity at 
+40 mV. Single channel opening is upward, from zero current (continuous line, c) to maximum open channel 
conductance (broken line, o). Trans [Ca2l was I mM. (A) & (B) The response ofRyRI (A) and RyR2 (B) to altered 
cis Ca2'; [Ca2l was decreased from 1 mM (upper trace in each panel, used for incorporation), to I µM (lower trace) 
by the addition of BAPTA. (C) Average data (n= l 5 for RyRl and n=9 for RyR2) from both +40 mV and -40 mV for 
relative open probability (logP0 J- logP0 C) from channels in A & B. (D) & (E) Following RyR I (D) and RyR2 (E) 
incorporation and control recording (upper trace in each panel), 2 mM ATP was added to the cis chamber, activating 
the channel (lower trace). (F) Average data (n= I I fo r RyRI and n=9 for RyR2) for relative open probability 
(logP J -logP 0 C) from channels in D & E. Asterisks (*) indicate average values significantly different from the control 
(P<0.05 Student's paired I-test). 
3.3.1.3.2 ATP 
ATP in the cytoplasm is a potent RyR I activator (Smjth et al. , 1986). It is believed that ATP 
potentiates channel activity in two ways, either by binding directly to the RyR (Laver et al. , 
200 1; Meissner et a l. , 1986), or by facilitating R)(R phosphorylation through hydro lysis 
(Dulhunty et al. , 200 I b). Two mM ATP was added to the cis chamber in the presence of 1 µM 
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cis Ca2+ to increase channel activity . This a lso determines the identi ty and orientation of the 
channel incorporated into the lipid bi layers. The addition of ATP led to a significant increase in 
channel activity (3.24±0.6 1-fo ld and 3 .67±0.92-fold increase in average P0 in RyR 1 and RyR2 
respecti ve ly) at both +40 mV and -40 mV (F ig. 3-3 D-F). The activation occurred within 1-2 min 
after ATP addition, suggesting the correct RyR incorporation. Channels that could not be 
activated by 2 mM ATP were exc luded from further channel analysis. 
3.3.1.3.3 Ruthenium red 
Ruthenium red , also known as arnmoniated ruthenium oxychloride, is an inorganic po lycationic 
dye with an intense red co lour (Luft, 1971). It acts as a highly specific antagonist ofRyR Ca2+ 
channels. Micromolar concentrations of ruthenium red specifica lly decrease the chan nel open 
probabi li ty of skeleta l (Chen et al. , 1992; Hymel et al. , 1988; Lai et al. , 1988; Ma, 1993 ; Smith 
et al. , 1985 ; Smith et a l. , 1988) and cardiac (Ashley and Williams, 1990; Holmberg and 
Wi lliams, 1989; Lindsay and Williams, 1991 ; Rousseau et al. , 1986 ; Xu et a l. , 1999) RyRs by 
inducing prolonged channel closings. Because ruthenium red is known to irreversibly block 
RyR channels, it was added on ly at the completion of the experiment, and was used to confirm 
the channel was a RyR. Addition of20 µM ruthenium red to the cis chamber at the end of 
channel record ings a lmost completely blocked purified RyRJ opening to levels close to zero at 
both +40 and -40 mV (F ig. 3-4A). In comparison, the inhibition of purified RyR2 by 20 µM 
ruthenium red fel l into two groups: 1) - 20% of channels tested di splayed an a lmost complete 
abo li tion of channel activ ity, with only rare and ve ry brief openings remaining, similar to that 
observed for purified Ry RI (Fig. 3-4B); 2) the activity of - 80% purified RyR2 channels was 
fo und to be less sensitive to ruthenium red inhibition than purifi ed RyR 1 (Fig. 3-4C). These 
findin gs are consistent with previous observations with purified cardiac RyR Ca2+ channe l 
inhibition induced by ruthen ium red (Anderson et a l. , 1989; Lindsay and Williams, 1991 ). 
Analys is of a random sample of acti vity from a channel fa lling into the second category (Fig. 3-
4C) suggested an average of - 85% decrease in RyR2 chan nel open probab ility (Fig. 3-40). 
Blockage by ruthenium red occurred within 1-3 min of its add ition to the cis chamber fo r both 
RyR 1 and RyR2 channel types. 
3.3.2 Purification of full length junctin (FLjun) 
3.3.2.1 Endogenousjunctin purification from muscle 
Purified junctin from rabbit ske letal muscle using SOS preparative ge l electrophoresis (section 
2.5. 1 and 3.2.3. 1) reso lved as a homogenous protein band at - 25 kDa on SOS-PAG E (F ig. 3-5A 
lane 2). The 25 kDa prote in was confirmed to be junctin by immunoblot using po lyc lona l anti-
junctin antibody (F ig. 3-58 ). Purifiedjunctin was a lso immunoprobed by anti-triad in and anti-
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F igure 3-4 RyR responses to ruthenium red. (A-C) Three second records of single channel activity at both +40 mV 
and -40 rnV. Channels are opening upward from zero current (continuous line, c) to maximum open conductance 
(broken line, o or D i. one channel open~ o2 and o3 simultaneous opening of two or three channels) at +40 mV and 
downward at -40 rnV. Channels \Vere recorded in the presence of l µM cis Ca2+ and 1 rnM trans ca2+_ (A) Changes in 
RyR I activity with the addition of20 µM ruthenium red to cis chamber. (B) & (C) RyR2 responses to cis ruthenium 
red fell into two groups: 1) channel activity almost totally abolished by ruthenium red (B); 2) channel remains 
opening but to a much lesser extent (C). (D) Average data (n~I2) from both +40 mV and -40 mV for RyR2 relative 
open probabiLity (P0 ) from channels in C. Asterisks(*) indicate average values significantly different from the control 
(P<0.05 Student's paired I-test). Overall, ruthenium red blocked both RyR I and RyR2 channels at both potentials 
(second and bottom traces in each panel). 
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CSQ antibodies to establish protein purity. No detectable CSQ or triad in was found in the 
purified junctin samp le (Fig. 3-SB). 
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Figure 3- 5 Endogenous and recombinant FLjun purification. (A)-(C) Rabbit skel etal musclejunct in 
purification from the SR using SDS preparat ive gel electrophoresis. Purifi ed junctin (0.2 µg) was analyzed on a 
I 0% SDS-PAGE gel fol lowed by coomassie staining (lane 2 in A). lmmunoblot with ant i-junctin, anti-CSQ, and 
anti-triad in antibodies confirmed the presence and the purity of junctin (no CSQ and tri ad in contamination) (B}; 
positive control loaded with ves icles iso lated from rabbit skeletal muscle is shown in C. (D)-(E) Purification of 
recombinant FLjun. (D) 6 xl-lis - FLjun fusion protein was analyzed on a 12% SDS-PAGE gel followed by 
coomassie staining (2 µg FLjun, lane 4 in D). (E) lmmunoblot (with - I µ g recombinant FLjun) using anti-junctin 
antibody to confirm the identity of junctin . Arrows indicate junctin, triad in and CSQ bands on immune-blot. 
Molecu lar \veight markers are shown in lane I and lane 3. Pink band corresponds to the molecular weight noted. 
3.3.2.Z Recombinant Fljun expression and purification 
Full length can ine cardiac junctin has been previously expressed in Sf21 cells using the 
BaculoGold System (Gyorke et al. , 2004a; Zhang et al. , 1997). The final protein was so lubili zed 
in detergent-containing so lutions, either with 0.1 % Triton X-100 (Zhang et al. , 1997) or I% 
CHAPS (Gyorke et al. , 2004a). Recombinant protein production using the Baculovirus- insect 
ce lls (e.g. Sf21 cell s) system allows a lmost al l the post-translational modifications required for 
biological activity . However, it is worth noting that the post-translational modifications 
occurring with thi s system differs from those in mammalian cells (Sridhar et al., 1994). In 
addition express ion in insect cells is very time-consuming (Sridhar et al. , 1994), with the time 
from transfect ion to harvest being typically 3-4 weeks. Also, the express ion leve l can be 
variable and the cost is relatively high compared to some other expression systems (e.g. bacteria 
and yeast systems). In comparison, although bacteria E.coli cell s lack the ab ility to perform 
certain eukaryotic post-translational modificati ons, such as glycosylation , £. coli is sti ll the 
preferred host for recombinant prote in express ion (Y in et al., 2007). As the quickest method 
deve loped so far, the use of E.coli is well documented fo r its advantages of low cost, easy 
transformation and fermentation , high protein yie lds and scalability. To date, there have been no 
reports of FLjun expression in£. coli system, presumably due to inherent difficulties in integral 
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membrane protein expression and purification. In this study, recombinant FLjun was 
successfully expressed and purified from E. coli stra in BL2 I (DE3). 
As mentioned, integra l membrane proteins such as junctin are notoriously difficult to express, to 
so lubilize and purify, and to maintain properly-fo lded during purification . E.co li strain 
BL21 (DE3) is the most commonly used host for overexpress ion of membrane proteins, in 
combination with a pET vector. However, one inherent issue is that membrane proteins are 
inserted into membranes, and the availability of membrane structures in most cell s is limited. 
Although heterologous overexpression often results in protein aggregation and misfo lding due 
to the hydrophobic nature oftransmembrane segments, one way of avoiding the limitations set 
by the ava ilab ility of membrane is to produce the membrane protein as inclusion bodies. 
Preparation of active protein can then be achieved through solubilization of the inclusion bod ies 
using denaturants, followed by refolding. However, refolding of a -helical membrane proteins 
(e.g. , junctin) from inclusion bodies presents a greater challenge than refolding ~-barrel 
membrane proteins (Bannwarth and Schul z, 2003). 
Express ion was trialled at different temperatures (37 °C, 25 °C, 18 °C) and for different times (2, 
3, 4 h and overnight). The longer induction period increased degradation and resulted in a low 
yield. A relatively short period (3-4 h) at 37 °C produced the maximum yield. Purification of 
recombinant FLjun was then attempted by solubilizing the cell pellets and puri fy ing the protein 
with IM.AC under denaturing conditions using 8 M Urea. However, further refo lding could not 
be achieved because the protein was extremely prone to precipitate during detergent exchange 
(from 8 M Urea to different percentages of CHAPS or CHAPS/PC). The problem was overcome 
by so lubilizing and purifying the protein under native conditions using 1 % Triton X-100 . 
Although the resultant yield ofjunctin was relatively lower than that using the denaturing 
protoco l because Trion X-100 is less potent than Urea in protein solubilization, the output was 
still satisfactorily high, and was far above that from muscle junctin purificat ion. 
An additional problem with this procedure was the presence of high amount of Triton X-1 00 
(1%), which posed a challenge for lipid bilayer experiments because Triton X-100 would 
destabilize the artificial membrane. Therefore, it was necessary to remove Triton X-1 00 from 
the final product. This could not be achieved by diluting and washing the prote in as done with 
muscle junctin buffer exchange (see Methods, section 2.5.1). This was because at least a I 00-
fold dilution would have been required to disrupt the protein-detergent micelles, as Triton X-
100 has a low critical micelle concentration (- 0.01-0.015%, w/v) (Tiller et al. , 1984). Thi s 
would have been time-consuming and substanti al amounts of protein would have been lost 
during washing and concentrating steps. Therefore Bio-Beads SM-2 non-polar polystyrene 
adsorbents were used fo r Triton X-100 removal (Holloway, 1973). The incubation conditions 
for SM-2 adsorbent and protein so lution were optimized (i.e., I hand 45 min at room 
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temperature) in order to remove any res idual Triton X-100 and minimize loss of the membrane 
protein since it cou ld be adsorbed onto SM-2 as we ll. Using this method, a final sample without 
detergent was obta ined. One point was noted during the protein storage, which may be 
wo rthwhil e mention ing for puri fy ing other membrane prote ins: undesirable aggregation of the 
protein in the presence of I% Triton X-100 was visib le as a precipitate when the prote in was 
kept at 4 °C for an extended period (- 36-48 h). Therefore, the whole procedure shou ld be 
conducted with an in termediate delay of no longer than 36 hat 4 °C, espec ially when the protein 
concentration is high. Alternatively, the sample can be stored at -20 °C if a relative ly long 
stopping point is needed. 
The purified recombinant FLjun sample was eva luated by SOS-PAG E and identified using 
immuneb lot (Fig. 3-5D&E). A purity of over 90% was routinely achieved. 
3.3.3 Physical interactions between FLjun and RyRl and RyR2 
Purified ske letal FL jun binding to RyR I and recombinant can ine FL jun binding to RyR2 have 
been previously reported (Goonasekera et al. , 2007; Zhang et a l. , 1997). In this study, to re-
confi m1 the binding of skeletal FLjun to the RyRI and examine its ability to bind to RyR2, a 
modified co- IP was conducted as described in section 2.8. 1 and 3.2.4. The final eluted proteins 
were assessed using SOS-PAGE and immunoblot. The presence of the RyRI or RyR2 (the 
protein band above 25 0 kDa) andjunctin (- 25 kDa) detected by anti-RyR 34C (recognizing 
both RyRI and RyR2) and anti-junctin antibody) (F ig. 3-6 lane 1&2) confinned that the eluted 
proteins were junctin and the RyR. Control experiments were performed using prote in A/G 
agarose a lone (i.e. in the absence of antibody). No detectable RyR I, RyR2 (F ig. 3-6 lane 3&4) 
or FLjun (F ig. 3-6 lane 5) was bound to the prote in A/G agarose in the absence of antibody. The 
binding was therefore due to the interaction between junctin and the RyR. The ability of 
purified FLjun to interact with RyR also indicated that the refolded junctin , purified us ing SDS 
1 2 3 4 5 
~~oa - I • - l+- Anti-RyR 
EE] 25 -
. 
J+-Anti-junctin 
Figure 3-6 Interactions of the purified F'Ljun with purified Ry RI or Ry R2. lmmunob lot of the eluted proteins 
from FLjun/RyR co-IP using monoclonal anti-RyR 34C and po lyc lonal anti -junctin antibodies, confirming the direct 
physical interaction between puri fi ed ske letal FLjun and RyR I (lane I. n=3) or RyR2 (lane2, n=4). Protein A/G 
agarose a lone did not bind to e ithe r RyR I ( lane 3), RyR2 (lane 4) or FL jun (lane 5). The protein molecular weight 
makers are shown to the left of the immune-blot. 
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preparative gel electrophoresis, retained its functional characteristics. This result is consistent 
with previous studies (Goonasekera et al. , 2007; Wei et al., 2009a). 
It should be noted that the difference in the intensity between RyRl and RyR2 bands (Fig. 3-6 
Jane I &2, upper bands) was mainly due to the anti-RyR 34C antibody used, which has a higher 
sensitivity in detecting RyRl than in detecting RyR2 (exemplified in Fig. 2-1 , Chapter 2). This 
also applies to the results obtained with Cjun (Chapter 4, F ig. 4-2), Nj un (Chapter 5, Fig. 5-2) 
and JunKE KE (Chapter 6, Fig. 6-1). 
3.3.4 Purified RyRl/2 regulation by FLjun (luminal interaction) 
3.3.4.1 The effect of Fljun on purified RyR1 or RyR2 activity 
The result from protein complex imrnunoprecipitation demonstrates that purified FLjun is ab le 
to associate with both the purified skeletal and cardiac RyR. Previous studies with single 
channel recording have shown that the addition of junctin to the luminal so lution in bilayers 
enhanced the purified RyR I (Wei et al. , 2009a) and RyR2 (Gyorke et al., 2004a) channel 
opening, indicating a positive role of junctin on RyR channel gating. However, in the latter 
study (Gyorke et al. , 2004a), the [Ca2+] of trans solution, which represents luminal side of SR, 
was either too low at 20 µMor too high at 5 mM to reflect the physiological range of [Ca2l sR 
(0.1- 1.5 mM, (Chen et al. , 1996; Ginsburg et al. , 1998) and reviewed in (Bers, 2002; Dulhunty 
et al. , 2012)) in the heart. To investigate the functional consequences of the phys ical interactions 
between FLjun and the RyR2 at resting lurninal [Ca2l (l mM), lipid bilayer experiments were 
conducted. The regulation of purified RyR I by FL jun was re-examined in this study both to: a) 
compare with the FLjun effect on cardiac RyR2 (this study); and b) confirm the activating effect 
ofFLjun on skeleta l RyRl observed by Wei et al. (2009a). Purified RyRl or RyR2 channels 
were incorporated into lipid bilayers using standard cis and trans solutions (see section 2.9.3 for 
the composition of these solutions). Channel activity was recorded under sy=etrical (Cs+) 
conditions (section 2.9.4) in the presence of a trans [Ca2+] of l rnM. The cis [Ca2+] in thi s 
experiment was 1 µM for RyR2, and I µMor I 00 nM for RyRl (adjusted by the addition of 
BAPTA); 2mM ATP was added to cis solution in some cases (section 2.9.4). In contro l 
experiments, the addition of vehicle solutions Jacking active compounds (e.g. FLjun, Cj un, Nj un 
or JunKEkE), did not lead to changes in channel activity (Fig. 3-7 and 3-8; also see (Wei , 2008)). 
Therefore, the changes in channel activity shown in all figures in this thesis were specific 
changes in response to the addition of proteins or peptides (in this chapter the addition of FLjun). 
Five µg/ml (213 nM) FLjun was added to the luminal side of RyRl or RyR2, i.e. , trans chamber. 
This concentration was selected as it was similar to the concentration used in previous studies 
(Gyorke et al. , 2004a; Wei et al. , 2009a), and it has been previously shown in this laboratory to 
induce a maximal increase in RyRl channel activity (Wei et al. , 2009a). 
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Figure 3-7 MOPS buffer (20 mM MOPS, 150 mM NaCl, pH 7.4; for FLjun in this chapter and Cj un in 
Chapter 4) alone has no effect on purified RyRs channel activity. (A)-(C) average data fo r relati ve open 
probability (logP, J-logP, C, A), mean open time (logT, J-logT,C, B) and mean closed time (logT,J-logT,C, C). No 
significant differences fou nd before and after MOPS buffer add ition to either the trans (black bins) or cis (li ght grey 
bins) solution (P>0.05 Student's I-test, paired, n~4-6 fo r RyR I and n~5-8 for RyR2). 
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Figure 3-8 Mi ll iQ-water (for Nj un , Nj unscramblrd in C hapter Sand JunKEKE in C hapter 6) alone does not alter 
puri fi ed RyRs channe l act ivity. (A)-(C) average data fo r relati ve open probability (logP, J-logP,C. A). mean open 
time (logT, J-logT, C. B) and mean closed time (logT,J-l ogT,C, C). No significart differences found before and 
after Mil liQ-water addit ion to either the trans (black bins) or cis ( light grey bins) so lution (P>0.05 Student 's 1-test, 
paired. n~ -6 for RyR I and n~5-6 for RyR2). 
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The presence ofFLjun (muscle isolated) in the trans chamber bathing the luminal side of the 
channels induced a significant increase in both purified RyRI and RyR2 channel open 
probability (P0 ) (F ig. 3-9A&B). The open probability increased 1.86±0.1 4-fo ld in RyRI and 
2.81±0.44-fold in RyR2 (Fig. 3-9C). Average P 0 rose from 0.12±0.03 to 0.2 1±0.04 for RyRI 
and from 0.27±0.05 to 0.59±0.07 fo r RyR2. The results indicate thatjunctin is a potent luminal 
activator of both RyR I and RyR2. The abil ity of FL jun to enhance RyR I channel opening is 
consistent with that fo und in a previous study (Wei et al., 2009a). 
3.3.4.2 Changes in RyR1/ RyR2 channel gating properties induced by FLjun re-
association. 
To explore further the effect of FLjun on Ry RI and RyR2, single channel activ ity was analyzed 
in a subset ofrecordings where on ly one channel opening was recorded and changes in open and 
closed time underlying the changes in P0 were examined. The results show that after FLjun 
association with the RyRs, there was an average 2.23±0.64-fold and 2.11 ±0.36-fold increase in 
T0 for Ry RI and RyR2 respectively (Fig. 3-9D). The mean channel closed times were reduced 
by FLjun with an average -2-fold reduction in RyRl (to 0.56±0.06% of control level) and - 3-
fo ld decrease in RyR2 (to 0.35±0.04% of control) (F ig. 3-9E). The increase in open probability 
induced by FLjun was therefore due to an increase in the mean open time (T0 ) and a decrease in 
mean closed time (Tc) of both RyRI and RyR2 channels. 
The effects ofFLjun on the RyRl and RyR2 gating were further explored by examining the 
effects ofFLjun on the distribution of open and closed times, the changes in which underlie the 
increase in mean open time and decrease in mean closed time. The best exponential fit to both 
open and closed time distributions in control channel activity was obtained usi ng three time 
constants in both RyRI and in RyR2 channels (shown in Fig. 3-10 and Table 3-1). The average 
open time constants in RyRl channels were , 01 = 3.3±0.16 ms; , 02 = 16.5±0.48 ms; , 03 = 
151.1 ±3.36 ms and average closed time constants Tc 1 = 3 .4±0.18 ms; Tc 2 = 21.49±0.78 ms; Tc 3 = 
233.4±3.71 ms (Fig. 3-IOA&B). The time constant values after addition ofFLjun did not 
change significantly, but there were significant differences in distribution of events between the 
time constants. With channel openings, 57±8.2% of openings fell into , 01 before, and 43±6.6% 
after, addition of FLjun. Conversely, there were 2.6± 1.4% of openings in , 03 before and 
14.0±5.2% after, adding FL jun. There was a trend towards an increase in the number of events 
in , 02 with 37±5.8% before and 42±6.1 % after FLjun, although the difference was not 
significant. With the dwell times in the closed state, the fraction of events falling into , c2 and 
Tc 3 were reduced significantly from I 0±2.8% before, to 6.0±1.8% and 42±3.7% to 38±4.6% 
after adding FLjun respectively. There was however, an increase in the shortest time constant 
from 48±6.3% to 54±5.7%. 
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Figure 3-9 Addition ofFLjun to the luminal side of purified RyRs activates channels at I mM trans Ca2• . (A)-
(B) Records of3 s of single channel activity at -40 mY . Single channel opening is downward, from zero current 
(continuo us line, c) to maximum open channel conductance (broken line, o). The upper trace ii:t each panel shows 
control purified RyR activity and the lower trace shows acti vity after luminal addition of2 13 nM (5 µg/ml) FLjun to 
RyRl (A) or RyR2 (B). (C)-(E) Average pooled data from both +40 mY and -40 mY for relative open probabi lity 
(logP, J-logl',C), mean open time (logT0 J-logT0 C) and mean closed time (logT,J-l ogT,C), showing channel activation 
after adding FLjun . Asterisks (') ind icate average values sign ificantly different from the control (P<0.05 Student 's 
pai red I-test, n=6- 10 fo r RyRl and n= l 3- 14 fo r RyR2) . 
The open and closed time constants for contro l RyR2 activity were remarkab ly s imil ar to those 
determi ned fo r RyR I channel s. The average open time constants for RyRI were , 0 1 = 3.7±0.27 
ms; , 0 2 = 18.5±0.95 ms; , 03 = 130 .8± 12. 82 ms and average c losed time constants , c1 = 3.4±0. 19 
ms; , c2 = 2 1.9± 1 .37 ms; , c3 = 190.4± 12.51 ms (Fig. 3-1 OC&D). The consequence of FLjun 
addi ti on to the luminal so lution was a lso sim ilar to that seen in Ry RI , w ith RyR2 acti vity al so 
showing an increase in the number o f openings events in , 03 and a decrease , 0 1 (F ig. 3-1 OA&C). 
Likewise, there was a lso a reduction in long c losures ( in , c3) (Fig. 3-1 OB&D; Tab le 3- 1, row I 1-
12). Taken together, no a lterati on in the time constant va lues was induced by FLj un , but there 
was a signifi cant re-di stribution of events with an increase in long open events in , 03 (with 
fewer events in ' Ol ), and a decrease in long c losures in , c3 (with more events in , c1). 
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Figure 3-10 Effects ofll3 nM FLjun (trans) on average open (A&C) and closed (B&D) time constants and 
fraction of·cvents in each time constant of purified Ry Rs. The probability of events fa lling into each time constant 
is plotted against the time constant in ms (open time or closed time). Time constants are shown for control data (open 
circles) and 213 nM FLjun (fill ed circles) for RyR I (A&B) or RyR2 (C&D). Vertical bars indicate the SEM fo r event 
probability. Horizontal bars indicating the SEM for the time constant are contained with in the symbols. Asterisks (*) 
indicate s(gnificant differences between control data and with 2 13 nM FLjun (P<0.05 student 's I-test, paired, n=8 for 
RyRI and n= 13 for RyR2). 
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Table 3-1 A summary of the open and closed time constants before and after FLjun reassociation 
contro l(RyR I) Fljun+RyRI P value control(RyR2) Fljun+RyR2 P value 
' 0 1 3.32±0.16 3.06±0.12 0.1262 3.68±0.27 3.44±0.18 0.1848 
Pl 0.57±0.082 0.43±0.066 0.0255 0.59±0.076 0.39±0.069 0.0060 
' 02 16 .52±0.48 16.89±0.48 0.6845 18.46±0.95 l 9.36± l.20 0.5527 
P2 0.37±0.058 0.42±0.061 0.8079 0.33±0.050 0.48±0.055 0.0299 
' 03 15 1.11±3.36 159.38±4.22 0.1873 130.77± 12.82 130.45±6.97 0.4083 
P3 0.03±0.014 0.1 4±0.052 0.0255 0.07±0.040 0.13±0.030 0.0078 
' Cl 3.43±0. 18 3.56±0.07 0.4099 3.42±0.19 3.25±0.16 0.4649 
Pl 0.48±0.063 0.54±0.057 0.0139 0.41 ±0.062 0.47±0.059 0.105 5 
' C2 2 1.49±0.78 21.41 ±0.47 0.9067 21 .92± 1.37 19.69± 1.06 0.0553 
P2 0.42±0.03 7 0.38±0.046 0.0319 0.39±0.034 0.46±0.050 0.1 333 
' CJ 233.3 8±3.7 1 226 .25±4.40 0.2326 190.38± 12.51 169 .23±9 .3 7 0.1023 
P3 0.10±0.028 0.06±0.018 0.0499 0.21±0.046 0.07±0.021 0.0011 
n 8 8 13 13 
Pl , P2 and P3 denote probability. P value <0.05 are in bold, denoting significant difference from control value. 
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3.3.5 Cis FLjun does not alter purified RyR1 or RyRZ activity 
Experiments in this section were conducted by Mr Chris Thekkedam (Muscle Research Group, 
John Curtin School of Medical Research, Australian National Univers ity, Canberra, Australia). 
It has been reported that triad in enhances the activity of iso lated RyR in lipid bilayers when 
added into the luminal side of the RyR (Gyorke et al. , 2004a; Wei et al., 2009a), whereas 
cytoplasmic addition of skeletal triad in inhibits RyR 1 channel activity (Ohkura et al. , 1998), 
probably through binding to the cytoplasmic side of the RyR. Also a paper from Isabel Marty ' s 
lab shows that a peptide corresponding to the N-terminal domain of tr iadin inhibits channel 
activity when added to the cytoplasmic so lution (Groh et al. , 1999) (for detail , see Chapter 
1.8 .5.2). In add ition, it has been suggested previously that triadin can potentially ' flip ' in the 
membrane so that the longer C-terminal part of the protein might at times face the lumen of tbe 
SR, and under different conditions ' flip ' so that its C-terminal part faces the cytoplasm (Caswell 
and Brandt, 2002). Junctin is a homologous protein to triadin in the SR Ca2+ release complex, 
rai sing the question whether junctin added to the cytoplasmic side would have any effect on 
RyR channel activity or if dual membrane organization exists for junctin as proposed for triadin. 
To investigate this poss ibility, the response of purified RyRs to cytoplasmic FLjun was 
examined. This set of experiments was performed using single channel recordings under 
identical conditions as in the previous section (3 .3.4). Recombina·nt FLj un (section 3.3 .2.2) 
instead of muscle FLjun was used in thi s study due to difficulty in obtaining muscle FLjun 
sometimes as discussed in section 3 .4.1. Neither RyRl nor RyR2 channel activity was affected 
following the addition of2 13 nM FLjun to the cis chamber (F ig. 3-11). There was no significant 
change in channel open probability (P0 ) (Fig. 3-1 lC). This was reflected by a lack of changes in 
channel T0 and Tc (Fig. 3-11 D&E). These findings were similar to the observation by Gyorke et 
al. (2004a) that addition ofFLjun to the cytoplasm ic side did not alter purified RyR2 activity, 
although they used di fferent conditions (i.e., 20 µM or 5 mM trans [Ca2J used in the Gyorke 
study instead of 1 mM ). The results demonstrate that FLjun can only regulate the RyR when 
added ~o the luminal side. 
3.4 Discussion 
Previ~us studies have shown that the FLjun is able to bind to the RyR2 (Zhang et al. , 1997) and 
that it can directly modulate both skeletal and cardiac RyR activ ity (Altschafl et al. , 2011 ; 
Gyorke et a l., 2004a; Wei et al. , 2009a). However the regulation ofRyR2 by junctin per se in 
the presence of a resting luminal Ca2+ concentration of 1 mM remained to be clearly defined 
(for detail, see section 1.9.6. 1 and section 3. 1). This study investigated the direct effect of 
junctin on both purified RyR isoforms. The resu lts presented in thi s chapter show for the fi rst 
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Figure 3-11 Addition ofFLjun to cis side of purified RyRs does not alter channel activ ity. (A)-(B) Records of3 
s of single channel activity at-40 mV. Single channel opening is downward from zero current (continuous line, c) to 
maximum open conductance (broken line, o). The upper trace in each panel shows control activity and the lower 
trace shows activity after adding 213 nM FLjun to the cytoplasmic solution bathing RyR I (A) or RyR2 (B). (C)-(E) 
average data for relative open probability (logP,J -logP,C, C), mean open time (logT,J-JogT,C, D) and mean closed 
time (logT,J-JogT,C, E). No significant differences found with FLjun before and after protein addition (P>0.05 
student I-test, paired, n~J4 for RyRJ and n~12 for RyR2). 
time that in the presence of a physiological luminal [Ca2+] ( I mM trans Ca2+), FL jun added to 
luminal so lution enhances cardiac RyR channel activity by promoting long channel openings 
and reducing channel closures. Similar activating effects were observed with skeletal RyR 
exposed to luminal FLjun, which is consistent with a previous study by Wei et al. (2009a). 
3.4.1 Muscle FLjun purification 
A protocol modified from (Wei, 2008; Wei et al. , 2009a) was employed to isolatejunctin from 
skeletal muscle tissue. The one step preparative ge l electrophoresis technique yie lded similar 
separation results to those obta ined previously (Wei , 2008 ; Wei et al. , 2009a). In addition, a re-
nature step with KCI precipitation and detergent exchange resulted in a s imilar - 80% protein 
recovery (Wei , 2008 ; Wei et al. , 2009a). Sometimes however this method yie lded very low 
amounts ofjunctin. In th is case, multiple isolation experiments were required in order to obtain 
enough protein for downstream exper iments. As this was labour- and time-consuming, a method 
for the expression and purification of FLjun was developed. 
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3.4.2 Recombinant FLjun from E.coli 
In recombinant FLjun, the hexahistidine tag (6xHis-tag) on the N-terminal end ofFLjun had to 
be removed. This tag is composed of24 amino acids 
(1RRYTMGSSHHHHHHSSGLVPRGSH24). It is not necessary to remove the His-tag for most 
appl ications. It was also shown in this study that thi s tag seems not to cause an effect on 
regulation of RyRs by the hydrophili c C-tenninal domain of junctin (Cjun) (Chapter 4, Fig. 4-3). 
However, the His-tag attached here may present a problem in affecting membrane insertion via 
the N-terminal domain ofjunctin that is likely to occur in si ngle channel lipid bilayer studies. 
To address thi s issue, tag remova l through thrombin c leavage is underway (conducted by Miss 
Umayal Narayanan, Muscle Research Group, John Curtin School of Medica l Research, 
Australian National University, Canberra, Australia), prior to Triton X-100 remova l procedure. 
Currently, 60-70% cleavage efficiency has been achieved but this is still not ideal (data not 
shown). More trial experiments will be necessary to attain maximum recovery oftbe cleaved 
protein. Alternatively, it may be worth considering placing the tags on the C-termina l end of the 
protein to reduce such risk. Another approach is to re-clone FLjun into pHUE vector as for Cjun 
(Methods, section 2.5.4), although the effectiveness ofUsp2cc to cleave the 6xHis-ubiquitin tag 
in the presence of detergent remains to be determined (Baker et al. , 2005). However, due to time 
constraints this part of work was not performed. This can be investigated in the future . It is 
important now to exam ine the luminal interactions of expressed FLj un (without extra residues) 
with the Ry Rs. 
3.4.3 Luminal FL jun is a potent activator of purified RyR1 and RyR2 
In th is chapter the physical interaction between FLjun and purified RyR I and RyR2 has been 
examined. The modified co-IP assay showed a robust physical association between FLjun and 
the Ry Rs (Fig. 3-6). This repli cates the interaction seen between endogenous junctin from 
rabbit skeletal muscle and expressed WT RyR 1 (Goonasekera et al. , 2007) as well as can ine 
cardiac junctin and the RyR2 (Zhang et al. , 1997). In order to determine the functiona l 
consequence of the physical interaction, single channel experiments were subsequently 
conducted and the effect ofFLj un on channe l activity was monitored at I mM luminal [Ca2+], 
which is maintained under resting conditions in striated muscle (Chen et al. , 1996; Fryer and 
Stephenson, 1996). Addition of FL jun to luminal solution produced a signifi cant increase in 
channel open probab ility in both puri fied RyR isofonns, refl ecting an increased channel activity. 
The enhanced RyR I activity induced by luminal FLj un is in agreement with previous findings 
in this laboratory (Wei et al. , 2009a). These results also confirmed tbat the FLj un purified 
through preparative electrophores is (described in section 2.5.1 and 3.2.3.1) retained its 
functional properties, i.e. the effect on RyRI channel activity. 
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Strong activation of purified RyR2 charU1els was also observed upon luminal addition of FLjun 
under the same conditions, i.e., I mM trans [ca2•], suggesting thatjunctin is a RyR2 activator in 
cardiac muscle. This is similar to the increased RyR2 activity seen after adding recombinant 
canine cardiac FLjun to the trans chamber at 20 µMand 5 mM luminal Ca2• concentrations in a 
previous report (Gyorke et al. , 2004a). The similar observations in the present study and the 
study by Gyorke et al. (2004a), to some extent, indicate that the effect of luminal FLjun on 
RyR2 activity might be independent of luminal [Ca2+]. However, a complex regulation ofRyR2 
by junctin has been recently demonstrated in a junctin-KO study (Altschafl et al., 2011 ). The 
activity of RyR2 from junctin-KO and WT cardiac SR was monitored in parallel studies. The 
results suggest a dual effect of junctin on RyR2 activity depending on luminal Ca2• . Briefly, 
junctin appears to activate RyR2 at low luminal Ca2+ (<l mM) and inhibit the channel when 
luminal Ca2+ is high (> 1 mM) with the crossover point at - 1 mM luminal Ca2+ (for more detail , 
see Chapter 1.9.6. 1). This result differs from the activation seen in this study using I mM 
luminal ca2•. The reason for this discrepancy is not clear and warrants further study. 
Nevertheless, it is worth noting that it is possible that the dual effect observed in (Altschafl et 
al., 2011) may be related to regulation ofRyR2 by CSQ2 or other luminal proteins in the 
absence of junctin. Also, species-dependent differences and the effects of experimental 
conditions on the interactions between the cardiac isoforms of the proteins remain to be clarified. 
Notably, the finding that FLjun functions as a RyR2 channel activator was in contrast to a 
negative regulatory role ofjunctin indicated in most transgenic studies reported (Fan et al. , 2008; 
Fan et al., 2007; Kirchhefer et al., 2006; Yuan et al., 2007) (for more detail, refer to Chapter 
1.9.4. 1). However, this is not surprising since the conditions in whichjunctin exerts its effects 
on RyR2 activity are very likely to be different in the current study compared to the transgenic 
studies. Compensatory changes in expression of other proteins as well as in the cardiac T-
tubule/SRjunction also have an impact on Ca2+ handling (Franzini-Armstrong et al. , 2005; 
Kirchhefer et al., 2003). These complex changes would obscure the physiological alterations 
that cou ld be directly attributed to junctin removal. In addition, there is a strong possibility that 
the suggested inhibitory effect ofjunctin in these studies may be due to an indirect effect of 
junct in relaying CSQ2 signal to RyR2, rather than a direct effect ofjunctin per se. The effect of 
Cjun on the RyRs may also play a role in the overa ll changes in these transgenic studies (for 
data on Cjun effect, see Chapter 4). 
Ln this study, the increase in P0 of both RyR isoforms induced by luminal FLjun was attributed 
to a prolonged mean open time (T0 ) and an abbreviated mean closed time (Tc) (F ig. 3-9D&E). In 
particular, a - 2-fold increase in T0 and - 2-fold decrease in Tc in RyR 1 channels were similar to 
changes previously reported (Wei et al., 2009a), which showed an equivalent - 2-fold increase in 
T0 , although the reduction in Tc was relatively higher (- 3.5-fold). Further exam ination revealed 
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that in both RyR channel types, changes in mean open and closed times were not due to changes 
in open and closed time constants, since there were no significant alterations in the time 
constant va lues (Fig. 3-10 and Table 3- l) . lnstead, a significant re-distribution of events was 
observed upon FLjun addition. It appears that FLjun promotes channel openings by increasing 
long open events and reducing the number of opening events in the shortest open time constant 
, 0 1. The briefer mean closed times could be attributed to decrease in events in long closures in 
'tCJ . Notably, the three open and closed time constants in RyRl and RyR2 channels were 
remarkably similar. 
It has been suggested that in single channel recordings, junctin added to the trans chamber is 
very likely to insert into the bilayer in its normal orientation, i.e ., the N-terminal tail facing the 
cytoplasmic so lution and the C-terminal domain luminally (Wei et al., 2009a). Such an insertion 
of FL jun was further suggested in the current study, as both Njun applied to the cis solution and 
FLjun to the trans solution were shown to activate the channel (For data on Njun regulation of 
the RyR, see Chapter 5). To ensure the spec ificity of such luminal FLjun-RyR interaction, 
control experiments were performed by adding FLjun to the cis solution. In this case, junctin 
would be expected to insert in the opposite way with its N-terminus facing the luminal so lution. 
This was consistent with the fact that cytoplasmic FLj un (recombinant) did not influence the 
activity of e ither RyRI or RyR2 channels (Fig. 3-11), a lthough thi s may require further 
confirmation (see section 3.4.2, due to possible effects of the presence of 6xHis-tag). A 
previous study indeed suggests that addition of FLjun to the cis side had no effect on purified 
RyR2 channel activity (Gyorke et al., 2004a). Therefore, the data strongly suggest that the 
FLjun can only activate the RyRs when added luminally. 
3.4.4 Limitations 
Idea lly, the specificity of the luminal effect of FLjun on RyR activity should be exam ined. Tb.is 
could .be explored by repeating the experiments with native RyRI and RyR2 by add ing FLjun to 
the luminal so lution, as the native Ry Rs should already be bound and regulated by endogenous 
junctin . One would expect that adding exogenous FLj un to the trans side would not bind or 
induce any changes in RyR activity if the effect of FLjun (trans) is specific. However, due to 
time constraints, the experiments could not be conducted. This could be investigated in the 
future. 
3.4 .5 Conclusion 
Taken together, the results presented in thi s chapter provide the first evidence of the sole effect 
of junctin on purified cardiac Ry Rs in the absence of other proteins at a phys iologica l luminal 
Ca2+ concentration of I mM. The functional regulation of the RyRI and RyR2 by FLjun 
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provides a data base for the remainder of this thesis in which the molecular components of 
FLjun activation were investigated. 
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Chapter 4 Modulation of RyR1/2 activity by the C-terminal 
domain of junctin 
4.1 Introduction 
The role of full-length junctin (FL jun) as an activator of both the RyR I and RyR2 channels at 
resting (I mM) luminal [Ca2+] has been addressed in Chapter 3. As previously mentioned 
(Chapter 1.9. l), the majority (-78.6%) ofjunctin (FLj un ) is contained in its luminal C-terminal 
domain (Cjun). There is a long-he ld v iew that the major effect ofFLjun on RyR depends on 
luminal interactions between the two proteins since the luminal domain of junctin binds to 
RyR2, and this has led to the proposal that in intact muscle junctin interacts with RyR from the 
luminal surface of the SR membrane (Zhang et al. , 1997). This was supported in a study 
investigating binding regions on interacting domains of junctin and RyR2 (Altschafl et a l. , 
20 11 ). However that study focused only on Cjun with other segments (e.g. N-tenn ina l domain) 
not being considered (Altschafl et al. , 2011 ). More recently, Rossi et al. (2013) showed that the 
intraluminal domain ofjunctin, i. e., Cjun, contains minimal junctional SR targeting sequences. 
Together, these studies indicate that the presence of Cjun is probably sufficient both to loca lize 
junctin to the junctional SR and to a llow junctin to interact with RyR, CSQ and triad in. If thi s 
were the case, one wou ld expect Cjun added to the lurninal so lutio_n to impose a simi lar effect 
on RyR channel activity to that seen with FLjun, i.e ., an activation. As yet, there have not been 
any reports on the effects of Cjun skeletal and cardiac Ry Rs exc lusively. Therefore, the direct 
effects ofCjun on regulating RyRI and RyR2 were considered here . 
Aim: 
The aim of the work presented in thi s chapter was to determine (a) the direct phys ical 
interactions between Cjun and the Ry Rs, and (b) the potential regulatory effects of Cjun and 
purified RyRI and RyR2 channel activity. 
4.2 Materials and Methods 
4.2.1 Methods overview 
Recombinant Cjun was engineered in the study in th is chapter. The Cjun protein was expressed 
and purified from E.coli to examine its ab ility to bind and interact with RyR I and RyR2. The 
physical association between Cjun and the purified RyRs was examined us ing modified co-IP. 
Functional regulation of both purified RyR isofonns by Cjun was explored using single channel 
techniques under phys iological luminal [Ca2+] (I mM). Contro l experiments were also 
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performed to assess whether Cj un in the cytoplasm affects RyRs activity, both lipid bilayer 
studies and Ca2+ re lease spectrophotometric assay were performed in this case. 
4.2.2 SR vesicle isolation and RyR purification 
Purified ske leta l and cardiac RyRs as well as crude SR vesicles used in the experiments in this 
chapter were obtained using the methods described in section 2.3. 
4.2.3 Recombinant canine cardiac Cjun 
Cj un was expressed and purified from E.coli as detailed in section 2.5.3 and 2.5.4. In brief, 
recombinant Cj un was obtained by subcloning canine cardiac muscle junctin cDNA 
corresponding tojunctin aa46-2 10 and expressed in E.coli either as a poly-histidine (6x His) 
fusion (for Cj un sub-c loned into pETI 5b.ep vector) or po ly His-ubiquitin (6xHis-ub) fusion (for 
Cjun in pHUE vector) protein. Maximum yield of recombinant protein was achieved by 
expressing the prote in for 4 hat 37 °C following induction with 0.6 mM IPTG. After lysozyme 
so lubili zation of the bacteria, the cell membranes were ruptured and the contents of the cell 
were released with a cell di sruption bomb (Nitrogen decompress ion). The fusion protein was 
purified using Ni2+-nitrilotriacetic acid agarose matrix by IMAC under native conditions. 6 xHis-
Cjun or 6xHis-ub-Cjun was coupled to the affinity matrix after incubating the protein 
supernatant with the agarose. Any unbound prote ins were removed by extensive washing of the 
beads. The fus ion prote in was eluted against 500 mM imidazo le e lution buffer. For Cjun c loned 
in pET I 5b.ep vector, the 6x His tag was still attached to the N-terminal ofCj un ; for Cj un in 
pHUE vector, the 6xHis-ub was removed by Usp2cc c leavage. Purified recombinant Cj un 
(either with tag or without) was washed against a standard wash/exchange buffer and 
concentrated. 
4.2.4 Modified co-IP between Cjun and RyRl and RyR2 
The modified co-[P assay was carri ed out to investigate the direct binding of recombinant Cjun 
to the purified RyRI or RyR2 in the same way as fo r FLjun (see Method, section 2.8.1 or 
Chapter 3, section 3.2.4). Recombinant GST fu sion Cjun prote in binding to cardiac RyR2 has 
been previously reported (Zhang et al. , 1997). In thi s study, both Cj un with 6xHis tag and Cjun 
a lone were tested to check their interaction with RyR I or RyR2. Co- IP was conducted in two 
ways, either Cjun precipitated by RyRI (n=3) or RyR2 (n=3) co-IP or co- IP precipitation of 
RyR I (n=4) or RyR2 (n=4) by Cj un . After extensive washing to remove the unbound proteins, 
the final resultant complex (RyR/Cjun-antibody-protein NG agarose) was incubated with 
Laemmli sample buffer at 65 °C for IO min to elute the proteins and tested with SOS-PAGE and 
immunoblot . 
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4.2.5 Single channel recording and analysis 
Single RyR channel recording was undertaken and analyzed as described in section 2.9. Cjun 
was added to either the /rans or cis chamber to assess its effect on RyR channel activity. 
4.2.6 Ca2• release from skeletal and cardiac SR vesicles 
4.2.6.1 Cjun induced Ca2• release from SR vesicles 
Cjun-induced Ca2• release from SR vesicles was tested as described in section 2.10.1. The SR 
vesicles were first loaded with ca2+, then exposed to thapsigargin to block SERCA to prevent 
Ca2+ uptake during the experiment (Hanna et al., 2011 ; Jalilian et al., 2008; Sagara and lnesi , 
1991). Cjun (5 µM) was added 30 s after thapsigargin to examine its ability to immediately 
stimulate Ca2• release by measuring the optical density. This concentration of 5 µM was chosen 
because the effects of compounds often require higher concentrations to affect SR Ca2• release, 
than those needed to alter RyR activity in bilayers (Dulhunty et al., J 999). The rate of Ca2• 
release induced by Cjun was calculated (section 2. J 0.3) and the results were compared to 
control experiments where MOPS buffer (20 mM MOPS, 150 mM NaCl, pH 7.4, where Cjun 
was dissolved) was used in place of Cjun. 
4.2.6.2 Pre-incubation o/SR vesicles with Cjun 
Ca2+ release from SR vesicles pre-incubated with Cjun was assessed as detailed in section 
2.10.2. In brief, the SR vesicles were exposed to 5 µM Cjun for -30 min prior to thapsigargin 
addition (20 min pre-incubation plus IO min during Ca2+ loading), to provide sufficient time for 
RyR-Cjun interaction, if there were any, to be fully established. In these experiments, caffeine 
was used to stimulate Ca2+ release and the effect of pre-incubation with Cjun on caffeine-
induced Ca2+ release was measured. The rate of caffeine-induced Ca2• release was compared to 
control experiments in which the vesicles were pre-incubated with MOPS. The rate of Ca2• 
release was calculated in the same way as describe in section 2.10.3. 
4.3 Results 
4.3.1 Expression and purification of Cjun 
Recombinant Cjun (either with 6xHis-tag or without tag) purification was analyzed by SDS-
PAGE and identified using immuneblot (Fig. 4-1). A purity of over 95% was achieved in both 
cases. 
115 
A B C D 
= 
-
Wat 
KDa 25 
25 - - _. ~Anti -junctin 
20 - -
.<E-Anti-j unctin 
1 2 3 4 
Figure 4-1 Recombinantly expressed and purified Cjun. (A)-(B) Recombinant 6 xHis-Cjun using pETl5b.ep 
(mod.) vector. The fusion protein (- 0.5 µg) was analyzed on a 10% SDS-PAGE gel followed by coomassie staining 
(lane 2 in A) and immunoblot (B). (C)-(D) Recombinant Cjun utilizing pHUE vector. Cjun (-5 µg) was analyzed on a 
12% SDS-PAGE gel followed by coomassie staining (lane 4 in C) and immunoblot (D). The 6xHis-ub tag was 
cleaved with ubiquitin protease Usp2cc and removed by re-binding to the Ni -NAT resin. Immunoblot using anti-
junctin antibody confirmed the identity ofCjun obtained from both pETl5b.ep (mod.) and pHUE velors. Molecular 
weight markers are shown in lane I and lane 3 respect ive ly. Pink band corresponds to the molecular weight noted. 
4.3.2 Physical interaction-Cjun binds to purified RyR1 and RyR2 
The interaction between Cjun protein and the RyR was examined using modified co-lP and was 
visualized using SDS-PAGE and immunoblot (section 2.8.l and 4.2.4) (Fig. 4-2). Immunoblot 
of the RyR/Cjun-antibody complex probing with anti-RyR 34C and anti-junctin antibodies 
confinned that the eluted proteins were Cjun and the RyR (Fig. 4-2 lane 5-8). Control 
experiments were performed in the absence of antibody with no detectable RyR I or RyR2 
shown (Fig. 4-2 lane 1&2). Nor did 6xHis-Cjun or Cjun (no tag) bind to protein NG agarose 
(Fig. 4-2 lane 3&4). The co-IP results clearly demonstrated that both 6xHis-Cjun and Cj un (no 
tag) were able to bind directly to the purified skeletal RyR I and cardiac RyR2. 
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Figure 4-2 Binding of Cjun to purified Ry RI and Ry R2. lmmu noblot of the e luted proteins from Cj un/ Ry R co-IP 
using monoclonal anti -RyR 34C and polyclonal anti-junctin antibodies, confirming the association of purified RyRI 
and RyR2 with Cjun (with Hi s-tag) (lane 5 and 6 respectively, n=3 for RyR I, n=4 for RyR2). Some co-IP 
experiments were also performed \vith Cjun (without Hi s-tag) and purified RyRl and RyR2 with similar results ( lane 
7 and 8 for RyR I and RyR2 respectively), confirmed in 2 repeats. Protein NG agarose alone did not bind to either 
RyR I (lane\) or RyR2 (lane 2). nor did it bind to 6 xHis-Cjun (lane 3) or Cj un (no tage) (lane 4). Molecular weights 
to the left of lanes. 
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4.3.3 Functional effect ofCjun on RyRl/2 
The ability of Cjun to modify RyR channel activity was examined using single channel 
recordings and Ca2• release assays. Purified RyR I or RyR2 was incorporated into lipid bilayers 
using standard incorporating solutions (for composition of these solutions see section 2.9.3) and 
channel activity was recorded under symmetrical (Cs+) conditions (section 2.9.4), trans [Ca2+J 
was maintained at lmM under all conditions. Cjun (213 nM) was added either to the luminal 
side or the cytoplasmic side of RyRI or RyR2 accordingly. 
4.3.3.1 The effect of luminal addition of Cjun on purified RyRl or RyR2 activity 
In thi s experiment, 213 nM Cjun (with 6xHis-tag) was added to the luminal (trans) side of the 
purified Ry Rs. It was expected that the luminal addition of Cjun wou ld activate Ry Rs in the 
same way as FLjun since the major effect of FLjun has been assumed to be due to an interaction 
between the proteins within the lumen of the SR. ln contrast, Cjun induced a significant 
inhibition of both Ry RI and RyR2 channel activity after its addition to the luminal so lution. 
Channel P0 in RyR I fell to 0.68±0.17 of control and in RyR2 fell to 0.48± 0.06 of control (Fig. 
4-3A-C; P0 from 0.085±0.04 to 0.037±0.016 in RyRI , and from 0.348±0.026 to 0.174± 0.031 in 
RyR2). To exc lude the possibility of any non-specific interaction between 6xHis-tag and 
luminal RyR, identical experiments were carried out with the recorribinant Cjun (without any 
tag) . Adding Cjun (no tag) to the luminal side produced a significant decrease in the open 
probability in both channel types (Fig. 4-3C, cross-hatched bins), P0 fell to 0.38±0 .07 of control 
in RyRI (from 0.44± 0.07 to 0.19±0.06) and to 0.37±0.07 in RyR2 (from 0.246±0.055 to 
0.084±0 .014), similar to the effect of luminal 6xHis-Cjun on purified Ry Rs. The s imilarity of 
the response of purified RyRl and RyR2 to 6xHis-Cjun and Cjun (no tag) suggests that the 
inhibitory effect was due to the luminal interaction between Cjun and the RyR, but not the 
6xHis-tag. No apparent changes in channel activity were observed when adding Cj un to luminal 
side of native RyRl (n=l) or RyR2 (n=2) (data not shown). 
Further ·examination of the effect ofCjun on RyRl and RyR2 channel activity revealed that the 
decrease in channel activity was due to an abbreviation of average mean open times and 
prolonged mean closed times (Fig. 4-3D&E, black bins). After luminal addition of Cj un (6xHis-
Cjun),' the mean channel open time was reduced with an average -2-fold reduction in RyR I (to 
0.48± 0.06 of contro l) and - 1.4-fold reduction in RyR2 (to 0.70±0.09). In contrast, there was an 
average 8.18±2.20-fold and 5.74±2.03-fold increase in mean closed times for RyR I and RyR2 
respectively (Fig. 4-3D&E, black bins). Ana lys is of data obtained with luminal addition of Cjun 
(no tag) to purified RyRs showed a similar change in T0 and Tc(T0 : to 0.64±0. 15 of control in 
RyRI and 0.49±0.04 in RyR2; Tc: 2.98±0 .79-fold increase in RyRI and 3 .8±0.53 increase in 
RyR2) (Fig. 4-3D&E, cross-hatched bins). 
11 7 
The changes in RyR channel gat ing in thi s set of experiment was al so accompanied by 
corresponding changes in time constant di stributions (Fig. 4-4; Table 4-1 ). As can be seen w ith 
FLjun (see Chapter 3.3.4.2), three open time constants and three closed time constants were 
used w ith both RyRI and RyR2 channel activity to obta in the best exponential fit. The average 
open time constants in RyRI channels were , 0 1 = 2.9±0.1 2 ms; 1:02 = 16.7±0.19 ms; 1:03 = 
165 .0± I. 78 ms and average c losed time constants Tc1 = 3. 1 ± 0. 16 ms; 1:c2 = 22.6±0.37 ms; 1:c3 = 
235.3±2.5 1 ms. Add ition ofCjun did not induce significant changes in the time constant values, 
but the number of events fa lling into these time constants was significantly different. With the 
dwell times in the open state, 79±2 .5% of openings fe ll into 1:01 before, and 87±3 .8% after, Cjun 
addition. Conversely, the fraction of events in , 02 were 20±2 .3% before and 13±3.7% after 
adding Cj un. In addition, there was a trend towards a reduction in the number of events fallin g 
into 1:03 with 0.5±0 .2 1 % before and 0 .2±0. 16% after Cjun , although the difference was not 
significant. With channel closings, the number of events in 1:c2 was decreased sign ificantly from 
42±2.5% before, to 34±3.4% after, adding Cj un. By contrast, 16±2.4% of clos ings fell into 1:c3 
before, and 3 1±6.4% after, the addition ofCjun. There was a lso a significant decrease in the 
number of events in the shortest closed time constant from 42±4.5% to 34±5.6% after Cj un 
addition (F ig. 4-4A&B). 
The open and c losed time constant va lues for RyR2 activi ty were again similar befo re and after 
luminal addition ofCjun, and were a lso s imilar to those determined for RyRI channels. The 
average open time constants for RyR2 channels were , 01 = 2.5±0.11 ms; 1:02 = 15.5±0.1 7 ms; 
1:03 = 144.2±2. 17 ms and average c losed time constants 1:c1 = 4. 1 ± 0.1 4 ms; 1:c2 = 22.4±0 .26 ms; 
, c3 = 257.1 ±2. 16 ms. Cjun addition to the lumina l so lution produced similar effects to those 
seen in RyR I . There was an increase in the number of opening events in , 01 (from 62±8.9% to 
75±6.4%) and a decrease in the longest closures 1:03 (from 2.0±0. 7% to 0.6±0.19%). A - 1.5 -fo ld 
reduction in events occurring w ithin , 02 was al so observed (from 36±8.4% to 24±63%), 
a lthough the difference was not stati stica lly significant. With the number of c losed events, after 
adding Cj un , RyR2 acti vity showed a - 2.4-fo ld increase in long c losures ( in , c3, from 8.5±2.5% 
to 22±6.2%) with no significant changes in , c1 and 1:c2. As with FLj un (see Chapter 3.3.4.2), 
there was no differe nce between effects of Cj un on RyRI and Ry R2 (Fig. 4-4, Table 4- 1). 
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Figure 4-3 Luminal addition ofCjun inhibits purified RyR channel activity at I mM tnms Ca'+. (A)-(B) Records of3 s of single channel acti vity at -40 mV. Single channel opening is 
downward from zero current (c, continuous line) to maximum open conductance (o, broken lines). The top recording in each panel shows control channel activi ty and the lower trace shows 
activity in the same channel after addition of 213 nM FLjun to the luminal solution bathing RyR I (A) and RyR2 (B). (C)-(E) Average pooled data from both potentials for relative open 
probability ( logP,J-logP,C, C), mean open time (logT,J-logT,C, D), and mean closed time ( logT,J-logT,C, E) for RyRI and RyR2. Data are shown for effects of the Cj un (with 6xHis-tag, 
Methods section 2_5_3 and 4.2 .3) on the lumi nal side of RyRI (n=9- 12) and RyR2 (n= l 1-1 7) (filled bins). Some experiments were also performed with luminal addition ofCjun (without 
l-lis-tag, Methods section 2.5.4 and 4.2 .3) with similar results in RyRI (n=7-8) and RyR2 (n=6) (cross-hatched bins). The asterisk(*) indicates average values significantly different from 
the control (P<0.05 Student ' s I-test, paired) . 
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Figure 4-4 Effects of 2 13 nM Cjun (trans) on the average open (A&C) and cl osed (B&D) ti me constants and 
fract ion of eve nts in each tim e constant of purifi ed Ry Rs. The probabil ity of events falli ng in to each time 
constant is plotted against the time constant in ms (open time or c losed time). Ti me constants are shown for control 
data (open circles) and 2 13 nM Cjun (fil led ci rcles) for RyR I (A& B) or RyR2 (C&D).Yertical bars indicate the 
SEM for event probability. Horizontal bars indicating the SEM fo r the time constant are contained within the 
symbols. Asteri sks( ' ) indicate significant differences between contro l data and with 2 13 nM FLjun (P<0.05 
Student's I-test, paired, n= \ 2 for RyRI and n= IO for RyR2). 
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Table 4-1 A summary of the open and closed time constants before and after Cjun reassociation 
control(RyRl) Cjun+RyRl P value control(RyR2) Cjun+RyR2 
t o, 2.85±0.]2 2.97±0.14 0.3927 2.50±0.11 2.35±0.28 
Pl 0.79±0.02 0.87±0.04 0.0219 0.62±0.09 0.75±0.06 
t 02 16.71 ±0.19 16.85±0.31 0.5205 15.49±0.17 15.42±0.30 
P2 0.20±0.02 0.13±0.04 0.0229 0.36±0.08 0.24±0.06 
! 03 165.04± 1.78 160.00±2.21 0.1474 144.2±2.17 143.1 ±2.40 
P3 0.005±0.002 0.002±0.00 I 0.1175 0.02±0.01 0.006±0.002 
t c1 3.13±0.16 3.11±0.16 0.8166 4.09±0.14 4.48±0.14 
Pl 0.42±0.05 0.34±0.06 0.0382 0.46±0.05 0.39±0.05 
t c2 22.61±0.37 21.89±0.39 0.1585 24.40±0.26 23.42±0.55 
P2 0.42±0.02 0.34±0.03 0.0343 0.45±0.03 0.39±0.02 
t e3 235 .33±2.51 236.17± 1.4 7 0.7599 257.10±2.16 260.80±3.06 
P3 0.16±0.02 0.31±0.06 0.0118 0.09±0.03 0.22±0.06 
n 12 12 IO 10 
PI , P2 and P3 denote probability. P va lue <0.05 are in bold, denoting significant difference from control value. 
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P value 
0.4839 
0.0428 
0.8251 
0.0503 
0.1852 
0.0421 
0.0701 
0.1536 
0.1162 
0.1915 
0.1354 
0.0130 
4.3.3.2 Cytoplasmic interaction between Cjun and RyR1/ RyR2 
4.3.3.2.1 Cytoplasmic addition of Cjun causes weak inhibition of both purified RyRl 
and RyRZ channel activity 
The cytoplasmic effect of Cj un on purified Ry Rs was also determined. The experiment 
conditions and the concentration of added Cj un (2 13 nM) were the same as in the previous 
sect ion. Unlike cis FLjun (see Chapter 3.3.5), the addition ofCj un to the cytoplasmic (cis) 
so lution produced a significant decrease in both puri fied RyR I and RyR2 channel activ ity (F ig. 
4-5). The average relative P0 values (calcu lated for individual channels) was 0.72±0.06 and 
0.82±0.05 in RyRI and RyR2 respectively (Fig. 4-5C, black bins; control P0 was reduced from 
0.3 8±0.08 to 0.28±0.07 in RyRI and from 0.3 7±0.04 to 0.27±0.03 in RyR2). But the reduction 
was sign ificantly less than that seen when adding Cj un to the luminal side (Fig. 4-5C, cross-
hatched bins) . 
The channel gating properties, mean open time and mean c losed time (T0 and Tc) were examined 
as we ll for thi s series of experiments . The results suggest that the average decrease in RyR 1 
channel open probability with cis Cjun could be attributed to a significant increase in mean 
closed time (- 2.6-fold increase); there was no significant change in T0 when Cjun was added. 
For RyR2, the reduction in channel activity was primarily due to a significant prolongation of Tc 
(- 1.5-fold increase) with a trend towards lower T0 va lues wi th (Fig. 4-5D&E, black bins). Again , 
changes in T0 and Tc induced by cytoplasmic Cjun was smaller than those caused by lumina l 
Cj un . 
The weak inhibition induced by Cjun cis may be due to Cjun acting directly at a cytoplasmic 
domain of the RyRs, or in a luminal microdomain that is a lso ava ilab le from the cis chamber. 
An alternative poss ibili ty is that Cj un may cross the membrane and access the luminal domain 
to act as luminal Cj un , a lthough this is less li kely due to the high density of charged res idues 
that it contain s (for detai l, see Chapter l .9.2). Neverthe less, if thi s were the case, one wou ld 
expect that the effect of Cj un add ition to ei ther chamber be e liminated or at least reduced if it 
was added fi rst to the oppos ite so lution. To examine these poss ibilities, Cj un was either applied 
first to luminal s ide and then to cytoplasmic so lution (Fig. 4-6A&B), or in the reverse order (F ig. 
4-6C&D). (NB. Part of thi s wo rk was performed by Prof. Esther Gallant from Muscle Research 
Group, John Curtin Schoo l of Medica l Research, Austra li an National Un ivers ity, Canberra, 
Austra li a). In both cases, the strong inhibition with luminal add ition and weak inhibition with 
cytoplasmic add ition were maintained irrespecti ve of which side had Cj un added first (Fig. 4-6). 
These observations indicate that the altered RyR activity by cis Cjun was through Cj un acting 
on a cytoplasmic site. ln the fo llowing sections (section 4.3.3.2.2 and 4.3.3.2.3), further 
investigations were carried out to determine the specificity of thi s cytoplasmic effect ofCj un . 
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4.3.3.2.2 Effect ofCjun (cis) on native RyRl and RyR2 channel activity 
Similar experiments were repeated with native RyRI and RyRZ by adding Cjun to the 
cytoplasmic solution to determine the specificity of this cytoplasmic effect. Since the native 
Ry Rs already contain endogenous junctin, one would expect that if some junctin was inserted 
into the membrane with its C-terminus facing the cis side, and if the C-tail binding was specific, 
then adding exogenous Cjun to the cis side could not bind or induce any changes in RyR 
activity. Interestingly, in these experiments, native RyR I and RyRZ were shown to respond 
differentially to cytoplasmic Cjun, which was inconsistent with the RyR isoform independent 
actions ofFLjun (Chapter 3), Cjun (this Chapter), Njun (Chapter 5) and Jun KEKE (Chapter 6) 
seen in all other experiments. Addition of Cjun to cytoplasmic solution again induced a small 
reduction in native RyRZ channel activity (Fig. 4-7C 4111 black bin), similar to its effect on 
purified RyRZ channels (Fig. 4-7C 3rd cross-hatch bin), suggesting the non-physiological nature 
of the cytoplasmic Cjun-RyR2 interaction as endogenous Cjun would presumably already be 
bound to sites that it had occupied in vivo. Curiously, there was no effect ofCjun on native 
RyRI channels in bilayers, in contrast to its inhibitory effect on purified RyR I (Fig. 4-7C I" 
two bins). 
4.3.3.2.3 No effect ofCjun on Ca2• release from SR vesicles 
The cytoplasmic effect of Cjun on native Ry Rs was further explored by examining its effects on 
Ca2• release from intact SR vesicles. Investigations into this interaction were undertaken by Mrs. 
Suzy Pace (Muscle Research Group, Joh.n Curtin School of Medical Research, Australian 
National University, Canberra, Australia). In contrast to s ingle channel studies, the Ca2• release 
assay with intact SR vesicles provided a more intact system. The assay was conducted in two 
ways as described in section 2.10 and 4.2.6. 
In one case, Ca2• release was stimulated by addition of Cjun to a so lution containing RyRI or 
RyR2 channels in SR vesicles (section 2.10.1 and 4.2.6.1 ). In control experiments, MOPS 
buffer was used . The rates of Ca2+ release immediately after Cjun in MOPS buffer addition were 
measured and compared with the rate with MOPS buffer alone. Similar to the failure of cis Cj un 
to affect native RyR I channels in lipid bilayers, Cjun did not cause a significant change in the 
rate ofCa2• release from RyRl-containing vesicles (Fig. 4-8 I" black bin ; from 97.92± 1.99 in 
the absence of Cj un in control experiment to 87.28± 11. 73 nmol Ca2•/mg protein/min). On the 
other hand, Cjun also had no significant effect on Ca2• release from SR vesicles containing 
RyR2 (from 5.95± 1.29 (control) to 4.24±1 ,43 nmol Ca2•/mg protein/min), in contrast to its 
inhibition of native RyR2 channels in bilayers, although there was a trend towards a reduced 
rate of Ca2• release (Fig. 4-8 2"d black bin). 
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In the second case, the vesicles were pre-incubated with Cjun fo r 20 min prior to the 
experiments. Caffe ine was used to stimulate Ca2+ rel ease. The rate of caffeine-induced Ca2• 
re lease from vesic les pre-incubated with Cj un was compared to contro l experiments in which 
the vesicles were pre-incubated with MOPS buffer. No overa ll changes were observed in the 
rate of caffeine-induced Ca2• release from vesicles contain ing e ither Ry RI or RyR2 after pre-
incubation with Cjun (Fig. 4-8 light grey bins; from a contro l of 229 .54±40.50 to 278. 13±33 .27 
(with Cjun) nmol Ca2•1tng protein/min in RyRl , and from 56.25±3.87 (control) to 5 1.63±3.35 
nmol ca2•/mg protein/min in RyR2). This was again in contrast to the negative effect of Cjun on 
native RyR2 channe l acti vity in bilayers but consistent with its lack of an effect on nati ve RyR I 
channels. 
Taken together, the inconsistent results obtained with native RyRs (section 4.3.3.2.2 and 
4.3 .3.2.3) question the signifi cance of the cytoplasmic effect ofCj un. 
4.4 Discussion 
In this chapter, the physical interaction and functiona l regulation of the purified RyR 1 and 
RyR2 by junctin ' s luminal domain, Cjun, were extensively investigated at a resting luminal 
[Ca' •] of l mM. Cjun expressed and purified from E. coli was re-associated with purified RyRs 
in the absence of other junctin segments and FLjun. For the first time, the effects of Cjun have 
been characteri zed on sing le RyR 1 and RyR2 channels and Cjun was shown to regulate puri fied 
RyRs. The unexpected finding was that purified RyRs are inhibited by luminal Cjun, in contrast 
to the activation by luminal FLjun. The novel resu lts presented in thi s chapter challenge the 
long-held assumption that FLjun regu lates RyRs simply thro ugh its C-terminal domain and 
suggest a more comp lex mechanism fo r FLj un regulation of RyRs. 
4.4.1 Cjun expression and purification 
Topology analys is has revea led the C-term inal, luminal domain of junctin (Cjun) encompasses 
amino ac ids 45 -2 10 (J ones et al. , 1995). In an early study (Zhang et al. , 1997), GST-fused Cjun 
protein (canine cardiac isoform , residues 46-2 10) was found to be only poorly expressed in 
E.coli. This was poss ib ly due to the vector being improperl y selected or to potential Cjun 
degradation during express ion. Recently, also us ing E. coli, Lee et a l. (2012) were ab le to 
express 6xHi s-tagged mouse junctin. This construct however, only contained res idues 68-207, 
corresponding to canine j unctin res idues 66-210, i.e., without the initial luminal part (res idues 
45-65). For thi s reason, a protocol for express ion of Cjun of its full sequence was deve loped . In 
thi s study, the issue of poor express ion of fu ll length Cjun observed in (Zhang et al. , 1997) was 
reso lved by constructing cani ne Cj un (res idues 46-210) as 6xH is-fusion protein using a 
modifi ed pET 15b.ep vector, and E.coli strain BL2 1(DE3) as a host for the express ion (for 
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Figure 4-5 Weak inhibition of pu rified RyR channel act ivity by cytoplasmic addition ofCjun . (A)-(B) Records of3 s of s ingle channel activity al -40 mV. Single channel opening is 
downward from zero current (continuous line, c) to max imum open conductance (broken lines, 0 1, o2) . Top traces in each panel show purified RyR contro l activity and the lower traces show 
acti vity in the same channel afte r add ition of 2 13 nM Cjun to the cytopl asm ic solution bathing RyR I (A) and RyR2 (B). (C)-(E) Average data for re lati ve open probability ( logP 0 .l-logP ,C, 
C), mean open time (logT,J-logT, C, D), and mean c losed lime (logT,J-l ogT,C, E) from both potentials, before and after adding Cjun cytoplasmically (b lack bins) (Cj un (luminal add ition) 
data are from previous fi gures and inc luded for comparison, cross-hatched bins). Asterisks(*) indicate s ignificant differences between control data and with 213 nM Cjun cis (P<0.05 
Student's /·lest, pai red, n- 10-12 for RyRI and n- 17-27 fo r RyR2). 
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Figure 4-6 Sequentia l add ition of Cj un to the cytop lasm ic and lum ina l sol ution induces a two-step 
inhibition of purified RyRs a t resting 1 mM trans [Ca2+[. (A)-(D) Representative traces of3 s records 
illustrating the additive effects of Cjun (213 nM) added to the trans and cis chamber on RyR channel 
activity (n=3 for RyR I and n=6 for RyR2). Current recordin gs were obtained at -40 mV. Channe l 
openings are downward from zero current (continuous line, c) to maximum open conductance (broken 
line, o). The top record in each pane l shows control purified RyR activity, the middle record was 
obtained after first adding 2 13 nM Cjun to either trans (A& B) or cis (C&D) solution, and the bottom 
record after second add it ion of2 I 3 nM Cj un cytoplasmical ly (A& B) or lurninally (C&D). The ? 0 val ue 
measured for each channel trace is given on top of the current records. Cytop lasmi c (cis) [Ca2+] was I 
µM under all conditions. 
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Figure 4-7 Addition of 213 nM Cjun (cis) to native RyRs containing endogenous junctin causes different effect on Ry RI and RyR2 channel activity. (A)-(B) Records of 3 s of 
single channel activity at -40 mV. Single channel opening is downward from zero current (continuous line, c) to maximum open conductance (broken line, o). The upper trace in each panel 
shows control activ ity and the lower trace shows act ivity after adding 213 nM Cjun to the cytoplasmic solution bathing RyR I (A) or RyR2 (B). (C)-(E) average data for relative open 
probability ( logP0 J-logP0 C, C), mean open time (logT,J-logT, C, D) and mean closed time (logT,J-logT,C, E), determined for individual channel for RyR I (n=6) and RyR2 (n=7-8). No 
significant differences in nati ve RyRI activity found with Cjun before and afte r protein addition (P>0.05 Student I-test, paired), whereas a small reduct ion in RyR2 channel activity was 
observed upon Cj un addition (P<0.05, Student's 1-test, paired). Cjun (cytoplasmic add ition) to purified RyRs data from Fig. 4-5 are included for comparison (cross-hatched bins). 
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Figure 4-8 The rate of Ca2+ release from SR vesicles remain unaffected by the addition of 5 µM Cjun to the 
extravesicular solution. Adding Cjun produced no effect in the rate ofCa2+ release from either skeletal (n=4) or 
cardiac (n~3) SR through RyRs containing endogenousjunctin (black bins). Preincubation in 5 µM Cj un did not 
alter the rate of caffeine induced Ca2+ release through RyR 1 (n~4) and RyR2 (n~3) (light grey bins). No significant 
difference found from control value (P>0 .05 Student's I-test, paired). 
detail, see Methods, section 2.5.3). Expression conditions for 6xHis-Cjun were optimized at 37 
"C for 4 h, which was simi lar to that used for FLjun expression (section 2.5.2 and 3.3.2.2). 
As mentioned in section 3.4.2, the 6xHis-tag produced using pET15b.ep (mod.) contains 24 
amino acids tRRYTMGSSHHHHHHSSGLVPRGSH24), which may interfere with the 
interaction between Cjun and the RyRs. Therefore, it was necessary to remove the tag in order 
to exclude any potential interactions of the tag and the RyRs as we ll as to ensure the specificity 
of Cjun-RyR interaction. However, trial experiments with thrombin under many different 
conditions (e.g. , different temperatures at different time points) often resulted in multiple bands 
monitored by SDS-PAGE. This was possibly due to : 1) low efficiency of thrombin cleavage 
used here; 2) potential proteolysis at other site(s) ofCjun by thrombin (Jenny et al., 2003), 
a lthough no thrombin cleavage sites currently known were detected in Cjun sequence; 3) protein 
se lf-degradation under the conditions tested. It is worth mentioning that thi s part of the work 
was done before recombinant FLjun expression in E.coli (see Chapter 3), thrombin from 
different sources was used (Thrombin from bovine plasma, Sigma-Aldrich #T4648 in this 
chapter and Thrombin CleanCleave Kit, Sigma-Aldrich #RECOMT in the previous chapter). 
Therefore, the low success rate encountered with Cjun cleavage could be accounted for by 
lower grade (less pure) thrombin being used. In addition , Cjun may have been more susceptible 
to degradation in normal MOPS buffer than FLjun in a buffer containing detergent and glycero l. 
Multiple bands a lso occurred in contro l experiments incubating Cjun alone under the same 
conditions as Cjun!fhrombin . In order to combat these problems, an in-house pHUE vector was 
employed (Methods, section 2.5.4, also see (Baker et al., 2005 ; Catanzariti et al. , 2004b)). This 
expression system is fairl y robust and has been shown to be effective and applicab le to a wide 
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range of protein expression (Catanzariti et al., 2004b). Cjun protein (without His-tag residues) 
of over 95% purity was achieved using this method (Fig. 4-1 C&D). This once again proves the 
effectiveness and efficiency of the pHUE-based E.coli expression system. 
4.4.2 Cjun in the luminal solution is a potent inhibitor of purified RyRl and RyRZ 
channels 
Results obtained with co-IP clearly demonstrate that Cjun binds directly to purified cardiac 
RyR2 (Fig. 4-2 lane 6&8), in agreement with previous results from other assays showing the in 
vitro binding between the RyR2 and recombinant Cjun fused to a 6xHis tag and a GST tag 
(Zhang et al. , 1997). As expected, similar physical interactions between Cjun and purified 
skeletal RyRI were detected (Fig. 4-2 lane5&7). Lipid bilayer experiments revealed the 
functional consequences of such a physical link between the proteins. For the first time, Cjun 
added to the luminal solution was shown to elicit strong inhibition on both purified RyR I and 
RyR2 using I mM luminal [Ca2+], with a reduction in long channel openings and encouraging 
long channel closures (Fig. 4-3&4-4). Direct regulation of the RyRs by luminal Cjun was not 
unexpected since it has been suggested thatjunctin primarily interacts with the RyRs via the 
luminal domain (Zhang et al., 1997). In fact, the findings that Cjun, but not the N-terminal 
domain of junctin (Njun) binds to RyR2 led the authors to believe that junctin must interact with 
the RyR from the luminal side of the SR in intact muscle (Zhang et-al. , 1997). Overall, if this 
were true, then the effect ofjunctin on RyR would depend only on luminal interactions between 
the two proteins, i.e . luminal addition of Cjun would be expected to activate Ry Rs as FL jun 
does. However, the suppressed channel activity induced by Cjun was in complete contrast to 
what we expected and also contrasts with the general concepts. Despite the failure to detect the 
physical association between Njun and RyR2 in a previous report (Zhang et al., 1997), the 
opposite actions exhibited by luminal FLjun and Cjun presented in the previous chapter and this 
chapter strongly indicate thatjunctin N-terminus residing in the cytoplasm, or transmembrane 
residues, may interact with cytoplasmic or transmembrane RyR domains. These interactions 
potentia)ly play an important role in the overall FLjun regulation of the RyRs. In fact, Njun does 
appear to have an effect on the RyRs (see Chapter 5). 
Few previous studies have addressed the specific role ofCjun. To date, in addition to the study 
by Zhang et al. (1997), showing the binding between Cjun and RyR2 as mentioned above, the 
targeting of Cjun to the j unctional SR has been examined (Rossi et al. , 2013 ). Expression of 
deletion mutants ofjunctin in primary myoblast demonstrated that Cjun alone is targeted to the 
junctional SR membrane, though a correct link between Cjun and the RyR, CSQ or triadin 
remains questionable (Rossi et al., 2013). There. have been no investigations of the functional 
consequence of such targeting. However, it would be intriguing to see ifCjun could impose a 
similar inhibitory effect on the RyRs or Ca2+ release in vivo in transgenic mice or in vitro in 
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myotubes or cardiomyocytes, where co locali zation ofCj un and RyR as we ll as CSQ or triadin 
coul d be detem1 ined. However, due to time and technica l constraints, thi s work could not be 
perfom1ed. 
4.4.3 The significance of cytoplasmic interaction of Cjun and the RyRs 
Whether the inhibition of purified RyRl and RyR2 observed with cytoplasmic Cjun has any 
phys iologica l significance remains questionable (Fig. 4-5 black bins). Experiments with 
sequentia l addition ofCjun to cis and trans so lutions indicate cis Cjun a lters channel acti vity by 
acting on a cytoplasmic site of the RyR (Fig. 4-6). Nevertheless, trypsin digestion of SR 
ves ic les ind icates that the C-terminal domain of junctin is large ly located inside the SR (Jones et 
a l. , 1995). That Cjun has a similar inhibitory effect on native RyR2s containing endogenous 
junctin suggests the cytoplasmic binding site fo r Cjun is not occupied by endogenous j unctin 
and thus may not be phys iological. Curiously, Cj un caused no changes in the rate of Ca2+ 
release fro m SR ves icles contai ning RyR2. Also curiously, addition of cytoplasmic Cjun did not 
a lter nati ve RyR I activity or Ca2+ re lease from RyR ]-containing ves ic les . These results are 
inconsistent with the isoform independent actions of all other junctin constructs on RyR, also 
rai sing the question of the spec ificity of the cytoplasmic Cjun-RyR interaction. The like ly non-
speci fi c ity of thi s interaction is furth er supported by the observation that the junctin KEKE 
motif peptide fa il ed to replicate the action on the cytoplasmic domain of the purified RyRs, 
whereas the same peptide reproduced the inhibitory effect on channel acti vity seen when Cjun 
was added lumina lly (Chapter 6). FLj un a lso had an effect on the luminal side but no effect on 
the cytoplasmic side of purified Ry Rs (Chapter 3). Consequently, it seems doubtful that a 
cytoplas mic Cj un-RyR interaction occurs phys io logica lly . That sa id, it is not imposs ible that the 
C-terminal part of junctin would be exposed to the cytoplasm during targeting to junctional SR 
or during development and that under these c ircumstances the activity of the RyR is influenced 
by the interaction. 
4.4.4 Conclusion 
The results presented in this chapter prov ide novel information on the regu lation of the RyRI 
and RyR2 by the luminal, C-term ina l domain ofj unctin , Cj un . For the first time, it has been 
demo nstrated that Cj un plays an inhib itory ro le in regulat ing RyR channel acti vity, which is in 
marked contrast to the activating ro le of FLj un . Potentia l regulation of the RyR by the N-
termina l or transmembrane do main ofj unctin may underl ie the di fference between FLjun and 
Cjun effects. Therefore, in the next chapter, a study of the interaction between Nj un and purified 
RyRI and RyR2 is described . 
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Chapter 5 The N-terminal domain ofjunctin modulates RyR1 
and RyR2 activity 
5.1 Introduction 
In Chapter 3, FLjun was established as a RyR channel activator; while in chapter 4, contrary to 
expectations, Cjun was shown to be a potent channel inhibitor. The activating effect ofFLjun 
and the inhibiting effect ofCjun raise the question of whether the short N-terminal tail of 
junctin (Nj un) might have a functional role even though a previous study failed to show a 
physical interaction between Njun and RyR2 (Zhang et a l. , 1997). This possibility is supported 
by the observation that the cytoplasmic domain of skeletal triad in, which is structurally similar 
to junctin, can bind to the cytoplasmic domain of RyR I and inhibit the channel (Groh et al., 
1999; Ohkura et al. , 1998). However, there have been no reports addressing the effects of 
cytoplasmic regulation of the RyR by N-terminal junctin. Therefore, the direct effects ofNjun 
on RyRI and RyR2 were investigated. 
Aim: 
The aim of the experiments detai led in this chapter was to determine: I) the physical 
interactions between Njun and the RyRs; 2) the influence ofNjun alone on purified RyR 
activity; and 3) the contribution of cytoplasmic junctin-RyR interaction to RyR regulation in 
conjunction with the luminal interaction. 
5.2 Materials and Methods 
5.2.1 Methods overview 
Affinity chromatography was employed to evaluate the direct binding between Nj un and the 
RyRs. Single channel recordings in lipid bilayers were used to explore the functional regulation 
of both purified RyR isoforms by cytoplasmic Njun, as well as to examine the combined action 
ofNjun and Cjun. Recombinant RyR I and RyR2 were expressed and purified from HEK293 
cells in order to investigate their physical association with Njun (for explanations for using 
expressed RyRs rather than purified muscle RyRs see section 5.2.3). An Njun peptide, 
corresponding to the first 22 residues of canine cardiac junctin, was synthesized and tested for 
its ability to bind and interact with both RyRI and RyR2. It should be noted that the N-terminal 
domain ofjunctin contains 36.4% charged residues (8 of22) with an overall positive charge (a 
calculated pl of 9. 7) (Table 5-1, row I ; also see (Jones et al. , 1995)). Therefore it was poss ible 
the Njun peptide may interact in a non-specific manner with the RyRs which have excess 
negative charge (Takeshima et al., 1989). To explore this possibility, several control 
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experiments were conducted (section 5.3.4) to eva luate the specificity ofNjun ' s phys ica l 
binding with and functiona l effect on the RyRs. Further, lipid bilayer experiments were 
perfonned w ith native RyRs in conjunction with a Ca2+ release spectrophotometric assay with 
the aim of assessing the phys iological relevance of the cytoplasmic Njun-RyR interaction 
examined in this study. 
Table 5-1 Peptides used in this study 
Name Description Sequence 
Nj un Junctin N-tenninus 1MA EETKHGGHKNGRKGGLSGSS 22 
Nj un scrambled 
A scrambled Njun peptide used 
as a negative control STG ENKGHGLSGKHKS EGRAMG 
Blue and red ind icate negative ly and positively charged residues respectively. 
5.2.2 RyR preparation 
RyRI and RyR2 used for affi ni ty chromatography described in section 5.3. 1 were expressed and 
purified from HEK293 cells as detailed in section 2.4. Recombinant RyR express ion in l-lEK293 
ce lls was achieved either using ca lcium phosphate prec ipitation (for RyRI ) or tetracyc line 
induction (for RyR2). After harvesting, the cell pe ll ets were homogenized in sucrose-imidazole 
buffer. RyR express ion was verifi ed by subj ecting the ce ll homogenate to SOS-PAGE fo llowed 
by immunoblot. The presence of RyR I and RyR2 (the protein band above 250 kDa, Fig. 5- 1 
lane 2 and lane 4 respectively) as detected by anti-RyR 34C antibody confirmed that the 
expressed proteins were RyR I and RyR2. 
1 2 3 4 
:~08 -1 •• -I 
Figure 5- 1 Ex pression of recombinant RyR I and RyR2 . Fi lm exposed to a immunoblot membrane probed fo r 
Ry R I and RyR2 is shown. The membrane has been probed wilh anti-RyR 1 34C antibody to confim, expression of 
RyR I and Ry R2. lmrnuno-detected proteins at > 250 kDa indicate the presence of Ry Rs. Lane I was loaded with 
ves icl es from nat ive HEK.293 ce lls without transfect ion as a negat ive control. Lane 2 was loaded with vesic les from 
l-lEK293 ce lls af\er recombinanl RyR I DNA transfect ion and express ion . Lane 3 was loaded with Ry R-enriched SR 
ves icles iso lated from rabbit ske letal muscle as a positive control. Lane 4 was loaded with ves icles from stable. 
inducible HEK293 ce ll li nes a fter recomb inant RyR2 expression induction . Protein markers are shown to the left of 
the blot. 
132 
For single channel experiments, the Ry Rs were obtained as described in section 2.3: skeletal 
and cardiac SR vesicles were obtained from rabbit skeletal muscle and sheep heart respectively 
as described in section 2.3.1; RyRI and RyR2 were solubilized and purified from SR as detailed 
in section 2.3 .2. 
5.2.3 Affinity chromatography between Njun peptide and RyR1 and RyR2 
To determine the direct binding of the Njun peptide to recombinant RyRI or RyR2, 
NeutrAvidin agarose affinity chromatography was performed as described in section 2.8.2. 
RyRs purified from muscle were also tested for their binding to Njun, but they seemed to 
intrinsica lly bind to the agarose beads, with pre-clearing unable to resolve this problem (data not 
shown). This was likely due to the purification procedure leading to the exposure of residues 
which are normally buried in the RyR and which may contain binding sites for the agarose. 
Therefore, so lely recombinant RyR Is and RyR2s were used for this experiment. Pre-cleared 
recombinant RyRI or RyR2 was incubated with NeutrAvidin agarose-bound Njun peptide. 
After washing away unbound RyR, the NeutrAvidin agarose attachments were eluted, subjected 
to SDS-PAGE and probed for the presence ofNjun and RyR using StrepTactin-HRP conjugate 
and anti -RyR 34C antibodies respectively. The protein bands were visualized as described in 
section 2.6.4.3 and density was quantified using the Quantity One as descri bed in section 2.6.5. 
5.2.4 Single channel recording and analysis 
Lipid bilayer experiments were carried out and analyzed as described in section 2.9. Skeletal or 
cardiac SR vesicles, purified RyR I or RyR2 preparations were used and the junctin peptide 
(Njun or Njunscrnmbled) was added to RyRs reconstituted in artificial lipid bilayers. 
5.2.5 caz• release from skeletal and cardiac SR vesicles 
5.2.5.1 Njun induced Ca2 + release from SR vesicles 
Njun-induced Ca2+ release from SR vesicles were examined as described in section 2.1 O. l . In 
brief, following loading the SR vesicles with Ca2• and tbapsigargin addition to block SERCA 
(Hanna et al., 2011; Jalilian et al. , 2008), 5 µM (for consistency with experiments in Chapter 4, 
sectiori 4.2.6.1) Njun peptide was added 30 s after thapsigargin to determine whether it would 
induce Ca2+ release. In control experiments, MilliQ-water was added and the rate ofCa2• release 
after addition ofNjun in MilliQ-water was compared with the rate with MilliQ-water alone. The 
rate of Ca2+ release was calculated as described in section 2.10.3. 
5.2.5.2 Pre-incubation o/SR vesicles with Njun 
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Ca2+ release from SR vesic les pre-incubated with Njun was assessed as detailed in section 
2.10.2. In short, vesicles were exposed to 5 µM Nj un for - 20 min before Ca2+ loading and then 
thapsigargin addition. Fo llowing thapsigargin, Ca2+ release was stimulated by caffeine (0.5 mM 
and 5 mM for ske letal and cardiac SR vesicles respectively). The rate of caffeine-induced Ca2+ 
release after pre- incubation with Njun was compared to contro l experiments in which the 
vesicles were pre-incubated with MilliQ-water. 
5.3 Results 
5.3.1 Physical interaction between Njun and expressed RyRl or RyRZ 
Part of this work was conducted by Miss Umayal Narayanan (Muscle Research Group, John 
Curtin School of Med ica l Research, Australi an National Univers ity, Canberra, Australia) under 
my supervision. 
A substantial amount of RyRl or RyR2 was bound to Njun, with the presence of the RyR I or 
RyR2 seen as a band above 250 kDa (F ig. 5-2A lane 2&5, top bands) and the peptide band seen 
at - 10 kDa (Fig. 5-2A lane 2&5, bottom bands). A contro l experiment was performed using 
biotinylated Njun,cr,mbled peptide coupled NeutrAvid in agarose or the agarose alone (i.e. in the 
absence of peptides). No detectable Ry RI or RyR2 bound to the NeutrAvid in agarose in the 
absence of the biotinylated peptides (F ig . 5-2A Jane 1&4). Some RyRs were precipitated by 
Njunscrnmbled peptide, but to a lesser extent than seen with normal (non-scrambled) Njun (- 25% 
of that precipitated by Njun) (Fig. 5-2A lane 3&6 and Fig. 5-2B). Taken together with the 
results below showing that the Njun,crnmbled peptide had no effect on channel activity (see section 
5.3.3), it is like ly that the scrambled peptide binding was non-specific. Given that neither RyRI 
nor RyR2 bind to the NeutrAvid in agarose and there is much less binding to the Njun,crnmbled 
peptide, this suggests that Njun is ab le to associate specifica lly with the RyRs. As mentioned 
previously, this was unexpected , as it has been assumed that interactions between RyR and 
j unctin occurred onl y between the luminal domains of the two proteins, since the study by 
Zhang et al. ( 1997) fai led to detect an interaction between GST-fused Njun and RyR2. 
5.3.2 Cis Njun activates purified RyRl and RyRZ activity 
The functional conseq uences ofa direct interaction between Njun and purified RyRI and RyR2 
were examined with s ingle channel recording, using standard cis and trans so lutions with I µM 
Ca2+ in the cis chamber and I mM Ca2+ in the trans chamber (for methods and solution 
composition see section 2.9.2-2.9.4). 213 nM Njun was added to the cytoplasmic (cis) so lution 
fo llowing channel fusion with the bilayer and severa l minutes of recording of control channel 
activity. 
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Figure 5-2 Binding of the junctin N-termin al ta il (Njun) peptid e to RyRI and RyR2. (A) lmmunoblot 
showing the association of recomb inant RyR I and RyR2 with the biotinylated Njun peptide coupled to 
NeutrAvidin agarose (Lane 2 and 5). The upper half of the membrane was probed with anti -RyR 34C ant ibody, 
and the lower half was probed wi th Streptactin-HRP conj ungate to identify the biotin tagged peptides. 
NeutrAvidin-agarose alone did not bind to either RyR I (lane I) or RyR2 (lane 4). The Njunm=bl,d peptide bound 
to RyRI (lane 3) and RyR2 (lane 6), but to a lesser extent than that seen with Njun . Mo lecular weights to the left 
of lanes. (B) Average ofRyR I or RyR2 band density relat ive to peptide (Njun, black bin s; Njun ,"=b''" light 
grey bins) band density. The asterisk(*) indicates average values significantly different from Njun (P<0.05 
student's I-test, paired, n=8 for RyRI and n=7 for RyR2). 
Contrary to our expectations, the addition of Njun to the cis chamber elic ited a dramatic 
increase in the activity of purified RyR2 and Ry RI channe ls (Fig. 5-3). The open probabili ty 
increas~d 5.0± 1.0-fo ld in RyR 1 and 6.9±2.4-fold in RyR2 (F ig. 5-3 C). Average P 0 rose from 
0.02 1±0.01 to 0. 125±0.06 fo r RyR I and from 0.103±0.03 to 0.263±0.04 for RyR2. It is notable 
that the increase in open probability induced by cis Njun was significantly greater than the 
increase produced by FLj un added to the luminal so lution (see Chapter 3.3.4. 1 and Fig. 3-9C). 
Interestingly, a time delay was often observed before fu ll Njun activation was established: 
2.2±0.7 min in RyRl (n= l 2) and 3.4± 1. 1 min in RyR2 channels (n= l 2) respecti vely. This 
impl ies the binding site on cytoplasmic domain ofRyR for Njun was not easily access ible, 
although faster activation did occur in some experiments (6 out of 24). Overall, the results show 
that Njun is a potent acti vator of both Ry RI and RyR2 . 
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Figure 5-3 Cytoplasmic Njun increases RyRl and RyR2 channel activity. (A)-(B) Records of3 s of single 
channel activity at -40 mV . Single channel opening is downward from zero current (c, continuous line) to maximum 
open conductance (o, broken lines). The top recording in each panel shows control channel activity and the lower 
trace shows activity in the same channel after addition of 213 nM Nj un to the cytoplasmic solution bathing RyR I 
(A) and RyR2 (B). (C)-(E) Average data for relative open probability (logP0 J-logP0 C, C), mean open time 
(logT0 J-logT0 C, D), and mean closed time (logT,J-logT,C, B) for RyRI and RyR2. Data were pooled at both 
potentials before and after the addition ofNjun. The asterisk(*) indicates average values significantly different from 
the control (P<0.05 Student's I-test, paired, n~9 for RyRI and n~ I4 for RyR2). 
Further analysis revealed that the changes in RyR channel activity following Njun addition to 
the cytoplasmic solution was due to corresponding changes in mean open times and mean 
closed times. These changes fo llowed a simi lar pattern to that seen after adding FLjun to the 
luminal so lution, but to a greater extent (Fig. 5-3D&E, for comparison, see Chapter 3.3.4.2 and 
Fig. 3-9D&E). After cytoplasmic Njun assoc iation, RyRl displayed a 3.32± 1.27-fold increase in 
mean open times and a -4-fold (to 0.24±0.03) decrease in mean closed times. Similarly, there 
was a s ign ificant increase in mean open times (4.02±0.02-fo ld) and reduction in mean closed 
times (- 6-fold, to 0.16±0.53) in RyR2. 
The changes in mean open and closed times were due to an alteration of the open and closed 
time distributions. Three time constants achieved the best exponential fit to both open and 
closed time distributions in both RyR 1 and RyR2 channel s (shown in Fig. 5-4A-D and Table 5-
2). The open and closed time constant va lues for RyRI activity were similar before and after 
cytop lasmic addition ofNjun. The average open time constants in RyR I channe ls were ,a,= 
2.1 ±0. J 7 ms; 1 02 = 17.0±0.84 ms; 1 03 = 149. J ± 1.93 ms and average closed time constants ,c, = 
3.4± 0.20 ms; 1c2 = 22.2±0.87 ms; , c3 = 245.2±5.67 ms. After the addition ofNjun, the number 
of open ing events in 1 0 1 fel l from 97± 1.2% to 78±8.6%. In contrast, there was a - 10-fold 
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increase in opening events in both , 02 and 1 0 3 (from 2.4± 1.1% to 19±7.1% and from 0.3±0.15% 
to 3±1.7% respectively) . Correspondingly, RyRI activity displayed an increase in the number of 
closed events in , c1 ( 15±7 .0% to 39±12.4%) and a decrease in the long closures in , c3 (from 
57±12.2% to 30±10.5%) (Fig. 5-4A&B). 
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Figure 5-4 Effects of213 nM Njun (cis) on the average open (A&C) and closed (B&D) time constants of 
purified Ry Rs. The probability of events falling into each time constant is plotted against the time constant in ms 
(open time or closed time). Time constants are shown fo r control data (open circles) and 213 nM Njun (filled circles) 
for RyR I (A&B) or RyR2 (C&D).Vertical bars indicate the SEM for event probabili ty. Horizontal bars indicating 
the SEM for the time constant are contained within the symbo ls. Asterisks (*) indicate significant differences 
between c.ontrol data and with 213 nM Njun (P<0.05 student 's I-test, paired, n~9 for RyRI and n~JO for RyR2). 
Similar open and closed time constants were determined for RyR2 channels as those for RyRI 
(Fig. 5-4C&D; Table 5-2). Again, there were no sign ificant alterations of the time constant 
values after Njun addition. The average open time constants for RyR2 channels were , 0 1 = 
3.6±0.11 ms; , 02 = 15.8±0.32 ms; , 03 = 154.3±3.12 ms and the average closed time constants 
were , c1 = 3 .9±0.18 ms; , c2 = 22.5±0.57 ms; , c3 = 243.8±4.03 ms. The fraction of events falling 
into the long open time constants increased significantly in RyR2 (from 36±9.2% to 66±3.3% 
for , 02 and from 2.2± 1.4% to 13±3.2% for 1 0 3) (F ig. 5-4C) after adding Njun. Conversely, 
events occurring within the shortest open time constant were reduced significantly (- 3-fold 
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Table 5-2 A summary of the open and closed time constants before and after Njun reassociation 
contro l(RyR I) Nj un+ RyRI P va lue control(RyR2) Nj un+RyR2 P va lue 
' 0 1 
2.08±0. 17 2.44±0.25 0.05324 18 3.63±0. 11 3.49±0.08 0.167851 
Pl 0.97±0.01 2 0.78±0.086 0.04946 0.62±0.101 0.2 1±0.03 1 0.0045 
To2 17.04±0.84 16 .63±0.58 0.4702099 15.82±0.32 17.0 1±0.54 0.10666 
P2 0.02±0.011 0.19±0.071 0.04323 0.36±0.092 0.66±0.033 0.016 
' OJ 
149. 10± 1.93 152. 11 ± 1.59 0.090252 154.30±3. 12 162.10±3.28 0.11873 8 
P3 0.003±0.001 5 0.03±0.0 17 0.04597 0.02±0.014 0. 13±0.032 0.0128 
' Cl 3.3 7±0.20 3.48±0.15 0.8267577 3.85±0. 18 3.86±0.08 0.957996 
Pl 0.15±0.070 0.39±0.124 0.02066 0.3 0±0.038 0.5 1±0.025 0.0005 
' Cl 
22.20±0.87 22.19±0.68 0.6558036 22.53±0.57 21.14±0.32 0.107736 
P2 0.28±0.076 0.32±0.076 0.9 15 1102 0.46±0.049 0.46±0.024 0.986526 
' CJ 
245.20±5.67 232.56±6.97 0.1848895 243.8±4.03 233.3 0±5.05 O.J 0018 
P3 0.57±0.122 0.30±0.105 0.01639 0.24±0.05 3 0.03±0.005 0.0031 
n 9 9 10 10 
PI , P2 and P3 denote probab ility. P va lue <0.05 are in bold, denoting significant difference from contro l va lue. 
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reduction, from 62± I 0.1 % to 21 ±3.1 %). The changes in the dwell times in the closed state after 
Njun addition were again similar to those seen in RyRl , with RyR2 activity also showing an 
increase in the number of events falling into i:c1 (from 30±3.8% to 51 ±2.5%) and a decrease in 
i:c3 (from 24±5.3% to 3±0.5%) (Fig. 5-4D). Altogether, Njun addition to the cytoplasmic 
solution did not alter the time constants but led to a dramatic re-distribution of events with more 
events in long openings in i:0 2 and i:03 (with a decrease in i:0 1 in RyR2), and fewer events in long 
closures in i:c3 (with an increase in i:c1). 
5.3.3 Cis scrambled Njun or trans Njun does not alter purified RyR1 or RyR2 activity 
To determine the specificity of the interaction between the Njun peptide and purified RyRs, two 
sets of control single channel experiments were performed. Experiments were conducted under 
the same conditions used with Njun (see section 5.3.3). 
In the first control experiment, the Njun,crnmbled peptide (section 2.1.2; Table 5-1) was added to 
the cytoplasmic solution of purified RyRI or RyR2 channels. The addition of213 nM cis 
Njun,crnmbled peptide did not alter purified RyR channel activity. The channels were exposed to 
Njun,crnmbled for at least 10 min, with no change in activity observed (P0 was 0.13 7±0.043 before 
and 0.114±0.031 after cis Njunscrnmblcd addition in RyRI, while 0.317±0.012 before and 
0.306±0.011 after peptide addition in RyR2; Fig. 5-5). Therefore the increase in channel activity 
by Njun required the specific native amino acid sequence in the N-terminal 22 residues of 
junctin. 
In the second control experiment, Njun was added to the luminal side of purified RyRI or RyR2. 
This also tested whether the activation ofRyRs by FLjun (Chapter 3.3.4) was due to a luminal 
action of the N-terminal domain of the full-len gth protein. Addition of213 nM trans Njun bad 
no effect on channel open probability of either RyRI or RyR2 (P0 from 0.233±0.038; to 
0.246±0.049 in RyRI and from 0.073±0.029 to 0.076±0.032 in RyR2; Fig. 5-6C). This was 
reflecte~ by a lack of changes in channel T0 and Tc (Fig. 5-6D&E). The results demonstrate that 
Njun regulates the RyR only from the cytoplasmic side. 
Taken together, these data strongly suggest that the effects ofNjun peptide on purified RyRI 
and RyR2 are specific and only occur cytoplasmically. 
5.3.4 No effect of Njun on native RyR1 or RyR2 
As endogenous junctin is presumably absent in purified Ry Rs, it is important to determine 
whether the Njun interaction occurs with endogenous junctin and thus likely to have a 
physiological significance. To investigate this, both lipid bilayer experiments and calcium 
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Figure 5-5 Addition of2l3 nM scrambled Nju n (Njun,mmbi,,) peptide (cis) to purified R)'RS does not alter 
channel activity. (A)-(B) Records of3 s of single channel activity at -40 mV . Single channel openi ng is downward 
from zero current (continuous line, c) to maximum open conductance for one channel opening (broken line, o or o 1) 
or two channels open ing simultaneously (o2). The upper trace in each panel shows control activity and the lower 
trace shows activity after add ing 2 13 nM Nj un ,crambled to the cytop lasmic solution bathing RyR I (A) or RyR2 (B). 
(C)-(E) average data for re lat ive open probabil ity (logP0 J-logP0 C, C), mean open time (logT0 J- logT0 C, D) and mean 
closed time (logT,J- logT,C, E), determined fo r individual channel for RyRI (n= l2-1 6) and RyR2 (n=8). No 
significant differences found with Nj un ,crambl,d before and after peptide addit ion (P>0.05 Student ' s I-test, paired). 
release spectrophotometric assay were carried out using nati ve RyR channe ls w ith endogenous 
junctin still attached . It was expected Njun would not be able to bind or activate the native 
channels if the site in native RyRs was occupied by the N-terminal domain of endogenous 
junctin . 
5.3.4.1 No effect of cytoplasmic addition of Njun on native RyRl/2 activity 
ln thi s set o f experiments, s ingle channel record ings were conducted as described in section 
2.9.2-2 .9 .4. Nat ive ske letal or cardiac SR ves ic les were incorporated into bilayers wi th the usua l 
resting ( I mM) trans [Ca1+] and I µM cis [Ca1+]. As with cis Njunsc,,mbled and trans Nj un added 
to purified Ry Rs, the addit ion of2J 3 nM Nj un into the cis so lution had no significant effect on 
open probabili ty of either nati ve RyRI or RyR2 (P0 was 0.066±0.001 befo re and 0.067±0.011 
after cis Nj un addition in RyR I, while 0.109±0.02 1 before and 0.124±0.028 after peptide 
addition in RyR2; Fig. 5-7 A). Likew ise, no overall changes in T0 and Tc were observed (Fig. 5-
7B&C). 
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Figure 5-6 Purified RyRs remain unaffected by the additio n of213 nM Nj un to the trans chamber. (A)-(B) 
Records of3 s of single channel activity at-40 mV. Single channel opening is downward from zero current (c, 
continuous line) to maximum open conductance for one channel opening (broken line, o or o 1) or two channels 
opening simultaneously (o2). The upper trace in each panel shows control activity and the lower trace shows activity 
after adding 2 13 nM Njun to the luminal s ide of RyR I (A) or RyR2 (B). (C)-(E) average data fo r relative open 
probabili ty (logP0 J-logP0 C, C), mean open time (logT0 J-logT0 C, D) and mean closed time (logT,J-logT,C, E). No 
significant differences found before and after lurninal Njun addition (P>0.05 Student ' s I-test, paired, n=S- 14 for RyRI 
and n=S-9 for RyR2). 
5.3.4.2 Effect of Njun on Ca2 + release from SR vesicles 
To further examine the effects ofNjun on native RyRs channel activity in a more intact setting, 
its ability to release Ca1+ from SR vesic les was determined. The Ca1+ release spectrophotometric 
assay was performed in two ways as described in section 2. 10 and 5.2.5 . 
In the first, Njun was added to a so lution containing RyR I or RyR2 channels in SR vesicles to 
see if it would stimulate Ca2+ release (section 2.10.1 and 5.2.5 . l). In control experiments, 
MilliQ-water was used. Addition of peptide caused a small increase in the rate ofCa1+ release 
from RyR2-containing vesicles (from 4.76±0.45 in the absence ofNjun in control experimenst, 
to 5.10±0.44 nmol Ca1+/mg protein/min) (Fig. 5-70 2"d black bin). There was no significant 
change in Ca2+ release from vesic les containing RyRl (Fig. 5-70 I " black bin). 
In the second experiment, the vesicles were pre-incubated with Njun for 20 min prior to the 
experiment to provide sufficient time for any RyR-Njun interaction to be fully established. 
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Caffe ine was used to stimulate Ca2+ release. The rate of caffeine-induced Ca2• release from 
ves icles pre-incubated with Njun was compared to control experiments in which the vesicles 
were pre-incubated w ith MilliQ-water. A small but significant increase in the rate of caffeine-
induced Ca2+ release occurred when SR vesicles were pre-incubated with 5 µM Njun, from 
64.4±7.1 0 (control) to 73 .3±8.23 nmol Ca2+/mg protein/min in RyRl , and from 28.3±7.09 
(control) to 31.7±7 .97 nmol Ca2+/mg protein/min in RyR2 (Fig. 5-7D light grey bins). The small 
increase in Ca2+ release may have been due to a few cytoplasmic Njun binding sites that were 
not occupied by endogenous junctin, allowing Njun to bind and thus activate the native channels 
or to a small effect of non-specific binding. This will be discussed in section 5.4.2. 
Together, the results obtained from native RyRs imply that the Njun binding site on the 
cytoplasmic surface of the Ry Rs is occupied by the N-terrninal tail of endogenous junctin and 
thus , the cytoplasmic Njun-RyR interaction is likely to be phys iologically significant. 
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Figure 5-7 Njun has minimal effect on native Ry Rs containing endogenous junctin. (A)-(C) Addition of 213 nM 
Njun to the cytoplasmic side of native RyRs. Average data for relative open probability (logP0 J-logP0 C. A), mean 
open (logT0 J-logT0 C, B) and closed (logT,J-logT,C, C) times, for RyRI (left) and RyR2 (right). No significant 
difference found before and after cytoplasmic addit ion ofNjun to native RyRs (P>0.05 Student's 1-test, paired, 
n= 12-14 for RyRI and n= l l-1 3 for RyR2). (D) The rate ofCa2• release from SR vesicles after adding 5 µM Njun to 
the extraves icular solution . Addition ofNj un produced an immediate small increase in the rate of Ca2+ release from 
cardiac SR through RyR2 (n=3), but not from skeletal SR (n=4) through RyR I (black bins). Preincubation in 5 µM 
Njun produced a significant increase in the rate of caffeine induced Ca2• release through RyR I (n= 12) and RyR2 
(n=7) (li ght grey bins). Asterisks(*) indicate the average values significantly different from the contro l (P<0.05 
Student· s 1-tesL paired). 
142 
5.3.5 Combined effects ofCjun and Njun on purified RyRl and RyR2 channels 
In vivo, junctin is inserted into the SR membrane with its N-terminal ta il in the cytoplasm and 
its C-terminal domain in the SR lumen. Isolated FLjun is also likely to insert into the bilayer 
membrane in the same orientation when added to the luminal (trans) so lution, as the short N-
tenninal domain would be more likely to pass through the bilayer than the bulky, highly 
charged C-terminal domain. Thus it is possible that, in bilayer experiments and in the cellular 
context, junctin regulates Ry Rs through both its N-terminal and C-terminal domains. Therefore 
it was of interest to investigate the effect of adding Njun to the cytoplasmic side and Cjun to the 
luminal side of RyR channels, in order to evaluate how the combined binding might impinge on 
RyR activity and whether thi s reproduced the effect of FLjun. 
Cjun and Njun were reassociated with the reconstituted purified RyR sequentially. The 
experiment conditions and the concentration of added Njun and Cjun (213 nM) were the same 
as in the previous sections (Cjun: Chapter 4.3.3 .1 ; Njun: section 5.3.2). Two different 
experimental protocols were used, with either Njun being added first to the cytoplasmic solution 
and then Cj un added to the luminal solution, or Cjun being added first to the luminal so lution 
and then Njun added to the cytoplasmic solution. In the first case (Fig. 5-8A&C), after the 
typical increase in RyR I and RyR2 activity with cytoplasmic Njun was established (Fig. 5-
8A&C, middle traces; and Fig. 5-9A black bins, - 5-fold rise in P0 of RyRI (from 0.016±0.004 
to 0.063±0.03) and RyR2 channels (from 0.05±0.02 to 0.21 ±0.07)), Cjun was added to luminal 
side of the Njun-regulated RyRs. The Njun-induced channel activation was attenuated after 
luminal Cjun addition (Fig. 5-8A&C, bottom traces), with a significant reduction in channel 
activity by 37±9.7% and 26±8 .1 % in P0 compared with the activity ofNjun-activated RyRls 
and RyR2s respectively (Fig. 5-9A cross hatched bins; P0 0.029±0.008 for RyRI , 0.185±0.08 
for RyR2). Notably, P0 remained higher than control activity. For comparison, the effect of 
FLjun alone (data from Fig. 3-9C-E, Chapter 3) is included in Fig. 5- 10. As described 
previously (section 5.3.2), the increase in activity produced by cytoplasmic Njun alone was 
significa,ntly greater than that when FLjun was added to the luminal solution. Notably, the levels 
of activity following the subsequent luminal addition of Cjun were not significantly different 
from those seen with luminal FLjun (Fig. 5-1 OA&8 3'd black bins and I st light stippled bins). 
Njun and Cjun were then added in the reverse order, i.e. Cjun was added first to the luminal 
so lution and then Njun added to the cytoplasmic solution (Fig. 5-88&D). There were the usual 
decreases in the open probability of Ry RI and RyR2 channels (66± 14.3% and 43±4.9% 
decrease respectively; P0 fell from 0.168±0.04 to 0.06±0.04 for RyRI and from 0.30±0.076 to 
0.17±0.04 for RyR2) when Cjun was added first to the luminal solution , which once again 
confirms that Cjun inhibits RyRs (Fig. 5-88&0, middle traces; Fig. 5-98 black bins; for 
comparison, see Chapter 4, Fig. 4-3). Subsequent cytoplasmic addition ofNj un caused a - 2 fold 
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increase in the open probability (F ig. 5-8, bottom traces; Fig. 5-9B, cross-hatched bins; P0 
0.093±0.065 for Ry RI , 0.29±0.069 for RyR2). However, the activity remained lower than 
control and was thus in marked contrast to the activation when cytoplasmic Njun was added 
a lone (compare w ith F ig. 5-3). The channel acti vity when Cjun was added to the luminal 
so lution, fo llowed by Nj un to the cytoplasmic so lution was close to initial control leve l in RyR2 
and - 50% of control level in RyRJ , and this is also very different from the activation seen when 
FL jun was added luminally (F ig. 5-1 OA&B last grey stippled bins comparing to I st li ght stippled 
bins). It appears that the when Cjun is associated first with the Juminal domain ofRyR, the 
abi li ty ofNjun to activate the channel is aboli shed. 
The effects of these additions on channel gating properties, T0 and T" were al so examined. A 
decrease in Tc after addition ofNjun (Fig. 5-1 lC&D 2"d black bins) was consistent with the 
results presented in section 5.3.2 (Fig. 5-3E). Upon Cjun reassociation w ith the RyR/Njun 
complex, Tc was significantly increased in RyRl causing the suppression of channel acti vity and 
was not altered in RyR2 (Fig. 5-1 lC&D 3'd black bins). Despite the prolongation in T" the 
mean c losed time remained significantly shorter (40± 12.7% and 62±5.0% Jess) than the purified 
RyRl and RyR2 control respective ly (Fig. 5-1 lC&D 3'd black bins). This indicates that channel 
closures with the Njun-RyR-Cj un combination are shorter than closures of purified RyRs alone 
(control ). It is notable that the leve ls of Tc were then not significantly different from those seen 
w ith luminal FLjun (Fig. 5-1 l C&D 1st light stippled bins). There was no significant change in 
T0 in thi s set of experiments, although there was a trend towards higher T0 values (F ig. 5-
1 lA&B black bins). Therefore, the changes in relative open probability with FLjun or with 
Njun (cis) followed by Cjun (trans) were mainly due to significant changes in Tc in both RyRI 
and RyR2 chan nels. 
By contrast , in the second experiment where Cj un was added first to the luminal so lution and 
then Nj un added to the cytop lasmic so lution, T0 decreased by 45±12. 1 % in RyR I and 46± 18 .9% 
in RyR2 with the luminal add ition ofCj un , then increased after the cytoplasmic add ition of 
Njun, but onl y to cootro l leve ls (Fig. 5-11 A&B last two grey stippl ed bins). In addition, luminal 
Cju n evoked a marked increase in average Tc (- 8-fold in RyR2, - 12-fo ld in RyRI ). Subsequent 
addit ion ofNjun reduced Tc to contro l levels in RyR2 but had no effect on RyR I (Fig. 5-
11 C&D last two grey stippled bins). These changes in T0 and Tc with Cj un (trans) fo ll owed by 
Njun (cis) were agai n very different from the changes induced by luminal FLjun (F ig. 5-1 I A-D 
I" li ght stippled bins). 
To summarize, the results indicate that the increase in RyR channel activity seen when FLj un is 
added to the luminal so lution may depend on the cytop lasmic tai l binding to the RyR fi rst and 
then the luminal doma ins of the proteins interacting. 
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Figure 5-8 Seq uential addition of Nju n to the cytoplasmic solution and Cj un to the luminal solution of purified 
RyRs at I mM trans Ca'•. (A)-(D) Records of3 s of single channel acti vity at -40 mV showing the sequentia l 
addition of either Njun cis I ", Cjun trans 2"' (A&C) or Cj un trans I " and then Njun cis to purified RyR I (A&B) or 
RyR2 (C&D). Single channel opening is downward from zero current (continuous line, c) to maximum open 
conductance (broken line, o). The top traces show purified RyR contro l activ ity at I mM trans Ca2\ the midd le traces 
show activity after adding 213 nM of either Njun to cis chamber (A&C) or Cjun to trans chamber (B&D); and the 
bottom traces show activ ity after addition of either 213 nM Cjun Juminally (A&C) or 2 13 nM Njun cytoplasmically 
(B&D). Two types of regulat ion of the RyR are demonstrated in the two sets of experiments: I) adding 213 nM Njun 
first to th·e cytoplasmic solution induced a dramatic increase in channel activ ity, which was anenuated by the following 
luminal Cjun addition, but remained higher than control (A&C); 2) Juminal addition of 2 13 nM Cjun inhibited channel 
activity, the fo llowing addition ofNjun cytoplasmicall y increased channel activity, but remained less than control 
(B&D). 
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Figure 5-9 Summ arised data of r elative open probability for the effect of sequential addition of Njun (N) cis and Cjun (C) tra11s to the purified Ry Rs. (A)-(B) Pooled data from 
+40 mV and -40 mV for relati ve open probability (logP 0 J-logP0 C) fo r experiments as illustrated in Fig. 5-8. Channels activity was increased after the addition of 213 nM Njun first to the 
cytop lasmic solution (A, black bins), and was attenuated by the fo llowing luminal Cjun addit ion (A, cross hatched bins), but remained higher than contro l activity. (B) Channel activity was 
decreased with the luminal addi tion of 2 13 nM Cjun (B. black bins), then increased after the cytoplasmic additi on of Nj un (B, cross hatched bins), but remained less than control. (*): 
significant differences between control and wi th 2 13 nM Njun or Cjun . (#): data value significant ly different from the previous channel activity (P<0.05. Student's paird /-test, n= ! 0 fo r 
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Figure 5- 10 Channel activity of purified Ry Rs after sequential addition of Njun (NJ to the ci.< cha,mber, then Cjun (CJ tram, reflects activity seen with luminal FLjun. (A)-(B) 
Average data for re lati ve open probabili ty (logP,J-logl'oC) for poo led data from both +40 mV and -40 mV, before and after the addi tion of21 3 nM FLjun, Njun or Cjun (Njun, Cjun data are 
from Fig. 5-9, FLjun data are from Fig. 3-9 and included for comparison). Three experiments are shown in each panel: I) 21 3 nM FLjun added alone to luminal chamber (1 " light stippled 
bins); 2) 2 13 nM Njun added first to the cytoplasmic solution, then Cjun luminally (black bins); 3) 2 13 nM Cjun added first to the luminal soluti on, then Njun cytoplasmically (grey stippled 
bins). The asterisk (*) indicates significant differences between contro l parameters and with 21 3 nM FLjun, Cjun or Njun. The at (@) denotes significant difference between parameters with 
luminal FLj un and cytoplasmic Njun or luminal Cj un. The hash (#) indicates data value significantly different from the previous data set, i.e. significant effects of adding luminal Cj un with 
cytoplasmic Njun (3'' black bin), or of add ing cytoplasmic Njun wi th luminal Cjun (5'h grey stippled bin) (P<0.05 ANOV A and Student ' s paired 1-test, n= I O for RyR I and n=8-l 4 for 
RyR2). The red dots indicate changes in open probability that are similar after luminal addition of FL jun alone and after cytoplasmi c Njun followed by luminal Cj un. 
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RyR2 (B& D) (FLjun data are from Fig. 3-9 and included for comparison). Three experiments are shown in each 
panel, fro m left to right : I) 2 13 nM FLj un added alone to luminal chamber ( I" light st ippled bins); 2) 21 3 nM Njun 
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luminal addition of FL jun alone and after cytoplasmi c Nj un plus luminal Cj un . 
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5.4 Discussion 
The results of the physical interaction and functional regulation of the purified RyRs by the N-
tenninal tail ofjunctin (Njun) are described in this chapter, for the first time in either skeletal or 
cardiac muscle. The effects of cis Njun in conjunction with trans Cjun on RyRs were also 
explored at resting ( I mM) luminal (Ca2+]. The novel results clearly demonstrate that Njun is 
able to bind to RyRs directly and potentiate purified RyR channel activity in vitro, the latter is 
achieved by promoting long channel openings and reducing long channel c losures. Mechanisms 
underlying FLjun regulation of the RyRs were revealed by the combined actions ofNjun and 
Cjun, which indicate that the interaction between Njun and RyR dictates the functional 
consequences of the full length protein binding to RyR channels, and allows Cjun to modulate 
the channel in vivo. 
5.4.1 Njun binds to the purified RyR 
Although it has been assumed that the interactions between junctin and the RyRs occurred only 
between the luminal domains of the two proteins as mentioned in Chapter 4, results obtained in 
this study (Chapter 3 and 4) provide a strong indication that there are additional interactions 
between junctin and the RyRs. Therefore, the ability Njun to bind to the RyRs was tested. Data 
from affinity chromatography showed a physical interaction between Njun and the RyRs, in 
support of the hypothesis. 
Interestingly, and in contrast to the results shown here, Zhang et al. ( 1997) reported that GST-
fused Njun peptide did not bind to cardiac RyR2. This led to the general belief over the last 
decade that there were no interaction between junctin and the RyR on the cytoplasmic side. It 
was possible that the relative ly large size of the GST tag (26 kDa vs. - 2.2 kDa (Njun)) might 
have interfered with Njun binding to the RyR in the Zhang study (Zhang et al., 1997). This is 
different from the small size of the biotin tag (244 Da) used in this study. In addition, the time 
delay (2-3 min) for full activation by Njun (section 5.3.2) might contribute to a failure to detect 
binding (Zhang et al. , 1997). The different results reported in this study and by Zhang et al. 
(1997) are most likely due to methodological differences between laboratories rather than 
reflecting real differences in the interaction between Njun and the RyR. 
Given that Njun is a short, relatively charged peptide, it was possible that the binding between 
Njun peptide and the RyRs was a non-specific charge interactions since charged residues are 
abundant in the RyRs (Takeshima et al. , 1989). The specificity ofNjun effects was examined 
using an Njunscrnmbled peptide. The physical association with the RyRs was greatly reduced 
although still present when the original Njun sequence was scrambled (Fig. 5-2). This was 
considered to be non-specific binding as the scrambled peptide did not affect channel activity 
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(F ig. 5-5). Overa ll , the greater binding ofNj un (than Njun,crambled) to the RyRs suggests that a 
spec ific sequence ofNjun is important for this physica l interaction. 
5.4.2 Cytoplasmic Njun modulates purified RyRl and RyR2 channel activity 
Despite the long-stand ing ass umption that the functional effect ofjunctin on RyRs depends on 
luminal interactions between the proteins, the results obta ined in prev ious chapters (Chapter 3 
and 4) indicate that the cytop lasmic N-terminal domain of junctin may play a part in regulation 
of the RyRs by the who le junctin (FLjun) protein. ln support of this hypothesis, the direct 
cytoplasm ic Njun/ RyR association led to a dramatic increase in channel activ ity of both RyR 
isoforms at the resting luminal Ca2+ concentration ( I mM), to leve ls significantly greater than 
the increase induced by luminal FLjun. This was in marked contrast to the inhibition of RyR I 
by N-terminal triad in residues (Groh et al. , 1999). A series of control experiments were 
conducted to ensure the functional Nj un interaction was not a non-specific effect of the peptide. 
Firstly, the scrambled Njun peptide added to cytoplasm ic so lutions did not activate the channels, 
reinforcing that the specific sequence is critical for Njun activity . Second ly, there was no 
interaction between Njun and the luminal domain of the RyR since trans addition ofNjun 
caused no effect on channel activ ity, suggesting that activation by cis Nj un was not due to its 
crossing the membrane and the action ofNjun on the cytoplasmic domain of the RyRs was a 
specific effect. 
In addition to specificity, it was equall y important to determine the poss ible phys iological 
significance of the cytoplasmic Njun-RyR interaction. Native RyRs in SR ves icles containing 
endogenous junctin provided as a useful tool in thi s case s ince, if the cytoplasmic interaction 
occurred in the ce ll , the cytoplasm ic junctin binding site would be occupied by endogenous 
junctin, hence exogenous Njun wou ld not exert its usual effect. Indeed, addition ofNjun to 
native RyRs in lipid bilayers resulted in no change in channel activity. The lack of an effect of 
Nj un on nati ve RyRs suggests that a cytoplasmic binding site for Nj un in RyRs does exist and 
that this cytoplasmic interaction is physiologically relevant. This is furthe r supported by the 
observation that Njun added to the cytoplasm ic s ide of SR vesicles after - 30 min had only a 
minimal effect on Ca2+ release. The small increase in Ca2+ re lease could be due to Njun binding 
to a few cytoplasmic junctin binding sites that were not occupied by endogenous junctin . Indeed, 
Zhang et al. (1997) fo und that only a fraction of cardiac RyRZs were bound tojunctin in the 
detergent extract. This was attributed by the authors to some RyRZs being bound to triadin and 
occ ludingjunctin binding s ites, or other unknown factors . Therefore, if the cytoplasmic, N-
terminal tail of triad in did bind to the cytoplasmic domain of RyR in SR vesicles , and if this s ite 
were the same as or s imi lar to Njun binding site as the N-terminal domains ofjunctin and triadin 
share certai n sequence s imilarity (an example shown in Fig. 5- 12), then it is poss ible that the 
added Njun peptide wou ld compete with triadin for those binding sites. In addition, it has been 
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shown that cytoplasmic domain of skeletal triad in binding to the cytoplasmic domain of RyR 1 
inhibited the channel (Groh et al. , 1999; Ohkura et al., 1998). Accordingly, it was possib le that 
Nj un could displace triad in and cause some activation, as seen here in this study. On the other 
hand, the small increase was not observed in lipid bilayer experiments and this could be 
attributed to: 1) much fewer RyRs in SR vesic les being exposed to Njun in bilayer studies than 
that in Ca2+ release assays, since the latter wou ld allow all RyRs contained in the membrane 
vesicles to be accessib le to Njun thus increase the chance ofNjun to either compete with triadin 
or to associate with the unoccupied binding sites in some RyRs; 2) a re latively brief exposure 
(<15 min) of channels to Njun in comparison with the longer incubation of vesicles with Nj un 
(-30 min) in Ca2+ release assay; 3) the higher concentration ofNjun used in the vesicle studies. 
Together, the weak effect ofNj un on the cytoplasmic side of native Ry Rs indicates that the 
cytoplasmic interaction is established in vivo and thus likely to be physiologically significant. 
In conclusion, the resu lts provide the first evidence for an interaction between the cytoplasmic 
domains of junctin and RyR. Njun positively regulates the RyR channels from cytoplasmic side 
in a specific manner that is likely to be physiologically relevant. 
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Figure 5-12 Cytoplasmic N-terminal domains oftriadin and junctin seq uence 3Iignment and similarity. N-
terminal sequence alignment of sequences corresponding to rabbit ske leta l triadin (residues 1-47; NCBI accession 
number NP _00 I 076212) or rabbit cardiac triad in I (residues 1-47; NCB I accession number AAC48496) (rs/c), and 
can ine cardiac (cc) junctin (residues 1-22; NCB I accession number NP _001003 196). The aligned residues are either 
identical (*), similar(:), weakly similar (.) or dissimi lar. Alignment and sim ilarity was determined using a 
CLUSTALW multiple sequence al ignment (Combet et al. , 2000). 
5.4.3 Njun plays a dominant role in FLjun regulation of the RyR 
Based on the data showing that cytop lasmic Njun activates RyRs (this chapter, Fig. 5-138), 
luminal Cjun inhibits RyRs (Chapter 4, Fig. 5- I 3C) and FLj un moderate ly activates RyRs 
(Chapter 3, F ig. 5-13A), it was possible that cis Nj un in conjunction with trans Cjun would 
affect RyR channel activity in a similar way to FLjun. Indeed, the excess activation induced by 
Njun being added first to the cytoplasmic so lution was subsequently attenuated by the luminal 
addition of Cjun, and the resultant moderate activation remarkably resembles the effect of 
luminal FLjun. However, when Cjun was first assoc iated with RyR lum inally, cytoplasmic 
addition ofNjun no longer activated the channel. This was in marked contrast to the FLj un 
effect and was complete ly unexpected. The results suggest that when FLjun is added to the 
luminal side of the RyR channels, its N-terrninal tail and C-terminal tail may associate with the 
RyR in a sequential manner, and that the cytoplasmic interaction must be established before any 
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luminal binding in order to achieve the normal modulation of RyR channels displayed by full 
length junctin. This also suggests that in vivo, the cytoplasmic interaction may first anchor 
junctin to the RyR, following which the luminal interaction is able to proceed. The hypothet ical 
mechanism ofjunctin regulation ofRyR at 1 mM luminal Ca2+ is illustrated in Fig. 5- 130. 
A model for junctin regulation ofRyR activity 
D 
Step I: Njun "docking" 
-strong activation 
Step 2: Cjun "modulating" 
-+ inhibition 
.. ·· 
.. ···•· 
1,,:.·· 
···:> 
1 mMluminal 
Ca2• 
Consequence: FLjun 
-+moderate activation 
~ Ljun j TM helix " Njun ~ Cjun T Purified RyR 
Figure 5-13 A hypothetical model of dual junctin/RyR interaction sites at resting I mM JCa 2•1. (A)-(C) 
Interact ions betweenjunctin and RyR at I mM resting trans [Ca2+] after addition ofFLjun (trans , A), Njun (cis , B) or 
Cjun (trans , C) to purified RyRs. (D) The hypothetical mechani sm ofjunctin modulation of Ry R at I mM luminal 
[Ca2J may proceed as follows: I) the interaction between the cytoplasmic domain ofjunctin and RyR occurs first , 
which anchorsjunctin to the RyR and induces strong activation of the channels (left); 2) the luminal modulation of 
RyR by th e C-terminal domai n of junctin is then allowed to take place, which evokes a small inhibition (middl e); 3)the 
combined actions ofNjun and Cjun results in moderate acti vati on of the RyR chann el (right). So lid red upward arrows 
indicate activating effects on the RyR, whil e green downward arrows denote inhibition. Double red arrows indicate 
strong activation. Question marks indicate effects or interact ions that have not thus far been determined. 
It should be kept in mind that post-translationa l modifications were miss ing in both the Cjun 
and Njun used in thi s study, since the Cjun was expressed in E.coli and the Njun was chemically 
synthes ized. Such modifications may exist in endogenousjunctin, such as phosphorylation (e.g., 
9 res idues have been predicted as potential phosphorylation sites us ing KinasePhos, Fig. 5-14), 
although to date no studies have reported or specifically investigated thi s. It shou ld be noted that 
there is also a poss ibili ty of interactions between the transmembrane domains of junctin and the 
RyR (Figure 5- 13, with question mark), which was not tested in thi s study as the peptide would 
be very hydrophobic and difficult to purify, probably insoluble. Regardless, the 
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ANINEJUNCTIN 
,Locations Phosp~orylated ~l E- d lca_talytic 
(AA) I Sites S value . Kioases II. HMMs l Logo core .;JI.I •• ::-,_, -~. ~·- ____ . __ 
19 I KGGLSGSSF I -3. a I 13 I ATM I HMM I 
·:L~~J9~~ 
87 I AKRKTKAKV I -0. 4 I 3 . 2 I PKC HMM I 
·i~~""T~~~ 
87 I AKRKTKAKV 1-4. 6 I 12 I PKA I HMM I 
·~eB;T~ 
95 I VKELTKEEL I 2.0 I 0.83 I CKII I HMM I 
·~~~\'T~ 
106 I EKEKTESRK 1-2 . a I 12 I PKC HMM I ·:~,;:;.,,T~;~~ 
143 I SRKESPKGK 1-2.5 I 5 . a I PKG I HMM I 
·ioo~S~~ • Q ..,,.. ~- -¥ .. 
143 I SRKESPKGK I -o. 5 I 5 I cdc2 I HMM I 
·t~~SE~~ 
166 I KAKE SRKKS I -2 . 1 I 4 . a I PKG I HMM I 
·too~t~~ 
170 I SRKKSTNVK i -o. 7 I 2 . a I PKG I HMM I --·t oo;;S~~ 
171 I RKKSTNVKD 1-1.112 .aJ PKA I 
HMM 
I ·:beBiT~ 
178 I KDAS SKTAS 1-0 . 312. 91 CKI I 
HMM 
I ·!L~!j;S~~ 
MAEETKHGGH KNGRKGGLSG SSFFTWFMVI ALLGVWTSVA VVWFDLVDYE EVLGKLGVYD 60 
ATM 
ADGDGDFDVD DAKVLLEGPG GVAKRKTKAK VKELTKEELK KEKEKTESRK ENKNEERRKG 120 
ASRDKDDTKE GKTS SKHTHS AKGNNQKRKN 210 
PKC 
PKA 
CKII 
PKC 
180 
PKG 
cdc2 
PKG 
PKG 
PKA 
CKI 
Figure 5-14 Potential phosphorylation sites in canine cardiac junctin (accession number: NP _001003196.1). 
Phosphorylation sites are predicted using online analys is to"oi KinasePhos (http://kinasephos.mbc.nctu.edu. tw/) 
(Huang et al. , 2005). 
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reprod uction of lumina l FLjun (iso lated from muscle) activity by additi on of cytoplasmic Njun 
fo llowed by addi tion of lumina l Cjun indicates that a) any post-translati onal modificati ons o f 
the N- and C-termina l domains of junctin and b) interactions between the transmembrane 
domains of the two proteins are probably not important fo r RyR acti vation by luminal FLjun in 
vitro. Nevertheless, it rema ins poss ible that potenti a l modifi cati ons ofjunctin and/or 
transmembrane domai n ofjun ctin interaction with the RyR may play roles in its interaction w ith 
other prote ins and/or its functi on in the SR in vivo. 
5.4.4 Conclusion 
The results presented so far in thi s thes is provide nove l insight into the complex mecha ni sms 
underly ing the regulatory effects of FLjun on Ry R chan ne l acti v ity. Junctin regulates both 
RyRI and RyR2 v ia two distinct interactions, invo lving both cytoplasmic and SR lumina l 
doma ins. The interaction between the cytoplasmic doma ins of junctin and the RyR appears to 
dictate the functiona l consequences of the full length prote in binding to RyR channels, fo llowed 
by a modulati on thro ugh luminal domain interaction. However, it remains unknown exactly 
which res idues injunctin interact w ith the RyRs to achieve the fun ctional effects . Therefore, the 
locali zat ion of the RyR-binding sites on junctin was investigated in order to gain a deeper 
understanding of the interaction betweenjunctin and the Ry Rs, as well as a fuller picture of the 
j unctin regulatory mechani sm. T he results are described in the fi na l chapter of thi s thes is. 
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Chapter 6 Localization and characterization of a RyR interacting 
domain in junctin 
6.1 Introduction 
Inter-protein interactions constitute one of the most important aspects of protein function. 
Fundamental to protein-protein interactions are the specific domains within proteins which 
physically interact with one another in order to accomplish specific functional effects. Therefore, 
locating the domains of two different proteins which interact provides a global view of the 
protein interaction network, and possibly gives clues to overall protein functions. 
The interacting regions between junctin and RyR are less well defined than those of triad in and 
RyRI. With triadin, it has been suggested that only three acid ic residues - D4878, D4907 and E4908 
- flanking the pore loop in RyR I, and residues 200-232 with the presence of a KEKE motif in 
Trisk 95 are critical for triadin-RyRI interaction (Goonasekera et al., 2007; Lee et al., 2004). A 
similar binding site for triadin on RyR2 has also been proposed (Dulhunty et al., 2012). It bas 
been demonstrated thatjunctin and triadin interact with different sites of RyRl , since I) 
disrupting the putative triadin binding sites on RyRl does not alter junctin binding 
(Goonasekera et al. , 2007) and 2) junctin and triad in activate skeletal RyR I in an additive 
fashion (Wei et al., 2009a). A recent study by Altschafl et al. (2011) identified two distinct 
domains of junctin that bind to two different luminal domains of RyR2 (see Chapter !, section 
1.9.6.l ), which again contrasts with the single triadin-RyR binding site. Notab ly, junctin binds 
to the pore loop ofRyR2 (residues 4789-4846), a highly conserved domain rich in charged 
amino acids (Nakai et al. , 1990), and the same region that triadin binds to. Overall, these 
observations suggest that multiple binding sites are required for the junctin-RyR interaction. 
KEKE motifs (for definition, refer to (Realini et al., 1994)) have been proposed to faci litate 
protein-protein associations by acting as polar zippers (Perutz, 1994; Realini and Rechsteiner, 
1995; West et al. , 2000). Junctin contains multiple KEKE motifs in its luminal C-terminal 
domain, with one qualifying as a "true" KEKE motif according to Realini ' s criteria (Realini et 
al. , 1994) (e.g. , 85KRKTKAKVKELTKEELK.KEKEK106 in human short isoform) and other 
KEKE-_]ike motifs. It has been suggested that KEKE motifs injunctin potentially bind to the 
pore loop of the RyRs (Zhang et al. , 1997). The observation that the ful l fragment ofajunctin 
luminal domain (residues 78-210) but not smaller fragments containing KEKE-like domains, 
binds to RyR2 pore loop indicates that multiple KEKE motifs are likely required for thi s 
interaction. On the other hand, deletion of residues 86-102 in human junctin isoform, which 
contains >70% of the "true" KEKE motif of junctin, prevents junctin loca lization to the 
junctional SR, suggesting that this KEKE motif is likely to be involved in proper junctin 
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targeting (Rossi et al. , 2013). To date, however, the role ofKEKE motifs, if any, in the 
interaction betweenjunctin and the RyR has not been investigated. Therefore, interactions 
between junctin KEKE motif and Ry Rs isolated from the heart and skeletal muscle were 
investigated. 
Aim: 
In thi s chapter, experiments were performed to determine (a) RyR binding residues in junctin 
luminal domain, in particular the KEKE motif, and (b) potential functional effect of the KEKE 
motif of junctin on the RyR channel activity. 
6.2 Materials and Methods 
6.2.1 Methods overview 
Affinity chromatography was utilized to assess the ability of junctin KEKE motif peptide to 
bind to RyRI and RyR2 ; single channel recordings were conducted to explore the direct 
regu lation of both RyR isoforms by this junctin KEKE motif. 
6.2.2 RyR preparation 
Recombinant RyRI and RyR2 were used for affinity chromatography to assess binding between 
JunKEKEcanin, peptide and the RyR as that used forNjun (Chapter 5). The recombinant RyRI and 
RyR2 were expressed and purified from HEK.293 cells as detailed in section 2.4 and 5.2.2. 
For lipid bilayer experiments, RyRI and RyR2 were solubilized and purified from SR as 
described in section 2.3.2. 
6.2.3 Affinity chromatography 
Affi ni ty chromatography assays were performed as described in section 2.8.2 to determine the 
phys ica l interact ion between JunKEKE,anin, peptide and RyRI and RyR2. The assay invo lved 
binding the biotin ylated Jun KEKEcaninc peptide to agarose us ing neutrav idin covered res in. Then 
pre-c leared RyR constructs were incubated with the peptide-bound resin. The RyRs bound to 
the resin by interaction with the peptide we re assessed using SOS-PAGE and immunoblot. 
6.2.4 Single channel recording and analysis 
Sing le chan nel recording was conducted and analyzed as described in section 2.9. Prior to 
addition of Jun KEKE peptide the cis and trans chambers consisted of: cis so lution (23 0 mM 
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CsCH30 3S, 20 mM CsCl, I OmM TES and I µM free Ca2+, pH 7.4) and trans solution (230 mM 
CsCH30 3S, 20 mM CsCl, IOmM TES and I mM CaC12, pH 7.4). 
6.3 Results 
6.3.1 Identification of RyRl binding residues in Cjun 
The pore loop ofRyR I and RyR2 is a region of high charge density and influences the gating 
and conductance of the channel. This region has been shown to bind to a KEKE motif (residues 
200-232, Fig. 6-2A) in triadin (Goonasekera et al. , 2007; Wium et al. , 2012). Furthermore, 
addition of this triadin KEKE moti f peptide to the luminal s ide of purified RyRI produces a 
significant increase in channel activity (Wium et al. , 2012). Since the C-terminal domain of 
junctin binds to thi s pore loop of RyR2 (Altschafl et al., 20 I I) and probably ofRyR I, and a 
similar KEKE motif a lso exist in this domain (residues 85-106 in human junctin isoform, Fig. 6-
2A), it was interesting to investigate whether thi s region interacts with the RyRs. Therefore, 
peptides corresponding to this KEKE motif of two junctin isoforrns (Jun KEKErnbbit and 
CjunKEJ<Ecanine) were synthesized (section 2.1.2) and binding and functi onal interactions of the 
peptides with the Ry Rs were examined. 
6.3.1.lPhysical interaction between KEKE motif and RyRl/2 
NeutrAvidin agarose affinity chromatography was performed as described in section 2.8.2 and 
6.2.3 to determine whether the JunKEl<Ecanine peptide bound to RyRI or RyR2. Recombinant 
RyRI and RyR2 were used in thi s study as for Nj un (Chapter 5, section 5.2.2 and 5.2.3), which 
were shown not to bind to the agarose (see Fig. 5-28 lane I &4, Chapter 5). The final 
NeutrAvidin agarose attachments (biotinylated JunKEKE,anine peptide + RyRs) were subj ected to 
gel electrophoresis and immunoblot. Probing the immunoblot with anti-RyR 34C antibody and 
StrepTactin-HRP conjugate revealed the presence of the RyR I and RyR2 resolving at > 250 
kDa and the peptide at - IO kDa (Fig. 6-1 lane I &2 respectively). Therefore, there is a strong 
KDa ~ _. 
250 
I 
10-f -
2 
l<E-- RyR (anti-RyR) 
i ]<E-- Peptide (StrepTactin) 
Figure 6-1 A region of junctin that binds to RyRs. Im munoblot showing the association of recombinant RyR I 
and RyR2 with the biotinylated Jun KEKEc.anine peptide coupled to neutravidin agarose (Lane I and 2, respect ively, 
n- 3 for RyR I and n-3 for RyR2). The upper half of the membrane was probed with ant i-RyR 34C antibody, and 
the lower half was probed with Streptactin-HRP conjungate to identify the biotin tagged peptides. Positions of 
molecular weight marker are shown to the left of lanes. 
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association between the junctin KEKE peptide and RyR 1 or RyR2 at least in vitro. This was in 
contrast to a study by Altschafl et al. (2011) where blot overlay assays did not detect a binding 
ofa recombinantjunctin fragment (residues 76-161 , human isoform), which contains the KEKE 
motif, to RyR2. 
6.3.3.2 Functional effect of JunKEl<E on purified RyR1 and RyR2 (luminal) 
Since the junctin KEKE motif peptide binds to the Ry Rs, the functional consequences of this 
interaction were tested using single channel recording with standard cis and trans solutions as 
described in section 2 .9.3 and 2.9.4. Purified RyRl or RyR2 was reconstituted into planar lipid 
bilayers and channel activity was recorded under symmetrical (Cs+) conditions (section 2.9.4). 
The cytoplasmic (cis) [Ca2+] was 1 µM, and the luminal (trans) [Ca2+] lmM. 213 nM 
JunKEKEcabbit peptide was added to the trans chamber. 
A strong inhibition in channel activity of both RyRl and RyR2 was apparent with the presence 
of luminal JunKEKErnbbit peptide (Fig. 6-2B&C). There was a 54± 8.7% decrease in activity of 
RyRl channels (P0 fell from 0.16±0.036 to 0.09±0.038) and a 55±4.8% reduction in average P0 
(from 0.35± 0.065 to 0.16± 0.038) in RyR2 (Fig. 6-2D black bins). This decrease in open 
probability could be attributed to a significant prolongation of mean closed time Tc ( 4.08± 0.368-
fold increase in RyRl and 2.38±0.334-fold in RyR2) with abbreviation of mean open times T0 
(38±10.0% decrease in RyRl and 30±8.3% in RyR2)(Fig. 6-2E&F black bins) . Interestingly, 
the inhibition induced by KEKE peptides added to the luminal solution was similar to that seen 
w ith luminal w hole Cjun construct (see Chapter 4 , Fig. 4-3), suggesting that residues of the 
junctin KEKE peptide is likely to be involved in the specific inhibitory interaction between 
luminal Cjun and RyRI or RyR2. 
It should be noted that there is a two-residue difference in junctin KEKE motif between rabbit 
and canine/human isoforms (Fig. 6-2A, residues hi ghlighted in red) . In order to determine 
whether the inhibitory effect seen w ith Jun KEKEcabbit was spec ies specific, a peptide 
corresponding to the same KEKE motif of canine or human junctin (both have identica l 
sequences), referred to as Jun KEKEcanine in this study, was synthes ized (Methods, section 2 . 1.2 and 
Fig. 6-2A). Addition of Jun KEKEcanine peptide to to the luminal s ide of purified RyRs also 
inhibited channe l activity in a si milar way to Cjun (F ig. 6-2D li ght grey bins), with a trend 
towards a longer mean c losed time and a shorter mean open time (F ig. 6-2E&F li ght grey bins). 
The results suggest that there is no species difference w ith respect to the effect of Jun KEKE motif 
peptide on Ry Rs and that the two residues that differ between canine/human and rabbit are not 
important in the abi li ty of Jun KEKE peptide to regulate RyR activity. 
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A JunKEKEhuman: 85KRKTKAKVKELTKEELKKEKEK106 
JunKEKEcanine: 84KRKTKAKVKELTKEELKKEKEK105 
JunKEKErabbit: 86KRKTKAKVKELIKEELKKGKEK107 
Trisk 95200_232 : 20°KTVTKEEKKARTKEKIEEKTKKEVKGVKQEKVK232 
-JunKEKErabbit tum D JunKEKEcanine tum 
B Control RyR1 ( Control RyR2 
l'MMIIIWR"WI~: 11~,111•m1u[~_: 
213nM JunKEKE (trans) 213nM JunKEKE (trans) 
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. ~ 1 1 on on on 
_g -1.2 _g _g -0.4 . 
RyR1 RyR2 
-0.5 
RyR1 RyR2 RyR1 RyR2 
Figure 6-2 Addition of junctin KEKE peptide (J unKEKE) to the trans chamber inhibits purified RyR channel 
activ ity. (A) Conservation of the sequence of the KEKE motif in human. dog and rabbit junct in and comparison with 
the active KEKE motif in the luminal domain of skeletal triadin. (B)-(C) Records-6f3 s of single channel acti vity, at -
40 mV. Single channel opening is downward from zero current (c, continuous line) to maximum open conductance (o , 
broken lines). The top recording in each panel shows control channel activity and the lower trace shows activity in the 
same channel after add ition of2 l3 nM Jun KEKE to the luminal solution. (D)-(F) Average pooled data from both -40 
mV and +40 mV for re lative open probability (logP, J-logP,C, D), mean closed time (logT, J- logT,C, E), and mean 
open time (logT, J-logT, C, F). Data are shown for effects oftbe rabbit KEKE peptide on the luminal side ofRyRI 
(n= I 0-12) and RyR2 (n= l 2- 16) (black bins). Some experiments were also performed with luminal addition of the 
canine KEKE peptide (as Cjun was derived from the full length canine junctin (Methods, section 2.5.3)) with similar 
results in RyR2 I (n=2-4) and RyR2 (n=4) (light grey bins). The asterisk(*) indicates average values significantly 
different from the control (P<0.05 Student 's I-test, paired). 
Regulation of purified RyRl or RyR2 by JunKEKErabbit peptide added to the cis side of the 
channel was finally examined as a negative control. The experimental conditions and the 
concentration of added Cjun Jun KEKE<abbit (213 nM) were the same as above. The presence of 
JunKEKErabbit had no effect on channel activity of either RyRI or RyR2 (P0 was 0.16±0.035 
before and 0_ 18±0_035 after cis JunKEKErabbit addition in RyR I, whi le 0.28±0.033 before and 
OJ 1±0.045 after peptide addition in RyR2; Fig. 6-3) . This lack of overall regu latory effect on 
the RyR indicates the KEKE motif peptide ofjunctin can regu late the RyR only from the SR 
lumen. This was in contrast to the weak inhibiti9n imposed by cytoplasmic Cj un under the same 
conditions (Chapter 4, Fig. 4-5). 
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Figure 6-3 Cytoplasmic addition of 213 nM JunKEKE peptide to purified Ry Rs does not alter channel activity. 
(A)-(B) Records of3 s of single channel activity at -40 mV. Single channel opening is downward from zero current 
(c, continuous line) to maximum open conductance (broken line, o). The upper trace in each panel shows control 
activity and the lower trace shows activity after adding 213 nM JunKEKE to the cytoplasmic solution bathing RyRI 
(A) or RyR2 (B). (C)-(E) average data for relative open probability (logP0 J-logP0 C, C), mean open time 
(logT0 J-logT0 C, D) and mean closed time (logT,J-logT,C, E), determined for individual channel for RyRl (n~?-8) 
and RyR2 (n~S-8). No significant differences found with JunKEKE before and after peptide addition (P>0.05 
Student's I-test, paired). 
Taken together, the results in Fig. 6-2 and Fig. 6-3 show that the KEKE motif between junctin 
residues 85 and 110 can bind to RyR 1 and RyR2 directly and by itse lf can reproduce the 
functional effects of full Cjun construct on the luminal side of the channels. 
6.4 Discussion 
In order to ful ly elucidate junctin-RyR interaction, it is important to determine their interacting 
regions. However, only one study has addressed the specific binding domains in RyR and 
junctin in cardiac muscle (Altschatl et al. , 2011 ). In the present study, the interaction between a 
potential RyR-binding s ite ofjunctin and the RyR was investigated. One of the RyR-binding 
s ites of junctin has been mapped to a K.EKE motif (residues 86-107 in rabbit cardiac junctin and 
84-105 in canine cardiac junctin), and for the first time the KEKE motif has been shown to 
regulate RyR I and RyR2 channel activity with a sim ilar inhibitory effect to that of luminal Cjun 
(for Cjun data, see Chapter 4). 
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6.4.1 The KEKE motif ofjunctin binds to and regulates purified RyR 
6.4.1.1 A RyR-binding site on junctin - the KEKE motif 
In this study, one of the RyR binding sites on the luminal domain ofjunctin (in the canine 
cardiac isoform) has been localized to residues 84-105 , a region with a primary structure able to 
be characterized as a KEKE motif. Such motifs have been implicated in protein-protein binding 
in many studies (Jones et al., 1995; Kobayashi et al., 2000; Zhang et al. , 1997). Affinity 
chromatography data clearly show that the KEKE motif peptide binds directly to skeletal and 
cardiac RyRs. This was not surpris ing considering the high abundance of charged residues 
contained in the peptide, which contribute to a theoretical pl of I 0. Further, a KEKE motif with 
simi lar sequence found in triadin has been shown to bind to the pore loop ofRyRI 
(Goonasekera et al. , 2007). The pore loop has high sequence identity across RyR isoforms and it 
contains high densities of acidic residues (section 1.6.3.2, Fig. 1-10), with a calculated pl of 
3.96. The observation that trans, but not cis, JunKEKE peptide regulates RyR channel activity 
(Fig. 6-2 and Fig. 6-3) supports the notion that the KEKE motif peptide binds to RyR through a 
luminal domain but not through a cytoplasmic domain. Therefore, while the present results are 
not sufficient to draw any firm conclusions, it is plausible that this KEKE motif in junctin would 
interact directly with charged residues in the pore loop of the RyR, and thus supports Cjun ' s 
binding to the pore loop ofRyR2 (Altschafl et al., 2011) and probabJy ofRyRI. 
Curiously, a recombinantjunctin peptide (residues 78- I 61) containing the 84-105 KEKE motif 
has been shown in blot overlay assays to bind to neither the M5-M6 linker nor the pore loop of 
RyR2 ; however, the full length of a luminal domain fragment (res idues 78-210) binds to the 
pore loop, again suggesting that multiple KEKE motifs are required for the interaction between 
the pore loop andjunctin (Altschafl et al. , 2011). This to some extent, contradicts our 
speculation, since our results show that the KEKE motif alone can pull down both RyR 
isoforms. The reason for this disparity is unclear and may be due to methodological differences 
between laboratories. However, it should be kept in mind that the binding regions on the RyR 
for its direct interactions with the junctin KEKE motif have not been located and it therefore 
remains possible thatjunctin' s KEKE moti f binds to regions other than the pore loop on the 
luminal domain of the RyR. Binding assays using the junctin-derived KEKE motif peptide 
along with the iso lated pore loop of the RyR may shed light on whether there is indeed a direct 
physical association between the two, but due to time and technical constraints this avenue was 
not further pursued in thi s study. 
6.4.1.2 KEKE motif exerts an inhibitory effect on purified RyR, similar to that seen in 
Cjun luminal effect 
16 1 
The functional consequences of such a physical link between the KEKE peptide ofjunctin and 
the RyRs were revealed in lipid bilayers. A significant reduction in channel open probability of 
both purified skeletal and cardiac RyRs was observed upon addition of the KEKE motif peptide 
to the trans chamber, accompanied by abbreviated mean open times and prolonged mean closed 
times. It appears, therefore, that the KEKE motif is a potent Juminal RyR inhibitor. Depressed 
channel activity by the KEKE peptide is reminiscent of the action of Juminal Cjun, which 
imposes a similar inhibition on both RyRI and RyR2 (for Cjun data, see Chapter 4, Fig. 4-3). 
Thus, it is likely that the KEKE motif in Cjun participates in the full Cjun construct regulation 
ofRyRl and RyR2. It would be interesting to see how the KEKE motif peptide cooperates with 
other parts of junctin to exert the full Cjun or FL jun effect. Also it would be interesting to know 
whether this KEKE motif peptide is involved in conveying CSQl signal to RyRI (Wei et al. , 
2009a) as it has been shown thatjunctin binds to CSQ2 through multiple KEKE motifs 
(Kobayashi et al. , 2000). However, due to time limits no further specific testing of the KEKE 
peptide function was carried out for this thesis. Interestingly, the junctin KEKE peptide-induced 
channel inhibition was very different from the significant increase produced by the Juminal 
triadin KEKE200_232 peptide (Wium et al. , 2012), notwithstanding a similar KEKE content 
between the two (Fig. 6-2A). Significantly, neither peptide affects the channel from the 
cytoplasmic side (Fig. 6-7 and (Wium et al. , 2012)). 
6.4.1.3 Species-independence ofjunctin KEKE motif regulation of the Ry Rs 
Despite the high sequence similarity (>90%) ofthejunctin KEKE motif peptide across species 
(Fig. 6-2A), it was argued that the minor difference (2 out of 22 residues, see Fig. 6-2A, 
residues highlighted in red) implied that the KEKE motif may be unimportant in the function of 
junctin (Wetzel et al. , 2000). To resolve this problem, peptides corresponding to the KEKE 
motif of both rabbit cardiac and canine/human cardiac isoforms were applied in lipid bilayers. 
N o differences were observed in the regulatory effect of either peptide (referred to as 
Jun KEKEmbbit and Jun KEKEcanin,), suggesting that the KEKE motif may not be as unimportant as 
suggested (Wetze l et al. , 2000), but rather that the two residues play a neg lig ible role in the 
overall regulati on of RyR channel activity by the KEKE motif peptides. This al so implies that 
the effect of the KEKE peptide on RyRs is species-independent. 
6.4.2 Rationale for using the KEKE motif peptide from different species 
It should be noted that the KEKE peptide used in thi s study was either rabbit cardiac isoform or 
canine cardiac isofonn due to multiple reasons. Firstl y, the FLjun applied in lipid bilayer studies 
was the rabbit skeletal iso form. To compare the FLjun and the KEKE peptide effect, it was 
necessary to use oonstructs of the same isofonn . However, sequence of rabbit skeletal junctin is 
currentl y unavail able, whereas the cardiac isoform from the same species has been partially 
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deduced (NCBI accession number: AAF37204. I and (Wetze l et al. , 2000)). Since the same 
isoform of junctin is expressed in skeletal and cardiac muscle (Jones et al., 1995), a KEKE 
peptide corresponding to rabbit cardiac junctin isoforrn was thus used. Secondly, addition of 
JunKEKErnbb;, to luminal side of the RyRs inhibits channel activity in the same way as luminal 
Cjun, which was constructed from the canine cardiac DNA. Thus, it was interesting to know 
whether the KEKE peptide from the same origin (can ine) would have a similar effect. This 
would also help answer whether species differences exist and whether the two unconserved 
residues would make any difference as mentioned in section 6.4.1.3. Therefore, the functional 
effect of JunKEKE,an;oe was also tested. Finally, investigation of the binding of the junctin 
fragment containing the KEKE motif to the RyR was conducted previously on human cardiac 
junctin isoforrn (Altschafl et al. , 2011). For the sake of comparison, the KEKE peptide of canine 
cardiac junctin was employed in affinity chromatography, since there is no difference between 
the canine and human sequences (Fig. 6-2A). This also complemented the functional studies. 
6.4.3 Limitations 
One of the limitations of this study is a lack of negative controls. Apart from the buffer control 
(i .e., MilliQ-water added to RyR channels, see Chapter 3, Fig. 3-8), the onl y negative control in 
the experiments in this chapter was the addition of the KEKE peptide to cytoplasmic solution 
which produced no effect (Fig. 6-7), suggesting tbe KEKE peptide·ean only regulate the 
channels through luminal interaction. Nevertheless, no further controls were conducted to 
confirm the specificity of the KEKE motif-RyR interaction. Scrambled peptides were not 
considered due to the high content of Kand E res idues that would be preserved in any 
scrambled sequences. An alternative would be to introduce alanine mutations into the native 
junchn KEKE peptide sequence; thi s would also allow assessment of which residues within this 
sequence are potentially important for its binding to RyR as well as its functional effect on 
channel activity. In addition, control with native RyR channels should also be considered. As it 
would be expected that the KEKE motif peptide would not be able to bind or inhibit the native 
channels if the site in native RyRs is occupied by the KEKE motif of endogenous junctin. 
However, due to time constraints, the experiments could not be conducted. 
6.4.4 Conclusion 
ln this study, one RyR (both RyR J and RyR2) binding site injunctin bas been located to a 
KEKE motif (residues 84-105), therefore together with Chapter 5, at least two RyR-binding 
sites in junctin have been determined in this study - the junctin N-terrninal domain and the C-
terminal domain KEKE motif. In addition, we provide the first evidence that the KEKE motif of 
junctin alone reproduces the functional effects of full Cjun construct on the luminal side of the 
channels, suggesting its involvement in Cjun regulation of the RyR. A ltogether, multiple 
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interacting domains between junctin and the RyR indicate the complexity of junctin-RyR 
interaction as suggested for RyR2 regulation by junctin (detailed in Chapter 1.9.6 and (Altschafl 
et al. , 2011)). 
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Chapter 7 General Discussion 
This thesi s describes an in-depth investigation of the molecular interactions betweenjunctin and 
RyR isolated from skeletal and cardiac muscle. The direct regulation of the RyR by the full 
length junctin protein is described as well as the separate roles ofjunctin ' s luminal C-terminal 
domain and cytoplasmic N-terminal tail, and their combined actions in modulating RyR activity. 
In addition the interacting domains between junctin and the RyR are described. Overall the 
results suggest thatjunctin modulates RyR activity directly, and that thi s regu lation is through 
both cytoplasmic and luminal domain-domain interactions between the two proteins. The 
principal individual findings of this study are as follows: 
I) Full length junctin (FLjun) alters cardiac RyR2 gating directly when the resting luminal [Ca2+] 
is l mM. FLjun in the lumina l, but not cytoplasmic, solution enhances channel activity, mainly 
due to a re-distribution of opening and closing events, with more long open events and fewer 
long closure events. Similar findings were obtained in junctin regulating skeletal RyR. The 
increased RyRl activity by junctin is consistent with that reported by Wei et al. (2009a). 
2) Tbe luminal C-terminal domain of junctin (Cj un) interacts with the RyR. The phys ical 
association of Cjun and the RyR results in an unexpected inhibition of channel activity in lipid 
bilayers which is in contrast to the activation by FLjun. 
3) The cytoplasmic N-terminal tail ofjunctin (Njun) was for the first time shown to interact 
directly with the RyR and to have a significant effect on channel gating.The cytoplasmic 
interaction between Njun and the RyR leads to a dramatic increase in channel activity to a much 
greater level than that seen with FLjun. 
4) FLjun activation ofRyR depends on both cytoplasmic and luminal interactions between the 
two proteins, where the cytoplasmic interaction plays a dominant role. For the FLjun effect to 
occur, the cytoplasmic interaction must be established before the luminal binding, indicative of 
the fme-tuning ofRyR activity by junctin. 
5) A RyR-binding site on the luminal domain of juncti.n was located at a KEKE motif (residues 
86-107.of rabbit cardiac isoform, or 84- 105 of canine cardiac isoform). The KEKE motif 
peptide alone was shown to inhibit RyR in the same way as full Cjun construct. This result 
suggests the involvement of the KEKE motif in overall regulation ofRyR by junctin. 
6) Substantial differences between junctin and triad in interactions with Ry Rs were shown in thi s 
study. First, the multiple binding sites for junctil) detennined here (cytoplasmic and luminal 
domains) and by Altschatl et al. (20 I I) are in contrast to the single triad in binding site in the 
pore loop (Goonasekera et al., 2007). Second, on the cytoplasmic side, the N-terminal tail of 
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junctin enhances RyRl and RyR2 activity, in contrast to the inhibition of RyR l by triad in N-
terminal domain (Groh et al. , 1999). Third, for the luminal interaction, the KEKE motif of 
junctin (residues 86-107) inhibits RyR channels, whereas a corresponding region of triad in 
acti vates RyRl (residues 200-232) (Wium et al. , 2012). The differences support the idea that 
junctin and triadin serve distinct functions as suggested by Wei et al. (2009a). 
7) All junctin constructs in this study were found to regulate RyRl and RyR2 in a very s imilar 
fashion , suggesting that conserved regions in the two proteins may be responsible for their 
binding to junctin. 
7.1 Distinct functional consequences of Njun and Cjun association with 
RyRs 
7.1.1 The significance ofNjun interaction with RyRs 
It was surprising that the N-terminal residues of junctin not only bound to Ry Rs but also caused 
a substantial enhancement in channel activity (Chapter 5). Preliminary data by Dr. Shamaruh 
Mirza from the Muscle Research Group suggest that the binding site for Njun resides in residues 
183-2156 ofRyRl , and the Njun-binding site in RyR2 is likely to be similar to that in RyRl but 
requires further exploration (personal communication with Prof. Angela Dulhunty). These 
findings are in contrast to a previous report proposing that junctin interacts with the RyR only 
through Juminal domains because Njun binding to RyR2 was not detected, whereas Cjun bound 
to RyR2 (Zhang et al. , 1997). Nevertheless, N-terminal binding is not unprecedented. The 
cytoplasmic N-terrninal residues of the structurally similar protein triad in (aa 18-46) in the cis 
so lution inhibits RyRl activity and binds directly to RyRl (Groh et al. , 1999), although other 
studies failed to detect a phys ical interaction between the cytoplasmic domain oftriadin and the 
RyR l (Caswell et al. , 1999; Guo and Campbell, 1995). Reasons for thi s di screpancy remain 
unclear, but the poss ibility that there is a cytoplasmic interaction between RyR and triadin in 
vivo cannot be excluded. Similarly, it is plausible that the cytoplasmic Njun-RyR interaction 
exists in vivo. lndeed, pre liminary findings by Dr. Shamaruh Mirza indicate less association of 
the tri ad in-binding deficient mutant (Goonasekera et al. , 2007) with Cjun than with FLjun, 
consistent with binding ofFLjun to the RyR at both cytoplasmic and luminal sites, although thi s 
could also be ex pla ined by a second Juminal site . Furthermore, the activating effect on RyRs 
imposed by cytoplasmic Njun and Juminal FLjun in contrast to the inhibition by luminal Cjun 
indicates that the N-terminal tail ofjunctin may play a significant role in FLjun regulation of the 
RyRs. Thi s is furth er supported by the combined actions of Njun and Cj un where adding Njun 
cytoplasmically, fo llowed by Cj un luminally, but not in the reverse order, reproduced the FLjun 
effect. That the cytoplasmic interaction must be establi shed first suggests that thi s interaction 
may anchor junctin to the RyRs and dictate the functional consequences of the full length 
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protein binding to RyR channels. The luminal modulation ofRyR by the C-terminal domain of 
junctin is then allowed to take place in vivo. The physiological relevance of the cytoplasmic 
interaction between j unctin and RyR is further strengthened by an absence of the strong 
activating effect of cytoplasmic Njun on native Ry Rs conta ining endogenous junctin, in contrast 
to the effect that was seen with purified RyRs. 
7.1.2 Implication of Cjun as a channel inhibitor 
It was unexpected that Cjun would impose an inhibitory effect on channel acti vity, rather than 
the activation seen with FLjun (Chapter 4). That sa id, Cjun acting as a channel inhibitor on 
iso lated RyR2 in bilayers may help explain the negative regulatory role of junctin deri ved from 
most transgenic studies in cardiac system (detailed in Chapter 1.9.4.1 ). The depressed 
contractility of heart and reduced Ca'+ release in junctin overexpression models may be partly 
attributed to an accumulation of free junctin in the SR lumen, since the availability of SR 
membrane structures is limited. 1n addition, it might be less likely for a correct stoichiometri c 
ratio of junctin to RyR to occur when the excess junctin is competing for space in the membrane. 
Thus, the inhibitory effect of the C-terrninal domain ofjunctin may outweigh the activating 
effect of FLjun (Chapter 3 and (Gyorke et al. , 2004a)) or FLjun in conjunction with CSQ2 (as 
suggested in (Wei et al. , 2009b)). However, the question remains as to why junctin ablation 
would lead to enhanced contractili ty and augmented Ca' + transients, especially in the cases 
wherejunctin was completely absent (A ltschafl et al. , 201 1; Yuan et a l. , 2007). A poss ible 
explanation is that the changes may be caused by an increased SR Ca'+ load accompanying 
junctin reduction; alternatively, or in addition, altered luminal Ca2+ sens itivity of RyR2 possibly 
caused by an impaired physical interaction between the RyR and CSQ2 with junctin removal or 
other luminal proteins in vivo. Whatever the explanation, the results indicate that the loss of 
FLjun-specific activation of RyR2 plays only a small part in the response to junctin ablation. 
7.2 Similar actions ofjunctin on RyR1 and RyR2 
It is noteworthy that alljunctin constructs used in this study- FLjun, Cjun, Njun and the KEKE 
motif peptide-bound to skeletal and cardiac RyRs in similar amounts. It is also worth noting 
that each construct regulated RyRl and RyR2 channels in remarkably similar ways, whether 
added to the cytoplasmic or luminal solution. This is not surpri sing since the same junctin 
isoform is expressed in skeletal and cardiac muscle. On the other hand, despite a high level of 
identity between the RyRl and RyR2 isoforms (>60%, Chapter 1.6.1 ), there is still considerable 
sequence di versity. Therefore, the similar actions of junctin and its fragments on RyR l and 
RyR2 activity indicate that the binding sites fC;r junctin are possibly in regions where the 
sequences are homologous in the two RyR isofo rrns. Preliminary results obtained by Dr. 
Shamaruh Mirza show that Cjun binds to the same luminal loops-the M5-M6 linker and the 
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pore loop--in both Ry RI and RyR2, although this requires further confirmation, in particular 
with the M5-M6 linker (for explanations, see below). These results further support the likely 
homology of junctin binding sites. The pore loop between RyR isoforms has a high sequence 
identity and influences the gating and conductance of the channel. Notably, it contains high 
densities of acidic residues at the mouth of the pore (Fig. 1-9, and also section 1.6.3.2, Fig. I-
I 0) which, it has been suggested, are important in ion handling and gating characteristic in 
RyR2 (Mead-Savery et al. , 2009). As a Cjun fragment (residues 78-210) containing the junctin 
KEKE motif region binds to the RyR2 pore loop (Altschafl et al. , 2011), and full Cjun (residues 
45-210) binds to Ry RI pore loop (as mentioned above), it is likely that the junctin KEKE motif 
region binds to the pore loop, possibly through a direct interaction with the charged residues at 
the luminal end of the pore. On the other hand, the M5-M6 linker is less homologous compared 
to the pore loop in RyRI and RyR2, particularly in its C-terminal region. Nevertheless, the N-
terminal residues in M5-M6 linker in RyRI and RyR2 do share certain similarities 
( 4582VSDSPPGE4589 and 45 23VSTSSVVE45 30 in rabbit RyRI and RyR2 respectively). Thus, if 
Cjun does bind to the M5-M6 linker, then the similar residues in the N-terminal region in M5-
M6 linker are likely to support its binding tojunctin (e.g. , residues 47-47 in (Altschafl et al., 
2011 )), and the C-terminal region in M5-M6 linker may not contribute to the binding. However, 
there is also possibility that Cjun does not bind to the M5-M6 linker in RyRI considering the 
sequence differences between the two isoforms. To reiterate, the results obtained with Cjun 
binding to luminal loops in RyRI so far are rather tentative and more testing is needed. 
7.2.1 Implication of the similar actions in CSQ/junctin/RyR interaction 
It has been previously shown that CSQI inhibits RyRI viajunctin (Wei et al. , 2009a), while 
CSQ2 activates RyR2 (withjunctin and triadin associated) in the presence of 1 mM luminal 
Ca2+ (Wei et al., 2009b ). If CSQ2 activation is also through junctin, then either different 
confonnational alterations in junctin occur upon binding to CSQI and CSQ2 owing to the 
difference between the two CSQ isoforms, or changes in the conformation of junctin are similar 
butjunctin interacts in different ways with RyRI and RyR2 upon CSQ binding. Indeed, CSQI 
imposes oppos ite effects on RyRI and RyR2 activity, where it inhibits native RyRI but 
activates native RyR2 when both conta in endogenous junctin (Wei et al. , 2009b). Thus the 
CSQ I /junctin comp lex must interact differently with RyR I and RyR2, possibly through 
sequence diversity between RyRI and RyR2 in the way in which binding is communicated to 
channel gating mechanism. Although the precise pathways remain to be elucidated, it is very 
I ikely that the sequence difference between CSQ I and CSQ2 and between RyR I and RyR2 
would have a profound impact on the overa ll functional consequences of the interaction among 
CSQ, junctin and the RyR (Fig. 7- 1 ). 
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7.3 Implications of multiple interacting domains between Ry Rs and 
junctin 
The distinct regulatory modes of RyR regulation by luminal Cjun and cytoplasmic Njun suggest 
a presence of both cytoplasmic and luminal interacting sites on RyR for junctin. ln support of 
this, biochemical experiments using Njun, Cjun or JunKEKE and RyR I or RyR2, together with 
the preliminary findings mentioned in section 7.1.1 and 7.2, indicate that at least two or three 
distinct domains ofRyRl interact withjunctin, including luminal domains binding to Cjun and 
a cytoplasmic region binding to Njun. This was further strengthened by the observation that 
both FLjun (Goonasekera et al. , 2007) and Cjun (mentioned in section 7.1.1 , work by Dr. 
Shamaruh Mirza) retained their ability to bind to RyR I after mutating three residues in the pore 
loop that are critical for triadin binding. Two luminal binding sites for junctin on RyR2 have 
also been demonstrated (Altschafl et al. , 2011 ). Although a binding site for Njun on cytoplasmic 
domain of RyR2 remains to be determined, it is c lear that such a cytoplasmic interaction does 
exist at least in vitro and the Njun-binding region ofRyR2 is expected to be similar to that of 
RyR I as discussed in section 7.1.1. Therefore, junctin can potentially interact with RyR through 
at least two or three distinct domains to influence channel activity (illustrated in Fig. 7-1). In 
this case, cytoplasmic and luminal factors may impose a fine modification of the overall 
regulation ofRyRs by junctin through these different regulatory !llOdes. 
The KEKE motifs in junctin and triad in have long been presumed to be involved in their 
interactions with RyR as well as CSQ (Jones et al., 1995; Kobayashi et al., 2000; Zhang et al. , 
1997). lndeed, it is suggested that multiple KEKE motifs injunctin are involved in its binding to 
CSQ (Kobayashi et al. , 2000), as well as multiple binding sites between junctin and RyR (this 
study and (Altschafl et al., 2011 )). These properties distinguish junctin from triad in. The KEKE 
motif in triad in is critical for its binding to RyR and is thought to be the same as the s ite 
responsible for CSQ binding (Dulhunty et al., 2009; Kobayashi et al. , 2000; Lee et al. , 2004). 
Thus the question arises whether triad in can bind to RyR and CSQ at the same time. An 
inability to bind both simultaneously would provide a structural basis for the inability oftriadin 
to convey signals from CSQl to RyRl as CSQ I binding to triadin may alter its binding to RyR I 
((Wei et al. , 2009a); illustrated in Fig. 7-1 , under section 7.4 ). In contrast, junctin can mediate 
signalling between CSQ I and RyR I (Wei et al. , 2009a), hence it can presumably bind to CSQ I 
and RyR I simultaneously through its multiple binding sites for CSQ and for RyR as mentioned 
above. When CSQ I binds to RyR I-associated junctin, the additional binding sites between 
Ry RI and junctin would keep junctin anchored to Ry RI , allowing the information of CSQ to be 
communicated viajunctin to RyR I and thus to influence channel activity ((Wei et al. , 2009a); 
Fig. 7-1 B&D). Furthermore, ifCSQ binds to ihe same KEKE motif injunctin that is 
presumably bound to the RyR pore loop, the connection between junctin and the pore loop of 
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RyR would be interrupted (Fig. 7-1 C&E). In this case, the functional consequences of CSQ I 
binding may depend on removal of the KEKE motif inhibitory effect (Chapter 6) on RyRs and 
reveal the effects ofjunctin binding to the M5-M6 linker ofRyR which are likely to be different 
between RyRl and RyR2 since there is very low sequence similarity in the C-terminal region of 
the M5-M6 linker between the two, this is based on the assumption thatjunctin binds to the M5-
M6 linker of Ry RI as seen that with RyR2 (Altschafl et al., 2011 ). On the other hand , it is also 
possible thatjunctin does not bind to M5-M6 linker in RyRl (see section 7.2), which would 
again differ from that with RyR2. And such difference would similarly be revealed as a 
consequence of CSQ I binding as discussed above. This may also provide some basis for the 
mechanism underlying the inhibition ofRyRI but activation ofRyR2 by CSQI under the same 
conditions (Wei et al. , 2009b ). 
7.4 Interplay between triadin/junctin/CSQ/RyR in skeletal and cardiac 
muscle 
In the skeletal system, separate roles of junctin and triad in have been also been indicated in 
intact myotubes. Studies in dyspedic myotubes (Goonasekera et al. , 2007) and in C2C 12 cells 
(Wang et al., 2009) suggest that triadin facilitates depolarization-induced Ca2+ release and so is 
more involved in EC coupling, while junctin plays a major role in SR Ca2+ load and supports 
Ca2+ homeostasis and the resting activity ofRyR channels, consistent withjunctin mediating 
Ca2+-dependent signals between CSQl and RyRI (Wei et al., 2009a). However, recent mouse 
models with either junctin knockout or triad in knockout or junctin/triadin double knockout 
suggest that the disruption oftriadin/CSQI link has a more profound impact on myoplasmic 
Ca2+ regulation than disruption of junctin/CSQ I association (Boncompagni et al., 2012). 
Nevertheless, knocking out the triadin/junctin is accompanied by changes injunctional SR 
structure and CSQ I expression and perhaps expression of other junctional proteins 
(Boncompagni et al. , 2012), all of which would complicate the transgenic results and prevent a 
c lear assessment of alterations directly attributable to a disrupted triadin/CSQ I or junctin/CSQ I 
complex. Therefore, the precise roles of triad in and junctin in SR Ca2+ regulation in ske letal 
muscle remain to be clearly elucidated. 
In the cardiac system, the separate roles of junctin-CSQ2 and triadin-CSQ2 are yet to be 
addressed. There are only two studies directly testing the action of combined junctin and triad in 
in transmitting CSQ2 s igna l to RyR2 (Gyorke et al. , 2004a; Wei et al. , 2009b ), with di sparate 
results. In one study, addition ofCSQ2 to the reconstituted RyR2/triadin/junctin complex 
inhibits canine RyR2 and allows SR luminal Ca2+ regulation of the channel (Gyorke et al., 
2004a). In contrast, the other study with sheep RyR2 under different conditions shows that 
CSQ2 activates (does not inhibit) the CSQ-devoid native RyR2 (containing endogenousjunctin 
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and triadin) (Wei et al. , 2009b). Undoubtedly, species- and experimenta l condition-differences 
require further clarification, for example, the presence or absence of cytosolic Mg2+ and ATP, as 
it has been demonstrated that CSQ2 decreased or increased RyR2 channel activity when 
cytosolic MgA TP was present or absent respectively (see (Chen et al. , 20 13 ) and Chapter 
1.7.3.3), and it remains possible that there is also interaction between CSQ2 and other luminal 
proteins in vivo and the effects of which may impinge on the effects mediated through the 
CSQ2/triadin/junctin/RyR2 complex. The relative ratios of junctin/CSQ2 and triadin/CSQ2 may 
also account for the disparities between the two studies- 5 µg/ml ofjunctin, triadin and CSQ2 
in (Gyorke et al., 2004a), while 16 µg/ml of CSQ2 with endogenous junctin and triad in 
(concentrations unknown) in (Wei et al. , 2009b). It has been shownjunctin-CSQ2 ratios have a 
great impact on reversible CSQ2 polymerization and depolymerization, which may further 
affect CSQ2 sensing luminal [Ca2J and its influence on RyR2 activity (Lee et al. , 20 12). The 
triadin-CSQ2 ratio being a critical modulator of the SR Ca2+ signalling has also been suggested 
in ventricular myocytes (Kucerova et al., 20 12). So far, no studies have further characterized the 
specific effect ofjunctin or triadin alone on CSQ2 regulation of RyR2. 
A hypothetical mechan ism of the potential interplay between junctin/triadin/CSQ/RyR in 
skeletal and cardiac muscle is illustrated in Fig. 7- 1. This model ties together previously 
published results (Altschafl et al. , 2011 ; Goonasekera et al. , 2007; Gyorke et al. , 2004a; Wei et 
al. , 2009a; Wei et al. , 2009b) with the findings and speculations of this study (under Discussion 
section 7.2-7.4). This model is based on the fo llowing assumptions: I) the single KEKE motif 
binding site in triad in is unable to bind to RyR and CSQ simultaneously, thus binding of CSQ to 
triad in results in di sruption of triad in binding to RyR, 2) the junctin (poss ibly the "true" KEKE 
motif)-binding site in RyR pore loop is a separate site from that of triad in . Multiple binding sites 
on junctin and RyR for the junctin-RyR interaction are shown in thi s model (those interactions 
not been clearly defined yet are indicated with question marks in Fig. 7-1 ), supporting the 
notion thatjunctin can bind to RyR and CSQ at the same time thus is able to convey signals 
from CSQ to RyR. 
Despite the numerous gaps that remain in the CSQ-junctin/triadin-RyR story, it is clear that a 
complex integration of signals arising from the interactions between these proteins regulates 
Ca2+ homeostasis in skeletal and cardiac muscle. There is still a long way to go before we grasp 
the whole picture of the interactions between the proteins, including the influence of each on the 
express ion of the others. However, knowledge of the basic elements of these interactions is 
essentia l for building an understanding of the whole process. 
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A model of potential interplay between junctin/triadin/CSQ/RyR in skeletal and cardiac 
muscle 
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Figure 7- 1 A schema tic model for potential interplay between CSQ/junctin /RyR/triadin in skeletal and cardiac 
muscle. (A) Cartoon ofRyRs associated withjunctin (JUN) and triadin (TRI) before CSQ addition. (B) & (C) 
Interaction between CSQ (CSQ I/CSQ2), junctin, ske letal triadin and RyR I. (D) & (E) interaction between CSQ 
(CSQl /2), junctin, cardiac triadin and RyR2. Triadin is shown to bind to a separate RyR site in the pore loop from that 
of junctin. The quaternary CSQ-junctin-RyR-triadin interaction tethers CSQ c lose to the release channel pore. CSQ 
binding to triadin resu lts in di sruption oftriadin binding to RyR. There are two possibi lities for CSQ binding to 
junctin when th e same CSQ isoform was added: I) CSQ binds to junctin through different sites from that of RyR to 
junctin. di ffe rences between RyR I and RyR2 results in different changes in RyR channel acti vi ty upon CSQ addition 
(B& D): 2) CSQ binds to junct in through the same KEKE motif in j unctin that is presumably bound to the RyR pore 
loop. therefore binding of CSQ to junctin resu lts in removal of the KEKE motif inhibitory effect on Ry Rs and reveals 
the effects of junctin bindin g to the M5 -M6 linker of Ry R (C&E). The effects are likely to be di fferent between RyR I 
and RyR2 (act iva tion or inh ibit ion as ind icated by purple arrows) which is due to the possibi li ty that ei ther (a) there is 
low sequence similarity in the C-terminal region of the M5-M6 linker (C-M5/M6 linker) if j unctin does binds to thi s 
region in RyR I: or (b) junctin binds to the M5-M6 linker in RyR2 but not in RyR I. The difference between CSQ I and 
CSQ2 may account fo r their diffe rent effects on the overall functi onal conseq uences of the interaction between CSQ, 
junctin and the RyR isoform channel (e.g. , RyR I is inhibited by CSQ I but acti vated by CSQ2, indicated in the light 
blue box). So lid purple downward arrows indicate inhibitory effects on the RyR, while upward arrows denote 
activa ti on. Question marks indicate interactions/effects that have not thus far been definitely determined. 
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7.5 Conclusion 
In conclusion, this research has provided novel information on the molecular mechanism 
underlyingjunctin regulating the RyR Ca2+ release charmel in skeletal and cardiac muscle . Of 
particular importance are the new details of the effects of the cytoplasmic N-terminal domain of 
junctin on RyRs. The results have shed important light on the complex regu lation of the RyR 
from both its cytoplasmic and luminal side by junctin and provide an explanation of the 
mechanism for CSQl /RyR/junctin complex interactions. 
7.6 Future directions 
The work presented in this thesis has advanced our knowledge ofjunctin-RyR interaction; 
however there are still many unknowns in the junctin-related regulatory effects on RyR Ca2+ 
release that remain to be resolved and may be included in future research plans. 
• In the present study it has been established that there are RyR 1-junctin interacting sites 
on the cytoplasmic and luminal domains of the proteins, however the actual binding 
sites remains to be precisely located. The Njun-binding site in RyR I has been localized 
in the cytoplasmic domain (residues 183-2156, work by Dr. Shamaruh Mirza). An aim 
of future research would be to identify the binding region in RyR I for Njun. The 
identification of the precise location of the Njun binding site in RyR2 is of equal 
importance. Regarding Cjun-binding site in RyR 1, further examinations are required. 
Site-directed mutagenesis in the M5-M6 linker and the pore loop of the RyRl and/or 
RyR2 may provide valuable insight into residues that are critical for Cjun binding. 
Overall , the information yielded from these studies will help us better understand the 
Njun "docking" and Cjun "modulating" theory. 
• Biochemical and functional studies demonstrated that the one "true" KEKE motif (for 
definition, see Chapter 6.1 and (Realini et al. , 1994)) in junctin is able to bind to and 
inhibit RyRs. In order to obtain a more complete understanding of the role of this 
KEKE motif in the binding and inhibition of Ry Rs, mutation and knock out in either the 
FLjun or the Cjun should be performed, with binding and RyR activity studies. ln 
addition , a reconstitution of mutated FLjun, CSQ I and RyRl in lipid bilayer system 
may provide some insight into whether junctin's KEKE motif is involved in junctin 
relaying CSQ I signal to RyR I. Further investigations also need to be carried out to 
identify the precise binding site for the KEKE motif in RyR. Likewise, mutations could 
be carried out in the pore loop ofRyR which is speculated above to be the KEKE motif-
binding site. Similar studies could be performed on other sites if new binding domains 
other than the pore loop in RyR for the KEKE motif are identified. The ability of the 
KEKE motif peptide to modulate the mutated RyRs could be assessed in lipid bilayers. 
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• ln addition to the " true" KEKE motif, there are other KEKE-like motifs in junctin (e.g., 
113ESKHEER.KRGK.KEK 126, 149KKSKEKEKAESAKTKENRKK168 in rabbit cardiac 
isoform). Questions as to whether they can interact with the RyR directly and modulate 
channel activity and whether they are involved in RyR/CSQ/triadin/junctin interactions 
remain to be answered. 
• ln this study, it has been demonstrated that Njun and Cjun have distinct roles in junctin 
regulating RyRs: dictator and modulator, respectively. Asjunctin can convey CSQI 
s ignal to RyRJ , it is an interesting question that which domain (s) ofjunctin is/are 
responsible for junctin as a transmitter. This project is currently underway. The 
investigation of the contributions ofNjun and Cjun in transmitting signa ls between 
CSQl and RyRl wi ll g ive valuable insight intojunctin/CSQJ /RyRJ interaction. 
• Junctin-CSQ2 molar ratios have been shown to be important in Ca2•-dependent CSQ 
depolymerization . A ratio of - 1 results in the most CSQ2 depolymerization , whereas 
either higher or lower ratios cause less depolymerization, indicating the importance of a 
stoichiometric interaction of junctin and CSQ2 in CSQ2 depolymerization (Lee et al. , 
2012). Therefore, it would be interesting to test what the functional consequences of 
different ratios ofjunctin-CSQ2 on RyR2 activity at different luminal Ca2+ 
concentrations. Knowledge of this may provide valuable insight into the observed 
alterations in transgenic studies or in some heart fai lure conditions where CSQ2 or 
junctin levels are significantly changed. 
• The results presented in this thesis were exclusively obtained from in vitro studies. Thus, 
it will be necessary to test the interactions identified here in an in vivo setting in order to 
validate their physiological relevance . This includes confirmation ofNjun interaction 
with Ry Rs, the s ignificance of which has been tested in severa l ways with native Ry R s 
in vitro. For example a mice model could be engineered that expresses only Cj un but 
not FL jun, since Cjun has been shown to be able to target to jSR by itself (Ross i et al. , 
2013). In this case, expression levels of RyR , CSQ and triadin or other Ca 2+ handling 
proteins in the SR would a lso need to be assessed. The model may shed some light on 
the contribution ofCjun and Njun to the formation of the quaternary protein complex 
(RyR/CSQ/triadin/junctin ), and to regulating RyR Ca2+ release and contraction in the 
heart and in ske letal musc le. 
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